10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

AMENDMENT NO.1

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 000-20501

AXA Equitable Life Insurance Company

(Exact name of registrant as specified in its charter)

New York	13-5570651
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

1290 Avenue of the Americas, New York, New York	10104
(Address of principal executive offices)	(Zip Code)

(212) 554-1234

(Registrant’s telephone number, including area code)

Not applicable

(Former name, former address, and former fiscal year if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an “emerging growth company”. See definition of “accelerated filer,” “large accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	x  (Do not check if a smaller reporting company)	Smaller reporting company	¨
Emerging growth company	¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨ No x

As of November 20, 2017, 2,000,000 shares of the registrant's Common Stock were outstanding.

EXPLANATORY NOTE

The sole purpose of this Amendment No. 1 to our Quarterly Report on Form 10-Q for the period ended September 30, 2017, is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 201 of Regulation S-T, which extends the date by which the interactive data file is required to be submitted by six business days.

No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.

Item 6.    Exhibits

Number		Description and Method of Filing
18.1	(1)	Preferability Letter from PricewaterhouseCoopers, LLP for Accounting Principle Changes
31.1	(1)	Certification of the Registrant’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	(1)	Certification of the Registrant’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	(1)	Certification of the Registrant’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	(1)	Certification of the Registrant’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

(1) Incorporated by reference to Quarterly Report on Form 10-Q for quarterly period ended September 30, 2017, submitted on November 20, 2017

4

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, AXA Equitable Life Insurance Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 20, 2017	AXA EQUITABLE LIFE INSURANCE COMPANY
		By:	/s/ Anders Malmstrom
			Name:	Anders Malmstrom
			Title:	Senior Executive Director
				and Chief Financial Officer
Date: November 20, 2017			/s/ Andrea Nitzan
			Name:	Andrea Nitzan
			Title:	Executive Director
				Chief Accounting Officer and Controller

5

XML

DOCUMENT AND ENTITY INFORMATION - shares	9 Months Ended
	Sep. 30, 2017	Nov. 20, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2017
Amendment Flag	true
Entity Registrant Name	AXA EQUITABLE LIFE INSURANCE CO
Entity Central Index Key	0000727920
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding		2,000,000
Amendment Description	The sole purpose of this Amendment No. 1 to our Quarterly Report on Form 10-Q for the period ended September 30, 2017, is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 201 of Regulation S-T, which extends the date by which the interactive data file is required to be submitted by six business days. No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.

XML

CONSOLIDATED BALANCE SHEET (UNAUDITED) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
ASSETS
Fixed maturities available for sale, at fair value (amortized cost of $32,139 and $32,123)	$ 33,300	$ 32,570
Mortgage loans on real estate (net of valuation allowances of $8 and $8)	10,605	9,757
Policy loans	3,322	3,361
Other equity investments	1,337	1,323
Real estate held for production of income	391	56
Trading securities, at fair value	12,053	9,134
Other invested assets	2,515	2,226
Total investments	63,523	58,427
Cash and cash equivalents	4,190	2,950
Cash and securities segregated, at fair value	789	946
Broker-dealer related receivables	2,206	2,100
Deferred policy acquisition costs	4,550	4,666
Goodwill and other intangible assets, net	3,717	3,741
Amounts due from reinsurers	5,016	4,664
Loans to affiliates	703	703
Guaranteed minimum income benefit reinsurance contract asset, at fair value	10,933	10,309
Other assets	4,258	4,260
Separate Accounts’ assets	119,184	111,403
Total Assets	219,069	204,169
LIABILITIES
Policyholders’ account balances	42,679	38,825
Future policy benefits and other policyholders’ liabilities	29,423	28,859
Broker-dealer related payables	529	484
Securities sold under agreements to repurchase	1,837	1,996
Amounts due to reinsurers	116	125
Customers related payables	2,384	2,360
Short-term and Long-term debt	500	513
Current and deferred income taxes	3,148	2,714
Other liabilities	2,869	2,108
Separate Accounts’ liabilities	119,184	111,403
Total liabilities	202,669	189,387
Commitments and contingent liabilities (Note 11)	0	0
Redeemable noncontrolling interest	441	403
Stockholders' Equity Attributable to Parent [Abstract]
Common stock, $1.25 par value; 2 million shares authorized, issued and outstanding	2	2
Capital in excess of par value	5,361	5,339
Retained earnings	7,265	5,941
Accumulated other comprehensive income (loss)	362	1
Total AXA Equitable’s equity	12,990	11,283
Noncontrolling interest	2,969	3,096
Total equity	15,959	14,379
Total Liabilities, Redeemable Noncontrolling Interest and Equity	$ 219,069	$ 204,169

XML

CONSOLIDATED BALANCE SHEET (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Fixed maturities available for sale, amortized cost	$ 32,139
Mortgage loans on real estate, valuation allowances	$ 8	$ 8
Common Stock par value (in dollars per share)	$ 1.25	$ 1.25
Common Stock authorized (in shares)	2,000,000	2,000,000
Common stock issued (in shares)	2,000,000	2,000,000
Common stock outstanding (in shares)	2,000,000	2,000,000
Fixed Maturities
Fixed maturities available for sale, amortized cost	$ 32,139	$ 32,123

XML

CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
REVENUES
Policy charges and fee income	$ 914	$ 854	$ 2,626	$ 2,468
Premiums	204	226	645	638
Net derivative gains (losses)	(318)	(446)	1,376	1,621
Net investment income (loss)	677	595	1,993	1,893
Investment gains (losses), net:
Total other-than-temporary impairment losses	0	(10)	(13)	(35)
Portion of loss recognized in other comprehensive income (loss)	0	0	0	0
Net impairment losses recognized	0	(10)	(13)	(35)
Other investment gains (losses), net	(8)	6	4	70
Total investment gains (losses), net	(8)	(4)	(9)	35
Investment management and service fees	1,003	943	2,974	2,770
Other Income	48	9	68	26
Total revenues	2,520	2,177	9,673	9,451
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	995	616	3,308	2,790
Interest credited to policyholders’ account balances	350	303	1,008	779
Compensation and benefits	449	430	1,324	1,284
Commissions	256	271	828	812
Distribution related payments	106	96	305	276
Interest expense	9	4	20	11
Amortization of deferred policy acquisition cost, net	(33)	55	15	64
Other operating costs and expenses	449	319	992	1,070
Total benefits and other deductions	2,581	2,094	7,800	7,086
Income (loss) from continuing operations, before income taxes	(61)	83	1,873	2,365
Income tax (expense) benefit	127	54	(196)	(586)
Net income (loss)	66	137	1,677	1,779
Less: net (income) loss attributable to the noncontrolling interest	(122)	(126)	$ (353)	(334)
Net income (loss) attributable to AXA Equitable	$ (56)	$ 11		$ 1,445

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 66	$ 1,714	$ (120)	$ 137	$ 576	$ 1,067	$ 1,593	$ 1,642	$ 1,677	$ 1,779	$ 524	$ 1,070	$ 3,100
Other comprehensive income (loss) net of income taxes:
Foreign currency translation adjustment	6			(1)					20	3
Change in unrealized gains (losses), net of reclassification adjustment	(55)	315	108	16	610	717	423	1,327	362	1,342	(180)	(831)	891
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment	(3)			0					(2)	0
Total other comprehensive income (loss), net of income taxes	(52)	295	143	15	605	726	438	1,331	380	1,345	(201)	(860)	847
Comprehensive income (loss)	14	2,009	23	152	1,181	1,793	2,031	2,973	2,057	3,124	323	210	3,947
Less: Comprehensive (income) loss attributable to noncontrolling interest	(154)			(127)					(372)	(335)
Comprehensive income (loss) attributable to AXA Equitable	$ (140)	$ 1,916	$ (102)	$ 25	$ 1,093	$ 1,673	$ 2,031	$ 2,765	$ 1,685	$ 2,789	$ (156)	$ (178)	$ 3,589

XML

CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($) $ in Millions	Total	Parent	Common Stock	Additional Paid-in Capital	Retained Earnings	AOCI Attributable to Parent	Noncontrolling Interest
Accumulated other comprehensive income, beginning of year after accounting change					$ 4,876	$ (618)
Dividends					381
Other comprehensive income (loss)	$ 847					876
Net Income (Loss) Attributable to Parent	2,713
End of year at Dec. 31, 2014	16,387	$ 13,425
Accumulated other comprehensive income, beginning of year after accounting change					7,208	258
Dividends					912
Other comprehensive income (loss)	(860)					(845)
Net Income (Loss) Attributable to Parent	667
End of year at Dec. 31, 2015	15,530	12,471		$ 5,321	8,896	208	$ (3,059)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets				(1,933)		23
Accumulated other comprehensive income, beginning of year after accounting change					6,963	185
Other comprehensive income (loss)	726					723
Net Income (Loss) Attributable to Parent	950
End of year at Mar. 31, 2016	17,183	14,140			7,913	908
Beginning of year at Dec. 31, 2015	15,530	12,471		5,321	8,896	208	(3,059)
Other comprehensive income (loss)	1,331					1,331
Net Income (Loss) Attributable to Parent	1,434
End of year at Jun. 30, 2016	17,744	14,733			7,897	1,516
Beginning of year at Dec. 31, 2015	15,530	12,471		5,321	8,896	208	(3,059)
Net income (loss) attributable to noncontrolling interest							326
Dividends					(500)		(287)
Dividends paid to noncontrolling interest							92
Other comprehensive income (loss)	1,345					1,344	1
Net Income (Loss) Attributable to Parent	1,445				1,445
Other changes in noncontrolling interest				(8)			(5)
End of year at Sep. 30, 2016	17,764	14,752		5,313	7,908	1,529	3,012
Beginning of year at Dec. 31, 2015	15,530	12,471		5,321	8,896	208	(3,059)
Dividends					1,050
Other comprehensive income (loss)	(201)					(184)
Net Income (Loss) Attributable to Parent	28
End of year at Dec. 31, 2016	14,379	11,283		5,339	5,941	1	(3,096)
Beginning of year at Mar. 31, 2016	17,183	14,140			7,913	908
Other comprehensive income (loss)	605
Net Income (Loss) Attributable to Parent	485
End of year at Jun. 30, 2016	17,744	14,733			7,897	1,516
Other comprehensive income (loss)	15
Net Income (Loss) Attributable to Parent	11
End of year at Sep. 30, 2016	17,764	14,752		5,313	7,908	1,529	3,012
Common stock, at par value, beginning of year and end of period	2
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets				0		0
Accumulated other comprehensive income, beginning of year after accounting change					5,941	1
Beginning of year at Dec. 31, 2016	14,379	11,283		5,339	5,941	1	(3,096)
Other comprehensive income (loss)	143					136
Net Income (Loss) Attributable to Parent	(238)
End of year at Mar. 31, 2017	14,227	11,181			5,700	137
Beginning of year at Dec. 31, 2016	14,379	11,283		5,339	5,941	1	(3,096)
Other comprehensive income (loss)	438					451
Net Income (Loss) Attributable to Parent	1,362
End of year at Jun. 30, 2017	11,100	13,116			7,301	452
Beginning of year at Dec. 31, 2016	14,379	11,283		5,339	5,941	1	(3,096)
Net income (loss) attributable to noncontrolling interest							311
Dividends					0		(347)
Dividends paid to noncontrolling interest							96
Other comprehensive income (loss)	380					361	19
Net Income (Loss) Attributable to Parent					1,324
Other changes in noncontrolling interest				22			14
End of year at Sep. 30, 2017	15,959	12,990		5,361	7,265	362	2,969
Beginning of year at Mar. 31, 2017	14,227	11,181			5,700	137
Other comprehensive income (loss)	295
Net Income (Loss) Attributable to Parent	1,601
End of year at Jun. 30, 2017	11,100	13,116			7,301	452
Other comprehensive income (loss)	(52)
Net Income (Loss) Attributable to Parent	(56)
End of year at Sep. 30, 2017	15,959	$ 12,990		$ 5,361	$ 7,265	$ 362	$ 2,969
Common stock, at par value, beginning of year and end of period	$ 2		$ 2

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015
Net income (loss)	$ 1,677	$ 1,779
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances	(1,008)	(779)
Policy charges and fee income	(2,626)	(2,468)
Net derivative (gains) losses	(1,376)	(1,621)
Investment (gains) losses, net	9	(35)
Realized and unrealized (gains) losses on trading securities	(188)	(117)
Amortization of deferred compensation	27	7
Amortization of deferred sales commissions	25	32
Other depreciation and amortization	(90)	(61)
Amortization of deferred cost of reinsurance asset	111	115
Amortization of other intangible assets	23	21
Net broker-dealer and customer related receivables/payables	(56)	80
Reinsurance recoverable	(361)	(182)
Segregated cash and securities, net	157	73
Deferred policy acquisition costs	15	64
Future policy benefits	1,289	935
Current and deferred income taxes	639	93
Other, net	711	341
Net cash provided by (used in) operating activities	994	(165)
Proceeds from Sale/Maturity/Prepayment of:
Fixed maturities, available for sale	3,873	5,038
Mortgage loans on real estate	(1,534)	(2,193)
Trading account securities	(9,307)	(6,543)
Other	(207)	(177)
Payment For Purchase/Origination Of Productive Assets [Abstract]
Fixed maturities, available for sale	(3,721)	(6,991)
Mortgage loans on real estate	695	595
Trading account securities	6,565	4,664
Other	58	31
Cash settlements related to derivative instruments	(929)	994
Decrease in loans to affiliates	0	383
Change in short-term investments	(266)	72
Investment in capitalized software, leasehold improvements and EDP equipment	(67)	(58)
Purchase of business, net of cash acquired		133	$ 21
Other, net	(258)	73
Net cash provided by (used in) investing activities	(5,231)	(4,133)
Cash flows from financing activities:
Deposits	5,871	6,032
Withdrawals	(2,574)	(1,970)
Policyholders' accounts balance transfer (to) from Separate Accounts	1,617	1,618
Change in short-term financings	(216)	(197)
Change in collateralized pledged assets	724	(64)
Change in collateralized pledged liabilities	664	202
(Decrease) increase in overdrafts payable	66	(75)
Shareholder dividend paid	0	500
Repurchase of AB Holding units	(134)	(129)
Distribution to noncontrolling interests in consolidated entities	(347)	(287)
Increase (decrease) in Securities sold under agreement to repurchase	(159)	253
(Increase) decrease in securities purchased under agreement to resell	0	79
Other, net	0	7
Net cash provided by (used in) financing activities	5,460	4,929
Effect of exchange rate changes on cash and cash equivalents	17	7
Cash and cash equivalents, beginning of year	2,950	3,063
Cash and Cash Equivalents, End of Period	4,190	3,701
Variable Interest Entity, Primary Beneficiary
Cash flows from financing activities:
Distribution to noncontrolling interests in consolidated entities	$ (52)	$ (40)

XML

ORGANIZATION AND BASIS OF PRESENTATION

9 Months Ended

Sep. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Basis of Presentation

ORGANIZATION AND BASIS OF PRESENTATION

The preparation of the accompanying unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions (including normal, recurring accruals) that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. The accompanying unaudited interim consolidated financial statements reflect all adjustments necessary in the opinion of management for a fair statement of the consolidated financial position of AXA Equitable and its consolidated results of operations and cash flows for the periods presented. All significant intercompany transactions and balances have been eliminated in consolidation. These statements should be read in conjunction with the audited consolidated financial statements of AXA Equitable for the year ended December 31, 2016. The results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the full year.

The accompanying consolidated financial statements include the accounts of AXA Equitable and its subsidiaries engaged in insurance related businesses (collectively, the “Insurance segment”); other subsidiaries, principally AB, engaged in investment management related businesses (the “Investment Management segment”), partnerships and real estate and non-real estate joint ventures in which AXA Equitable or its subsidiaries have control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation (collectively the “Company”).

At September 30, 2017 and December 31, 2016, AXA Equitable’s economic interest in AB was 29.3% and 29.0%. At September 30, 2017 and December 31, 2016, respectively, AXA and its subsidiaries’ economic interest in AB was 64.9% and 63.7%.

On May 10, 2017, AXA announced its intention to pursue the sale of a minority stake in our indirect parent, AXA Equitable Holdings, Inc. ("Equitable Holdings"), through a proposed initial public offering ("IPO") in the first half of 2018.  On November 13, 2017, Equitable Holdings filed a Form S-1 registration statement with the Securities and Exchange Commission (the "SEC"). The completion of the proposed IPO will depend on, among other things, the SEC filing and review process and customary regulatory approvals, as well as market conditions.  There can be no assurance that the proposed IPO will occur on the anticipated timeline or at all.

The terms “third quarter 2017” and “third quarter 2016” refer to the three months ended September 30, 2017 and 2016, respectively. The terms “first nine months of 2017” and “first nine months of 2016” refer to the nine months ended September 30, 2017 and 2016, respectively.

Prior period information has been revised to reflect the revision of errors identified by management in its previous financial statements and the implementation of the accounting change. See "Accounting Change" and "Revision of Prior Period Financial Statements" in Note 2.

XML

SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Significant Accounting Policies

SIGNIFICANT ACCOUNTING POLICIES AND SIGNIFICANT OTHER CHANGES

Accounting Change

In third quarter 2017, the Company voluntarily changed to fair value accounting for variable annuity products with the Guaranteed Minimum Income Benefits feature with a no-lapse guarantee ("GMIBNLG") as a retrospective change in accounting principle.  Changes in the estimated fair value of the embedded derivative is reported in Net derivative gains (losses). The Company believes that the new method of accounting for the GMIBNLG as an embedded derivative at fair value more accurately reflects the economics of the NLG feature and is more meaningful to users of our financial statements.

The comparative periods of the prior year have been adjusted to apply the new method retrospectively. The impact of the change in accounting principle to net income (loss) during the third quarter 2016 and first nine months of 2016 was an increase of $104 million and a decrease of $1,030 million, respectively. The Company’s opening retained earnings decreased $1,933 million as of January 1, 2016 for the effect of retroactive application of the accounting change.

Adoption of New Accounting Pronouncements

In January 2017, the Financial Accounting Standards Board (the “FASB”) issued updated guidance to simplify the accounting for goodwill impairment. The revised guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The Company elected to early adopt the new guidance effective January 1, 2017. Adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In January 2017, the FASB issued new guidance that amends the definition of a business to provide a more robust framework for determining when a set of assets and activities is a business. The definition primarily adds clarity for evaluating whether certain transactions should be accounted for as acquisitions/dispositions of assets or businesses, the latter of which is subject to guidance on business combinations, but also may interact with other areas of accounting where the defined term is used, such as in the application of guidance on consolidation and goodwill impairment. The new guidance is effective for fiscal years ending December 31, 2018 and thereafter. The Company elected to early adopt the new guidance for the year ending December 31, 2016. Adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In October 2016, the FASB issued updated guidance on consolidation of interests held through related parties that are under common control, which alters how a decision maker needs to consider indirect interests in a VIE held through an entity under common control. The new guidance amends the recently adopted consolidation guidance analysis. Under the new guidance, if a decision maker is required to evaluate whether it is the primary beneficiary of a VIE, it will need to consider only its proportionate indirect interest in the VIE held through a common control party. The Company adopted the revised guidance effective January 1, 2017. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In March 2016, the FASB issued new guidance simplifying the transition to the equity method of accounting. The amendment eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investments had been held. The Company adopted the revised guidance effective January 1, 2017. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In March 2016, the FASB issued new guidance on improvements to employee share-based payment accounting. The amendment includes provisions intended to simplify various aspects related to how share-based payments are accounted for and presented in the financial statements including: income tax effects of share-based payments, minimum statutory tax withholding requirements and forfeitures. The Company adopted the revised guidance effective January 1, 2017. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Future Adoption of New Accounting Pronouncements

In August 2017, the FASB issued Accounting Standards Codification (“ASC”) 815 Derivatives and Hedging, “Targeted Improvements to Accounting for Hedging Activities”. The FASB’s objective is to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition to that main objective, the amendments in this update make certain targeted improvements to simplify the application of the hedge accounting guidance in current U.S. GAAP. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early application is permitted in any interim period after issuance of the update. All transition requirements and elections should be applied to hedging relationships existing (that is, hedging relationships in which the hedging instrument has not expired, been sold, terminated, or exercised or the entity has not removed the designation of the hedging relationship) on the date of adoption. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption (that is, the initial application date).

In May 2017, the FASB issued guidance on stock compensation. The new guidance provides clarity and reduces both diversity in practice and cost and complexity when applying the guidance to a change to the terms or conditions of a share based payment award. The new guidance is effective for interim and annual periods beginning after December 15, 2017 with early adoption permitted. The new guidance will be applied prospectively to an award modified on or after the adoption of this guidance. Management is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.

In March 2017, the FASB issued guidance that requires certain premiums on callable debt securities to be amortized to the earliest call date. The new guidance willbetter align interest income recognition with the manner in which market participants price these instruments.  The new guidance is effective for interim and annual periods beginning after December 15, 2018 with early adoption permitted and is to be applied on a modified retrospective basis. Management is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.

In March 2017, the FASB issued new guidance on the presentation of net periodic pension and post-retirement benefit costs that required bifurcation of net benefit cost. The service cost component will be presented with other employee compensation costs in operating income (or capitalized in assets). The other components will be reported separately outside of operations and will not be eligible for capitalization. The new guidance is effective for interim and annual periods beginning after December 15, 2017 with early adoption permitted and is to be applied retrospectively for changes in the income statement presentation of net benefit cost and prospectively for changes in capitalization eligibility. Management is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.

In February 2016, the FASB issued revised guidance to lease accounting. The revised guidance will require lessees to recognize a right-of-use asset and a lease liability for virtually all of their leases. Lessor accounting will continue to be similar to the current model, but updated to align with certain changes to the lessee model. Extensive quantitative and qualitative disclosures, including significant judgments made by management, will be required to provide greater insight into the extent of revenue and expense recognized and expected to be recognized from existing contracts. The revised guidance is effective for interim and annual periods, beginning after December 15, 2018, with early adoption permitted.  Management is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.

In May 2014, the FASB issued new revenue recognition guidance that is intended to improve and converge the financial reporting requirements for revenue from contracts with customers with International Financial Reporting Standards (“IFRS”). The new guidance applies to contracts that deliver goods or services to a customer, except when those contracts are for: insurance, leases, rights and obligations that are in the scope of certain financial instruments (i.e., derivative contracts) and guarantees other than product or service warranties. The new guidance is effective for interim and annual periods, beginning after December 15, 2017, with early adoption permitted for interim and annual periods beginning after December 15, 2016. The Company has not yet completed this analysis, but based on the analysis completed to date, management does not expect the standard to have a material impact on our financial condition or results of operations.

Consolidation of VIEs

A VIE must be consolidated by its primary beneficiary, which generally is defined as the party who has a controlling financial interest in the VIE. The Company is deemed to have a controlling financial interest in a VIE if it has (i) the power to direct the activities of the VIE that most significantly affect the VIE’s economic performance, and (ii) the obligation to absorb losses of the VIE or the right to receive income from the VIE that potentially could be significant to the VIE. For purposes of evaluating (ii) above, fees paid to the Company as a decision maker or service provider are excluded if the fees are compensation for services provided commensurate with the level of effort required to be performed and the arrangement includes only customary terms, conditions or amounts present in arrangements for similar services negotiated at arm’s length.

If the Company has a variable interest in an entity that is determined not to be a VIE, the entity then is evaluated for consolidation under the voting interest entity (“VOE”) model. For limited partnerships and similar entities, the Company is deemed to have a controlling financial interest in a VOE, and would be required to consolidate the entity, if the Company owns a majority of the entity’s kick-out rights through voting limited partnership interests and other limited partners do not hold substantive participating rights (or other rights that would indicate that the Company does not control the entity). For entities other than limited partnerships, the Company is deemed to have a controlling financial interest in a VOE if it owns a majority voting interest in the entity.

The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate.

At September 30, 2017, the Insurance segment’s General Account held approximately $1,169 million of investment assets in the form of equity interests issued by non-corporate legal entities determined under the new guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds, and real estate-related funds. As an equity investor, the Insurance segment is considered to have a “variable interest” in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests and/or other financial arrangements, if any, the Insurance segment was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheet as “Other equity investments” and to apply the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $168,625 million, and the Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1,169 million at September 30, 2017. Except for approximately $719 million of unfunded commitments at September 30, 2017, the Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations.

AB regularly provides seed capital to new company-sponsored investment funds. As such, it may consolidate or de-consolidate a variety of company-sponsored investment funds each quarter. Due to the similarity of risks related to its involvement with each company-sponsored investment fund, disclosures required under the VIE model are aggregated, such as those disclosures regarding the carrying amount and classification of assets.

AB is not required to provide financial support to company-sponsored investment funds and only the assets of such funds are available to settle its own liabilities. AB’s exposure to loss with respect to consolidated company-sponsored investment funds is limited to its investment in, and its management fee earned from, such funds. Equity and debt holders of such funds have no recourse to AB’s assets or to the general credit of AB. The balances of consolidated VIEs and VOEs included in the Company’s balance sheet at September 30, 2017 were assets of $1,252 million, liabilities of $594 million, Redeemable noncontrolling interest of $416 million, Equity attributable to the Company of $71 million and $1 million attributable to non-redeemable noncontrolling interest. The balances of consolidated VIEs and VOEs included in the Company’s balance sheet at December 31, 2016 were assets of $956 million, liabilities of $293 million, Redeemable noncontrolling interest of $384 million, Equity attributable to the Company of $71 million and $35 million attributable to non-redeemable noncontrolling interest.

As of September 30, 2017, the net assets of company-sponsored investment products that are non-consolidated VIEs are approximately $52,100 million, and AB’s maximum risk of loss is its investment of $7 million in these VIEs and advisory fee receivables from these VIEs, which are not material.

Revision of Prior Period Financial Statements

During the first nine months of 2017 management identified errors in its previous financial statements. These errors primarily related to errors in the calculation of policyholders’ benefit reserves for one of the Company’s variable annuity products with indexed-linked features and the calculation of DAC amortization for certain variable and interest sensitive life products. Management evaluated the impact of these errors both individually and in the aggregate and concluded they were not material to any previously reported annual and quarterly financial statements. In order to improve the consistency and comparability of the financial statements, management has voluntarily revised the consolidated balance sheet as of and for the year ended December 31, 2016 and 2015; March 31, 2017 and 2016; June 30, 2017 and 2016 and September 30, 2016 and the related consolidated statements of income (loss), comprehensive income (loss), shareholders’ equity and of cash flows for the years ended December 31, 2016, 2015 and 2014 and for the discrete and year to date interim periods of 2017 an 2016, to include the revisions discussed above and all previously recorded out of period adjustments in each of the applicable periods for comparability purposes. The impacts of these revisions to each of the previously reported consolidated statements are disclosed below.

The following tables present line items for prior period financial statements that have been affected by the revision. For these items, the tables detail the amounts as previously reported, the impact upon those line items due to the revision, and the amounts as currently revised within the financial statements.

	September 30, 2016
	As Previously Reported		Impact of Revisions			As Revised
	(In millions)
Assets:
Other equity investments	$	1,454	$	(93	)	$	1,361
Trading securities, at fair value	8,702		65			8,767
Other invested assets	2,192		39			2,231
Total investments	60,968		11			60,979
DAC	4,516		(123		)	4,393
Amounts due from reinsurers	4,550		27			4,577
Total Assets	$	209,034	$	(85	)	$	208,949
	—		—			—
Liabilities:
Policyholders' account balance	$	36,920	$	(76	)	$	36,844
Future policyholders' benefits and other policyholders' liabilities	26,191		109			26,300
Current and deferred taxes	6,160		(46		)	6,114
Total Liabilities	188,005		(13		)	187,992
	—		—			—
Equity:
Retained Earnings	10,954		(83		)	10,871
AXA Equitable Equity	17,882		(83		)	17,799
Noncontrolling interest	3,001		11			3,012
Equity	20,883		(72		)	20,811
Total Liabilities and Equity	$	209,034	$	(85	)	$	208,949

	Three Months Ended September 30, 2016									Nine Months Ended September 30, 2016
	As Previously Reported			Impact of Revisions			As Revised			As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	978		$	(53	)	$	925		$	2,794		$	(123	)	$	2,671
Premiums	141			85			226			388			250			638
Net derivative gains (losses)	(656		)	(21		)	(677		)	3,184			65			3,249
Total revenues	2,006			11			2,017			11,090			192			11,282
Benefits and other deductions:
Policyholders' benefits	640			(16		)	624			2,920			143			3,063
Interest credited to Policyholders' Account Balances	272			31			303			797			(18		)	779
Amortization of deferred policy acquisition costs, net	4			43			47			(80		)	118			38
Total benefits and other deductions	2,036			58			2,094			7,090			243			7,333
Income (loss) from operations, before income taxes	(30		)	(47		)	(77		)	4,000			(51		)	3,949
Income tax (expense) benefit	52			58			110			(1,197		)	57			(1,140		)
Net income (loss)	22			11			33			2,803			6			2,809
Less: net (income) loss attributable to the noncontrolling interest	(98		)	(28		)	(126		)	(307		)	(27		)	(334		)
Net income (loss) attributable to AXA Equitable	$	(76	)	$	(17	)	$	(93	)	$	2,496		$	(21	)	$	2,475
Statements of Comprehensive Income (Loss):
Net income (loss)	$	22		$	11		$	33		$	2,803		$	6		$	2,809
Change in unrealized gains (losses), net of reclassification adjustment	(22		)	30			8			1,383			20			1,403
Other comprehensive income	(23		)	30			7			1,386			20			1,406
Comprehensive income (loss)	(1		)	41			40			4,189			26			4,215
Less: Comprehensive (income) loss attributable to noncontrolling interest	$	(99	)	$	(28	)	$	(127	)	$	(308	)	$	(27	)	$	(335	)
Comprehensive income (loss) attributable to AXA Equitable	$	(100	)	$	13		$	(87	)	$	3,881		$	(1	)	$	3,880

Nine Months Ended September 30, 2016	As Previously Reported		Impact of Revisions			As Revised
	(in millions)
Statements of Equity:
Retained earnings, beginning of year	$	8,958	$	(62	)	$	8,896
Net income (loss)	2,496		(21		)	2,475
Retained earnings, end of period	10,954		(83		)	10,871
Accumulated other comprehensive income, beginning of year earnings, beginning of year	228		(20		)	208
Other comprehensive income (loss)	1,385		20			1,405
Total AXA Equitable’s equity, end of period	17,882		(83		)	17,799
Noncontrolling interest, beginning of year	3,086		(27		)	3,059
Net income (loss) attributable to noncontrolling interest	299		27			326
Noncontrolling interest, end of period	3,001		11			3,012
Total Equity, End of Period	$	20,883	$	(72	)	$	20,811

Nine Months Ended September 30, 2016	As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	2,803		$	6		$	2,809
Policy charges and fee income	(2,794		)	123			(2,671		)
Interest credited to policyholders’ account balances	797			(18		)	779
Net derivative (gains) loss	(3,184		)	(65		)	(3,249		)
Deferred Policy Acquisition costs	(80		)	118			38
Changes in:
Future policy benefits	1,253			(45		)	1,208
Reinsurance recoverable	(120		)	(62		)	(182		)
Current and deferred income taxes	704			(57		)	647
Net cash provided by (used in) operating activities	$	(165	)	$	—		$	(165	)

	As Previously Reported				Impact of Revisions						As Revised
	December 31,				December 31,						December 31,
	2016		2015		2016			2015			2016		2015
	(In millions)
Assets:
Other equity investments	$	1,408	$	1,477	$	(29	)	$	(81	)	$	1,379	$	1,396
Trading securities, at fair value	9,134		6,805		—			81			9,134		6,886
Other invested assets	2,186		1,788		40			—			2,226		1,788
Total investments	58,416		52,527		11			—			58,427		52,527
DAC	4,301		4,469		(175		)	(36		)	4,126		4,433
Amounts due from reinsurers	4,635		4,466		29			46			4,664		4,512
Guaranteed minimum income benefit reinsurance asset, at fair value	10,309		10,570		—			8			10,309		10,578
Other assets	4,260		4,634		—			13			4,260		4,647
Total Assets	$	203,764	$	194,626	$	(135	)	$	31		$	203,629	$	194,657
Liabilities:
Policyholders' account balance	$	38,782	$	33,033	$	43		$	(138	)	$	38,825	$	32,895
Future policyholders' benefits and other policyholders' liabilities	25,358		24,531		123			332			25,481		24,863
Current and deferred taxes	3,816		4,647		(109		)	(2		)	3,707		4,645
Other liabilities	2,108		2,586		—			(52		)	2,108		2,534
Total Liabilities	186,945		177,018		57			140			187,002		177,158
Equity:
Retained Earnings	7,983		8,958		(203		)	(62		)	7,780		8,896
Accumulated other comprehensive income (loss)	7		228		—			(20		)	7		208
AXA Equitable Equity	13,331		14,509		(203		)	(82		)	13,128		14,427
Noncontrolling interest	3,085		3,086		11			(27		)	3,096		3,059
Equity	16,416		17,595		(192		)	(109		)	16,224		17,486
Total Liabilities and Equity	$	203,764	$	194,626	$	(135	)	$	31		$	203,629	$	194,657

	As Previously Reported									Impact of Revisions									As Revised
	Year Ended December 31,									Year Ended December 31,									Year Ended December 31,
	2016			2015			2014			2016			2015			2014			2016			2015			2014
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	3,423		$	3,208		$	3,115		$	192		$	316		$	248		$	3,615		$	3,524		$	3,363
Premiums	880			854			874			(26		)	(26		)	(27		)	854			828			847
Net derivative gains (losses)	(1,277		)	(208		)	5,409			43			(131		)	(168		)	(1,234		)	(339		)	5,241
Total revenues	9,151			9,833			15,480			209			159			53			9,360			9,992			15,533
Benefits and other deductions:
Policyholders' benefits	2,913			2,743			3,579			172			123			375			3,085			2,866			3,954
Interest credited to Policyholder's Account Balances	981			1,048			1,155			101			(72		)	(118		)	1,082			976			1,037
Amortization of deferred policy acquisition costs	162			(331		)	(413		)	171			13			34			333			(318		)	(379		)
Other operating costs and expenses	1,458			1,415			1,692			—			82			(24		)	1,458			1,497			1,668
Total benefits and other deductions	8,720			8,183			9,365			444			146			267			9,164			8,329			9,632
Income (loss) from operations, before income taxes	431			1,650			6,115			(235		)	13			(214		)	196			1,663			5,901
Income tax (expense) benefit	113			(186		)	(1,695		)	121			(2		)	75			234			(188		)	(1,620		)
Net income (loss)	544			1,464			4,420			(114		)	11			(139		)	430			1,475			4,281
Less: net (income) loss attributable to the noncontrolling interest	(469		)	(403		)	(387		)	(27		)	—			—			(496		)	(403		)	(387		)
Net income (loss) attributable to AXA Equitable	$	75		$	1,061		$	4,033		$	(141	)	$	11		$	(139	)	$	(66	)	$	1,072		$	3,894
Statements of Comprehensive Income (Loss):
Net income (loss)	$	544		$	1,464		$	4,420		$	(114	)	$	11		$	(139	)	$	430		$	1,475		$	4,281
Change in unrealized gains (losses), net of reclassification adjustment	(217		)	(881		)	969			20			(20		)	—			(197		)	(901		)	969
Total other comprehensive income (loss), net of income taxes	(238		)	(910		)	925			20			(20		)	—			(218		)	(930		)	925
Comprehensive income (loss)	306			554			5,345			(94		)	(9		)	(139		)	212			545			5,206
Less: Comprehensive (income) loss attributable to noncontrolling interest	(452		)	(388		)	(358		)	(27		)	—			—			(479		)	(388		)	(358		)
Comprehensive income (loss) attributable to AXA Equitable	$	(146	)	$	166		$	4,987		$	(121	)	$	(9	)	$	(139	)	$	(267	)	$	157		$	4,848

	As Previously Reported									Impact of Revisions									As Revised
	Year Ended December 31,									Year Ended December 31,									Year Ended December 31,
	2016			2015			2014			2016			2015			2014			2016			2015			2014
	(In millions)
Statements of Equity:
Capital in excess of par value, beginning of year	$	5,321		$	5,957		$	5,934		$	—		$	—		$	(26	)	$	5,321		$	5,957		$	5,908
Deferred tax on dividend of AB Units	—			(35		)	(26		)	—			—			26			—			(35		)	—
Capital in excess of par value, end of year	5,339			5,321			5,957			—			—			—			5,339			5,321			5,957
Retained earnings, beginning of year	$	8,958		$	8,809		$	5,205		$	(62	)	$	(73	)	$	18		$	8,896		$	8,736		$	5,223
Stockholder dividends	(1,050		)	(912		)	(429		)	—			—			48			$	(1,050	)	$	(912	)	$	(381	)
Net income (loss)	75			1,061			4,033			(141		)	11			(139		)	(66		)	1,072			3,894
Retained earnings, end of period	7,983			8,958			8,809			(203		)	(62		)	(73		)	7,780			8,896			8,736
Accumulated other comprehensive income (loss), beginning of year	228			351			(603		)	(20		)	—			—			208			351			(603		)
Other comprehensive income (loss)	(221		)	(895		)	954			20			(20		)	—			(201		)	(915		)	954
Accumulated other comprehensive income (loss), end of year	7			228			351			—			(20		)	—			7			208			351
Total AXA Equitable’s equity, end of period	13,331			14,509			15,119			(203		)	(82		)	(73		)	13,128			14,427			15,046
Noncontrolling interest, beginning of year	3,086			2,989			2,903			(27		)	(27		)	21			3,059			2,962			2,924
Net income (loss) attributable to noncontrolling interest	464			403			387			27			—			—			491			403			387
Dividend of AB Units by AXA Equitable to AXA Financial	—			145			48			—			—			(48		)	—			145			—
Other changes in noncontrolling interest	104			132			143			11			—			—			115			132			143
Noncontrolling interest, end of year	3,085			3,086			2,989			11			(27		)	(27		)	3,096			3,059			2,962
Total Equity, End of Period	$	16,416		$	17,595		$	18,108		$	(192	)	$	(109	)	$	(100	)	$	16,224		$	17,486		$	18,008
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	544		$	1,464		$	4,420		$	(114	)	$	11		$	(139	)	$	430		$	1,475		$	4,281
Policy charges and fee income	(3,423		)	(3,208		)	(3,115		)	(192		)	(316		)	(248		)	(3,615		)	(3,524		)	(3,363		)
Interest credited to policyholders’ account balances	981			1,048			1,155			101			(72		)	(118		)	1,082			976			1,037
Net derivative (gains) loss	462			208			(5,409		)	(43		)	131			168			419			339			(5,241		)
Amortization of deferred cost of reinsurance asset	159			39			302			—			82			(10		)	159			121			292
Changes in:
Future policy benefits	803			878			1,518			(32		)	162			214			771			1,040			1,732
Deferred Policy Acquisition costs	162			(331		)	(413		)	171			13			34			333			(318		)	(379		)
Reinsurance recoverable	(534		)	(916		)	(488		)	230			(13		)	174			(304		)	(929		)	(314		)
Current and deferred income taxes	(771		)	258			1,448			(121		)	2			(75		)	(892		)	260			1,373
Other	31			111			(98		)	—			(80		)	39			31			31			(59		)
Net cash provided by (used in) operating activities	$	(461	)	$	(244	)	$	(639	)	$	—		$	(80	)	$	39		$	(461	)	$	(324	)	$	(600	)

	As Previously Reported							Impact of Revisions								As Revised
	Year Ended December 31,							Year Ended December 31,								Year Ended December 31,
	2016			2015		2014		2016			2015		2014			2016			2015		2014
	(In millions)
Cash flows from financing activities:
Policyholders' accounts balance deposits	$	9,342		$	5,757	$	6,011	$	404		$	—	$	—		$	9,746		$	5,757	$	6,011
Policyholders' accounts balance transfer (to) from Separate Accounts	1,606			1,045		815		(404		)	—		—			1,202			1,045		815
(Decrease) increase in overdrafts payable	(85		)	—		—		—			80		(39		)	(85		)	80		(39		)
Net cash provided by (used in) financing activities	$	5,751		$	3,034	$	3,843	$	—		$	80	$	(39	)	$	5,751		$	3,114	$	3,804

The following table presents the effects of the revision to the Company's previously reported Consolidated Balance Sheets as of June 30, 2017 and 2016:

	As Previously Reported				Impact of Revisions						As Revised
	June 30				June 30						June 30
	2017		2016		2017			2016			2017		2016
	(In millions)
Assets:
Other equity investments	$	1,477	$	1,447	$	(21	)	$	(100	)	$	1,456	$	1,347
Trading securities, at fair value	—		7,843		—			73			—		7,916
Other invested assets	2,622		2,811		32			38			2,654		2,849
Total investments	62,111		60,979		11			11			62,122		60,990
DAC	4,141		4,496		(135		)	(126		)	4,006		4,370
Amounts due from reinsurers	4,870		4,523		31			49			4,901		4,572
Other assets	—		4,501		—			2			—		4,503
Total Assets	$	214,941	$	207,042	$	(93	)	$	(64	)	$	214,848	$	206,978
	—		—		—			—			—		—
Liabilities:
Policyholders' account balance	$	41,531	$	35,661	$	(15	)	$	(108	)	$	41,516	$	35,553
Future policyholders' benefits and other policyholders' liabilities	26,799		26,131		56			160			26,855		26,291
Current and deferred taxes	4,000		6,421		(50		)	(6		)	3,950		6,415
Total Liabilities	196,972		185,800		(9		)	46			196,963		185,846
Equity:
Retained Earnings	8,779		11,030		(95		)	(66		)	8,684		10,964
Accumulated other comprehensive income (loss)	493		1,637		—			(29		)	493		1,608
AXA Equitable Equity	14,635		17,987		(95		)	(95		)	14,540		17,892
Noncontrolling interest	2,973		3,026		11			(15		)	2,984		3,011
Equity	12,608		21,013		(84		)	(110		)	12,524		20,903
Total Liabilities and Equity	$	214,941	$	207,042	$	(93	)	$	(64	)	$	214,848	$	206,978

The following table presents the effects of the revision to the Company’s previously reported Consolidated Statements of Income (Loss), Statements of Comprehensive Income (Loss), Statements of Equity and Cash Flows for the three and six months ended June 30, 2017 and 2016:

	Three Months Ended June 30, 2017									Six Months Ended June 30, 2017
	As Previously Reported			Impact of Revisions			As Revised			As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	865		$	59		$	924		$	1,761		$	86		$	1,847
Net derivative gains (losses)	1,693			(38		)	1,655			969			(30		)	939
Total revenues	4,488			21			4,509			6,477			56			6,533
Benefits and other deductions:
Policyholders' benefits	1,452			30			1,482			2,343			67			2,410
Amortization of deferred policy acquisition costs, net	(82		)	4			(78		)	43			3			46
Total benefits and other deductions	2,691			34			2,725			5,253			70			5,323
Income (loss) from operations, before income taxes	1,797			(13		)	1,784			1,224			(14		)	1,210
Income tax (expense) benefit	(338		)	4			(334		)	(78		)	5			(73		)
Net income (loss)	1,459			(9		)	1,450			1,146			(9		)	1,137
	—
Less: net (income) loss attributable to the noncontrolling interest	(113		)	—			(113		)	(231		)	—			(231		)
Net income (loss) attributable to AXA Equitable	$	1,346		$	(9	)	$	1,337		$	915		$	(9	)	$	906
Statements of Comprehensive Income (Loss):
Net income (loss)	$	1,459		$	(9	)	$	1,450		$	1,146		$	(9	)	$	1,137
Comprehensive income (loss)	1,753			(9		)	1,744			1,619			(9		)	1,610
Comprehensive income (loss) attributable to AXA Equitable	$	1,660		$	(9	)	$	1,651		$	1,619		$	(9	)	$	1,610

	Three Months Ended June 30, 2016									Six Months Ended June 30, 2016
	As Previously Reported			Impact of Revisions			As Revised			As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	915		$	(29	)	$	886		$	1,816		$	(70	)	$	1,746
Premiums	121			82			203			247			165			412
Net derivative gains (losses)	1,562			(22		)	1,540			3,840			86			3,926
Total revenues	4,297			31			4,328			9,084			181			9,265
Benefits and other deductions:
Policyholders' benefits	1,211			35			1,246			2,280			159			2,439
Interest credited to Policyholders' Account Balances	274			(19		)	255			525			(49		)	476
Amortization of deferred policy acquisition costs, net	(74		)	43			(31		)	(84		)	75			(9		)
Total benefits and other deductions	2,581			59			2,640			5,054			185			5,239
Income (loss) from operations, before income taxes	1,576			(28		)	1,548			4,030			(4		)	4,026
Income tax (expense) benefit	(515		)	7			(508		)	(1,249		)	(1		)	(1,250		)
Net income (loss)	1,061			(21		)	1,040			2,781			(5		)	2,776
	—
Less: net (income) loss attributable to the noncontrolling interest	(92		)	1			(91		)	(209		)	1			(208		)
Net income (loss) attributable to AXA Equitable	$	969		$	(20	)	$	949		$	2,572		$	(4	)	$	2,568
Statements of Comprehensive Income (Loss):
Net income (loss)	$	1,061		$	(21	)	$	1,040		$	2,781		$	(5	)	$	2,776
Change in unrealized gains (losses), net of reclassification adjustment	625			(15		)	610			1,405			(9		)	1,396
Other comprehensive income	620			(15		)	605			1,409			(9		)	1,400
Comprehensive income (loss)	1,681			(36		)	1,645			4,190			(14		)	4,176
Less: Comprehensive (income) loss attributable to noncontrolling interest	$	(89	)	$	1		$	(88	)	$	(209	)	$	1		$	(208	)
Comprehensive income (loss) attributable to AXA Equitable	$	1,592		$	(35	)	$	1,557		$	3,981		$	(13	)	$	3,968

	Six Months Ended June 30,
	As Previously Reported				Impact of Revisions						As Revised
	2017		2016		2017			2016			2017		2016
	(In millions)
Statements of Equity:
Retained earnings, beginning of year	$	7,983	$	8,958	$	(86	)	$	(62	)	$	7,897	$	8,896
Net income (loss)	915		2,572		(9		)	(4		)	906		2,568
Retained earnings, end of period	8,779		11,030		(95		)	(66		)	8,684		10,964
Accumulated other comprehensive income, beginning of year earnings, beginning of year	7		228		—			(20		)	7		208
Other comprehensive income (loss)	486		1,409		—			(9		)	486		1,400
Accumulated other comprehensive income, end of period	493		1,637		—			(29		)	493		1,608
Total AXA Equitable’s equity, end of period	14,635		17,987		(95		)	(95		)	14,540		17,892
Noncontrolling interest, beginning of year	3,085		3,086		11			(27		)	3,096		3,059
Net income (loss) attributable to noncontrolling interest	118		203		—			1			118		204
Noncontrolling interest, end of period	—		3,026		11			(15		)	11		3,011
Total Equity, End of Period	$	17,617	$	21,013	$	(84	)	$	(110	)	$	17,533	$	20,903

	Six Months Ended June 30,
	As Previously Reported						Impact of Revisions						As Revised
	2017			2016			2017			2016			2017			2016
	(In millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	1,146		$	2,781		$	(9	)	$	(5	)	$	1,137		$	2,776
Policy charges and fee income	(1,761		)	(1,816		)	(86		)	70			(1,847		)	(1,746		)
Interest credited to policyholders’ account balances	658			525			—			(49		)	658			476
Net derivative (gains) loss	(969		)	(3,840		)	30			(86		)	(939		)	(3,926		)
Deferred Policy Acquisition costs	43			(84		)	3			75			46			(9		)
Changes in:
Future policy benefits	1,381			1,168			10			172			1,391			1,340
Reinsurance recoverable	(251		)	(92		)	57			(178		)	(194		)	(270		)
Current and deferred income taxes	(16		)	985			(5		)	1			(21		)	986
Other	—			119			—			(48		)	—			71
Net cash provided by (used in) operating activities	$	(75	)	$	(337	)	$	—		$	(48	)	$	(75	)	$	(385	)
(Decrease) increase in overdraft payables	$	—		$	—		$	—		$	48		$	—		$	48
Net cash provided by (used in) financing activities	$	—		$	4,016		$	—		$	48		$	—		$	4,064

The following table presents the effects of the revision to the Company's previously reported consolidated balance sheets as of March 31, 2017 and 2016:

	As Previously Reported				Impact of Revisions						As Revised
	March 31				March 31						March 31
	2017		2016		2017			2016			2017		2016
	(In millions)
Assets:
Other equity investments	$	1,463	$	1,398	$	(23	)	$	(120	)	$	1,440	$	1,278
Trading securities, at fair value	—		7,124		—			81			—		7,205
Other invested assets	2,050		2,462		34			39			2,084		2,501
Total investments	60,406		56,581		11			—			60,417		56,581
DAC	4,068		4,505		(88		)	(59		)	3,980		4,446
Amounts due from reinsurers	4,639		4,605		19			48			4,658		4,653
Other assets	—		4,516		—			13			—		4,529
Total Assets	$	209,098	$	199,983	$	(58	)	$	2		$	209,040	$	199,985
	—		—		—			—			—		—
Liabilities:
Policyholders' account balance	$	40,308	$	33,710	$	(16	)	$	(89	)	$	40,292	$	33,621
Future policyholders' benefits and other policyholders' liabilities	25,496		25,272		45			213			25,541		25,485
Current and deferred taxes	3,523		5,833		(34		)	14			3,489		5,847
Other liabilities	—		2,841		—			(50		)	—		2,791
Total Liabilities	192,712		179,802		(5		)	88			192,707		179,890
			—		—						—		—
			—		—						—		—
Retained Earnings	7,411		10,561		(64		)	(45		)	7,347		10,516
Accumulated other comprehensive income (loss)	179		1,014		—			(14		)	179		1,000
AXA Equitable Equity	12,934		16,894		(64		)	(59		)	12,870		16,835
Noncontrolling interest	3,035		69		11			(27		)	3,046		42
Equity	15,969		19,963		(53		)	(86		)	15,916		19,877
			—		—			—			—		—
Total Liabilities and Equity	$	209,098	$	199,983	$	(58	)	$	2		$	209,040	$	199,985

	Three Months Ended March 31, 2017									Three Months Ended March 31, 2016
	As Previously Reported			Impact of Revisions			As Revised			As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	896		$	29		$	925		$	901		$	(41	)	$	860
Premiums	—			—			—			126			83			209
Net derivative gains (losses)	(724		)	(9		)	(733		)	2,278			108			2,386
Increase (decrease in the fair value of the GMIB reinsurance contract asset	—			—			—			—			—			—
Total revenues	1,989			20			2,009			4,927			150			5,077
Benefits and other deductions:
Policyholders' benefits	891			21			912			1,069			124			1,193
Interest credited to Policyholders' Account Balances	337			(1		)	336			251			(30		)	221
Amortization of deferred policy acquisition costs, net	125			(1		)	124			131			32			163
Total benefits and other deductions	2,562			19			2,581			2,473			126			2,599
Income (loss) from operations, before income taxes	(573		)	1			(572		)	2,454			24			2,478
Income tax (expense) benefit	260			—			260			(734		)	(8		)	(742		)
Net income (loss)	(313		)	1			(312		)	1,720			16			1,736
	—
Less: net (income) loss attributable to the noncontrolling interest	(118		)	—			(118		)	(117		)	—			(117		)
Net income (loss) attributable to AXA Equitable	$	(431	)	$	1		$	(430	)	$	1,603		$	16		$	1,619
Statements of Comprehensive Income (Loss):
Net income (loss)	$	(313	)	$	1		$	(312	)	$	1,720		$	16		$	1,736
Change in unrealized gains (losses), net of reclassification adjustment	144			—			144			780			6			786
Other comprehensive income	179			—			179			789			6			795
Comprehensive income (loss)	(134		)	1			(133		)	2,509			22			2,531
Less: Comprehensive (income) loss attributable to noncontrolling interest	$	(125	)	$	—		$	(125	)	$	(120	)	$	—		$	(120	)
Comprehensive income (loss) attributable to AXA Equitable	$	(259	)	$	1		$	(258	)	$	2,389		$	22		$	2,411

	Three Months Ended March 31,
	As Previously Reported					Impact of Revisions						As Revised
	2017			2016		2017			2016			2017			2016
	(In millions)
Statements of Equity:
Retained earnings, beginning of year	$	7,842		$	8,958	$	(65	)	$	(62	)	$	7,777		$	8,896
Net income (loss)	(431		)	1,603		1			16			(430		)	1,619
Retained earnings, end of period	7,411			10,561		(64		)	(46		)	7,347			10,515
Accumulated other comprehensive income, beginning of year earnings, beginning of year	7			228		—			(20		)	7			208
Other comprehensive income (loss)	172			786		—			6			172			792
Total AXA Equitable’s equity, end of period	12,934			16,894		(64		)	(60		)	12,870			16,834
Noncontrolling interest, beginning of year	3,085			3,086		11			(27		)	3,096			3,059
Net income (loss) attributable to noncontrolling interest	118			117		—			—			118			117
Noncontrolling interest, end of period	3,035			3,069		11			(27		)	3,046			3,042
Total Equity, End of Period	$	15,969		$	19,963	$	(53	)	$	(87	)	$	15,916		$	19,876

	Three Months Ended March 31,
	As Previously Reported						Impact of Revisions						As Revised
	2017			2016			2017			2016			2017			2016
	(In millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	(313	)	$	1,720		$	1		$	16		$	(312	)	$	1,736
Policy charges and fee income	(896		)	(901		)	(29		)	41			(925		)	(860		)
Interest credited to policyholders’ account balances	337			251			(1		)	(30		)	336			221
(Increase) decrease in the fair value of the reinsurance contract asset	—			—			—			—			—			—
Net derivative (gains) loss	724			(2,278		)	9			(108		)	733			(2,386		)
Deferred Policy Acquisition costs	125			(10		)	—			32			125			22
Changes in:
Variable interest entities	—			—			—			—			—			—
Future policy benefits	185			491			20			130			205			621
Reinsurance recoverable	(44		)	(145		)	—			(89		)	(44		)	(234		)
Current and deferred income taxes	(327		)	733			—			8			(327		)	741
Accounts payable and accrued expenses	—			—			—			—			—			—
Other	—			50			—			91			—			141
Net cash provided by (used in) operating activities	$	18		$	99		$	—		$	91		$	18		$	190
(Decrease) increase in overdraft payables	$	50		$	—		$	—		$	(91	)	$	50		$	(91	)
Net cash provided by (used in) financing activities	$	2,306		$	1,468		$	—		$	(91	)	$	2,306		$	1,377

The following table presents the effects of the accounting change to the Company’s previously reported consolidated statement of balance sheets as of September 30, 2016:

	As Previously Reported and Adjusted Herein		Impact of Accounting Change			As Revised
	September 30,		September 30,			September 30,
	2016		2016			2016
	(In millions)
Assets:
DAC	4,393		483			4,876
Total Assets	$	208,949	$	483		$	209,432
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	26,300		5,169			31,469
Current and deferred taxes	6,114		(1,641		)	4,473
Total Liabilities	187,992		3,528			191,520
Equity:
Retained Earnings	10,871		(2,961		)	7,910
Accumulated other comprehensive income (loss)	1,613		(84		)	1,529
AXA Equitable Equity	17,799		(3,045		)	14,754
Equity	20,811		(3,045		)	17,766
Total Liabilities and Equity	$	208,949	$	483		$	209,432

The following tables present line items for prior periods that have been affected by the accounting change. For these items, the tables detail the amounts as previously reported and adjusted herein, the impact upon those line items due to the accounting change, and the amounts as currently revised within the financial statements.

	Three Months Ended September 30, 2016									Nine Months Ended September 30, 2016
	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised			As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	925		$	(71	)	$	854		$	2,671		$	(203	)	$	2,468
Net derivative gains (losses)	(677		)	231			(446		)	3,249			454			1,621
Total revenues	2,017			160			2,177			11,282			(1,831		)	9,451
Benefits and other deductions:
Policyholders' benefits	624			(8		)	616			3,063			(390		)	2,790
Amortization of deferred policy acquisition costs, net	47			8			55			38			26			64
Total benefits and other deductions	2,094			—			2,094			7,333			(247		)	7,086
Income (loss) from operations, before income taxes	(77		)	160			83			3,949			(1,584		)	2,365
Income tax (expense) benefit	110			(56		)	54			(1,140		)	554			(586		)
Net income (loss)	33			104			137			2,809			(1,030		)	1,779
Net income (loss) attributable to AXA Equitable	$	(93	)	$	104		$	11		$	2,475		$	(1,030	)	$	1,445
Statements of Comprehensive Income (Loss):
Net income (loss)	$	33		$	104		$	137		$	2,809		$	(1,030	)	$	1,779
Change in unrealized gains (losses), net of reclassification adjustment	8			8			16			1,403			(61		)	1,342
Other comprehensive income	7			8			15			1,406			(61		)	1,345
Comprehensive income (loss)	40			112			152			4,215			(1,091		)	3,124
Comprehensive income (loss) attributable to AXA Equitable	$	(87	)	$	—		$	25		$	3,880		$	—		$	2,789

Nine Months Ended September 30, 2016	As Previously Reported and Adjusted Herein		Impact of Accounting Change			As Revised
	(In millions)
Statements of Equity:
Retained earnings, beginning of year	$	8,896	$	(1,933	)	$	6,963
Net income (loss)	2,475		(1,030		)	1,445
Retained earnings, end of period	10,871		(2,963		)	7,908
Accumulated other comprehensive income, beginning of year earnings, beginning of year	208		(23		)	185
Other comprehensive income (loss)	1,405		(61		)	1,344
Accumulated other comprehensive income, end of period	1,613		(84		)	1,529
Total AXA Equitable’s equity, end of period	17,799		(5,926		)	14,752
						—
Total Equity, End of Period	$	20,811	$	—		$	17,764

Nine Months Ended September 30, 2016	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(In millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	2,809		$	(1,030	)	$	1,779
Policy charges and fee income	(2,671		)	203			(2,468		)
Net derivative (gains) loss	(3,249		)	1,628			(1,621		)
Changes in:
Future policy benefits	1,208			(273		)	935
Deferred Policy Acquisition costs	38			26			64
Current and deferred income taxes	647			(554		)	93
Net cash provided by (used in) operating activities	$	(165	)	$	—		$	(165	)

The following table presents the effects of the accounting change to the Company's previously reported consolidated balance sheets as of December 31, 2016 and 2015:

	As Previously Reported and Adjusted Herein				Impact of Accounting Change						As Revised
	December 31,				December 31,						December 31,
	2016		2015		2016			2015			2016		2015
	(In millions)
Assets:
DAC	4,126		4,433		540			563			4,666		4,996
Total Assets	$	203,629	$	194,657	$	540		$	563		$	204,169	$	195,220
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	25,481		24,863		3,378			3,572			28,859		28,435
Current and deferred taxes	3,707		4,645		(993		)	(1,053		)	2,714		3,592
Total Liabilities	187,002		177,158		2,385			2,519			189,387		179,677
Equity:
Retained Earnings	7,780		8,896		(1,845		)	(1,933		)	5,941		6,963
Accumulated other comprehensive income (loss)	7		208		(6		)	(23		)	1		185
AXA Equitable Equity	13,128		14,427		(1,845		)	(1,956		)	11,283		12,471
Equity	16,224		17,486		(1,845		)	(1,956		)	14,379		15,530
Total Liabilities and Equity	$	203,629	$	194,657	$	(3,150	)	$	563		$	204,169	$	195,220

	As Previously Reported and Adjusted Herein									Impact of Accounting Change									As Revised
	Year Ended December 31,									Year Ended December 31,									Year Ended December 31,
	2016			2015			2014			2016			2015			2014			2016			2015			2014
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	3,615		$	3,524		$	3,363		$	(273	)	$	(240	)	$	(207	)	$	3,342		$	3,284		$	3,156
Net derivative gains (losses)	(1,234		)	(339		)	5,241			114			(733		)	(1,823		)	(1,120		)	(1,072		)	3,418
Total revenues	9,360			9,992			15,533			(159		)	(973		)	(2,030		)	9,201			9,019			13,503
Benefits and other deductions:
Policyholders' benefits	3,085			2,866			3,954			(339		)	(411		)	(247		)	2,746			2,455			3,707
Amortization of deferred policy acquisition costs	333			(318		)	(379		)	35			61			34			368			(257		)	(345		)
Total benefits and other deductions	9,164			8,329			9,632			(304		)	(350		)	(213		)	8,860			7,979			9,419
Income (loss) from operations, before income taxes	196			1,663			5,901			145			(623		)	(1,817		)	341			1,040			4,084
Income tax (expense) benefit	234			(188		)	(1,620		)	(51		)	218			636			183			30			(984		)
Net income (loss)	430			1,475			4,281			94			(405		)	(1,181		)	524			1,070			3,100
Net income (loss) attributable to AXA Equitable	$	(66	)	$	1,072		$	3,894		$	94		$	(405	)	$	(1,181	)	$	28		$	667		$	2,713
Statements of Comprehensive Income (Loss):
Net income (loss)	$	430		$	1,475		$	4,281		$	94		$	(405	)	$	(1,181	)	$	524		$	1,070		$	3,100
Change in unrealized gains (losses), net of reclassification adjustment	(197		)	(901		)	969			17			70			(78		)	(180		)	(831		)	891
Total other comprehensive income (loss), net of income taxes	(218		)	(930		)	925			17			70			(78		)	(201		)	(860		)	847
Comprehensive income (loss)	212			545			5,206			111			(335		)	(1,259		)	323			210			3,947
Comprehensive income (loss) attributable to AXA Equitable	$	(267	)	$	157		$	4,848		$	111		$	(335	)	$	(1,259	)	$	(156	)	$	(178	)	$	3,589

	As Previously Reported and Adjusted Herein									Impact of Accounting Change									As Revised
	Year Ended December 31,									Year Ended December 31,									Year Ended December 31,
	2016			2015			2014			2016			2015			2014			2016			2015			2014
	(In millions)
Statements of Equity:
Retained earnings, beginning of year	$	8,896		$	8,736		$	5,223		$	(1,933	)	$	(1,528	)	$	(347	)	$	6,963		$	7,208		$	4,876
Stockholder dividends	(1,050		)	(912		)	(381		)	—			—			—			(1,050		)	(912		)	(381		)
Net income (loss)	(66		)	1,072			3,894			94			(405		)	(1,181		)	28			667			2,713
Retained earnings, end of period	7,780			8,896			8,736			(1,839		)	(1,933		)	(1,528		)	5,941			6,963			7,208
Accumulated other comprehensive income (loss), beginning of year	208			351			(603		)	(23		)	(93		)	(15		)	185			258			(618		)
Other comprehensive income (loss)	(201		)	(915		)	954			17			70			(78		)	(184		)	(845		)	876
Accumulated other comprehensive income (loss), end of year	7			208			351			(6		)	(23		)	(93		)	1			185			258
Total AXA Equitable’s equity, end of period	13,128			14,427			15,046			(1,845		)	(1,956		)	(1,621		)	11,283			12,471			13,425
Total Equity, End of Period	$	16,224		$	17,486		$	18,008		$	(1,845	)	$	(1,956	)	$	(1,621	)	$	14,379		$	15,530		$	16,387
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	430		$	1,475		$	4,281		$	94		$	(405	)	$	(1,181	)	$	524		$	1,070		$	3,100
Policy charges and fee income	(3,615		)	(3,524		)	(3,363		)	273			240			207			(3,342		)	(3,284		)	(3,156		)
Net derivative (gains) loss	419			339			(5,241		)	(114		)	733			1,823			305			1,072			(3,418		)
Changes in:
Future policy benefits	771			1,040			1,732			(339		)	(411		)	(247		)	432			629			1,485
Deferred Policy Acquisition costs	333			(318		)	(379		)	35			61			34			368			(257		)	(345		)
Current and deferred income taxes	(892		)	260			1,373			51			(218		)	(636		)	(841		)	42			737
Net cash provided by (used in) operating activities	$	(461	)	$	(324	)	$	(600	)	$	—		$	—		$	—		$	(461	)	$	(324	)	$	(600	)

The following table presents the effects of the accounting change to the Company's previously reported consolidated balance sheets as of June 30, 2017 and 2016:

	As Previously Reported and Adjusted Herein				Impact of Accounting Change						As Revised
	June 30,				June 30,						June 30,
	2017		2016		2017			2016			2017		2016
	(in millions)
Assets:
DAC	4,006		4,370		510			482			4,516		4,852
Total Assets	$	214,848	$	206,978	$	510		$	482		$	215,358	$	207,460
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	26,855		26,291		2,701			5,341			29,556		31,632
Current and deferred taxes	3,950		6,415		(767		)	(1,700		)	3,183		4,715
Total Liabilities	196,963		185,846		1,934			3,641			198,897		189,487
Equity:
Retained Earnings	8,684		10,964		(1,383		)	(3,067		)	7,301		7,897
Accumulated other comprehensive income (loss)	493		1,608		(41		)	(92		)	452		1,516
AXA Equitable Equity	14,540		17,892		(1,424		)	(3,159		)	13,116		14,733
Equity	12,524		20,903		(1,424		)	(3,159		)	11,100		17,744
Total Liabilities and Equity	$	214,848	$	206,978	$	510		$	482		$	215,358	$	207,460

The following table presents the effects of the accounting change to the Company’s previously reported consolidated statements of income (loss), statements of comprehensive income (loss), statements of equity and cash flows for the three and nine months ended June 30, 2017 and 2016:

	Three Months Ended June 30, 2017									Six Months Ended June 30, 2017
	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised			As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(in millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	924		$	(68	)	$	856		$	1,847		$	(135	)	$	1,712
Net derivative gains (losses)	1,655			342			1,997			939			775			1,714
Total revenues	4,509			274			4,783			6,533			640			7,173
Benefits and other deductions:
Policyholders' benefits	1,482			(134		)	1,348			2,410			(65		)	2,345
Amortization of deferred policy acquisition costs, net	(78		)	2			(76		)	46			4			50
Total benefits and other deductions	2,725			(132		)	2,593			5,323			(61		)	5,262
													—
Income (loss) from operations, before income taxes	1,784			406			2,190			1,210			701			1,911
Income tax (expense) benefit	(334		)	(142		)	(476		)	(73		)	(245		)	(318		)
				—									—
Net income (loss)	1,450			264			1,714			1,137			456			1,593
Net income (loss) attributable to AXA Equitable	$	1,337		$	264		$	1,601		$	906		$	456		$	1,362
Statements of Comprehensive Income (Loss):
Net income (loss)	$	1,450		$	264		$	1,714		$	1,137		$	456		$	1,593
Change in unrealized gains (losses), net of reclassification adjustment	314			1			315			458			(35		)	423
Other comprehensive income	294			1			295			473			(35		)	438
Comprehensive income (loss)	1,744			265			2,009			1,610			421			2,031
Comprehensive income (loss) attributable to AXA Equitable	$	1,651		$	265		$	1,916		$	1,610		$	421		$	2,031

	Three Months Ended June 30, 2016									Six Months Ended June 30, 2016
	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised			As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(in millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	886		$	(67	)	$	819		$	1,746		$	(132	)	$	1,614
Net derivative gains (losses)	1,540			(797		)	743			3,926			(1,859		)	2,067
Total revenues	4,328			(864		)	3,464			9,265			(1,991		)	7,274
Benefits and other deductions:
Policyholders' benefits	1,246			(159		)	1,087			2,439			(265		)	2,174
Amortization of deferred policy acquisition costs, net	(31		)	9			(22		)	(9		)	18			9
Total benefits and other deductions	2,640			(150		)	2,490			5,239			(247		)	4,992
				—									—
Income (loss) from operations, before income taxes	1,548			(714		)	834			4,026			(1,744		)	2,282
Income tax (expense) benefit	(508		)	250			(258		)	(1,250		)	610			(640		)
Net income (loss)	1,040			(464		)	576			2,776			(1,134		)	1,642
	—			—									—
Net income (loss) attributable to AXA Equitable	$	949		$	(464	)	$	485		$	2,568		$	(1,134	)	$	1,434
Statements of Comprehensive Income (Loss):
Net income (loss)	$	1,040		$	(464	)	$	576		$	2,776		$	(1,134	)	$	1,642
Change in unrealized gains (losses), net of reclassification adjustment	610			—			610			1,396			(69		)	1,327
Other comprehensive income	605			—			605			1,400			(69		)	1,331
Comprehensive income (loss)	1,645			(464		)	1,181			4,176			(1,203		)	2,973
Comprehensive income (loss) attributable to AXA Equitable	$	1,557		$	(464	)	$	1,093		$	3,968		$	(1,203	)	$	2,765

	Six Months Ended June 30,
	As Previously Reported and Adjusted Herein				Impact of Accounting Change						As Revised
	2017		2016		2017			2016			2017		2016
	(in millions)
Statements of Equity:
Retained earnings, beginning of year	$	7,897	$	8,896	$	(1,839	)	$	(1,933	)	$	6,058	$	6,963
Net income (loss)	906		2,568		456			(1,134		)	1,362		1,434
Retained earnings, end of period	8,684		10,964		(1,383		)	(3,067		)	7,301		7,897
Accumulated other comprehensive income, beginning of year earnings, beginning of year	7		208		(6		)	(23		)	1		185
Other comprehensive income (loss)	486		1,400		(35		)	(69		)	451		1,331
Accumulated other comprehensive income, end of period	493		1,608		(41		)	(92		)	452		1,516
Total AXA Equitable’s equity, end of period	14,540		17,892		(1,424		)	(3,159		)	13,116		14,733
Total Equity, End of Period	$	17,533	$	20,903	$	(1,424	)	$	(3,159	)	$	16,109	$	17,744

	Six Months Ended June 30,
	As Previously Reported and Adjusted Herein						Impact of Accounting Change						As Revised
	2017			2016			2017			2016			2017			2016
	(in millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	1,137		$	2,776		$	456		$	(1,134	)	$	1,593		$	1,642
Policy charges and fee income	(1,847		)	(1,746		)	135			132			(1,712		)	(1,614		)
Net derivative (gains) loss	(939		)	(3,926		)	(775		)	1,859			(1,714		)	(2,067		)
Changes in:
Future policy benefits	1,391			1,340			(65		)	(265		)	1,326			1,075
Deferred Policy Acquisition costs	46			(9		)	4			18			50			9
Current and deferred income taxes	(21		)	986			245			(610		)	224			376
Net cash provided by (used in) operating activities	$	(75	)	$	(385	)	$	—		$	—		$	(75	)	$	(385	)

The following table presents the effects of the accounting change to the Company's previously reported consolidated balance sheets as of March 31, 2017 and 2016:

	As Previously Reported and Adjusted Herein				Impact of Accounting Change						As Revised
	March 31,				March 31,						March 31,
	2017		2016		2017			2016			2017		2016
	(in millions)
Assets:
DAC	3,980		4,446		511			490			4,491		4,936
Total Assets	$	209,040	$	199,985	$	511		$	490		$	209,551	$	200,475
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	25,541		25,485		3,108			4,635			28,649		30,120
Current and deferred taxes	3,489		5,847		(908		)	(1,451		)	2,581		4,396
Total Liabilities	192,707		179,890		2,200			3,184			194,907		183,074
Equity:
Retained Earnings	7,347		10,516		(1,647		)	(2,602		)	5,700		7,914
Accumulated other comprehensive income (loss)	179		1,000		(42		)	(92		)	137		908
AXA Equitable Equity	12,870		16,835		(1,689		)	(2,694		)	11,181		14,141
Equity	15,916		19,877		(1,689		)	(2,694		)	14,227		17,183
Total Liabilities and Equity	$	209,040	$	199,985	$	511		$	490		$	209,551	$	200,475

The following table presents the effects of the accounting change to the Company’s previously reported consolidated statements of income (loss), statements of comprehensive income (loss), statements of equity and cash flows for the three and nine months ended March 31, 2017 and 2016:

	Three Months Ended March 31, 2017									Three Months Ended March 31, 2016
	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised			As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(in millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	925		$	(67	)	$	858		$	860		$	(65	)	$	795
Net derivative gains (losses)	(733		)	433			(300		)	2,386			(1,062		)	1,324
Total revenues	2,009			366			2,375			5,077			(1,127		)	3,950
Benefits and other deductions:							—									—
Policyholders' benefits	912			69			981			1,193			(106		)	1,087
Amortization of deferred policy acquisition costs, net	124			2			126			163			9			172
Total benefits and other deductions	2,581			71			2,652			2,599			(97		)	2,502
Income (loss) from operations, before income taxes	(572		)	295			(277		)	2,478			(1,030		)	1,448
Income tax (expense) benefit	260			(103		)	157			(742		)	361			(381		)
Net income (loss)	(312		)	192			(120		)	1,736			(669		)	1,067
Net income (loss) attributable to AXA Equitable	$	(430	)	$	192		$	(238	)	$	1,619		$	(669	)	$	950
Statements of Comprehensive Income (Loss):
Net income (loss)	$	(312	)	$	192		$	(120	)	$	1,736		$	(669	)	$	1,067
Change in unrealized gains (losses), net of reclassification adjustment	144			(36		)	108			786			(69		)	717
Other comprehensive income	179			(36		)	143			795			(69		)	726
Comprehensive income (loss)	(133		)	156			23			2,531			(738		)	1,793
Comprehensive income (loss) attributable to AXA Equitable	$	(258	)	$	156		$	(102	)	$	2,411		$	(738	)	$	1,673

	Three Months Ended March 31,
	As Previously Reported and Adjusted Herein					Impact of Accounting Change						As Revised
	2017			2016		2017			2016			2017			2016
	(in millions)
Statements of Equity:
Retained earnings, beginning of year	$	7,777		$	8,896	$	(1,839	)	$	(1,933	)	$	5,938		$	6,963
Net income (loss)	(430		)	1,619		192			(669		)	(238		)	950
Retained earnings, end of period	7,347			10,515		(1,647		)	(2,602		)	5,700			7,913
Accumulated other comprehensive income, beginning of year earnings, beginning of year	7			208		(6		)	(23		)	1			185
Other comprehensive income (loss)	172			792		(36		)	(69		)	136			723
Accumulated other comprehensive income, end of period	179			1,000		(42		)	(92		)	137			908
Total AXA Equitable’s equity, end of period	12,870			16,834		(1,689		)	(2,694		)	11,181			14,140
Total Equity, End of Period	$	15,916		$	19,876	$	(1,689	)	$	(2,694	)	$	14,227		$	17,182

	Three Months Ended March 31,
	As Previously Reported and Adjusted Herein						Impact of Accounting Change						As Revised
	2017			2016			2017			2016			2017			2016
	(in millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	(312	)	$	1,736		$	192		$	(669	)	$	(120	)	$	1,067
Policy charges and fee income	(925		)	(860		)	67			65			(858		)	(795		)
Net derivative (gains) loss	733			(2,386		)	(433		)	1,062			300			(1,324		)
Changes in:
Future policy benefits	205			621			69			(106		)	274			515
Deferred Policy Acquisition costs	125			22			2			9			127			31
Current and deferred income taxes	(327		)	741			103			(361		)	(224		)	380
Net cash provided by (used in) operating activities	$	18		$	190		$	—		$	—		$	18		$	190

Embedded Derivatives

Reserves for products that have a GMIB feature with a no-lapse guarantee rider GMIBNLG, GIB, GWBL, GMWB or GMAB features are considered embedded derivatives and measured at estimated fair value separately from the host variable annuity product, with changes in estimated fair value reported in net derivative gains (losses). The estimated fair values of these embedded derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees attributable to the guarantee. The projections of future benefits and future fees require capital markets and actuarial assumptions, including expectations concerning policyholder behavior. A risk neutral valuation methodology is used under which the cash flows from the guarantees are projected under multiple capital market scenarios using observable risk-free rates.

Additionally, the Company cedes reinsurance for products with GMIB features where both the GMIB reinsurance contract asset and liability is considered an embedded derivative. The GMIB reinsurance contract assets fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios.

Changes in the fair value of embedded derivatives are reported on the statement of income in Derivative gains (losses). Reserves for Guarantee embedded derivatives liabilities and assumed reinsurance contracts are reported in Future policyholders' benefits and other policyholders’ liabilities and the GMIB reinsurance contract asset is reported in a stand alone line in the consolidated balance sheets.

Assumption Updates

2017 Assumption Changes. In third quarter 2017, Company updated its expectation of long-term Separate Accounts volatility used in estimating policyholders’ benefits for variable annuities with GMDB and GMIB guarantees and variable universal life contracts with secondary guarantees. This update decreased policyholders’ benefits by $359 million. In addition, the Company updated the accrual period used to calculate policyholders’ benefits for variable annuities with GMDB and GMIB guarantees and the period over which DAC is amortized. This update increased policyholders’ benefits by $413million and reduced the Amortization of deferred policy acquisition costs by $14 million. In both the third quarter and nine months ending September 30, 2017, these updates decreased Income (loss) from continuing operations before income taxes and Net income by $40 million and $26 million, respectively.

In the second quarter 2017, the Company updated its expectations of long-term lapse and partial withdrawal behavior for variable annuities with GMDB and GMIB guarantees based on emerging experience. This update increased Policyholders’ benefits by $610 million, increased the GMIB reinsurance contract asset by $1,532 million, decreased Future policyholder benefits and other policyholders’ liabilities by $447 million, decreased the amortization of the deferred cost of reinsurance reported in Other operating costs and expenses by $226 million and decreased the Amortization of deferred policy acquisition costs, net by $32 million. In the nine months ending September 30, 2017, these updates increased Income (loss) from continuing operations before income taxes and Net income by $1,627 million, and $1,058 million, respectively.

2016 Assumption Changes. In third quarter 2016, as part of a planned model conversion, the Company updated the model used to calculate the variable life policyholder benefit reserves. The update aligned the renewal premium modeling used in the variable life benefit reserve calculation with the premium funding assumption used in the DAC and the initial fee liability calculations. In addition, as part of the planned model conversion, the calculation of premium loads resulting from the dynamic premium funding assumption was updated in the model used to calculate the interest sensitive life policyholder benefit reserve. The net impact of these model updates and assumption updates in the third quarter and first nine months of 2016 decreased Policyholders’ benefits by $144 million, increased the Amortization of deferred policy acquisition costs, net by $129 million and increased Policy charges and fee income by $14 million. In the nine months ending September 30, 2016, these model and assumption updates increased Income from continuing operations before income taxes and Net income by approximately $29 million and $19 million, respectively. 

In second quarter 2016, the Company updated its mortality assumption for certain VISL products due to favorable mortality experience, which decreased the Amortization of deferred policy acquisition costs, net and decreased the amortization of the initial fee liability reported in Policy charges and fee income by $105 million and $16 million respectively. Additionally, in the second quarter 2016 the Company updated the General Account spread assumption for certain VISL products to reflect lower expected investment yields which increased the Amortization of deferred policy acquisition costs, net and increased the amortization of the initial fee liability reported in Policy charges and fee income by $114 million and $4 million, respectively. In the nine months ending September 30, 2016, these assumption updates decreased Income from continuing operations before income taxes and Net income by approximately $21 million and $14 million, respectively.

In first quarter 2016, the Company raised cost of insurance (“COI”) rates for certain UL policies issued between 2004 and 2007, which have both issue ages 70 and above and a current face value amount of $1 million and above. The Company raised the COI rates for these policies as management expects future mortality and investment experience to be less favorable than what was anticipated when the original schedule of COI rates was established.  This COI rate increase was larger than the increase that previously had been anticipated in management’s reserve assumptions.  As a result, management updated the assumption to reflect the actual COI rate increase, which increased Policy charges and fee income by $71 million. In the nine months ending September 30, 2016, this assumption update increased Income from continuing operations before income taxes and Net income by $71 million and $46 million, respectively.

XML

INVESTMENTS

9 Months Ended

Sep. 30, 2017

Investments, Debt and Equity Securities [Abstract]

Investments

INVESTMENTS

Fixed Maturities and Equity Securities

The following table provides information relating to fixed maturities and equity securities classified as AFS:

Available-for-Sale Securities by Classification

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		OTTI in AOCI (3)
	(in millions)
September 30, 2017:
Fixed Maturity Securities:
Public corporate	$	12,429	$	748	$	39	$	13,138	$	—
Private corporate	7,069		256		34		7,291		—
U.S. Treasury, government and agency	10,842		473		379		10,936		—
States and political subdivisions	414		67		—		481		—
Foreign governments	369		29		5		393		—
Commercial mortgage-backed	280		8		26		262		1
Residential mortgage-backed(1)	249		16		—		265		—
Asset-backed(2)	30		1		1		30		2
Redeemable preferred stock	457		48		1		504		—
Total Fixed Maturities	32,139		1,646		485		33,300		3
Equity securities	135		—		—		135		—
Total at September 30, 2017	$	32,274	$	1,646	$	485	$	33,435	$	3
December 31, 2016:
Fixed Maturity Securities:
Public corporate	$	12,418	$	675	$	81	$	13,012	$	—
Private corporate	6,880		215		55		7,040		—
U.S. Treasury, government and agency	10,739		221		624		10,336		—
States and political subdivisions	432		63		2		493		—
Foreign governments	375		29		14		390		—
Commercial mortgage-backed	415		28		72		371		7
Residential mortgage-backed(1)	294		20		—		314		—
Asset-backed(2)	51		10		1		60		3
Redeemable preferred stock	519		45		10		554		—
Total Fixed Maturities	32,123		1,306		859		32,570		10
Equity securities	113		—		—		113		—
Total at December 31, 2016	$	32,236	$	1,306	$	859	$	32,683	$	10

(1) Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.

(2) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.

(3) Amounts represent OTTI losses in AOCI, which were not included in Net income (loss) in accordance with current accounting guidance.

The contractual maturities of AFS fixed maturities at September 30, 2017 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

Available-for-Sale Fixed Maturities

Contractual Maturities at September 30, 2017

	Amortized Cost		Fair Value
	(in millions)
Due in one year or less	$	1,701	$	1,723
Due in years two through five	7,349		7,686
Due in years six through ten	9,256		9,530
Due after ten years	12,817		13,300
Subtotal	31,123		32,239
Commercial mortgage-backed securities	280		262
Residential mortgage-backed securities	249		265
Asset-backed securities	30		30
Redeemable preferred stock	457		504
Total	$	32,139	$	33,300

The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during the third quarter and first nine months of 2017 and 2016:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
Proceeds from sales	$	1,287		$	1,080		$	1,822		$	2,866
Gross gains on sales	$	5		$	9		$	34		$	94
Gross losses on sales	$	(2	)	$	(1	)	$	(29	)	$	(47	)
Total OTTI	$	—		$	(10	)	$	(13	)	$	(35	)
Non-credit losses recognized in OCI	—			—			—			—
Credit losses recognized in income (loss)	$	—		$	(10	)	$	(13	)	$	(35	)

The following table sets forth the amount of credit loss impairments on fixed maturity securities held by the Company at the dates indicated.

Fixed Maturities - Credit Loss Impairments

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
Balances, beginning of period	$	(115	)	$	(166	)	$	(190	)	$	(198	)
Previously recognized impairments on securities that matured, paid, prepaid or sold	32			8			120			65
Recognized impairments on securities impaired to fair value this period(1)	—			—			—			(17		)
Impairments recognized this period on securities not previously impaired	—			(8		)	(13		)	(16		)
Additional impairments this period on securities previously impaired	—			(2		)	—			(2		)
Increases due to passage of time on previously recorded credit losses	—			—			—			—
Accretion of previously recognized impairments due to increases in expected cash flows	—			—			—			—
Balances at September 30,	$	(83	)	$	(168	)	$	(83	)	$	(168	)

(1) Represents circumstances where the Company determined in the current period that it intends to sell the security or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.

Net unrealized investment gains (losses) on fixed maturities and equity securities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated:

	September 30, 2017		December 31, 2016
	(in millions)
AFS Securities:
Fixed maturities:
With OTTI loss	$	—	$	19
All other	1,161		428
Equity securities	—		—
Net Unrealized Gains (Losses)	$	1,161	$	447

Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net income (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturity securities on which an OTTI loss has been recognized and all other amounts:

Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses

	Net Unrealized Gains (Losses) on Investments			DAC			Policyholders’ Liabilities			Deferred Income Tax Asset (Liability)			AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(in millions)
Balance, July 1, 2017	$	(6	)	$	2		$	1		$	1		$	(2	)
Net investment gains (losses) arising during the period	(5		)	—			—			—			(5		)
Reclassification adjustment:
Included in Net income (loss)	11			—			—			—			11
Excluded from Net income (loss)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			(1		)	—			—			(1		)
Deferred income taxes	—			—			—			(1		)	(1		)
Policyholders’ liabilities	—			—			(1		)	—			(1		)
Balance, September 30, 2017	$	—		$	1		$	—		$	—		$	1
Balance, July 1, 2016	$	15		$	—		$	—		$	(6	)	$	9
Net investment gains (losses) arising during the period	2			—			—			—			2
Reclassification adjustment:
Included in Net income (loss)	1			—			—			—			1
Excluded from Net income (loss)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			—			—			—			—
Deferred income taxes	—			—			—			(1		)	(1		)
Policyholders’ liabilities	—			—			—			—			—
Balance, September 30, 2016	$	18		$	—		$	—		$	(7	)	$	11

	Net Unrealized Gains (Losses) on Investments			DAC			Policyholders’ Liabilities			Deferred Income Tax Asset (Liability)			AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(in millions)
Balance, January 1, 2017	$	19		$	(1	)	$	(10	)	$	(3	)	$	5
Net investment gains (losses) arising during the period	—			—			—			—			—
Reclassification adjustment for OTTI losses:
Included in Net income (loss)	(19		)	—			—			—			(19		)
Excluded from Net income (loss)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			2			—			—			2
Deferred income taxes	—			—			—			3			3
Policyholders’ liabilities	—			—			10			—			10
Balance, September 30, 2017	$	—		$	1		$	—		$	—		$	1
Balance, January 1, 2016	$	16		$	—		$	(4	)	$	(5	)	$	7
Net investment gains (losses) arising during the period	(5		)	—			—			—			(5		)
Reclassification adjustment for OTTI losses:
Included in Net income (loss)	7			—			—			—			7
Excluded from Net income (loss)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			—			—			—			—
Deferred income taxes	—			—			—			(2		)	(2		)
Policyholders’ liabilities	—			—			4			—			4
Balance, September 30, 2016	$	18		$	—		$	—		$	(7	)	$	11

All Other Net Unrealized Investment Gains (Losses) in AOCI

	Net Unrealized Gains (Losses) on Investments			DAC			Policyholders’ Liabilities			Deferred Income Tax Asset (Liability)			AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(In Millions)
Balance, July 1, 2017	$	1,145		$	(172	)	$	(208	)	$	(267	)	$	498
Net investment gains (losses) arising during the period	18			—			—			—			18
Reclassification adjustment:
Included in Net income (loss)	(2		)	—			—			—			(2		)
Excluded from Net income (loss)(1)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			6			—			(11		)	(5		)
Deferred income taxes	—			—			—			22			22
Policyholders’ liabilities	—			—			(24		)	(11		)	(35		)
Balance, September 30, 2017	$	1,161		$	(166	)	$	(232	)	$	(267	)	$	496
Balance, July 1, 2016	$	3,079		$	(266	)	$	(471	)	$	(821	)	$	1,521
Net investment gains (losses) arising during the period	(17		)	—			—			—			(17		)
Reclassification adjustment:
Included in Net income (loss)	—			—			—			—			—
Excluded from Net income (loss)(1)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			79			—			—			79
Deferred income taxes	—			—			—			(21		)	(21		)
Policyholders’ liabilities	—			—			5			(1		)	4
Balance, September 30, 2016	$	3,062		$	(187	)	$	(466	)	$	(843	)	$	1,566

	Net Unrealized Gains (Losses) on Investments			DAC			Policyholders’ Liabilities			Deferred Income Tax Asset (Liability)			AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(in millions)
Balance, January 1, 2017	$	428		$	(87	)	$	(189	)	$	(53	)	$	99
Net investment gains (losses) arising during the period	705			—			—			—			705
Reclassification adjustment for OTTI losses:
Included in Net income (loss)	28			—			—			—			28
Excluded from Net income (loss)(1)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			(79		)	—			—			(79		)
Deferred income taxes	—			—			—			(214		)	(214		)
Policyholders’ liabilities	—			—			(43		)	—			(43		)
Balance, September 30, 2017	$	1,161		$	(166	)	$	(232	)	$	(267	)	$	496
Balance, January 1, 2016	$	674		$	(131	)	$	(230	)	$	(110	)	$	203
Net investment gains (losses) arising during the period	2,417			—			—			—			2,417
Reclassification adjustment for OTTI losses:
Included in Net income (loss)	(29		)	—			—			—			(29		)
Excluded from Net income (loss)(1)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			(56		)	—			8			(48		)
Deferred income taxes	—			—			—			(755		)	(755		)
Policyholders’ liabilities	—			—			(236		)	14			(222		)
Balance, September 30, 2016	$	3,062		$	(187	)	$	(466	)	$	(843	)	$	1,566

(1) Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in income (loss) for securities with no prior OTTI loss.

The following tables disclose the fair values and gross unrealized losses of the 577 issues at September 30, 2017 and the 794 issues at December 31, 2016 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:

	Less Than 12 Months				12 Months or Longer				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
	(in millions)
September 30, 2017:
Fixed Maturity Securities:
Public corporate	$	1,207	$	15	$	752	$	24	$	1,959	$	39
Private corporate	739		11		467		23		1,206		34
U.S. Treasury, government and agency	1,354		53		3,048		326		4,402		379
States and political subdivisions	—		—		—		—		—		—
Foreign governments	13		—		59		5		72		5
Commercial mortgage-backed	49		4		137		22		186		26
Residential mortgage-backed	7		—		13		—		20		—
Asset-backed	1		—		9		1		10		1
Redeemable preferred stock	50		—		12		1		62		1
Total	$	3,420	$	83	$	4,497	$	402	$	7,917	$	485
December 31, 2016:
Fixed Maturity Securities:
Public corporate	$	2,455	$	75	$	113	$	6	$	2,568	$	81
Private corporate	1,483		38		277		17		1,760		55
U.S. Treasury, government and agency	5,356		624		—		—		5,356		624
States and political subdivisions	—		—		18		2		18		2
Foreign governments	73		3		49		11		122		14
Commercial mortgage-backed	66		5		171		67		237		72
Residential mortgage-backed	47		—		4		—		51		—
Asset-backed	4		—		8		1		12		1
Redeemable preferred stock	218		9		12		1		230		10
Total	$	9,702	$	754	$	652	$	105	$	10,354	$	859

The Company’s investments in fixed maturity securities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of AXA Equitable, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.3% of total investments. The largest exposures to a single issuer of corporate securities held at September 30, 2017 and December 31, 2016 were $178 million and $169 million, respectively. Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium grade), 4 or 5 (below investment grade) or 6 (in or near default). At September 30, 2017 and December 31, 2016, respectively, approximately $1,523 million and $1,574 million, or 4.7% and 4.9%, of the $32,139 million and $32,123 million aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had net unrealized losses of $10 million and $28 million at September 30, 2017 and December 31, 2016, respectively. At September 30, 2017 and December 31, 2016, respectively, the $402 million and $105 million of gross unrealized losses of twelve months or more were concentrated in corporate, U.S. Treasury, government and agency and commercial mortgage-backed securities. In accordance with the policy described in Note 2, the Company concluded that an adjustment to income for OTTI for these securities was not warranted at either September 30, 2017 or 2016. At September 30, 2017 and December 31, 2016, the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis.

At September 30, 2017, the carrying value of fixed maturities that were non-income producing for the twelve months preceding that date was $1 million.

For the third quarter and first nine months of 2017 and 2016, investment income is shown net of investment expenses of $31 million, $40 million, $16 million and $47 million respectively.

At September 30, 2017 and December 31, 2016, respectively, the fair values of the Company's trading account securities were $12,053 million and $9,134 million, respectively. Also at September 30, 2017 and December 31, 2016, trading securities included the General Account’s investment in Separate Accounts, which had carrying values of $49 million and $63 million and costs of $31 million and $46 million.

Net unrealized and realized gains (losses) on trading account equity securities are included in Net investment income (loss) in the Consolidated Statements of Income (Loss). The table below shows a breakdown of Net investment income from trading account securities during the third quarter and first nine months of 2017 and 2016:

Net Investment Income (Loss) from Trading Securities

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
	(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period	$	45	$	7	$	153	$	126
Net investment gains (losses) recognized on securities sold during the period	10		1		35		(9		)
Unrealized and realized gains (losses) on trading securities arising during the period	55		8		188		117
Interest and dividend income from trading securities	54		34		143		82
Net investment income (loss) from trading securities	$	109	$	42	$	331	$	199

Mortgage Loans

Mortgage loans on real estate are placed on nonaccrual status once management determines the collection of accrued interest is doubtful. Once mortgage loans on real estate are classified as nonaccrual loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan on real estate has been restructured to where the collection of interest is considered likely. At September 30, 2017 and December 31, 2016, the carrying values of commercial mortgage loans on real estate that had been classified as nonaccrual loans were $19 million and $34 million, respectively.

Troubled Debt Restructurings

During second quarter 2017, the Company sold the property previously considered a TDR mortgage loan. As of September 30, 2017, no mortgage loan on the Company balance sheet was considered a TDR.

Valuation Allowances for Mortgage Loans:

Allowance for credit losses for commercial mortgage loans for the first nine months of 2017 and 2016 was as follows:

	2017		2016
Allowance for credit losses:	(in millions)
Beginning balance, January 1,	$	8	$	6
Charge-offs	—		—
Recoveries	—		(2		)
Provision	—		4
Ending balance, September 30,	$	8	$	8
September 30, Individually Evaluated for Impairment	$	8	$	8

There were no allowances for credit losses for agricultural mortgage loans for the first nine months of 2017 and 2016.

The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at September 30, 2017 and December 31, 2016, before adjustments for valuation allowance. The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value.

Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios

September 30, 2017

	Debt Service Coverage Ratio
Loan-to-Value Ratio:(2)	Greater than 2.0x		1.8x to 2.0x		1.5x to 1.8x		1.2x to 1.5x		1.0x to 1.2x		Less than 1.0x		Total Mortgage Loans
	(in millions)
Commercial Mortgage Loans(1)
0% - 50%	$	741	$	—	$	313	$	74	$	—	$	—	$	1,128
50% - 70%	4,094		555		1,048		416		146		—		6,259
70% - 90%	170		—		196		254		50		—		670
90% plus	—		—		27		—		—		—		27
Total Commercial Mortgage Loans	$	5,005	$	555	$	1,584	$	744	$	196	$	—	$	8,084
Agricultural Mortgage Loans(1)
0% - 50%	$	270	$	141	$	297	$	504	$	300	$	33	$	1,545
50% - 70%	118		56		213		334		210		49		980
70% - 90%	—		—		—		4		—		—		4
90% plus	—		—		—		—		—		—		—
Total Agricultural Mortgage Loans	$	388	$	197	$	510	$	842	$	510	$	82	$	2,529
Total Mortgage Loans(1)
0% - 50%	$	1,011	$	141	$	610	$	578	$	300	$	33	$	2,673
50% - 70%	4,212		611		1,261		750		356		49		7,239
70% - 90%	170		—		196		258		50		—		674
90% plus	—		—		27		—		—		—		27
Total Mortgage Loans	$	5,393	$	752	$	2,094	$	1,586	$	706	$	82	$	10,613

(1) The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.

(2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.

Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios

December 31, 2016

	Debt Service Coverage Ratio
Loan-to-Value Ratio:(2)	Greater than 2.0x		1.8x to 2.0x		1.5x to 1.8x		1.2x to1.5x		1.0x to 1.2x		Less than 1.0x		Total Mortgage Loans
	(in millions)
Commercial Mortgage Loans(1)
0% - 50%	$	738	$	95	$	59	$	56	$	—	$	—	$	948
50% - 70%	3,217		430		673		1,100		76		—		5,496
70% - 90%	282		65		229		127		28		46		777
90% plus	—		—		28		15		—		—		43
Total Commercial Mortgage Loans	$	4,237	$	590	$	989	$	1,298	$	104	$	46	$	7,264
Agricultural Mortgage Loans(1)
0% - 50%	$	254	$	138	$	296	$	468	$	286	$	49	$	1,491
50% - 70%	141		57		209		333		219		45		1,004
70% - 90%	—		—		2		4		—		—		6
90% plus	—		—		—		—		—		—		—
Total Agricultural Mortgage Loans	$	395	$	195	$	507	$	805	$	505	$	94	$	2,501
Total Mortgage Loans(1)
0% - 50%	$	992	$	233	$	355	$	524	$	286	$	49	$	2,439
50% - 70%	3,358		487		882		1,433		295		45		6,500
70% - 90%	282		65		231		131		28		46		783
90% plus	—		—		28		15		—		—		43
Total Mortgage Loans	$	4,632	$	785	$	1,496	$	2,103	$	609	$	140	$	9,765

(1) The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.

(2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.

The following table provides information relating to the aging analysis of past due mortgage loans at September 30, 2017 and December 31, 2016, respectively, before adjustments for valuation allowance.

Age Analysis of Past Due Mortgage Loans

	30-59     Days		60-89     Days		90     Days     or >		Total		Current		Total Financing Receivables		Recorded Investment 90 Days or > and Accruing
							(in millions)
September 30, 2017
Commercial	$	—	$	—	$	—	$	—	$	8,084	$	8,084	$	—
Agricultural	3		15		27		45		2,484		2,529		27
Total Mortgage Loans	$	3	$	15	$	27	$	45	$	10,568	$	10,613	$	27
December 31, 2016
Commercial	$	—	$	—	$	—	$	—	$	7,264	$	7,264	$	—
Agricultural	9		2		6		17		2,484		2,501		6
Total Mortgage Loans	$	9	$	2	$	6	$	17	$	9,748	$	9,765	$	6

The following table provides information regarding impaired mortgage loans at September 30, 2017 and December 31, 2016, respectively.

Impaired Mortgage Loans

	Recorded Investment		Unpaid Principal Balance		Related Allowance			Average Recorded Investment(1)		Interest Income Recognized
	(in millions)
September 30, 2017:
With no related allowance recorded:
Commercial mortgage loans - other	$	—	$	—	$	—		$	—	$	—
Agricultural mortgage loans	—		—		—			—		—
Total	$	—	$	—	$	—		$	—	$	—
With related allowance recorded:
Commercial mortgage loans - other	$	27	$	27	$	(8	)	$	27	$	1
Agricultural mortgage loans	—		—		—			—		—
Total	$	27	$	27	$	(8	)	$	27	$	1
December 31, 2016:
With no related allowance recorded:
Commercial mortgage loans - other	$	15	$	15	$	—		$	22	$	—
Agricultural mortgage loans	—		—		—			—		—
Total	$	15	$	15	$	—		$	22	$	—
With related allowance recorded:
Commercial mortgage loans - other	$	27	$	27	$	(8	)	$	48	$	2
Agricultural mortgage loans	—		—		—			—		—
Total	$	27	$	27	$	(8	)	$	48	$	2

(1) Represents a four-quarter average of recorded amortized cost.

Derivatives and Offsetting Assets and Liabilities

The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a Derivative Use Plan ("DUP") approved by the NYDFS. Derivatives are generally not accounted for using hedge accounting, with the exception of Treasury Inflation-Protected Securities (“TIPS”), which is discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps, equity options credit and foreign exchange derivatives as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets.

Derivatives utilized to hedge exposure to Variable Annuities with GMxB Features

The Company has issued and continues to offer variable annuity products with variable annuity guaranteed benefits (“GMxB”), including guaranteed minimum living benefits (“GMLBs”) (such as GMIBs, GMWBs and GMABs), and guaranteed minimum death benefits (“GMDBs”) (inclusive of return of premium death benefit guarantees). The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB derivative features liability is that under-performance of the financial markets could result in the GMxB derivative features' benefits being higher than what accumulated policyholders’ account balances would support.

For GMxB features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company.

From time to time the Company maintains an economic hedge program that uses interest rate swaps to partially protect the overall profitability of future variable annuity sales against declining interest rates.

Derivatives utilized to hedge crediting rate exposure on SCS, SIO, MSO and IUL products/investment options

The Company hedges crediting rates in the Structured Capital Strategies (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST variable annuity series (“SIO”), Market Stabilizer Option (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment.

In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers without any basis risk due to market exposures, thereby substantially reducing any exposure to market-related earnings volatility.

Derivatives used for General Account Investment Portfolio

The Company maintains a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible for investment under its investment guidelines through the sale of credit default swaps (“CDSs”). Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives generally have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net investment income (loss). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company generally transacts the sale of CDSs in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty’s option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these CDSs. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the dollar or euro-equivalent of the derivative notional amount. The Standard North American CDS Contract (“SNAC”) or Standard European Corporate Contract (“STEC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative.

The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond. At September 30, 2017 and December 31, 2016, the Company’s unrealized gains (losses) related to this program were $97 million and $97 million, respectively, and reported in AOCI.

The Company implemented a strategy to hedge a portion of the credit exposure in its General Account investment portfolio by buying protection through a swap. These are swaps on the “super senior tranche” of the investment grade CDX index. Under the terms of these swaps, the Company pays quarterly fixed premiums that, together with any initial amount paid or received at trade inception, serve as premiums paid to hedge the risk arising from multiple defaults of bonds referenced in the CDX index. These credit derivatives have terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net derivative gains (losses).

In 2016, the Company implemented a program to mitigate its duration gap using total return swaps for which the reference U.S. Treasury securities are sold to the swap counterparty under arrangements economically similar to repurchase agreements. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. Under this program the Company derecognized approximately $2,220 million U.S. Treasury securities for which the Company received proceeds of approximately $2,126 million at inception of the total return swap contract.  Under the terms of these swaps, the Company retains ongoing exposure to the total returns of the underlying U.S. Treasury securities in exchange for a financing cost. At September 30, 2017, the aggregate fair value of U.S. Treasury securities derecognized under this program was approximately $2,090 million. Reported in Other invested assets in the Company's balance sheet at September 30, 2017 is approximately $(8) million, representing the fair value of the total return swap contracts.

The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments.

Derivative Instruments by Category

	At September 30, 2017						Gains (Losses) Reported In Net Income (Loss) Nine Months Ended September 30, 2017
			Fair Value
	Notional Amount		Asset Derivatives		Liability Derivatives
	(in millions)
Freestanding derivatives:
Equity contracts:(1)
Futures	$	3,858	$	1	$	1	$	(512	)
Swaps	4,289		—		162		(596		)
Options	16,294		2,760		1,243		831
Interest rate contracts:(1)
Floors	—		—		—		—
Swaps	19,889		272		243		523
Futures	9,133		—		—		28
Credit contracts:(1)
Credit default swaps	3,156		35		5		16
Other freestanding contracts:(1)
Foreign currency contracts	1,262		17		9		(40		)
Margin	—		46		—		—
Collateral	—		16		1,442		—
Embedded derivatives:
GMIB reinsurance contracts(4)	—		10,933		—		537
GMxB derivative features liability(2,4)	—		—		4,375		1,151
SCS, SIO, MSO and IUL indexed features(3,4)	—		—		1,437		(562		)
Total	$	57,881	$	14,080	$	8,917	$	1,376

(1) Reported in Other invested assets in the consolidated balance sheets.

(2) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.

(3) SCS and SIO indexed features are reported in Policyholders’ account balances; MSO and IUL indexed features are reported in the Future policyholders’ benefits and other policyholders’ liabilities in the consolidated balance sheets.

(4) Reported in Net derivative gains (losses) in the consolidated statements of income (loss).

	At December 31, 2016						Gains (Losses) Reported In Net Earnings (Loss) September 30, 2016
			Fair Value
	Notional Amount		Asset Derivatives		Liability Derivatives
	(in millions)
Freestanding derivatives:
Equity contracts:(1)
Futures	$	5,086	$	1	$	1	$	(581	)
Swaps	3,529		13		67		(193		)
Options	11,465		2,114		1,154		435
Interest rate contracts:(1)
Floors	1,500		11		—		4
Swaps	18,933		246		1,163		1,460
Futures	6,926		—		—		(23		)
Swaptions	—		—		—		—
Credit contracts:(1)
Credit default swaps	2,757		20		15		9
Other freestanding contracts:(1)
Foreign currency contracts	730		52		6		(13		)
Margin	—		113		6		—
Collateral	—		713		748		—
Embedded derivatives:
GMIB reinsurance contracts(4)	—		10,309		—		2,576
GMxB derivative features liability(2,4)	—		—		5,289		(1,712		)
SCS, SIO, MSO and IUL indexed features(3,4)	—		—		875		(341		)
Total	$	50,926	$	13,592	$	9,324	$	1,621

(1) Reported in Other invested assets in the consolidated balance sheets.

(2) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.

(3) SCS and SIO indexed features are reported in Policyholders’ account balances; MSO and IUL indexed features are reported in the Future policyholders’ benefits and other policyholders’ liabilities in the consolidated balance sheets.

(4) Reported in Net derivative gains (losses) in the consolidated statements of income (loss).

Equity-Based and Treasury Futures Contracts

All outstanding equity-based and treasury futures contracts at September 30, 2017 are exchange-traded and net settled daily in cash. At September 30, 2017, the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000, and Emerging Market indices, having initial margin requirements of $124 million, (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $16 million and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200, and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $14 million.

Credit Risk

Although notional amount is the most commonly used measure of volume in the derivatives market, it is not used as a measure of credit risk. A derivative with positive fair value (a derivative asset) indicates existence of credit risk because the counterparty would owe money to the Company if the contract were closed at the reporting date. Alternatively, a derivative contract with negative fair value (a derivative liability) indicates the Company would owe money to the counterparty if the contract were closed at the reporting date. To reduce credit exposures in Over-the-Counter (“OTC”)

derivative transactions the Company generally enters into master agreements that provide for a netting of financial exposures with the counterparty and allow for collateral arrangements as further described below under “ISDA Master Agreements.” The Company further controls and minimizes its counterparty exposure through a credit appraisal and approval process.

ISDA Master Agreements

Netting Provisions. The standardized ISDA Master Agreement under which the Company conducts its OTC derivative transactions includes provisions for payment netting. In the normal course of business activities, if there is more than one derivative transaction with a single counterparty, the Company will set-off the cash flows of those derivatives into a single amount to be exchanged in settlement of the resulting net payable or receivable with that counterparty. In the event of default, insolvency, or other similar event pre-defined under the ISDA Master Agreement that would result in termination of OTC derivatives transactions before their maturity, netting procedures would be applied to calculate a single net payable or receivable with the counterparty.

Collateral Arrangements. The Company generally has executed a CSA under the ISDA Master Agreement it maintains with each of its OTC derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. These CSAs are bilateral agreements that require collateral postings by the party “out-of-the-money” or in a net derivative liability position. Various thresholds for the amount and timing of collateralization of net liability positions are applicable. Consequently, the credit exposure of the Company’s OTC derivative contracts is limited to the net positive estimated fair value of those contracts at the reporting date after taking into consideration the existence of netting agreements and any collateral received pursuant to CSAs. Derivatives are recognized at fair value in the consolidated balance sheets and are reported either as assets in Other invested assets or as liabilities in Other liabilities, except for embedded insurance-related derivatives as described above and derivatives transacted with a related counterparty. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed.

At September 30, 2017 and December 31, 2016, respectively, the Company held $1,429 million and $35 million in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. This unrestricted cash collateral is reported in Cash and cash equivalents. The aggregate fair value of all collateralized derivative transactions that were in a liability position with trade counterparties at September 30, 2017 and December 31, 2016, respectively, were $14 million and $128 million, for which the Company posted collateral of $14 million and $131 million at September 30, 2017 and December 31, 2016, respectively, in the normal operation of its collateral arrangements. Certain of the Company’s ISDA Master Agreements contain contingent provisions that permit the counterparty to terminate the ISDA Master Agreement if the Company’s credit rating falls below a specified threshold, however, the occurrence of such credit event would not impose additional collateral requirements.

Securities Repurchase and Reverse Repurchase Transactions

Securities repurchase and reverse repurchase transactions are conducted by the Company under a standardized securities industry master agreement, amended to suit the specificities of each respective counterparty. These agreements generally provide detail as to the nature of the transaction, including provisions for payment netting, establish parameters concerning the ownership and custody of the collateral securities, including the right to substitute collateral during the term of the agreement, and provide for remedies in the event of default by either party. Amounts due to/from the same counterparty under these arrangements generally would be netted in the event of default and subject to rights of set-off in bankruptcy. The Company’s securities repurchase and reverse repurchase agreements are accounted for as secured borrowing or lending arrangements, respectively and are reported in the consolidated balance sheets on a gross basis. The Company obtains or posts collateral generally in the form of cash and U.S. Treasury, corporate and government agency securities. The fair value of the securities to be repurchased or resold are monitored on a daily basis with additional collateral posted or obtained as necessary. Securities to be repurchased or resold are the same, or substantially the same, as those initially transacted under the arrangement. At September 30, 2017 and December 31, 2016, there were no balances outstanding under reverse repurchase transactions. At September 30, 2017 and December 31, 2016, the balance outstanding under securities repurchase transactions was $1,837 million and $1,996 million, respectively. The Company utilized these repurchase and reverse repurchase agreements for asset liability and cash management purposes. For other instruments used for asset liability management purposes, see “Obligation under funding agreements” included in Note 11.

The following table presents information about the Insurance Segment’s offsetting of financial assets and liabilities and derivative instruments at September 30, 2017.

Offsetting of Financial Assets and Liabilities and Derivative Instruments

At September 30, 2017

	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheets		Net Amounts Presented in the Balance Sheets
	(in millions)
ASSETS(1)
Description
Derivatives:
Equity contracts	$	2,761	$	1,406	$	1,355
Interest rate contracts	272		243		29
Credit contracts	35		5		30
Currency	17		9		8
Margin	46		—		46
Collateral	16		1,442		(1,426		)
Total Derivatives, subject to an ISDA Master Agreement	3,147		3,105		42
Total Derivatives, not subject to an ISDA Master Agreement	—		—		—
Total Derivatives	3,147		3,105		42
Other financial instruments	2,473		—		2,473
Other invested assets	$	5,620	$	3,105	$	2,515
Securities purchased under agreement to resell	$	—	$	—	$	—
LIABILITIES(2)
Description
Derivatives:
Equity contracts	$	1,406	$	1,406	$	—
Interest rate contracts	243		243		—
Credit contracts	5		5		—
Currency	9		9		—
Margin	—		—		—
Collateral	1,442		1,442		—
Total Derivatives, subject to an ISDA Master Agreement	3,105		3,105		—
Total Derivatives, not subject to an ISDA Master Agreement	—		—		—
Total Derivatives	3,105		3,105		—
Other financial liabilities	2,869		—		2,869
Other liabilities	$	5,974	$	3,105	$	2,869
Securities sold under agreement to repurchase(3)	$	1,830	$	—	$	1,830

(1) Excludes $1.8 million of derivative assets of consolidated VIEs and VOEs in the Investment Management segment.

(2) Excludes $2.8 million of derivative liabilities of consolidated VIEs and VOEs in the Investment Management segment.

(3) Excludes expense of $7 million in securities sold under agreement to repurchase.

The following table presents information about the Insurance segment’s gross collateral amounts that are not offset in the consolidated balance sheets at September 30, 2017.

Collateral Amounts Offset in the Consolidated Balance Sheets

At September 30, 2017

	Fair Value of Assets		Collateral (Received)/Held
			Financial Instruments			Cash			Net Amounts
	(in millions)
ASSETS:(1)
Total derivatives	$	1,423	$	—		$	(1,381	)	$	42
Other financial instruments	2,473		—			—			2,473
Other invested assets	$	3,896	$	—		$	(1,381	)	$	2,515
Securities purchased under agreement to resell	$	—	$	—		$	—		$	—
LIABILITIES:(2)
Securities sold under agreement to repurchase(3)	$	1,830	$	(1,894	)	$	—		$	(64	)

(1) Excludes Investment Management segment’s derivative assets of consolidated VIEs.

(2) Excludes Investment Management segment’s derivative liabilities of consolidated VIEs.

(3) Excludes expense of $7 million in securities sold under agreement to repurchase.

The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at September 30, 2017.

Repurchase Agreement Accounted for as Secured Borrowings

	At September 30, 2017
	Remaining Contractual Maturity of the Agreements
	Overnight and Continuous		Up to 30 days		30–90 days		Greater Than 90 days		Total
	(in millions)
Securities sold under agreement to repurchase(1)
U.S. Treasury and agency securities	$	—	$	1,830	$	—	$	—	$	1,830
Total	$	—	$	1,830	$	—	$	—	$	1,830
Securities purchased under agreement to resell
Corporate securities	$	—	$	—	$	—	$	—	$	—
Total	$	—	$	—	$	—	$	—	$	—

(1) Excludes expense accrual of $7 million in securities sold under agreement to repurchase.

The following table presents information about the Insurance segment’s offsetting financial assets and liabilities and derivative instruments at December 31, 2016.

Offsetting of Financial Assets and Liabilities and Derivative Instruments

At December 31, 2016

	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheets		Net Amounts Presented in the Balance Sheets
	(in millions)
ASSETS(1)
Description
Derivatives:
Equity contracts	$	2,129	$	1,220	$	909
Interest rate contracts	253		1,163		(910		)
Credit contracts	20		15		5
Currency	52		6		46
Margin	113		6		107
Collateral	713		748		(35		)
Total Derivatives, subject to an ISDA Master Agreement	3,280		3,158		122
Total Derivatives, not subject to an ISDA Master Agreement	4		—		4
Total Derivatives	3,284		3,158		126
Other financial instruments	2,100		—		2,100
Other invested assets	$	5,384	$	3,158	$	2,226
Securities purchased under agreement to resell	$	—	$	—	$	—
LIABILITIES(2)
Description
Derivatives:
Equity contracts	$	1,220	$	1,220	$	—
Interest rate contracts	1,163		1,163		—
Credit contracts	15		15		—
Currency	6		6		—
Margin	6		6		—
Collateral	748		748		—
Total Derivatives, subject to an ISDA Master Agreement	3,158		3,158		—
Total Derivatives, not subject to an ISDA Master Agreement	—		—		—
Total Derivatives	3,158		3,158		—
Other financial liabilities	2,108		—		2,108
Other liabilities	$	5,266	$	3,158	$	2,108
Securities sold under agreement to repurchase(3)	$	1,992	$	—	$	1,992

(1) Excludes $1.8 million of derivative assets of consolidated VIEs and VOEs in the Investment Management segment.

(2) Excludes $2.1 million of derivative liabilities of consolidated VIEs and VOEs in the Investment Management segment.

(3) Excludes expense of $4 million in securities sold under agreement to repurchase.

The following table presents information about the Insurance segment’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2016.

Collateral Amounts Offset in the Consolidated Balance Sheets

At December 31, 2016

	Net Amounts Presented in the Balance Sheets		Collateral (Received)/Held
			Financial Instruments			Cash			Net Amounts
	(in millions)
ASSETS:(1)
Total Derivatives	$	54	$	—		$	71		$	125
Other financial instruments	2,067		—			—			2,067
Other invested assets	$	2,121	$	—		$	71		$	2,192
Securities purchased under agreement to resell	$	—	$	—		$	—		$	—
LIABILITIES(2)
Securities sold under agreement to repurchase(3)	$	1,992	$	(1,986	)	$	(2	)	$	4

(1) Excludes Investment Management segment’s derivative assets of consolidated VIEs.

(2) Excludes Investment Management segment’s derivative liabilities of consolidated VIEs.

(3) Excludes expense of $4 million in securities sold under agreement to repurchase.

The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2016.

Repurchase Agreement Accounted for as Secured Borrowings

	At December 31, 2016
	Remaining Contractual Maturity of the Agreements
	Overnight and Continuous		Up to 30 days		30–90 days		Greater  Than 90 days		Total
	(in millions)
Securities sold under agreement to repurchase(1)
U.S. Treasury and agency securities	$	—	$	1,992	$	—	$	—	$	1,992
Total	$	—	$	1,992	$	—	$	—	$	1,992

(1) Excludes expense of $4 million in securities sold under agreement

XML

CLOSED BLOCK

9 Months Ended

Sep. 30, 2017

Closed Block Disclosure [Abstract]

Closed Block

CLOSED BLOCK

The excess of Closed Block liabilities over Closed Block assets (adjusted to exclude the impact of related amounts in AOCI) represents the expected maximum future post-tax earnings from the Closed Block that would be recognized in income from continuing operations over the period the policies and contracts in the Closed Block remain in force. As of January 1, 2001, AXA Equitable has developed an actuarial calculation of the expected timing of AXA Equitable’s Closed Block’s earnings.

If the actual cumulative earnings from the Closed Block are greater than the expected cumulative earnings, only the expected earnings will be recognized in net income. Actual cumulative earnings in excess of expected cumulative earnings at any point in time are recorded as a policyholder dividend obligation because they will ultimately be paid to Closed Block policyholders as an additional policyholder dividend unless offset by future performance that is less favorable than originally expected. If a policyholder dividend obligation has been previously established and the actual Closed Block earnings in a subsequent period are less than the expected earnings for that period, the policyholder dividend obligation would be reduced (but not below zero). If, over the period the policies and contracts in the Closed Block remain in force, the actual cumulative earnings of the Closed Block are less than the expected cumulative earnings, only actual earnings would be recognized in income from continuing operations. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside the Closed Block.

Many expenses related to Closed Block operations, including amortization of DAC, are charged to operations outside of the Closed Block; accordingly, net revenues of the Closed Block do not represent the actual profitability of the Closed Block operations. Operating costs and expenses outside of the Closed Block are, therefore, disproportionate to the business outside of the Closed Block.

Summarized financial information for the Closed Block follows:

	September 30, 2017		December 31, 2016
	(in millions)
CLOSED BLOCK LIABILITIES:
Future policy benefits, policyholders’ account balances and other	$	7,016	$	7,179
Policyholder dividend obligation	43		52
Other liabilities	301		43
Total Closed Block liabilities	7,360		7,274
ASSETS DESIGNATED TO THE CLOSED BLOCK:
Fixed maturities, available for sale, at fair value (amortized cost of $3,951 and $3,884)	4,126		4,025
Mortgage loans on real estate	1,804		1,623
Policy loans	795		839
Cash and other invested assets	316		444
Other assets	173		181
Total assets designated to the Closed Block	7,214		7,112
Excess of Closed Block liabilities over assets designated to the Closed Block	146		162
Amounts included in accumulated other comprehensive income (loss):
Net unrealized investment gains (losses), net of policyholder dividend obligation of $(43) and $(52)	142		100
Maximum Future Earnings To Be Recognized From Closed Block Assets and Liabilities	$	288	$	262

Closed Block revenues and expenses were as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
REVENUES:
Premiums and other income	$	52		$	55		$	167		$	177
Net investment income (loss)	82			96			244			270
Net investment gains (losses)	(2		)	—			(18		)	1
Total revenues	132			151			393			448
BENEFITS AND OTHER DEDUCTIONS:
Policyholders’ benefits and dividends	132			131			416			404
Other operating costs and expenses	1			1			2			3
Total benefits and other deductions	133			132			418			407
Net revenues (loss) before income taxes	(1		)	19			(25		)	41
Income tax (expense) benefit	1			(7		)	9			(15		)
Net Revenues (Losses)	$	—		$	12		$	(16	)	$	26

Reconciliation of the policyholder dividend obligation follows:

	Nine Months Ended September 30,
	2017			2016
	(in millions)
Balances, beginning of year	$	52		$	81
Unrealized investment gains (losses), net of DAC	(9		)	135
Balances, End of Period	$	43		$	216

XML

INSURANCE LIABILITIES

9 Months Ended

Sep. 30, 2017

Variable Annuity Contracts-GMDB GMIB And GWBL [Abstract]

GMDB, GMIB, GWBL and No Lapse Guarantee Features

A) Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features

The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following:

• Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals);

• Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals);

• Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages;

• Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or

• Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life.

The following table summarizes the GMDB and GMIB liabilities without NLG, before reinsurance ceded, reflected in the Consolidated Balance Sheet in Future policy benefits and other policyholders’ liabilities:

	GMDB			GMIB			Total
	(in millions)
Balance at January 1, 2017	$	3,165		$	3,872		$	7,037
Paid guarantee benefits	(272		)	(102		)	(374		)
Other changes in reserve	1,083			847			1,930
Balance at September 30, 2017	$	3,976		$	4,617		$	8,593
Balance at January 1, 2016	$	2,991		$	3,889		$	6,880
Paid guarantee benefits	(280		)	(249		)	(529		)
Other changes in reserve	478			903			1,381
Balance at September 30, 2016	$	3,189		$	4,543		$	7,732

The following table summarizes the ceded GMDB liabilities, reflected in the Consolidated Balance Sheet in amounts due to reinsurers:

	Nine Months Ended September 30,
	2017			2016
	(in millions)
Balance, beginning of year	$	1,558		$	1,430
Paid guarantee benefits	(132		)	(137		)
Other changes in reserve	555			253
Balance, End of Period	$	1,981		$	1,546

The liability for the GMxB derivative features and the liability for SCS, SIO, MSO and IUL indexed features are considered embedded or freestanding insurance derivatives and are reported at fair value. Summarized in the table below are the fair values of these liabilities at September 30, 2017 and December 31, 2016:

	September 30, 2017			December 31, 2016
	(In Millions)
GMIBNLG (1)	$	4,289		$	5,125
SCS,MSO, IUL features (2)	1,437			875
GWBL/GMWB(1)	85			114
GIB(1)	(6		)	30
GMAB(1)	8			20
Total Embedded derivatives liability(1)	$	5,813		$	6,164
GMIB reinsurance contract asset (3)	$	10,933		$	10,309

(1) Reported in Future policyholders' benefits and other policyholders' liabilities in the Consolidated Balance Sheets.

(2) Reported in Policyholders' account balances in the Consolidated Balance Sheets.

(3) Reported in GMIB reinsurance contract asset in the Consolidated Balance Sheets.

The September 30, 2017 values for variable annuity contracts in-force on such date with GMDB and GMIB features are presented in the following table. For contracts with the GMDB feature, the net amount at risk in the event of death is the amount by which the GMDB benefits exceed related account values. For contracts with the GMIB feature, the net amount at risk in the event of annuitization is the amount by which the present value of the GMIB benefits exceeds related account values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB guarantees may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive:

	Return of Premium			Ratchet			Roll-Up			Combo			Total
	(Dollars in millions)
GMDB:
Account values invested in:
General Account	$	13,860		$	112		$	67		$	207		$	14,246
Separate Accounts	$	44,277		$	9,375		$	3,479		$	35,272		$	92,403
Net amount at risk, gross	$	180		$	64		$	2,059		$	15,775		$	18,078
Net amount at risk, net of amounts reinsured	$	180		$	44		$	1,403		$	6,556		$	8,183
Average attained age of contractholders	51.4			66.2			72.8			68.1			55.3
Percentage of contractholders over age 70	9.6		%	39.4		%	62.4		%	45.6		%	18.0		%
Range of contractually specified interest rates	N/A			N/A			3%-6%			3%-6.5%			3%-6.5%
GMIB:
Account values invested in:
General Account	N/A			N/A			$	24		$	303		$	327
Separate Accounts	N/A			N/A			$	20,382		$	40,687		$	61,069
Net amount at risk, gross	N/A			N/A			$	982		$	6,655		$	7,637
Net amount at risk, net of amounts reinsured	N/A			N/A			$	297		$	1,649		$	1,946
Weighted average years remaining until annuitization	N/A			N/A			1.7			0.9			1.0
Range of contractually specified interest rates	N/A			N/A			3%-6%			3%-6.5%			3%-6.5%

At September 30, 2017, the Company had reinsured with non-affiliates and affiliates in the aggregate approximately 3.7% and 51.1%, respectively, of its current exposure to the GMDB obligation on annuity contracts in-force and, subject to certain maximum amounts or caps in any one period, approximately 17.2% and 57.3%, respectively, of its current liability exposure resulting from the GMIB feature.

B) Separate Account Investments by Investment Category Underlying GMDB and GMIB Features

The total account values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB benefits and guarantees. The investment performance of the assets impacts the related account values and, consequently, the net amount of risk associated with the GMDB and GMIB benefits and guarantees. Since variable annuity contracts with GMDB benefits and guarantees may also offer GMIB benefits and guarantees in each contract, the GMDB and GMIB amounts listed are not mutually exclusive:

Investment in Variable Insurance Trust Mutual Funds

	September 30, 2017		December 31, 2016
	(in millions)
GMDB:
Equity	$	75,751	$	69,625
Fixed income	2,288		2,483
Balanced	14,056		14,434
Other	308		348
Total	$	92,403	$	86,890
GMIB:
Equity	$	49,177	$	45,931
Fixed income	1,602		1,671
Balanced	10,148		10,097
Other	142		149
Total	$	61,069	$	57,848

C) Hedging Programs for GMDB, GMIB, GIB and GWBL and Other Features

Beginning in 2003, AXA Equitable established a program intended to hedge certain risks associated first with the GMDB feature and, beginning in 2004, with the GMIB feature of the Accumulator^® series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency, and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not reinsured. At September 30, 2017, the total account value and net amount at risk of the hedged variable annuity contracts were $54,712 million and $7,195 million, respectively, with the GMDB feature and $41,146 million and $2,866 million, respectively, with the GMIB and GIB feature.

These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in net investment income (loss) in the period in which they occur, and may contribute to income (loss) volatility.

D) Variable and Interest-Sensitive Life Insurance Policies - No Lapse Guarantee

The no lapse guarantee feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The no lapse guarantee remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements.

The following table summarizes the no lapse guarantee liabilities reflected in the General Account in Future policy benefits and other policyholders’ liabilities, the related reinsurance reserve ceded, reflected in Amounts due from reinsurers and deferred cost of reinsurance, reflected in Other assets in the Consolidated balance sheets.

	Direct Liability			Reinsurance Ceded			Net
	(in millions)
Balance at January 1, 2017	$	1,208		$	(619	)	$	589
Paid Guaranteed Benefits	—			—			—
Other changes in reserves	216			(70		)	146
Balance at September 30, 2017	$	1,424		$	(689	)	$	735
Balance at January 1, 2016	$	1,155		$	(519	)	$	636
Other changes in reserves	(29		)	(82		)	(111		)
Balance at September 30, 2016	$	1,126		$	(601	)	$	525

E) Loss Recognition Testing

After the initial establishment of reserves, loss recognition tests are performed using best estimate assumptions as of the testing date without provisions for adverse deviation. When the liabilities for future policy benefits plus the present value of expected future gross premiums for the aggregate product group are insufficient to provide for expected future policy benefits and expenses for that line of business (i.e., reserves net of any DAC asset), DAC is first written off, and thereafter a premium deficiency reserve is established by a charge to income.

In 2017 and 2016, we determined that we had a loss recognition in certain of our variable interest sensitive life insurance products due to low interest rates. As of September 30, 2017 and December 31, 2016, we wrote off $134 million and $308 million, respectively, of the DAC balance through accelerated amortization.

In addition, we are required to analyze the impacts from net unrealized investment gains and losses on our available-for-sale investment securities backing insurance liabilities, as if those unrealized investment gains and losses were realized. These adjustments result in the recognition of unrealized gains and losses on related insurance assets and liabilities in a manner consistent with the recognition of the unrealized gains and losses on available-for-sale investment securities within the statements of comprehensive income and changes in equity. Changes to net unrealized investment (gains) losses may increase or decrease the ending DAC balance. Similar to a loss recognition event, when the DAC balance is reduced to zero, additional insurance liabilities are established if necessary. Unlike a loss recognition event, based on changes in net unrealized investment (gains) losses, these adjustments may reverse from period to period. In 2017 and 2016, due primarily to the decline in interest rates increasing unrealized investments gains, we wrote-off $78 million and $22 million during the nine months ended September 30, 2017 and the year ended December 31, 2016, respectively, of our DAC balance, and a cumulative decrease in the accumulated effect of net unrealized investment gains of approximately $147 million and $41 million as of September 30, 2017 and December 31, 2016, respectively, with an offsetting amount recorded in other comprehensive income (loss). There was no impact to net income (loss).

XML

FAIR VALUE DISCLOSURES

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value Disclosures

FAIR VALUE DISCLOSURES

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance established a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:

Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.

Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.

The Company uses unadjusted quoted market prices to measure the fair value of instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.

Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.

Assets and liabilities measured at fair value on a recurring basis are summarized below. Fair value measurements also are required on a non-recurring basis for certain assets, including goodwill, equity real estate held for production of income, and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. At September 30, 2017 and December 31, 2016, no assets were required to be measured at fair value on a non-recurring basis.

Fair Value Measurements at September 30, 2017

	Level 1		Level 2			Level 3		Total
	(in millions)
Assets:
Investments:
Fixed maturities, available-for-sale:
Public Corporate	$	—	$	13,052		$	87	$	13,139
Private Corporate	—		6,231			1,059		7,290
U.S. Treasury, government and agency	—		10,936			—		10,936
States and political subdivisions	—		440			41		481
Foreign governments	—		393			—		393
Commercial mortgage-backed	—		14			248		262
Residential mortgage-backed(1)	—		265			—		265
Asset-backed(2)	—		22			8		30
Redeemable preferred stock	180		323			1		504
Subtotal	180		31,676			1,444		33,300
Other equity investments	4		—			1		5
Trading securities	481		11,572			—		12,053
Other invested assets:
Short-term investments	—		770			—		770
Assets of consolidated VIEs/VOEs	670		130			2		802
Swaps	—		(125		)	—		(125		)
Credit Default Swaps	—		30			—		30
Options	—		1,517			—		1,517
Subtotal	670		2,322			2		2,994
Cash equivalents	3,271		—			—		3,271
Segregated securities	—		789			—		789
GMIB reinsurance contract asset	—		—			10,933		10,933
Separate Accounts’ assets	115,810		2,918			337		119,065
Total Assets	$	120,416	$	49,277		$	12,717	$	182,410
Liabilities
GMxB derivative features’ liability	$	—	$	—		$	4,375	$	4,375
SCS, SIO, MSO and IUL indexed features’ liability	—		1,437			—		1,437
Liabilities of consolidated VIEs/VOEs	584		3			—		587
Contingent payment arrangements	—		—			12		12
Total Liabilities	$	584	$	1,440		$	4,387	$	6,411

(1) Includes publicly-traded agency pass-through securities and collateralized obligations.

(2) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.

Fair Value Measurements at December 31, 2016

	Level 1		Level 2			Level 3		Total
	(in millions)
Assets:
Investments:
Fixed maturities, available-for-sale:
Public Corporate	$	—	$	12,984		$	28	$	13,012
Private Corporate	—		6,223			817		7,040
U.S. Treasury, government and agency	—		10,336			—		10,336
States and political subdivisions	—		451			42		493
Foreign governments	—		390			—		390
Commercial mortgage-backed	—		22			349		371
Residential mortgage-backed(1)	—		314			—		314
Asset-backed(2)	—		36			24		60
Redeemable preferred stock	218		335			1		554
Subtotal	218		31,091			1,261		32,570
Other equity investments	3		—			5		8
Trading securities	478		8,656			—		9,134
Other invested assets:
Short-term investments	—		574			—		574
Assets of consolidated VIEs	342		205			6		553
Swaps	—		(925		)	—		(925		)
Credit Default Swaps	—		5			—		5
Options	—		960			—		960
Floors	—		11			—		11
Subtotal	342		830			6		1,178
Cash equivalents	1,529		—			—		1,529
Segregated securities	—		946			—		946
GMIB reinsurance contract asset	—		—			10,309		10,309
Separate Accounts’ assets	108,085		2,818			313		111,216
Total Assets	$	110,655	$	44,341		$	11,894	$	166,890
Liabilities:
GMxB derivative features’ liability	$	—	$	—		$	5,289	$	5,289
SCS, SIO, MSO and IUL indexed features’ liability	—		875			—		875
Liabilities of consolidated VIEs/VOEs	248		2			—		250
Foreign currency contracts	—		—			—		—
Contingent payment arrangements	—		—			18		18
Total Liabilities	$	248	$	877		$	5,307	$	6,432

(1) Includes publicly-traded agency pass-through securities and collateralized obligations.

(2) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.

At September 30, 2017 and December 31, 2016, respectively, the fair value of public fixed maturities was approximately $25,492 million and $24,918 million or approximately 14.9% and 16.0% of the Company’s total assets measured at fair value on a recurring basis (excluding GMIB reinsurance contracts and segregated securities measured at fair value on a recurring basis). The fair values of the Company’s public fixed maturity securities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturity securities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the security in a manner agreed as more consistent with current market observations, the security remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security.

At September 30, 2017 and December 31, 2016, respectively, the fair value of private fixed maturities was approximately $7,808 million and $7,652 million or approximately 4.6% and 4.9% of the Company’s total assets measured at fair value on a recurring basis. The fair values of the Company’s private fixed maturities are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made.

As disclosed in Note 3, at September 30, 2017 and December 31, 2016, respectively, the net fair value of freestanding derivative positions was approximately $1,422 million and $51 million or approximately 47.5% and 8.2% of Other invested assets measured at fair value on a recurring basis. The fair values of the Company’s derivative positions are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including OIS curves and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If, as a result, it is determined that the independent valuation service provider is able to reprice the derivative instrument in a manner agreed as more consistent with current market observations, the position remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security.

At September 30, 2017 and December 31, 2016, respectively, investments classified as Level 1 comprise approximately 70.5% and 71.1% of assets measured at fair value on a recurring basis and primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less, and are carried at cost as a proxy for fair value measurement due to their short-term nature.

At September 30, 2017 and December 31, 2016, respectively, investments classified as Level 2 comprise approximately 28.4% and 27.9% of assets measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury bills segregated by AB in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Exchange Act and for which fair values are based on quoted yields in secondary markets.

Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. At September 30, 2017 and December 31, 2016, respectively, approximately $282 million and $340 million of AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors.

Certain Company products such as the SCS and EQUI-VEST variable annuity products and the IUL product, as well as the MSO feature available in some life contracts, offer investment options that permit the contract owner to participate in the performance of an index, ETF or commodity price.  These investment options (depending on the product and index selected) can have 1, 3 or 5 year terms and permit participation in the index, ETF or commodity price up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g., holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETFs or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on prices obtained from independent valuation service providers.

At September 30, 2017 and December 31, 2016, respectively, investments classified as Level 3 comprised approximately 1.1% and 1.0% of assets measured at fair value on a recurring basis and primarily include CMBS and corporate debt securities, such as private fixed maturities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification at September 30, 2017 and December 31, 2016, respectively, were approximately $100 million and $111 million of fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data. The Company applies various due-diligence procedures, as considered appropriate, to validate these non-binding broker quotes for reasonableness, based on its understanding of the markets, including use of internally-developed assumptions about inputs a market participant would use to price the security. In addition, approximately $256 million and $373 million of mortgage- and asset-backed securities, including CMBS, are classified as Level 3 at September 30, 2017 and December 31, 2016, respectively. The Company utilizes prices obtained from an independent valuation service vendor to measure fair value of CMBS securities.

The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIBNLG, feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base.  The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base.  The GMAB feature increases the contract account value at the end of a specified period to a GMAB base.  The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base.

Level 3 also includes the GMIB reinsurance contract asset and liabilities which are accounted for as derivative contracts.  The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to Guarantee embedded derivative features over a range of market-consistent economic scenarios.

The valuations of the GMIB reinsurance contract asset and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity separate account funds.  The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements.  Incremental adjustment to the swap curve, adjusted for non-performance risk, is made to the resulting fair values of the GMIB reinsurance contract asset and liabilities to reflect change in the claims-paying ratings of counterparties. Equity and fixed income volatilities were modeled to reflect current market volatilities.  Due to the unique, long duration of the GMIBNLG feature, adjustments were made to the equity volatilities to remove the illiquidity bias associated with the longer tenors and risk margins were applied to the non-capital markets inputs to the GMIBNLG valuations.

After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $97 million and $139 million at September 30, 2017 and December 31, 2016, respectively, to recognize incremental counterparty nonperformance risk.

In the first nine months of 2017, AFS fixed maturities with fair values of $7 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with Fair Value of $6 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.1% of total equity at September 30, 2017.

In the first nine months of 2016, AFS fixed maturities with fair values of $50 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with Fair Value of $29 million were transferred from Level 2 into the Level 3 classification. During the third quarter 2016, one of AB’s private securities went public and, due to a trading restriction period, $24 million was transferred from a Level 3 to a Level 2 classification. These transfers in the aggregate represent approximately 0.5% of total equity at September 30, 2016.

The table below presents a reconciliation for all Level 3 assets and liabilities for the third quarter and first nine months of 2017 and 2016:

Level 3 Instruments

Fair Value Measurements

	Corporate			State and Political Sub- divisions			Foreign Govts		Commercial Mortgage- backed			Asset- backed
	(in millions)
Balance, July 1, 2017	$	1,068		$	42		$	—	$	290		$	12
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	2			—			—		—			—
Investment gains (losses), net	—			—			—		(9		)	—
Subtotal	2			—			—		(9		)	—
Other comprehensive income (loss)	6			—			—		8			(3		)
Purchases	196			—			—		—			—
Sales	(119		)	(1		)	—		(40		)	(1		)
Settlements	—			—			—		—			—
Transfers into Level 3(1)	—			—			—		—			—
Transfers out of Level 3(1)	(7		)	—			—		(1		)	—
Balance, September 30, 2017	$	1,146		$	41		$	—	$	248		$	8
Balance, July 1, 2016	$	495		$	45		$	—	$	402		$	26
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—			—			—		1			—
Investment gains (losses), net	1			—			—		(12		)	—
Subtotal	1			—			—		(11		)	—
Other comprehensive income (loss)	(2		)	—			—		10			(1		)
Purchases	256			—			—		—			—
Sales	(21		)	(1		)	—		(21		)	—
Transfers into Level 3(1)	11			—			—		—			—
Transfers out of Level 3(1)	(1		)	—			—		(6		)	—
Balance, September 30, 2016	$	739		$	44		$	—	$	374		$	25

	Corporate			State and Political Sub- divisions			Foreign Govts			Commercial Mortgage- backed			Asset- backed
	(in millions)
Balance, January 1, 2017	$	845		$	42		$	—		$	349		$	24
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	6			—			—			1			—
Investment gains (losses), net	—			—			—			(29		)	15
Subtotal	6			—			—			(28		)	15
Other comprehensive income (loss)	—			—			—			27			(10		)
Purchases	518			—			—			—			—
Sales	(224		)	(1		)	—			(99		)	(20		)
Settlements	—			—			—			—			—
Transfers into Level 3(1)	6			—			—			—			—
Transfers out of Level 3(1)	(5		)	—			—			(1		)	(1		)
Balance, September 30, 2017	$	1,146		$	41		$	—		$	248		$	8
Balance, January 1, 2016	$	420		$	45		$	1		$	503		$	40
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	(1		)	—			—			1			—
Investment gains (losses), net	1			—			—			(36		)	—
Subtotal	—			—			—			(35		)	—
Other comprehensive income (loss)	8			—			—			(1		)	1
Purchases	399			—			—			—			—
Sales	(89		)	(1		)	—			(81		)	(7		)
Transfers into Level 3(1)	29			—			—			—			—
Transfers out of Level 3(1)	(28		)	—			(1		)	(12		)	(9		)
Balance, September 30, 2016	$	739		$	44		$	—		$	374		$	25

	Redeemable Preferred Stock		Other Equity Investments(2)			GMIB Reinsurance Asset			Separate Accounts Assets			GMxB derivative features liability			Contingent Payment Arrangement
	(in millions)
Balance, July 1, 2017	$	1	$	8		$	11,290		$	333		$	(4,606	)	$	17
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—		—			—			—			—			—
Investment gains (losses), net	—		(4		)	—			4			—			—
Net derivative gains (losses)	—		—			(368		)	—			208			—
Subtotal	—		(4		)	(368		)	4			208			—
Other comprehensive income (loss)	—		—			—			—			—			—
Purchases(3)	—		—			55			1			23			—
Sales(4)	—		(1		)	(44		)	—			—			—
Settlements(5)	—		—			—			(1		)	—			(5		)
Activity related to consolidated VIEs	—		—			—			—			—			—
Transfers into Level 3(1)	—		—			—			—			—			—
Transfers out of Level 3(1)	—		—			—			—			—			—
Balance, September 30, 2017	$	1	$	3		$	10,933		$	337		$	(4,375	)	$	12
Balance, July 1, 2016	$	—	$	18		$	13,311		$	307		$	(7,286	)	$	31
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—		—			—			—			—			—
Investment gains (losses), net	—		—			—			7			—			—
Net derivative gains (losses)	—		—			(79		)	—			187			—
Subtotal	—		—			(79		)	7			187			—
Other comprehensive income (loss)	—		—			—			—			—			—
Purchases(3)	—		—			57			3			1			11
Sales(4)	—		—			(176		)	—			—			—
Settlements(5)	—		—			—			(1		)	—			(24		)
Activity related to consolidated VIEs	—		15			—			—			—			—
Transfers into Level 3(1)	—		—			—			—			—			—
Transfers out of Level 3(1)	—		(24		)	—			(1		)	—			—
Balance, September 30, 2016	$	—	$	9		$	13,113		$	315		$	(7,098	)	$	18

	Redeemable Preferred Stock		Other Equity Investments(2)			GMIB Reinsurance Asset			Separate Accounts Assets			GMxB derivative features liability			Contingent Payment Arrangement
	(in millions)
Balance, January 1, 2017	$	1	$	11		$	10,309		$	313		$	(5,289	)	$	18
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—		—			—			—			—			—
Investment gains (losses), net	—		(4		)	—			22			—			—
Net derivative gains (losses)	—		—			537			—			1,151			—
Subtotal	—		(4		)	537			22			1,151			—
Other comprehensive income (loss)	—		—			—			—			—			—
Purchases(3)	—		5			166			7			(237		)	—
Sales(4)	—		(3		)	(79		)	(2		)	—			—
Settlements(5)	—		—			—			(4		)	—			(6		)
Activity related to consolidated VIEs	—		(7		)	—			—			—			—
Transfers into Level 3(1)	—		1			—			1			—			—
Transfers out of Level 3(1)	—		—			—			—			—			—
Balance, September 30, 2017	$	1	$	3		$	10,933		$	337		$	(4,375	)	$	12
Balance, January 1, 2016	$	—	$	17		$	10,578		$	313		$	(5,150	)	$	31
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—		—			—			—			—			—
Investment gains (losses), net	—		(1		)	—			19			—			—
Net derivative gains (losses)	—		—			2,576			—			(1,712		)	—
Subtotal	—		(1		)	2,576			19			(1,712		)	—
Other comprehensive income (loss)	—		—			—			—			—			—
Purchases(3)	—		—			166			12			(236		)	11
Sales(4)	—		—			(207		)	—			—			—
Settlements(5)	—		—			—			(6		)	—			(24		)
Activity related to consolidated VIEs	—		17			—			—			—			—
Transfers into Level 3(1)	—		—			—			1			—			—
Transfers out of Level 3(1)	—		(24		)	—			(24		)	—			—
Balance, September 30, 2016	$	—	$	9		$	13,113		$	315		$	(7,098	)	$	18

(1) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.

(2) Includes Level 3 amounts for Trading securities and consolidated VIE investments.

(3) For the GMIB reinsurance contract asset and GWBL and other features reserves, represents premiums.

(4) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GWBL and other features reserves represents benefits paid.

(5) For contingent payment arrangements, it represents change in estimates.

The table below details changes in unrealized gains (losses) for the third quarter and first nine months of 2017 and 2016 by category for Level 3 assets and liabilities still held at September 30, 2017 and 2016, respectively:

	Income (Loss)
	Investment Gains (Losses), Net		Net Derivative Gains (losses)			OCI
	(in millions)
Level 3 Instruments
Third Quarter 2017
Held at September 30, 2017:
Change in unrealized gains (losses):
Fixed maturities, available-for-sale:
Corporate	$	—	$	—		$	4
Commercial mortgage-backed	—		—			9
Asset-backed	—		—			(2		)
Subtotal	$	—	$	—		$	11
GMIB reinsurance contracts	—		(368		)	—
Separate Accounts’ assets(1)	4		—			—
GMxB derivative features' liability	—		208			—
Total	$	4	$	(160	)	$	11
Level 3 Instruments
Third Quarter 2016
Held at September 30, 2016:
Change in unrealized gains (losses):
Fixed maturities, available-for-sale:
Commercial mortgage-backed	—		—			10
Asset-backed	—		—			(1		)
Subtotal	$	—	$	—		$	9
GMIB reinsurance contracts	—		(79		)	—
Separate Accounts’ assets(1)	6		—			—
GMxB derivative features' liability	—		187			—
Total	$	6	$	108		$	9

	Income (Loss)
	Net Investment Income (Loss)		Investment Gains (Losses), Net			OCI
Level 3 Instruments
First Nine Months of 2017
Held at September 30, 2017:
Change in unrealized gains (losses):
Fixed maturities, available-for-sale:
Commercial mortgage-backed	—		—			26
Asset-backed	—		—			(9		)
Subtotal	$	—	$	—		$	17
GMIB reinsurance contracts	—		537			—
Separate Accounts’ assets(1)	22		—			—
GMxB derivative features' liability	—		1,151			—
Total	$	22	$	1,688		$	17
Level 3 Instruments
First Nine Months of 2016
Held at September 30, 2016:
Change in unrealized gains (losses):
Fixed maturities, available-for-sale:
Corporate	$	—	$	—		$	9
State and political subdivisions	—		—			1
Commercial mortgage-backed	—		—			(6		)
Asset-backed	—		—			1
Subtotal	$	—	$	—		$	5
GMIB reinsurance contracts	—		2,576			—
Separate Accounts’ assets(1)	19		—			—
GMxB derivative features' liability	—		(1,712		)	—
Total	$	19	$	864		$	5

(1) There is an investment expense that offsets this investment gain (loss).

The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities as of September 30, 2017 and December 31, 2016, respectively.

Quantitative Information about Level 3 Fair Value Measurements

September 30, 2017

	Fair Value			Valuation Technique	Significant Unobservable Input	Range	Weighted Average
	(in millions)
Assets:
Investments:
Fixed maturities, available-for-sale:
Corporate	$	41		Matrix pricing model	Spread over the industry-specific benchmark yield curve	100 bps - 565 bps	173 bps
	779			Market comparable  companies	EBITDA multiples Discount rate Cash flow multiples	5.1x- 27.3x 7.2%-17.0% 9.0x- 17.7x	12.2x 11.2% 13.1x
Separate Accounts’ assets	318			Third party appraisal	Capitalization rate	4.6%
					Exit capitalization rate	5.7%
					Discount rate	6.6%
	1			Discounted cash flow	Spread over U.S. Treasury curve	243 bps
					Discount factor	4.0%
GMIB reinsurance contract asset	10,933			Discounted cash flow	Lapse Rates	1.0%- 6.3%
					Withdrawal Rates	0.0% - 8.0%
					GMIB Utilization Rates	0.0% - 16.0%
					Non-performance risk	5 bps - 10 bps
					Volatility rates - Equity	10.0% - 30.0%
Liabilities:
GMIBNLG	4,289			Discounted cash flow	Non-performance risk Lapse Rates Withdrawal Rates Annuitization NLG Forfeiture Rates Long-term equity Volatility	1.0% 0.8% - 26.2% 0.0% - 12.4% 0.0% - 16.0% 0.55% - 2.1% 20.0%
GWBL/GMWB	85			Discounted cash flow	Lapse Rates Withdrawal Rates Utilization Rates Volatility rates - Equity	0.9% - 5.7% 0.0% - 7.0% 100% after delay 10.0% - 30.0%
GIB	(6		)	Discounted cash flow	Lapse Rates Withdrawal Rates Utilization Rates Volatility rates - Equity	0.9% - 5.7% 0.0% - 8.0% 0.0% - 16.0% 10.0% - 30.0%
GMAB	8			Discounted cash flow	Lapse Rates Volatility rates - Equity	0.5% - 11.0% 10.0% - 30.0%

Quantitative Information about Level 3 Fair Value Measurements

December 31, 2016

	Fair Value		Valuation Technique	Significant Unobservable Input	Range	Weighted Average
	(in millions)
Assets:
Investments:
Fixed maturities, available-for-sale:
Corporate	$	55	Matrix pricing model	Spread over the industry-specific benchmark yield curve	0 bps - 565 bps	143 bps
	636		Market comparable companies	EBITDA multiples Discount Rate Cash flow Multiples	4.3x-25.6x 7.0% - 17.8% 14.0x - 16.5x	11.7x 11.4% 15.6x
Asset-backed	2		Matrix pricing model	Spread over U.S. Treasury curve	25 bps - 687 bps
Separate Accounts’ assets	295		Third party appraisal	Capitalization rate	4.8%
				Exit capitalization rate	5.7%
				Discount rate	6.6%
	3		Discounted cash flow	Spread over U.S. Treasury curve	273 bps - 512 bps	283 bps
				Discount factor	1.1% - 7.0%	4.3%
GMIB reinsurance contract asset	10,309		Discounted Cash flow	Lapse Rates	1.5% - 5.7%
				Withdrawal Rates	0.0% - 8.0%
				GMIB Utilization Rates	0.0% - 16.0%
				Non-performance risk	5 bps - 17 bps
				Volatility rates - Equity	11.0%- 38.0%
Liabilities:
GMIBNLG	5,125		Discounted cash flow	Non-performance risk Lapse Rates Withdrawal Rates Annuitization NLG Forfeiture Rates Long-term equity Volatility	1.1% 1.2% - 26.2% 0.0% - 8.0% 0.0% - 16.0% 0.55% - 2.1% 20.0%
GWBL/GMWB	114		Discounted cash flow	Lapse Rates Withdrawal Rates Utilization Rates Volatility rates - Equity	1.0% - 5.7% 0.0% - 7.0% 100% after delay 9.0% - 35.0%
GIB	30		Discounted cash flow	Lapse Rates Withdrawal Rates Utilization Rates Volatility rates - Equity	1.0% - 5.7% 0.0% - 8.0% 100% after delay 9.0% - 35.0%
GMAB	20		Discounted cash flow	Lapse Rates Volatility rates - Equity	1.0% - 11.0% 9.0% - 35.0%

Excluded from the tables above at September 30, 2017 and December 31, 2016, are approximately $645 million and $594 million, respectively, of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not reasonably available. The fair value measurements of these Level 3 investments comprise approximately 36.2% and 37.5% of total assets classified as Level 3 at September 30, 2017 and December 31, 2016, respectively, and represent only 0.4% and 0.4% of total assets measured at fair value on a recurring basis. These investments primarily consist of certain privately placed debt securities with limited trading activity, including commercial mortgage-, residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments.

Included in the tables above at September 30, 2017 and December 31, 2016, respectively, are approximately $820 million and $691 million fair value of privately placed, available-for-sale corporate debt securities classified as Level 3. The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique, representing approximately 71.6% and 81.8% of the total fair value of Level 3 securities in the corporate fixed maturities asset class. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities.

Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above at September 30, 2017 and December 31, 2016, there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities.

Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit tenant loans, and equipment financings. Included in the tables above at September 30, 2017 and December 31, 2016, are approximately 0.0% and 8.3%, respectively, of the total fair value of these Level 3 securities that is determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would result in significantly lower (higher) fair value measurements.

Assets of VIEs and VOEs classified as Level 3 securities primarily consist of corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities.

Separate Accounts’ assets classified as Level 3 in the table at September 30, 2017 and December 31, 2016, primarily consist of a private real estate fund with a fair value of approximately $318 million and $295 million, a private equity investment with a fair value of approximately $0 million and $1 million and mortgage loans with fair value of approximately $1 million and $2 million, respectively. A third party appraisal valuation technique is used to measure the fair value of the private real estate investment fund, including consideration of observable replacement cost and sales comparisons for the underlying commercial properties, as well as the results from applying a discounted cash flow approach. Significant increase (decrease) in isolation in the capitalization rate and exit capitalization rate assumptions used in the discounted cash flow approach to the appraisal value would result in a higher (lower) measure of fair value. A discounted cash flow approach is applied to determine the private equity investment for which the significant unobservable assumptions are a gross domestic product rate formula and a discount factor that takes into account various risks, including the illiquid nature of the investment. A significant increase (decrease) in the gross domestic product rate would have a directionally inverse effect on the fair value of the security. With respect to the fair value measurement of mortgage loans a discounted cash flow approach is applied, a significant increase (decrease) in the assumed spread over U.S. Treasuries would produce a lower (higher) fair value measurement. Changes in the discount rate or factor used in the valuation techniques to determine the fair values of these private equity investments and mortgage loans generally are not correlated to changes in the other significant unobservable inputs. Significant increase (decrease) in isolation in the discount rate or factor would result in significantly lower (higher) fair value measurements. The remaining Separate Accounts’ investments classified as Level 3 excluded from the table consist of mortgage- and asset-backed securities with fair values of approximately $12 million and $6 million at September 30, 2017 and $12 million and $3 million at December 31, 2016, respectively. These fair value measurements are determined using substantially the same valuation techniques as earlier described above for the Company’s General Account investments in these securities.

Significant unobservable inputs with respect to the fair value measurement of the Level 3 GMIB reinsurance contract asset and the Level 3 liabilities identified in the table above are developed using the Company's data. Validations of unobservable inputs are performed to the extent the Company has experience. When an input is changed the model is updated and the results of each step of the model are analyzed for reasonableness.

The significant unobservable inputs used in the fair value measurement of the Company’s GMIB reinsurance contract asset are lapse rates, withdrawal rates and GMIB utilization rates. Significant increases in GMIB utilization rates or decreases in lapse or withdrawal rates in isolation would tend to increase the GMIB reinsurance contract asset.

Fair value measurement of the GMIB reinsurance contract asset includes dynamic lapse and GMIB utilization assumptions whereby projected contractual lapses and GMIB utilization reflect the projected net amount of risks of the contract. As the net amount of risk of a contract increases, the assumed lapse rate decreases and the GMIB utilization increases. Increases in volatility would increase the asset and liabilities.

The significant unobservable inputs used in the fair value measurement of the Company’s GMIBNLG liability are lapse rates, withdrawal rates, GMIB utilization rates, adjustment for Non-performance risk and NLG forfeiture rates.  NLG forfeiture rates are caused by excess withdrawals above the annual GMIB benefit accrual rate that cause the NLG to expire.   Significant decreases in lapse rates, NLG forfeiture rates, adjustment for non-performance risk and GMIB utilization rates would tend to increase the GMIBNLG liability, while decreases in withdrawal rates and volatility rates would tend to decrease the GMIBNLG liability.

The significant unobservable inputs used in the fair value measurement of the Company’s GMWB and GWBL liability are lapse rates and withdrawal rates. Significant increases in withdrawal rates or decreases in lapse rates in isolation would tend to increase these liabilities. Increases in volatility would increase these liabilities.

The three AB acquisition-related contingent consideration liabilities (with a combined fair value of $12 million and $18 million at September 30, 2017 and December 31, 2016, respectively) were valued using projected AUM growth rates with a weighted average of 18.0% for one acquisition and revenue growth rates and discount rates ranging from 4.0% to 31.0% and 1.4% to 6.4%, respectively, for the three acquisitions.

The carrying values and fair values at September 30, 2017 and December 31, 2016 for financial instruments not otherwise disclosed in Note 3 are presented in the table below. Certain financial instruments are exempt from the requirements for fair value disclosure, such as insurance liabilities other than financial guarantees and investment contracts, limited partnerships accounted for under the equity method and pension and other postretirement obligations.

	Carrying Value		Fair Value
			Level 1		Level 2		Level 3		Total
	(in millions)
September 30, 2017:
Mortgage loans on real estate	$	10,605	$	—	$	—	$	10,686	$	10,686
Loans to affiliates	703		—		772		—		772
Policyholders’ liabilities: Investment contracts	2,122		—		—		2,236		2,236
Funding Agreements	2,715		—		2,727		—		2,727
Policy loans	3,322		—		—		4,220		4,220
Short-term debt	500		—		500		—		500
Separate Account Liabilities	7,083		—		—		7,083		7,083
December 31, 2016:
Mortgage loans on real estate	$	9,757	$	—	$	—	$	9,608	$	9,608
Loans to affiliates	703		—		775		—		775
Policyholders’ liabilities: Investment contracts	2,226		—		—		2,337		2,337
Funding Agreements	2,255		—		2,202		—		2,202
Policy loans	3,361		—		—		4,257		4,257
Short-term debt	513		—		513		—		513
Separate Account Liabilities	6,194		—		—		6,194		6,194

Fair values for commercial and agricultural mortgage loans on real estate are measured by discounting future contractual cash flows to be received on the mortgage loan using interest rates at which loans with similar characteristics and credit quality would be made. The discount rate is derived from taking the appropriate U.S. Treasury rate with a like term to the remaining term of the loan and adding a spread reflective of the risk premium associated with the specific loan. Fair values for mortgage loans anticipated to be foreclosed and problem mortgage loans are limited to the fair value of the underlying collateral, if lower.

The Company’s short-term debt primarily includes commercial paper issued by AB with short term maturities and book value approximates fair value. The fair values of the Company’s borrowing and lending arrangements with AXA affiliated entities are determined in the same manner as for such transactions with third parties, including matrix pricing models for debt securities and discounted cash flow analysis for mortgage loans.

Fair values for FHLBNY funding agreements are determined from a matrix pricing model and are internally assessed for reasonableness. The matrix pricing model for FHLBNY funding agreements utilizes an independently-sourced U.S. Treasury curve which is separately sourced from Barclays’ suite of curves.

The fair values for the Company’s association plans contracts, supplementary contracts not involving life contingencies deferred annuities and certain annuities, which are included in Policyholder’s account balances are estimated using projected cash flows discounted at rates reflecting current market rates. Significant unobservable inputs reflected in the cash flows include lapse rates and withdrawal rates. Incremental adjustments may be made to the fair value to reflect non-performance risk. Certain other products such as Access Accounts and FHLBNY funding agreements and escrow shield plus product policyholders’ account balances are held at book value.

XML

SHARE-BASED COMPENSATION PROGRAMS

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation Programs

SHARE-BASED COMPENSATION PROGRAMS

AXA and AXA Financial sponsor various share-based compensation plans for eligible employees and financial professionals of AXA Financial and its subsidiaries. AB also sponsors its own unit option plans for certain of its employees.

Compensation costs for the third quarter and first nine months of 2017 and 2016 for share-based payment arrangements as further described herein are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
	(in thousands)
Performance Shares	$	2,630	$	2,953	$	15,588	$	14,774
Stock Options	350		110		1,088		825
AB Stock Options	—		200		—		200
AB Restricted Units	5,600		1,200		26,900		6,400
Other compensation plans(1)	1,518		154		1,546		(759		)
Total Compensation Expenses	$	10,098	$	4,617	$	45,122	$	21,440

(1) Other compensation plans include Restricted Stock, Stock Appreciation Rights and AXA Miles.

Performance Shares

2017 Grant. On June 21, 2017, under the terms of the Performance Share Plan, AXA awarded approximately 1.69 million unearned performance shares to employees of AXA Equitable. The extent to which 2017-2019 cumulative performance targets measuring the performance of AXA and the insurance related businesses of AXA Financial are achieved will determine the number of performance shares earned, which may vary in linear formula between 0% and 130% of the number of performance shares at stake. The performance shares earned during this performance period will vest and be settled on the fourth anniversary of the award date. The plan will settle in shares to all participants. In the first nine months of 2017, the expense associated with the June 21, 2017 grant of performance shares was $8 million.

Settlement of 2014 Grant in 2017. On March 24, 2017, share distributions totaling approximately $21 million were made to active and former AXA Equitable employees in settlement of 1.0 million performance shares earned under the terms of the first tranche of the AXA Performance Share Plan 2014.

Stock Options

2017 Grant. On June 21, 2017, 487,840 options to purchase AXA ordinary shares were granted to employees of AXA Equitable under the terms of the Stock Option Plan at an exercise price of 23.92 euros. All of those options have a five-year graded vesting schedule, with one-third vesting on each of the third, fourth, and fifth anniversaries of the grant date. Of the total options awarded on June 21, 2017, 275,942 are further subject to conditional vesting terms that require the AXA ordinary share price to outperform the Euro Stoxx Insurance Index over a specified period. All of the options granted on June 21, 2017 have a ten-year term. The weighted average grant date fair value per option award was estimated at 1.78 euros using a Black-Scholes options pricing model with modification to measure the value of the conditional vesting feature. Key assumptions used in the valuation included expected volatility of 25.05%, a weighted average expected term of 8.8 years, an expected dividend yield of 6.53% and a risk-free interest rate of 0.59%. The total fair value of these options (net of expected forfeitures) of approximately $1 million is charged to expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible. In the first nine months of 2017, the Company recognized expenses associated with the June 21, 2017 grant of options of approximately $0.4 million.

2017 AXA Shareplan. In 2017, eligible employees of participating AXA Financial subsidiaries were offered the opportunity to purchase newly issued AXA ordinary shares, subject to plan limits, under the terms of AXA Shareplan 2017. Eligible employees could have reserved a share purchase during the reservation period from August 28, 2017 through September 8, 2017 and could have canceled their reservation or elected to make a purchase for the first time during the retraction/subscription period from October 13, 2017 through October 17, 2017. The U.S. dollar purchase price was determined by applying the U.S. dollar/Euro forward exchange rate on October 11, 2017 to the discounted formula subscription price in Euros. “Investment Option A” permitted participants to purchase AXA ordinary shares at a 20% formula discounted price of 20.19 euros/per share. “Investment Option B” permitted participants to purchase AXA ordinary shares at an 8.98% formula discounted price of 22.96 euros per share on a leveraged basis with a guaranteed return of initial investment plus a portion of any appreciation in the undiscounted value of the total shares purchased. For purposes of determining the amount of any appreciation, the AXA ordinary share price will be measured over a fifty-two week period preceding the scheduled end date of AXA Shareplan 2017, which is July 1, 2022. All subscriptions became binding and irrevocable on October 17, 2017.

AB Long-term Incentive Compensation Plans. During the third quarter and first nine months of 2017, AB purchased 0.3 million and 5.9 million Holding Units for $7 million and $135 million respectively (on a trade date basis). These amounts reflect open-market purchases of 0.3 million and 5.2 million Holding Units for $7 million and $117 million, respectively, with the remainder relating to purchases of Holding Units from employees to allow them to fulfill statutory tax withholding requirements at the time of distribution of long-term incentive compensation awards.

During the third quarter and first nine months of 2016, AB purchased 2.0 million and 5.8 million Holding units for $45 million and $129 million respectively (on a trade date basis). These amounts reflect open-market purchases of 2.0 million and 5.7 million Holding Units for $45 million and $127 million, respectively, with the remainder relating to purchases of Holding units from employees to allow them to fulfill statutory tax withholding requirements at the time of distribution of long-term incentive compensation awards.

During the first nine months of 2017 and 2016, AB granted to employees and eligible Directors $2.2 million and 0.7 million restricted Holding awards, respectively. In the first nine months of 2017 and 2016, AB used Holding Units repurchased during the period and newly issued Holding Units to fund the restricted Holding Unit awards.

During the first nine months of 2017 and 2016, AB Holding issued 1.0 million and 0.1 million AB Holding Units, respectively, upon exercise of options to buy AB Holding Units. AB Holding used the proceeds of $18 million and $2 million, respectively, received from employees as payment in cash for the exercise price to purchase the equivalent number of newly-issued AB Units.

XML

INCOME TAXES

9 Months Ended

Sep. 30, 2017

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

Income taxes for the interim periods ended September 30, 2017 and 2016 have been computed using an estimated annual effective tax rate. This rate is revised, if necessary, at the end of each successive interim period to reflect the current estimate of the annual effective tax rate.

In the first nine months of 2017, the Company recognized a tax benefit of $221 million related to the conclusion of an IRS audit for tax years 2008 and 2009.

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2017

Related Party Transactions [Abstract]

Related Party Transactions Disclosure

RELATED PARTY TRANSACTIONS

The Company has cost sharing and service agreements with AXA Financial, its subsidiaries and affiliates including agreements related to personnel services, employee benefits, facilities, supplies, equipment, technology, professional development arrangements and investment management services. In addition, the Company has selling agreements to sell insurance products on behalf of affiliates or to have affiliates sell the Company’s insurance products. AB and AXA Equitable FMG also act as investment managers for some of the Company’s affiliates and receive investment management fee revenue for the services provided. There have been no material changes in these service agreements from those disclosed in the 2016 Form 10-K.

At September 30, 2017 and December 31, 2016, AXA Equitable’s GMIB reinsurance contract asset with AXA Arizona had carrying values of $8,720 million and $8,574 million, respectively, and is reported in Guaranteed minimum income benefit reinsurance contract asset, at fair value in the consolidated balance sheets. Ceded premiums, deposits and fee income to AXA Arizona in the third quarter and first nine months of 2017 and 2016 related to the Annuity, UL and no lapse guarantee riders totaled approximately $44 million, $268 million, $113 million and $329 million, respectively. Ceded claims paid and surrenders in the third quarter and first nine months of 2017 and 2016 were $59 million, $194 million, $62 million and $336 million, respectively.

In 2016, AXA Equitable sold artwork to AXA Financial and recognized a $20 million gain on the sale. AXA Equitable used the proceeds received from this sale to make a $21 million donation to AXA Foundation, Inc. (the “Foundation”). The Foundation was organized for the purpose of distributing grants to various tax-exempt charitable organizations and administering various matching gift programs for AXA Equitable, its subsidiaries and affiliates.

In June 2009, AXA Equitable sold real estate property valued at $1,100 million to a non-insurance subsidiary of AXA Financial in exchange for $700 million in cash and $400 million in 8.0%ten-year term mortgage notes on the property reported in Loans to affiliates in the consolidated balance sheets. In November 2014, this loan was refinanced and a new $382 million, seven-year term loan with an interest rate of 4.0% was issued. In January 2016, the property was sold and a portion of the proceeds was used to repay the $382 million term loan outstanding and a $65 million prepayment penalty.

In 2016, AXA Equitable and Saum Sing LLC (“Saum Sing”), an affiliate, formed Broad Vista Partners LLC (“Broad Vista”), AXA Equitable owns 70% and Saum Sing owns 30% of Broad Vista. On June 30, 2016, Broad Vista entered into a real estate joint venture with a third party and AXA Equitable invested approximately $25 million which is reported in Other equity investments in the consolidated balance sheets.

XML

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

9 Months Ended

Sep. 30, 2017

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income (Loss)

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

AOCI represents cumulative gains (losses) on items that are not reflected in income (loss). The balances as of September 30, 2017 and 2016 follow:

	September 30,
	2017			2016
	(in millions)
Unrealized gains (losses) on investments	$	400		$	1,560
Foreign currency translation adjustments	(57		)	(56		)
Defined benefit pension plans	(48		)	(43		)
Total accumulated other comprehensive income (loss)	295			1,461
Less: Accumulated other comprehensive (income) loss attributable to noncontrolling interest	67			68
Accumulated other comprehensive income (loss) attributable to AXA Equitable	$	362		$	1,529

The components of OCI, net-of-taxes for the third quarter and first nine months of 2017 and 2016 follow:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
Foreign currency translation adjustments:
Foreign currency translation gains (losses) arising during the period	$	6		$	(1	)	$	20		$	3
(Gains) losses reclassified into net income (loss) during the period	—			—			—			—
Foreign currency translation adjustment	6			(1		)	20			3
Net unrealized gains (losses) on investments:
Net unrealized gains (losses) arising during the period	6			(10		)	458			1,568
(Gains) losses reclassified into net income (loss) during the period(1)	8			1			6			(14		)
Net unrealized gains (losses) on investments	14			(9		)	464			1,554
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other	(69		)	25			(102		)	(212		)
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(2), $7, $234, and $20	(55		)	16			362			1,342
Change in defined benefit plans:
Less: reclassification adjustments to net income (loss) for:
Net gain (loss) arising during the period	(3		)	—			(2		)	—
Change in defined benefit plans (net of deferred income tax expense (benefit) of $0, $0, $1 and $0.	(3		)	—			(2		)	—
Total other comprehensive income (loss), net of income taxes	(52		)	15			380			1,345
Less: Other comprehensive (income) loss attributable to noncontrolling interest	(32		)	(1		)	(19		)	(1		)
Other comprehensive income (loss) attributable to AXA Equitable	$	(84	)	$	14		$	361		$	1,344

(1) See “Reclassification adjustments” in Note 3. Reclassification amounts presented net of income tax expense (benefit) of $4 million, $3 million, $1 million and $(8) million, for the third quarter and first nine months of 2017 and 2016, respectively.

Investment gains and losses reclassified from AOCI to net income (loss) primarily consist of realized gains (losses) on sales and OTTI of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to net income (loss) as related to defined benefit plans primarily consist of amortizations of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in Compensation and benefit expenses in the consolidated statements of income (loss). Amounts presented in the table above are net of tax.

XML

COMMITMENT AND CONTINGENT LIABILITIES

9 Months Ended

Sep. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingent Liabilities

COMMITMENTS AND CONTINGENT LIABILITIES

Litigation

Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek or they may be required only to state an amount sufficient to meet a court's jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, the use of captive reinsurers, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters.

As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters.

The outcome of a litigation or regulatory matter is difficult to predict and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company's litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period.

For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of September 30, 2017, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $9 million.

For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company's accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews.

In July 2011, a derivative action was filed in the United States District Court for the District of New Jersey entitled Mary Ann Sivolella v. AXA Equitable Life Insurance Company and AXA Equitable Funds Management Group, LLC(“Sivolella Litigation”) and a substantially similar action was filed in January 2013 entitled Sanfordet al.v. AXA Equitable FMG (“Sanford Litigation”). These lawsuits were filed on behalf of a total of twelve mutual funds and, among other things, seek recovery under (i) Section 36(b) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), for alleged excessive fees paid to AXA Equitable and AXA Equitable FMG for investment management services and administrative services and (ii) a variety of other theories including unjust enrichment. The Sivolella Litigation and the Sanford Litigation were consolidated and a 25-day trial commenced in January 2016 and concluded in February 2016. In August 2016, the District Court issued its decision in favor of AXA Equitable and AXA Equitable FMG, finding that the plaintiffs had failed to meet their burden to demonstrate that AXA Equitable and AXA Equitable FMG breached their fiduciary duty in violation of Section 36(b) of the Investment Company Act or show any actual damages. In September 2016, the plaintiffs filed a motion to amend the District Court’s trial opinion and to amend or make new findings of fact and/or conclusions of law. In December 2016, the District Court issued an order denying the motion to amend and plaintiffs filed a notice to appeal the District Court’s decision to the U.S. Court of Appeals for the Third Circuit. We are vigorously defending this matter.

In April 2014, a lawsuit was filed in the United States District Court for the Southern District of New York, now entitled Ross v. AXA Equitable Life Insurance Company. The lawsuit is a putative class action on behalf of all persons and entities that, between 2011 and March 11, 2014, directly or indirectly, purchased, renewed or paid premiums on life insurance policies issued by AXA Equitable (the “Policies”). The complaint alleges that AXA Equitable did not disclose in its New York statutory annual statements or elsewhere that the collateral for certain reinsurance transactions with affiliated reinsurance companies was supported by parental guarantees, an omission that allegedly caused AXA Equitable to misrepresent its “financial condition” and “legal reserve system.” The lawsuit seeks recovery under Section 4226 of the New York Insurance Law of all premiums paid by the class for the Policies during the relevant period. In July 2015, the Court granted AXA Equitable’s motion to dismiss for lack of subject matter jurisdiction. In April 2015, a second action in the United States District Court for the Southern District of New York was filed on behalf of a putative class of variable annuity holders with “Guaranteed Benefits Insurance Riders,” entitled Calvin W. Yarbrough, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. The new action covers the same class period, makes substantially the same allegations, and seeks the same relief as the Ross action. In October 2015, the Court, on its own, dismissed the Yarbrough litigation on similar grounds as the Ross litigation. In December 2015, the Second Circuit denied the plaintiffs motion to consolidate their appeals but ordered that the appeals be heard together before a single panel of judges. In February 2017, the Second Circuit affirmed the decisions of the district court in favor of AXA Equitable, and that decision is now final because the plaintiffs failed to file a further appeal.

In November 2014, a lawsuit was filed in the Superior Court of New Jersey, Camden County entitled Arlene Shuster, on behalf of herself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all AXA Equitable variable life insurance policyholders who allocated funds from their policy accounts to investments in AXA Equitable’s separate accounts, which were subsequently subjected to volatility-management strategy, and who suffered injury as a result thereof. The action asserts that AXA Equitable breached its variable life insurance contracts by implementing the volatility management strategy. In February 2016, the Court dismissed the complaint. In March 2016, the plaintiff filed a notice of appeal. In August 2015, another lawsuit was filed in Connecticut Superior Court, Judicial Division of New Haven entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all persons who purchased variable annuities from AXA Equitable which were subsequently subject to the volatility management strategy and who suffered injury as a result thereof. Plaintiff asserts a claim for breach of contract alleging that AXA Equitable implemented the volatility management strategy in violation of applicable law. In November 2015, the Connecticut Federal District Court transferred this action to the United States District Court for the Southern District of New York. In March 2017, the Southern District of New York granted AXA Equitable’s motion to dismiss the complaint. In April 2017, the plaintiff filed a notice of appeal. We are vigorously defending these matters.

In February 2016, a lawsuit was filed in the United States District Court for the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of universal life ("UL") policies subject to AXA Equitable’s COI increase. In early 2016, AXA Equitable raised COI rates for certain UL policies issued between 2004 and 2007, which had both issue ages 70 and above and a current face value amount of $1 million and above. The current complaint alleges a claim for breach of contract and a claim that the AXA Equitable made misrepresentations in violation of Section 4226 of the New York Insurance Law (“Section 4226”). Plaintiff seeks (a) with respect to its breach of contract claim, compensatory damages, costs, and, pre- and post-judgment interest, and (b) with respect to its claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiff and the putative class. AXA Equitable’s response to the complaint was filed in February 2017. Additionally, a separate putative class action and seven individual actions challenging the COI increase have been filed against AXA Equitable in Federal or State courts. Within that group, all but one of the outstanding Federal actions (the second putative class action and two individual actions) have been transferred to the Federal court where the Brach Family Foundation, Inc. litigation is pending. In October 2017, the Brach court entered an order consolidating the Brach class action and the other putative class action for all purposes and ordered that the two individual actions be consolidated with the Brach litigation for the purposes of coordinating pre-trial activities. We are vigorously defending each of these matters.

Restructuring

In an effort to further reduce its global real estate footprint, AB completed a comprehensive review of its worldwide office locations and began implementing a global space consolidation plan in 2012. This resulted in the sublease of office space primarily in New York as well as offices in England, Australia and various U.S. locations.

In the first nine months of 2017 and 2016, AB recorded new real estate charges of $39 million and $25 million, respectively, relating to the further consolidation of office space at its New York offices. Real estate charges are recorded in Other operating costs and expenses in the Company’s Consolidated Statements of Income (Loss).

Obligation under funding agreements

As a member of the FHLBNY, AXA Equitable has access to collateralized borrowings. It also may issue funding agreements to the FHLBNY. Both the collateralized borrowings and funding agreements would require AXA Equitable to pledge qualified mortgage-backed assets and/or government securities as collateral. AXA Equitable issues short-term funding agreements to the FHLBNY and uses the funds for asset liability and cash management purposes. AXA Equitable issues long-term funding agreements to the FHLBNY and uses the funds for spread lending purposes. Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets. For other instruments used for asset liability management purposes see “Derivative and offsetting assets and liabilities” included in Note 3. Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets.

	Outstanding balance at end of period		Maturity of Outstanding balance	Issued during the period		Repaid during the period
September 30, 2017:	(in millions)
Short-term FHLBNY funding agreements	$	500	less than one month	$	4,500	$	4,500
Long-term FHLBNY funding agreements	548		less than 4 years	174		—
	923		Less than 5 years	303		—
	744		greater than five years	—		—
Total long-term funding agreements	2,215			477		—
Total FHLBNY funding agreements at September 30, 2017	$	2,715		$	4,977	$	4,500
December 31, 2016:
Short-term FHLBNY funding agreements	$	500	less than one month	$	6,000	$	6,000
Long-term FHLBNY funding agreements	58		less than 4 years	58		—
	862		Less than 5 years	862		—
	818		greater than five years	818		—
Total long-term funding agreements	1,738			1,738		—
Total FHLBNY funding agreements at December 31, 2016	$	2,238		$	7,738	$	6,000

Other Commitments

AXA Equitable had approximately $18 million of undrawn letters of credit issued in favor of third party beneficiaries primarily related to reinsurance as well as $719 million (including $213 million with affiliates) and $709 million of commitments under equity financing arrangements to certain limited partnership and existing mortgage loan agreements, respectively, at September 30, 2017.

AXA Financial has legally assumed primary liability from AXA Equitable for all current and future liabilities of AXA Equitable under certain employee benefit plans that provide participants with medical, life insurance, and deferred compensation benefits. AXA Equitable remains secondarily liable for its obligations under these plans and would recognize such liability in the event AXA Financial does not perform under the terms of the agreements.

XML

SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION

The following tables reconcile segment revenues and income (loss) from continuing operations before income taxes to total revenues and income (loss) as reported on the consolidated statements of income (loss) and segment assets to total assets on the consolidated balance sheets.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
Segment revenues:
Insurance(1)	$	1,713		$	1,434		$	7,309		$	7,227
Investment Management(2)	814			750			2,383			2,243
Consolidation/elimination	(7		)	(7		)	(19		)	(19		)
Total Revenues	$	2,520		$	2,177		$	9,673		$	9,451

(1) Includes investment expenses charged by AB of approximately $18 million, $42 million, $14 million and $39 million for the third quarter and first nine months of 2017 and 2016, respectively, for services provided to the Insurance segment.

(2) Intersegment investment advisory and other fees of approximately $29 million, $65 million, $21 million and $58 million for the third quarter and first nine months of 2017 and 2016, respectively, are included in total revenues of the Investment Management segment.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017		2016
	(in millions)
Segment income (loss) from continuing operations, before income taxes:
Insurance	$	(229	)	$	(99	)	$	1,385	$	1,875
Investment Management	168			183			488		490
Consolidation/elimination	—			(1		)	—		—
Total Income (Loss) from Continuing Operations, before income taxes	$	(61	)	$	83		$	1,873	$	2,365

	September 30, 2017		December 31, 2016
	(in millions)
Segment assets:
Insurance	$	205,176	$	191,033
Investment Management(1)	13,893		13,139
Consolidation/elimination	—		(3		)
Total Assets	$	219,069	$	204,169

(1) In accordance with SEC regulations, the assets of the Investment Management segment include securities with a fair value of $723 million and $893 million which have been segregated in a special reserve bank custody account at September 30, 2017 and December 31, 2016, respectively, for the exclusive benefit of securities broker-dealer or brokerage customers under the Exchange Act. They also include cash held in several special bank accounts for the exclusive benefit of customers. As of September 30, 2017 and December 31, 2016, $62 million and $53 million, respectively, of cash were segregated in these bank accounts.

XML

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

SUBSEQUENT EVENTS

At the end of the third quarter of 2017, changes to the Company’s organization structure were internally announced by the Company’s management.  Implementation of these changes commenced in the beginning of the fourth quarter of 2017, and, as a result, we are in the process of reassessing our reportable segments. The reportable segment changes will be based on management’s organization and view of the Company’s business when making operating decisions and assessing performance. The purpose of the internal changes is to flatten the organization structure, reduce our costs and accelerate decision-making processes. These internal reporting changes, including changes to our reportable segments, will occur during the rest of the fourth quarter of 2017. The Company will begin reporting new reportable segments in the 2017 annual financial statements on Form 10-K and all prior periods reported will reflect the reportable segment changes.

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Derivatives, Embedded Derivatives [Policy Text Block]

Embedded Derivatives

Reserves for products that have a GMIB feature with a no-lapse guarantee rider GMIBNLG, GIB, GWBL, GMWB or GMAB features are considered embedded derivatives and measured at estimated fair value separately from the host variable annuity product, with changes in estimated fair value reported in net derivative gains (losses). The estimated fair values of these embedded derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees attributable to the guarantee. The projections of future benefits and future fees require capital markets and actuarial assumptions, including expectations concerning policyholder behavior. A risk neutral valuation methodology is used under which the cash flows from the guarantees are projected under multiple capital market scenarios using observable risk-free rates.

Additionally, the Company cedes reinsurance for products with GMIB features where both the GMIB reinsurance contract asset and liability is considered an embedded derivative. The GMIB reinsurance contract assets fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios.

Changes in the fair value of embedded derivatives are reported on the statement of income in Derivative gains (losses). Reserves for Guarantee embedded derivatives liabilities and assumed reinsurance contracts are reported in Future policyholders' benefits and other policyholders’ liabilities and the GMIB reinsurance contract asset is reported in a stand alone line in the consolidated balance sheets.

Accounting Change

Accounting Change

In third quarter 2017, the Company voluntarily changed to fair value accounting for variable annuity products with the Guaranteed Minimum Income Benefits feature with a no-lapse guarantee ("GMIBNLG") as a retrospective change in accounting principle.  Changes in the estimated fair value of the embedded derivative is reported in Net derivative gains (losses). The Company believes that the new method of accounting for the GMIBNLG as an embedded derivative at fair value more accurately reflects the economics of the NLG feature and is more meaningful to users of our financial statements.

The comparative periods of the prior year have been adjusted to apply the new method retrospectively. The impact of the change in accounting principle to net income (loss) during the third quarter 2016 and first nine months of 2016 was an increase of $104 million and a decrease of $1,030 million, respectively. The Company’s opening retained earnings decreased $1,933 million as of January 1, 2016 for the effect of retroactive application of the accounting change.

Adoption of New Accounting Pronouncements

Adoption of New Accounting Pronouncements

In January 2017, the Financial Accounting Standards Board (the “FASB”) issued updated guidance to simplify the accounting for goodwill impairment. The revised guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The Company elected to early adopt the new guidance effective January 1, 2017. Adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In January 2017, the FASB issued new guidance that amends the definition of a business to provide a more robust framework for determining when a set of assets and activities is a business. The definition primarily adds clarity for evaluating whether certain transactions should be accounted for as acquisitions/dispositions of assets or businesses, the latter of which is subject to guidance on business combinations, but also may interact with other areas of accounting where the defined term is used, such as in the application of guidance on consolidation and goodwill impairment. The new guidance is effective for fiscal years ending December 31, 2018 and thereafter. The Company elected to early adopt the new guidance for the year ending December 31, 2016. Adoption of this guidance did not have an impact on the Company's consolidated financial statements.

In October 2016, the FASB issued updated guidance on consolidation of interests held through related parties that are under common control, which alters how a decision maker needs to consider indirect interests in a VIE held through an entity under common control. The new guidance amends the recently adopted consolidation guidance analysis. Under the new guidance, if a decision maker is required to evaluate whether it is the primary beneficiary of a VIE, it will need to consider only its proportionate indirect interest in the VIE held through a common control party. The Company adopted the revised guidance effective January 1, 2017. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In March 2016, the FASB issued new guidance simplifying the transition to the equity method of accounting. The amendment eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investments had been held. The Company adopted the revised guidance effective January 1, 2017. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

In March 2016, the FASB issued new guidance on improvements to employee share-based payment accounting. The amendment includes provisions intended to simplify various aspects related to how share-based payments are accounted for and presented in the financial statements including: income tax effects of share-based payments, minimum statutory tax withholding requirements and forfeitures. The Company adopted the revised guidance effective January 1, 2017. Adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Future Adoption of New Accounting Pronouncements

Future Adoption of New Accounting Pronouncements

In August 2017, the FASB issued Accounting Standards Codification (“ASC”) 815 Derivatives and Hedging, “Targeted Improvements to Accounting for Hedging Activities”. The FASB’s objective is to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition to that main objective, the amendments in this update make certain targeted improvements to simplify the application of the hedge accounting guidance in current U.S. GAAP. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early application is permitted in any interim period after issuance of the update. All transition requirements and elections should be applied to hedging relationships existing (that is, hedging relationships in which the hedging instrument has not expired, been sold, terminated, or exercised or the entity has not removed the designation of the hedging relationship) on the date of adoption. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption (that is, the initial application date).

In May 2017, the FASB issued guidance on stock compensation. The new guidance provides clarity and reduces both diversity in practice and cost and complexity when applying the guidance to a change to the terms or conditions of a share based payment award. The new guidance is effective for interim and annual periods beginning after December 15, 2017 with early adoption permitted. The new guidance will be applied prospectively to an award modified on or after the adoption of this guidance. Management is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.

In March 2017, the FASB issued guidance that requires certain premiums on callable debt securities to be amortized to the earliest call date. The new guidance willbetter align interest income recognition with the manner in which market participants price these instruments.  The new guidance is effective for interim and annual periods beginning after December 15, 2018 with early adoption permitted and is to be applied on a modified retrospective basis. Management is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.

In March 2017, the FASB issued new guidance on the presentation of net periodic pension and post-retirement benefit costs that required bifurcation of net benefit cost. The service cost component will be presented with other employee compensation costs in operating income (or capitalized in assets). The other components will be reported separately outside of operations and will not be eligible for capitalization. The new guidance is effective for interim and annual periods beginning after December 15, 2017 with early adoption permitted and is to be applied retrospectively for changes in the income statement presentation of net benefit cost and prospectively for changes in capitalization eligibility. Management is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.

In February 2016, the FASB issued revised guidance to lease accounting. The revised guidance will require lessees to recognize a right-of-use asset and a lease liability for virtually all of their leases. Lessor accounting will continue to be similar to the current model, but updated to align with certain changes to the lessee model. Extensive quantitative and qualitative disclosures, including significant judgments made by management, will be required to provide greater insight into the extent of revenue and expense recognized and expected to be recognized from existing contracts. The revised guidance is effective for interim and annual periods, beginning after December 15, 2018, with early adoption permitted.  Management is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements.

In May 2014, the FASB issued new revenue recognition guidance that is intended to improve and converge the financial reporting requirements for revenue from contracts with customers with International Financial Reporting Standards (“IFRS”). The new guidance applies to contracts that deliver goods or services to a customer, except when those contracts are for: insurance, leases, rights and obligations that are in the scope of certain financial instruments (i.e., derivative contracts) and guarantees other than product or service warranties. The new guidance is effective for interim and annual periods, beginning after December 15, 2017, with early adoption permitted for interim and annual periods beginning after December 15, 2016. The Company has not yet completed this analysis, but based on the analysis completed to date, management does not expect the standard to have a material impact on our financial condition or results of operations.

Consolidation of VIEs

Consolidation of VIEs

A VIE must be consolidated by its primary beneficiary, which generally is defined as the party who has a controlling financial interest in the VIE. The Company is deemed to have a controlling financial interest in a VIE if it has (i) the power to direct the activities of the VIE that most significantly affect the VIE’s economic performance, and (ii) the obligation to absorb losses of the VIE or the right to receive income from the VIE that potentially could be significant to the VIE. For purposes of evaluating (ii) above, fees paid to the Company as a decision maker or service provider are excluded if the fees are compensation for services provided commensurate with the level of effort required to be performed and the arrangement includes only customary terms, conditions or amounts present in arrangements for similar services negotiated at arm’s length.

If the Company has a variable interest in an entity that is determined not to be a VIE, the entity then is evaluated for consolidation under the voting interest entity (“VOE”) model. For limited partnerships and similar entities, the Company is deemed to have a controlling financial interest in a VOE, and would be required to consolidate the entity, if the Company owns a majority of the entity’s kick-out rights through voting limited partnership interests and other limited partners do not hold substantive participating rights (or other rights that would indicate that the Company does not control the entity). For entities other than limited partnerships, the Company is deemed to have a controlling financial interest in a VOE if it owns a majority voting interest in the entity.

The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate.

At September 30, 2017, the Insurance segment’s General Account held approximately $1,169 million of investment assets in the form of equity interests issued by non-corporate legal entities determined under the new guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds, and real estate-related funds. As an equity investor, the Insurance segment is considered to have a “variable interest” in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests and/or other financial arrangements, if any, the Insurance segment was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheet as “Other equity investments” and to apply the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $168,625 million, and the Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1,169 million at September 30, 2017. Except for approximately $719 million of unfunded commitments at September 30, 2017, the Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations.

AB regularly provides seed capital to new company-sponsored investment funds. As such, it may consolidate or de-consolidate a variety of company-sponsored investment funds each quarter. Due to the similarity of risks related to its involvement with each company-sponsored investment fund, disclosures required under the VIE model are aggregated, such as those disclosures regarding the carrying amount and classification of assets.

AB is not required to provide financial support to company-sponsored investment funds and only the assets of such funds are available to settle its own liabilities. AB’s exposure to loss with respect to consolidated company-sponsored investment funds is limited to its investment in, and its management fee earned from, such funds. Equity and debt holders of such funds have no recourse to AB’s assets or to the general credit of AB. The balances of consolidated VIEs and VOEs included in the Company’s balance sheet at September 30, 2017 were assets of $1,252 million, liabilities of $594 million, Redeemable noncontrolling interest of $416 million, Equity attributable to the Company of $71 million and $1 million attributable to non-redeemable noncontrolling interest. The balances of consolidated VIEs and VOEs included in the Company’s balance sheet at December 31, 2016 were assets of $956 million, liabilities of $293 million, Redeemable noncontrolling interest of $384 million, Equity attributable to the Company of $71 million and $35 million attributable to non-redeemable noncontrolling interest.

As of September 30, 2017, the net assets of company-sponsored investment products that are non-consolidated VIEs are approximately $52,100 million, and AB’s maximum risk of loss is its investment of $7 million in these VIEs and advisory fee receivables from these VIEs, which are not material.

Fair Value Measurement, Policy

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance established a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:

Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.

Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.

The Company uses unadjusted quoted market prices to measure the fair value of instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.

Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.

XML

SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2017

Accounting Changes and Error Corrections [Abstract]

Schedule of Prior Period Financial Statements

	Six Months Ended June 30,
	As Previously Reported				Impact of Revisions						As Revised
	2017		2016		2017			2016			2017		2016
	(In millions)
Statements of Equity:
Retained earnings, beginning of year	$	7,983	$	8,958	$	(86	)	$	(62	)	$	7,897	$	8,896
Net income (loss)	915		2,572		(9		)	(4		)	906		2,568
Retained earnings, end of period	8,779		11,030		(95		)	(66		)	8,684		10,964
Accumulated other comprehensive income, beginning of year earnings, beginning of year	7		228		—			(20		)	7		208
Other comprehensive income (loss)	486		1,409		—			(9		)	486		1,400
Accumulated other comprehensive income, end of period	493		1,637		—			(29		)	493		1,608
Total AXA Equitable’s equity, end of period	14,635		17,987		(95		)	(95		)	14,540		17,892
Noncontrolling interest, beginning of year	3,085		3,086		11			(27		)	3,096		3,059
Net income (loss) attributable to noncontrolling interest	118		203		—			1			118		204
Noncontrolling interest, end of period	—		3,026		11			(15		)	11		3,011
Total Equity, End of Period	$	17,617	$	21,013	$	(84	)	$	(110	)	$	17,533	$	20,903

	Six Months Ended June 30,
	As Previously Reported						Impact of Revisions						As Revised
	2017			2016			2017			2016			2017			2016
	(In millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	1,146		$	2,781		$	(9	)	$	(5	)	$	1,137		$	2,776
Policy charges and fee income	(1,761		)	(1,816		)	(86		)	70			(1,847		)	(1,746		)
Interest credited to policyholders’ account balances	658			525			—			(49		)	658			476
Net derivative (gains) loss	(969		)	(3,840		)	30			(86		)	(939		)	(3,926		)
Deferred Policy Acquisition costs	43			(84		)	3			75			46			(9		)
Changes in:
Future policy benefits	1,381			1,168			10			172			1,391			1,340
Reinsurance recoverable	(251		)	(92		)	57			(178		)	(194		)	(270		)
Current and deferred income taxes	(16		)	985			(5		)	1			(21		)	986
Other	—			119			—			(48		)	—			71
Net cash provided by (used in) operating activities	$	(75	)	$	(337	)	$	—		$	(48	)	$	(75	)	$	(385	)
(Decrease) increase in overdraft payables	$	—		$	—		$	—		$	48		$	—		$	48
Net cash provided by (used in) financing activities	$	—		$	4,016		$	—		$	48		$	—		$	4,064

The following table presents the effects of the revision to the Company's previously reported Consolidated Balance Sheets as of June 30, 2017 and 2016:

	As Previously Reported				Impact of Revisions						As Revised
	June 30				June 30						June 30
	2017		2016		2017			2016			2017		2016
	(In millions)
Assets:
Other equity investments	$	1,477	$	1,447	$	(21	)	$	(100	)	$	1,456	$	1,347
Trading securities, at fair value	—		7,843		—			73			—		7,916
Other invested assets	2,622		2,811		32			38			2,654		2,849
Total investments	62,111		60,979		11			11			62,122		60,990
DAC	4,141		4,496		(135		)	(126		)	4,006		4,370
Amounts due from reinsurers	4,870		4,523		31			49			4,901		4,572
Other assets	—		4,501		—			2			—		4,503
Total Assets	$	214,941	$	207,042	$	(93	)	$	(64	)	$	214,848	$	206,978
	—		—		—			—			—		—
Liabilities:
Policyholders' account balance	$	41,531	$	35,661	$	(15	)	$	(108	)	$	41,516	$	35,553
Future policyholders' benefits and other policyholders' liabilities	26,799		26,131		56			160			26,855		26,291
Current and deferred taxes	4,000		6,421		(50		)	(6		)	3,950		6,415
Total Liabilities	196,972		185,800		(9		)	46			196,963		185,846
Equity:
Retained Earnings	8,779		11,030		(95		)	(66		)	8,684		10,964
Accumulated other comprehensive income (loss)	493		1,637		—			(29		)	493		1,608
AXA Equitable Equity	14,635		17,987		(95		)	(95		)	14,540		17,892
Noncontrolling interest	2,973		3,026		11			(15		)	2,984		3,011
Equity	12,608		21,013		(84		)	(110		)	12,524		20,903
Total Liabilities and Equity	$	214,941	$	207,042	$	(93	)	$	(64	)	$	214,848	$	206,978

	Three Months Ended March 31,
	As Previously Reported					Impact of Revisions						As Revised
	2017			2016		2017			2016			2017			2016
	(In millions)
Statements of Equity:
Retained earnings, beginning of year	$	7,842		$	8,958	$	(65	)	$	(62	)	$	7,777		$	8,896
Net income (loss)	(431		)	1,603		1			16			(430		)	1,619
Retained earnings, end of period	7,411			10,561		(64		)	(46		)	7,347			10,515
Accumulated other comprehensive income, beginning of year earnings, beginning of year	7			228		—			(20		)	7			208
Other comprehensive income (loss)	172			786		—			6			172			792
Total AXA Equitable’s equity, end of period	12,934			16,894		(64		)	(60		)	12,870			16,834
Noncontrolling interest, beginning of year	3,085			3,086		11			(27		)	3,096			3,059
Net income (loss) attributable to noncontrolling interest	118			117		—			—			118			117
Noncontrolling interest, end of period	3,035			3,069		11			(27		)	3,046			3,042
Total Equity, End of Period	$	15,969		$	19,963	$	(53	)	$	(87	)	$	15,916		$	19,876

	Three Months Ended March 31,
	As Previously Reported						Impact of Revisions						As Revised
	2017			2016			2017			2016			2017			2016
	(In millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	(313	)	$	1,720		$	1		$	16		$	(312	)	$	1,736
Policy charges and fee income	(896		)	(901		)	(29		)	41			(925		)	(860		)
Interest credited to policyholders’ account balances	337			251			(1		)	(30		)	336			221
(Increase) decrease in the fair value of the reinsurance contract asset	—			—			—			—			—			—
Net derivative (gains) loss	724			(2,278		)	9			(108		)	733			(2,386		)
Deferred Policy Acquisition costs	125			(10		)	—			32			125			22
Changes in:
Variable interest entities	—			—			—			—			—			—
Future policy benefits	185			491			20			130			205			621
Reinsurance recoverable	(44		)	(145		)	—			(89		)	(44		)	(234		)
Current and deferred income taxes	(327		)	733			—			8			(327		)	741
Accounts payable and accrued expenses	—			—			—			—			—			—
Other	—			50			—			91			—			141
Net cash provided by (used in) operating activities	$	18		$	99		$	—		$	91		$	18		$	190
(Decrease) increase in overdraft payables	$	50		$	—		$	—		$	(91	)	$	50		$	(91	)
Net cash provided by (used in) financing activities	$	2,306		$	1,468		$	—		$	(91	)	$	2,306		$	1,377

The following tables present line items for prior period financial statements that have been affected by the revision. For these items, the tables detail the amounts as previously reported, the impact upon those line items due to the revision, and the amounts as currently revised within the financial statements.

	September 30, 2016
	As Previously Reported		Impact of Revisions			As Revised
	(In millions)
Assets:
Other equity investments	$	1,454	$	(93	)	$	1,361
Trading securities, at fair value	8,702		65			8,767
Other invested assets	2,192		39			2,231
Total investments	60,968		11			60,979
DAC	4,516		(123		)	4,393
Amounts due from reinsurers	4,550		27			4,577
Total Assets	$	209,034	$	(85	)	$	208,949
	—		—			—
Liabilities:
Policyholders' account balance	$	36,920	$	(76	)	$	36,844
Future policyholders' benefits and other policyholders' liabilities	26,191		109			26,300
Current and deferred taxes	6,160		(46		)	6,114
Total Liabilities	188,005		(13		)	187,992
	—		—			—
Equity:
Retained Earnings	10,954		(83		)	10,871
AXA Equitable Equity	17,882		(83		)	17,799
Noncontrolling interest	3,001		11			3,012
Equity	20,883		(72		)	20,811
Total Liabilities and Equity	$	209,034	$	(85	)	$	208,949

The following table presents the effects of the accounting change to the Company’s previously reported consolidated statement of balance sheets as of September 30, 2016:

	As Previously Reported and Adjusted Herein		Impact of Accounting Change			As Revised
	September 30,		September 30,			September 30,
	2016		2016			2016
	(In millions)
Assets:
DAC	4,393		483			4,876
Total Assets	$	208,949	$	483		$	209,432
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	26,300		5,169			31,469
Current and deferred taxes	6,114		(1,641		)	4,473
Total Liabilities	187,992		3,528			191,520
Equity:
Retained Earnings	10,871		(2,961		)	7,910
Accumulated other comprehensive income (loss)	1,613		(84		)	1,529
AXA Equitable Equity	17,799		(3,045		)	14,754
Equity	20,811		(3,045		)	17,766
Total Liabilities and Equity	$	208,949	$	483		$	209,432

The following table presents the effects of the revision to the Company’s previously reported Consolidated Statements of Income (Loss), Statements of Comprehensive Income (Loss), Statements of Equity and Cash Flows for the three and six months ended June 30, 2017 and 2016:

	Three Months Ended June 30, 2017									Six Months Ended June 30, 2017
	As Previously Reported			Impact of Revisions			As Revised			As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	865		$	59		$	924		$	1,761		$	86		$	1,847
Net derivative gains (losses)	1,693			(38		)	1,655			969			(30		)	939
Total revenues	4,488			21			4,509			6,477			56			6,533
Benefits and other deductions:
Policyholders' benefits	1,452			30			1,482			2,343			67			2,410
Amortization of deferred policy acquisition costs, net	(82		)	4			(78		)	43			3			46
Total benefits and other deductions	2,691			34			2,725			5,253			70			5,323
Income (loss) from operations, before income taxes	1,797			(13		)	1,784			1,224			(14		)	1,210
Income tax (expense) benefit	(338		)	4			(334		)	(78		)	5			(73		)
Net income (loss)	1,459			(9		)	1,450			1,146			(9		)	1,137
	—
Less: net (income) loss attributable to the noncontrolling interest	(113		)	—			(113		)	(231		)	—			(231		)
Net income (loss) attributable to AXA Equitable	$	1,346		$	(9	)	$	1,337		$	915		$	(9	)	$	906
Statements of Comprehensive Income (Loss):
Net income (loss)	$	1,459		$	(9	)	$	1,450		$	1,146		$	(9	)	$	1,137
Comprehensive income (loss)	1,753			(9		)	1,744			1,619			(9		)	1,610
Comprehensive income (loss) attributable to AXA Equitable	$	1,660		$	(9	)	$	1,651		$	1,619		$	(9	)	$	1,610

	Three Months Ended June 30, 2016									Six Months Ended June 30, 2016
	As Previously Reported			Impact of Revisions			As Revised			As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	915		$	(29	)	$	886		$	1,816		$	(70	)	$	1,746
Premiums	121			82			203			247			165			412
Net derivative gains (losses)	1,562			(22		)	1,540			3,840			86			3,926
Total revenues	4,297			31			4,328			9,084			181			9,265
Benefits and other deductions:
Policyholders' benefits	1,211			35			1,246			2,280			159			2,439
Interest credited to Policyholders' Account Balances	274			(19		)	255			525			(49		)	476
Amortization of deferred policy acquisition costs, net	(74		)	43			(31		)	(84		)	75			(9		)
Total benefits and other deductions	2,581			59			2,640			5,054			185			5,239
Income (loss) from operations, before income taxes	1,576			(28		)	1,548			4,030			(4		)	4,026
Income tax (expense) benefit	(515		)	7			(508		)	(1,249		)	(1		)	(1,250		)
Net income (loss)	1,061			(21		)	1,040			2,781			(5		)	2,776
	—
Less: net (income) loss attributable to the noncontrolling interest	(92		)	1			(91		)	(209		)	1			(208		)
Net income (loss) attributable to AXA Equitable	$	969		$	(20	)	$	949		$	2,572		$	(4	)	$	2,568
Statements of Comprehensive Income (Loss):
Net income (loss)	$	1,061		$	(21	)	$	1,040		$	2,781		$	(5	)	$	2,776
Change in unrealized gains (losses), net of reclassification adjustment	625			(15		)	610			1,405			(9		)	1,396
Other comprehensive income	620			(15		)	605			1,409			(9		)	1,400
Comprehensive income (loss)	1,681			(36		)	1,645			4,190			(14		)	4,176
Less: Comprehensive (income) loss attributable to noncontrolling interest	$	(89	)	$	1		$	(88	)	$	(209	)	$	1		$	(208	)
Comprehensive income (loss) attributable to AXA Equitable	$	1,592		$	(35	)	$	1,557		$	3,981		$	(13	)	$	3,968

The following tables present line items for prior period financial statements that have been affected by the revision. For these items, the tables detail the amounts as previously reported, the impact upon those line items due to the revision, and the amounts as currently revised within the financial statements.

	September 30, 2016
	As Previously Reported		Impact of Revisions			As Revised
	(In millions)
Assets:
Other equity investments	$	1,454	$	(93	)	$	1,361
Trading securities, at fair value	8,702		65			8,767
Other invested assets	2,192		39			2,231
Total investments	60,968		11			60,979
DAC	4,516		(123		)	4,393
Amounts due from reinsurers	4,550		27			4,577
Total Assets	$	209,034	$	(85	)	$	208,949
	—		—			—
Liabilities:
Policyholders' account balance	$	36,920	$	(76	)	$	36,844
Future policyholders' benefits and other policyholders' liabilities	26,191		109			26,300
Current and deferred taxes	6,160		(46		)	6,114
Total Liabilities	188,005		(13		)	187,992
	—		—			—
Equity:
Retained Earnings	10,954		(83		)	10,871
AXA Equitable Equity	17,882		(83		)	17,799
Noncontrolling interest	3,001		11			3,012
Equity	20,883		(72		)	20,811
Total Liabilities and Equity	$	209,034	$	(85	)	$	208,949

	Three Months Ended September 30, 2016									Nine Months Ended September 30, 2016
	As Previously Reported			Impact of Revisions			As Revised			As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	978		$	(53	)	$	925		$	2,794		$	(123	)	$	2,671
Premiums	141			85			226			388			250			638
Net derivative gains (losses)	(656		)	(21		)	(677		)	3,184			65			3,249
Total revenues	2,006			11			2,017			11,090			192			11,282
Benefits and other deductions:
Policyholders' benefits	640			(16		)	624			2,920			143			3,063
Interest credited to Policyholders' Account Balances	272			31			303			797			(18		)	779
Amortization of deferred policy acquisition costs, net	4			43			47			(80		)	118			38
Total benefits and other deductions	2,036			58			2,094			7,090			243			7,333
Income (loss) from operations, before income taxes	(30		)	(47		)	(77		)	4,000			(51		)	3,949
Income tax (expense) benefit	52			58			110			(1,197		)	57			(1,140		)
Net income (loss)	22			11			33			2,803			6			2,809
Less: net (income) loss attributable to the noncontrolling interest	(98		)	(28		)	(126		)	(307		)	(27		)	(334		)
Net income (loss) attributable to AXA Equitable	$	(76	)	$	(17	)	$	(93	)	$	2,496		$	(21	)	$	2,475
Statements of Comprehensive Income (Loss):
Net income (loss)	$	22		$	11		$	33		$	2,803		$	6		$	2,809
Change in unrealized gains (losses), net of reclassification adjustment	(22		)	30			8			1,383			20			1,403
Other comprehensive income	(23		)	30			7			1,386			20			1,406
Comprehensive income (loss)	(1		)	41			40			4,189			26			4,215
Less: Comprehensive (income) loss attributable to noncontrolling interest	$	(99	)	$	(28	)	$	(127	)	$	(308	)	$	(27	)	$	(335	)
Comprehensive income (loss) attributable to AXA Equitable	$	(100	)	$	13		$	(87	)	$	3,881		$	(1	)	$	3,880

Nine Months Ended September 30, 2016	As Previously Reported		Impact of Revisions			As Revised
	(in millions)
Statements of Equity:
Retained earnings, beginning of year	$	8,958	$	(62	)	$	8,896
Net income (loss)	2,496		(21		)	2,475
Retained earnings, end of period	10,954		(83		)	10,871
Accumulated other comprehensive income, beginning of year earnings, beginning of year	228		(20		)	208
Other comprehensive income (loss)	1,385		20			1,405
Total AXA Equitable’s equity, end of period	17,882		(83		)	17,799
Noncontrolling interest, beginning of year	3,086		(27		)	3,059
Net income (loss) attributable to noncontrolling interest	299		27			326
Noncontrolling interest, end of period	3,001		11			3,012
Total Equity, End of Period	$	20,883	$	(72	)	$	20,811

Nine Months Ended September 30, 2016	As Previously Reported			Impact of Revisions			As Revised
	(In millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	2,803		$	6		$	2,809
Policy charges and fee income	(2,794		)	123			(2,671		)
Interest credited to policyholders’ account balances	797			(18		)	779
Net derivative (gains) loss	(3,184		)	(65		)	(3,249		)
Deferred Policy Acquisition costs	(80		)	118			38
Changes in:
Future policy benefits	1,253			(45		)	1,208
Reinsurance recoverable	(120		)	(62		)	(182		)
Current and deferred income taxes	704			(57		)	647
Net cash provided by (used in) operating activities	$	(165	)	$	—		$	(165	)

	As Previously Reported				Impact of Revisions						As Revised
	December 31,				December 31,						December 31,
	2016		2015		2016			2015			2016		2015
	(In millions)
Assets:
Other equity investments	$	1,408	$	1,477	$	(29	)	$	(81	)	$	1,379	$	1,396
Trading securities, at fair value	9,134		6,805		—			81			9,134		6,886
Other invested assets	2,186		1,788		40			—			2,226		1,788
Total investments	58,416		52,527		11			—			58,427		52,527
DAC	4,301		4,469		(175		)	(36		)	4,126		4,433
Amounts due from reinsurers	4,635		4,466		29			46			4,664		4,512
Guaranteed minimum income benefit reinsurance asset, at fair value	10,309		10,570		—			8			10,309		10,578
Other assets	4,260		4,634		—			13			4,260		4,647
Total Assets	$	203,764	$	194,626	$	(135	)	$	31		$	203,629	$	194,657
Liabilities:
Policyholders' account balance	$	38,782	$	33,033	$	43		$	(138	)	$	38,825	$	32,895
Future policyholders' benefits and other policyholders' liabilities	25,358		24,531		123			332			25,481		24,863
Current and deferred taxes	3,816		4,647		(109		)	(2		)	3,707		4,645
Other liabilities	2,108		2,586		—			(52		)	2,108		2,534
Total Liabilities	186,945		177,018		57			140			187,002		177,158
Equity:
Retained Earnings	7,983		8,958		(203		)	(62		)	7,780		8,896
Accumulated other comprehensive income (loss)	7		228		—			(20		)	7		208
AXA Equitable Equity	13,331		14,509		(203		)	(82		)	13,128		14,427
Noncontrolling interest	3,085		3,086		11			(27		)	3,096		3,059
Equity	16,416		17,595		(192		)	(109		)	16,224		17,486
Total Liabilities and Equity	$	203,764	$	194,626	$	(135	)	$	31		$	203,629	$	194,657

	As Previously Reported									Impact of Revisions									As Revised
	Year Ended December 31,									Year Ended December 31,									Year Ended December 31,
	2016			2015			2014			2016			2015			2014			2016			2015			2014
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	3,423		$	3,208		$	3,115		$	192		$	316		$	248		$	3,615		$	3,524		$	3,363
Premiums	880			854			874			(26		)	(26		)	(27		)	854			828			847
Net derivative gains (losses)	(1,277		)	(208		)	5,409			43			(131		)	(168		)	(1,234		)	(339		)	5,241
Total revenues	9,151			9,833			15,480			209			159			53			9,360			9,992			15,533
Benefits and other deductions:
Policyholders' benefits	2,913			2,743			3,579			172			123			375			3,085			2,866			3,954
Interest credited to Policyholder's Account Balances	981			1,048			1,155			101			(72		)	(118		)	1,082			976			1,037
Amortization of deferred policy acquisition costs	162			(331		)	(413		)	171			13			34			333			(318		)	(379		)
Other operating costs and expenses	1,458			1,415			1,692			—			82			(24		)	1,458			1,497			1,668
Total benefits and other deductions	8,720			8,183			9,365			444			146			267			9,164			8,329			9,632
Income (loss) from operations, before income taxes	431			1,650			6,115			(235		)	13			(214		)	196			1,663			5,901
Income tax (expense) benefit	113			(186		)	(1,695		)	121			(2		)	75			234			(188		)	(1,620		)
Net income (loss)	544			1,464			4,420			(114		)	11			(139		)	430			1,475			4,281
Less: net (income) loss attributable to the noncontrolling interest	(469		)	(403		)	(387		)	(27		)	—			—			(496		)	(403		)	(387		)
Net income (loss) attributable to AXA Equitable	$	75		$	1,061		$	4,033		$	(141	)	$	11		$	(139	)	$	(66	)	$	1,072		$	3,894
Statements of Comprehensive Income (Loss):
Net income (loss)	$	544		$	1,464		$	4,420		$	(114	)	$	11		$	(139	)	$	430		$	1,475		$	4,281
Change in unrealized gains (losses), net of reclassification adjustment	(217		)	(881		)	969			20			(20		)	—			(197		)	(901		)	969
Total other comprehensive income (loss), net of income taxes	(238		)	(910		)	925			20			(20		)	—			(218		)	(930		)	925
Comprehensive income (loss)	306			554			5,345			(94		)	(9		)	(139		)	212			545			5,206
Less: Comprehensive (income) loss attributable to noncontrolling interest	(452		)	(388		)	(358		)	(27		)	—			—			(479		)	(388		)	(358		)
Comprehensive income (loss) attributable to AXA Equitable	$	(146	)	$	166		$	4,987		$	(121	)	$	(9	)	$	(139	)	$	(267	)	$	157		$	4,848

	As Previously Reported									Impact of Revisions									As Revised
	Year Ended December 31,									Year Ended December 31,									Year Ended December 31,
	2016			2015			2014			2016			2015			2014			2016			2015			2014
	(In millions)
Statements of Equity:
Capital in excess of par value, beginning of year	$	5,321		$	5,957		$	5,934		$	—		$	—		$	(26	)	$	5,321		$	5,957		$	5,908
Deferred tax on dividend of AB Units	—			(35		)	(26		)	—			—			26			—			(35		)	—
Capital in excess of par value, end of year	5,339			5,321			5,957			—			—			—			5,339			5,321			5,957
Retained earnings, beginning of year	$	8,958		$	8,809		$	5,205		$	(62	)	$	(73	)	$	18		$	8,896		$	8,736		$	5,223
Stockholder dividends	(1,050		)	(912		)	(429		)	—			—			48			$	(1,050	)	$	(912	)	$	(381	)
Net income (loss)	75			1,061			4,033			(141		)	11			(139		)	(66		)	1,072			3,894
Retained earnings, end of period	7,983			8,958			8,809			(203		)	(62		)	(73		)	7,780			8,896			8,736
Accumulated other comprehensive income (loss), beginning of year	228			351			(603		)	(20		)	—			—			208			351			(603		)
Other comprehensive income (loss)	(221		)	(895		)	954			20			(20		)	—			(201		)	(915		)	954
Accumulated other comprehensive income (loss), end of year	7			228			351			—			(20		)	—			7			208			351
Total AXA Equitable’s equity, end of period	13,331			14,509			15,119			(203		)	(82		)	(73		)	13,128			14,427			15,046
Noncontrolling interest, beginning of year	3,086			2,989			2,903			(27		)	(27		)	21			3,059			2,962			2,924
Net income (loss) attributable to noncontrolling interest	464			403			387			27			—			—			491			403			387
Dividend of AB Units by AXA Equitable to AXA Financial	—			145			48			—			—			(48		)	—			145			—
Other changes in noncontrolling interest	104			132			143			11			—			—			115			132			143
Noncontrolling interest, end of year	3,085			3,086			2,989			11			(27		)	(27		)	3,096			3,059			2,962
Total Equity, End of Period	$	16,416		$	17,595		$	18,108		$	(192	)	$	(109	)	$	(100	)	$	16,224		$	17,486		$	18,008
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	544		$	1,464		$	4,420		$	(114	)	$	11		$	(139	)	$	430		$	1,475		$	4,281
Policy charges and fee income	(3,423		)	(3,208		)	(3,115		)	(192		)	(316		)	(248		)	(3,615		)	(3,524		)	(3,363		)
Interest credited to policyholders’ account balances	981			1,048			1,155			101			(72		)	(118		)	1,082			976			1,037
Net derivative (gains) loss	462			208			(5,409		)	(43		)	131			168			419			339			(5,241		)
Amortization of deferred cost of reinsurance asset	159			39			302			—			82			(10		)	159			121			292
Changes in:
Future policy benefits	803			878			1,518			(32		)	162			214			771			1,040			1,732
Deferred Policy Acquisition costs	162			(331		)	(413		)	171			13			34			333			(318		)	(379		)
Reinsurance recoverable	(534		)	(916		)	(488		)	230			(13		)	174			(304		)	(929		)	(314		)
Current and deferred income taxes	(771		)	258			1,448			(121		)	2			(75		)	(892		)	260			1,373
Other	31			111			(98		)	—			(80		)	39			31			31			(59		)
Net cash provided by (used in) operating activities	$	(461	)	$	(244	)	$	(639	)	$	—		$	(80	)	$	39		$	(461	)	$	(324	)	$	(600	)

	As Previously Reported							Impact of Revisions								As Revised
	Year Ended December 31,							Year Ended December 31,								Year Ended December 31,
	2016			2015		2014		2016			2015		2014			2016			2015		2014
	(In millions)
Cash flows from financing activities:
Policyholders' accounts balance deposits	$	9,342		$	5,757	$	6,011	$	404		$	—	$	—		$	9,746		$	5,757	$	6,011
Policyholders' accounts balance transfer (to) from Separate Accounts	1,606			1,045		815		(404		)	—		—			1,202			1,045		815
(Decrease) increase in overdrafts payable	(85		)	—		—		—			80		(39		)	(85		)	80		(39		)
Net cash provided by (used in) financing activities	$	5,751		$	3,034	$	3,843	$	—		$	80	$	(39	)	$	5,751		$	3,114	$	3,804

Schedule of Changes in Accounting Principles

The following table presents the effects of the accounting change to the Company’s previously reported consolidated statement of balance sheets as of September 30, 2016:

	As Previously Reported and Adjusted Herein		Impact of Accounting Change			As Revised
	September 30,		September 30,			September 30,
	2016		2016			2016
	(In millions)
Assets:
DAC	4,393		483			4,876
Total Assets	$	208,949	$	483		$	209,432
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	26,300		5,169			31,469
Current and deferred taxes	6,114		(1,641		)	4,473
Total Liabilities	187,992		3,528			191,520
Equity:
Retained Earnings	10,871		(2,961		)	7,910
Accumulated other comprehensive income (loss)	1,613		(84		)	1,529
AXA Equitable Equity	17,799		(3,045		)	14,754
Equity	20,811		(3,045		)	17,766
Total Liabilities and Equity	$	208,949	$	483		$	209,432

The following tables present line items for prior periods that have been affected by the accounting change. For these items, the tables detail the amounts as previously reported and adjusted herein, the impact upon those line items due to the accounting change, and the amounts as currently revised within the financial statements.

	Three Months Ended September 30, 2016									Nine Months Ended September 30, 2016
	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised			As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	925		$	(71	)	$	854		$	2,671		$	(203	)	$	2,468
Net derivative gains (losses)	(677		)	231			(446		)	3,249			454			1,621
Total revenues	2,017			160			2,177			11,282			(1,831		)	9,451
Benefits and other deductions:
Policyholders' benefits	624			(8		)	616			3,063			(390		)	2,790
Amortization of deferred policy acquisition costs, net	47			8			55			38			26			64
Total benefits and other deductions	2,094			—			2,094			7,333			(247		)	7,086
Income (loss) from operations, before income taxes	(77		)	160			83			3,949			(1,584		)	2,365
Income tax (expense) benefit	110			(56		)	54			(1,140		)	554			(586		)
Net income (loss)	33			104			137			2,809			(1,030		)	1,779
Net income (loss) attributable to AXA Equitable	$	(93	)	$	104		$	11		$	2,475		$	(1,030	)	$	1,445
Statements of Comprehensive Income (Loss):
Net income (loss)	$	33		$	104		$	137		$	2,809		$	(1,030	)	$	1,779
Change in unrealized gains (losses), net of reclassification adjustment	8			8			16			1,403			(61		)	1,342
Other comprehensive income	7			8			15			1,406			(61		)	1,345
Comprehensive income (loss)	40			112			152			4,215			(1,091		)	3,124
Comprehensive income (loss) attributable to AXA Equitable	$	(87	)	$	—		$	25		$	3,880		$	—		$	2,789

Nine Months Ended September 30, 2016	As Previously Reported and Adjusted Herein		Impact of Accounting Change			As Revised
	(In millions)
Statements of Equity:
Retained earnings, beginning of year	$	8,896	$	(1,933	)	$	6,963
Net income (loss)	2,475		(1,030		)	1,445
Retained earnings, end of period	10,871		(2,963		)	7,908
Accumulated other comprehensive income, beginning of year earnings, beginning of year	208		(23		)	185
Other comprehensive income (loss)	1,405		(61		)	1,344
Accumulated other comprehensive income, end of period	1,613		(84		)	1,529
Total AXA Equitable’s equity, end of period	17,799		(5,926		)	14,752
						—
Total Equity, End of Period	$	20,811	$	—		$	17,764

Nine Months Ended September 30, 2016	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(In millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	2,809		$	(1,030	)	$	1,779
Policy charges and fee income	(2,671		)	203			(2,468		)
Net derivative (gains) loss	(3,249		)	1,628			(1,621		)
Changes in:
Future policy benefits	1,208			(273		)	935
Deferred Policy Acquisition costs	38			26			64
Current and deferred income taxes	647			(554		)	93
Net cash provided by (used in) operating activities	$	(165	)	$	—		$	(165	)

The following table presents the effects of the accounting change to the Company's previously reported consolidated balance sheets as of December 31, 2016 and 2015:

	As Previously Reported and Adjusted Herein				Impact of Accounting Change						As Revised
	December 31,				December 31,						December 31,
	2016		2015		2016			2015			2016		2015
	(In millions)
Assets:
DAC	4,126		4,433		540			563			4,666		4,996
Total Assets	$	203,629	$	194,657	$	540		$	563		$	204,169	$	195,220
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	25,481		24,863		3,378			3,572			28,859		28,435
Current and deferred taxes	3,707		4,645		(993		)	(1,053		)	2,714		3,592
Total Liabilities	187,002		177,158		2,385			2,519			189,387		179,677
Equity:
Retained Earnings	7,780		8,896		(1,845		)	(1,933		)	5,941		6,963
Accumulated other comprehensive income (loss)	7		208		(6		)	(23		)	1		185
AXA Equitable Equity	13,128		14,427		(1,845		)	(1,956		)	11,283		12,471
Equity	16,224		17,486		(1,845		)	(1,956		)	14,379		15,530
Total Liabilities and Equity	$	203,629	$	194,657	$	(3,150	)	$	563		$	204,169	$	195,220

	As Previously Reported and Adjusted Herein									Impact of Accounting Change									As Revised
	Year Ended December 31,									Year Ended December 31,									Year Ended December 31,
	2016			2015			2014			2016			2015			2014			2016			2015			2014
	(In millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	3,615		$	3,524		$	3,363		$	(273	)	$	(240	)	$	(207	)	$	3,342		$	3,284		$	3,156
Net derivative gains (losses)	(1,234		)	(339		)	5,241			114			(733		)	(1,823		)	(1,120		)	(1,072		)	3,418
Total revenues	9,360			9,992			15,533			(159		)	(973		)	(2,030		)	9,201			9,019			13,503
Benefits and other deductions:
Policyholders' benefits	3,085			2,866			3,954			(339		)	(411		)	(247		)	2,746			2,455			3,707
Amortization of deferred policy acquisition costs	333			(318		)	(379		)	35			61			34			368			(257		)	(345		)
Total benefits and other deductions	9,164			8,329			9,632			(304		)	(350		)	(213		)	8,860			7,979			9,419
Income (loss) from operations, before income taxes	196			1,663			5,901			145			(623		)	(1,817		)	341			1,040			4,084
Income tax (expense) benefit	234			(188		)	(1,620		)	(51		)	218			636			183			30			(984		)
Net income (loss)	430			1,475			4,281			94			(405		)	(1,181		)	524			1,070			3,100
Net income (loss) attributable to AXA Equitable	$	(66	)	$	1,072		$	3,894		$	94		$	(405	)	$	(1,181	)	$	28		$	667		$	2,713
Statements of Comprehensive Income (Loss):
Net income (loss)	$	430		$	1,475		$	4,281		$	94		$	(405	)	$	(1,181	)	$	524		$	1,070		$	3,100
Change in unrealized gains (losses), net of reclassification adjustment	(197		)	(901		)	969			17			70			(78		)	(180		)	(831		)	891
Total other comprehensive income (loss), net of income taxes	(218		)	(930		)	925			17			70			(78		)	(201		)	(860		)	847
Comprehensive income (loss)	212			545			5,206			111			(335		)	(1,259		)	323			210			3,947
Comprehensive income (loss) attributable to AXA Equitable	$	(267	)	$	157		$	4,848		$	111		$	(335	)	$	(1,259	)	$	(156	)	$	(178	)	$	3,589

	As Previously Reported and Adjusted Herein									Impact of Accounting Change									As Revised
	Year Ended December 31,									Year Ended December 31,									Year Ended December 31,
	2016			2015			2014			2016			2015			2014			2016			2015			2014
	(In millions)
Statements of Equity:
Retained earnings, beginning of year	$	8,896		$	8,736		$	5,223		$	(1,933	)	$	(1,528	)	$	(347	)	$	6,963		$	7,208		$	4,876
Stockholder dividends	(1,050		)	(912		)	(381		)	—			—			—			(1,050		)	(912		)	(381		)
Net income (loss)	(66		)	1,072			3,894			94			(405		)	(1,181		)	28			667			2,713
Retained earnings, end of period	7,780			8,896			8,736			(1,839		)	(1,933		)	(1,528		)	5,941			6,963			7,208
Accumulated other comprehensive income (loss), beginning of year	208			351			(603		)	(23		)	(93		)	(15		)	185			258			(618		)
Other comprehensive income (loss)	(201		)	(915		)	954			17			70			(78		)	(184		)	(845		)	876
Accumulated other comprehensive income (loss), end of year	7			208			351			(6		)	(23		)	(93		)	1			185			258
Total AXA Equitable’s equity, end of period	13,128			14,427			15,046			(1,845		)	(1,956		)	(1,621		)	11,283			12,471			13,425
Total Equity, End of Period	$	16,224		$	17,486		$	18,008		$	(1,845	)	$	(1,956	)	$	(1,621	)	$	14,379		$	15,530		$	16,387
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	430		$	1,475		$	4,281		$	94		$	(405	)	$	(1,181	)	$	524		$	1,070		$	3,100
Policy charges and fee income	(3,615		)	(3,524		)	(3,363		)	273			240			207			(3,342		)	(3,284		)	(3,156		)
Net derivative (gains) loss	419			339			(5,241		)	(114		)	733			1,823			305			1,072			(3,418		)
Changes in:
Future policy benefits	771			1,040			1,732			(339		)	(411		)	(247		)	432			629			1,485
Deferred Policy Acquisition costs	333			(318		)	(379		)	35			61			34			368			(257		)	(345		)
Current and deferred income taxes	(892		)	260			1,373			51			(218		)	(636		)	(841		)	42			737
Net cash provided by (used in) operating activities	$	(461	)	$	(324	)	$	(600	)	$	—		$	—		$	—		$	(461	)	$	(324	)	$	(600	)

The following table presents the effects of the accounting change to the Company’s previously reported consolidated statements of income (loss), statements of comprehensive income (loss), statements of equity and cash flows for the three and nine months ended June 30, 2017 and 2016:

	Three Months Ended June 30, 2017									Six Months Ended June 30, 2017
	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised			As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(in millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	924		$	(68	)	$	856		$	1,847		$	(135	)	$	1,712
Net derivative gains (losses)	1,655			342			1,997			939			775			1,714
Total revenues	4,509			274			4,783			6,533			640			7,173
Benefits and other deductions:
Policyholders' benefits	1,482			(134		)	1,348			2,410			(65		)	2,345
Amortization of deferred policy acquisition costs, net	(78		)	2			(76		)	46			4			50
Total benefits and other deductions	2,725			(132		)	2,593			5,323			(61		)	5,262
													—
Income (loss) from operations, before income taxes	1,784			406			2,190			1,210			701			1,911
Income tax (expense) benefit	(334		)	(142		)	(476		)	(73		)	(245		)	(318		)
				—									—
Net income (loss)	1,450			264			1,714			1,137			456			1,593
Net income (loss) attributable to AXA Equitable	$	1,337		$	264		$	1,601		$	906		$	456		$	1,362
Statements of Comprehensive Income (Loss):
Net income (loss)	$	1,450		$	264		$	1,714		$	1,137		$	456		$	1,593
Change in unrealized gains (losses), net of reclassification adjustment	314			1			315			458			(35		)	423
Other comprehensive income	294			1			295			473			(35		)	438
Comprehensive income (loss)	1,744			265			2,009			1,610			421			2,031
Comprehensive income (loss) attributable to AXA Equitable	$	1,651		$	265		$	1,916		$	1,610		$	421		$	2,031

	Three Months Ended June 30, 2016									Six Months Ended June 30, 2016
	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised			As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(in millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	886		$	(67	)	$	819		$	1,746		$	(132	)	$	1,614
Net derivative gains (losses)	1,540			(797		)	743			3,926			(1,859		)	2,067
Total revenues	4,328			(864		)	3,464			9,265			(1,991		)	7,274
Benefits and other deductions:
Policyholders' benefits	1,246			(159		)	1,087			2,439			(265		)	2,174
Amortization of deferred policy acquisition costs, net	(31		)	9			(22		)	(9		)	18			9
Total benefits and other deductions	2,640			(150		)	2,490			5,239			(247		)	4,992
				—									—
Income (loss) from operations, before income taxes	1,548			(714		)	834			4,026			(1,744		)	2,282
Income tax (expense) benefit	(508		)	250			(258		)	(1,250		)	610			(640		)
Net income (loss)	1,040			(464		)	576			2,776			(1,134		)	1,642
	—			—									—
Net income (loss) attributable to AXA Equitable	$	949		$	(464	)	$	485		$	2,568		$	(1,134	)	$	1,434
Statements of Comprehensive Income (Loss):
Net income (loss)	$	1,040		$	(464	)	$	576		$	2,776		$	(1,134	)	$	1,642
Change in unrealized gains (losses), net of reclassification adjustment	610			—			610			1,396			(69		)	1,327
Other comprehensive income	605			—			605			1,400			(69		)	1,331
Comprehensive income (loss)	1,645			(464		)	1,181			4,176			(1,203		)	2,973
Comprehensive income (loss) attributable to AXA Equitable	$	1,557		$	(464	)	$	1,093		$	3,968		$	(1,203	)	$	2,765

The following table presents the effects of the accounting change to the Company's previously reported consolidated balance sheets as of March 31, 2017 and 2016:

	As Previously Reported and Adjusted Herein				Impact of Accounting Change						As Revised
	March 31,				March 31,						March 31,
	2017		2016		2017			2016			2017		2016
	(in millions)
Assets:
DAC	3,980		4,446		511			490			4,491		4,936
Total Assets	$	209,040	$	199,985	$	511		$	490		$	209,551	$	200,475
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	25,541		25,485		3,108			4,635			28,649		30,120
Current and deferred taxes	3,489		5,847		(908		)	(1,451		)	2,581		4,396
Total Liabilities	192,707		179,890		2,200			3,184			194,907		183,074
Equity:
Retained Earnings	7,347		10,516		(1,647		)	(2,602		)	5,700		7,914
Accumulated other comprehensive income (loss)	179		1,000		(42		)	(92		)	137		908
AXA Equitable Equity	12,870		16,835		(1,689		)	(2,694		)	11,181		14,141
Equity	15,916		19,877		(1,689		)	(2,694		)	14,227		17,183
Total Liabilities and Equity	$	209,040	$	199,985	$	511		$	490		$	209,551	$	200,475

The following table presents the effects of the accounting change to the Company’s previously reported consolidated statements of income (loss), statements of comprehensive income (loss), statements of equity and cash flows for the three and nine months ended March 31, 2017 and 2016:

	Three Months Ended March 31, 2017									Three Months Ended March 31, 2016
	As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised			As Previously Reported and Adjusted Herein			Impact of Accounting Change			As Revised
	(in millions)
Statements of Income (Loss):
Revenues:
Policy charges and fee income	$	925		$	(67	)	$	858		$	860		$	(65	)	$	795
Net derivative gains (losses)	(733		)	433			(300		)	2,386			(1,062		)	1,324
Total revenues	2,009			366			2,375			5,077			(1,127		)	3,950
Benefits and other deductions:							—									—
Policyholders' benefits	912			69			981			1,193			(106		)	1,087
Amortization of deferred policy acquisition costs, net	124			2			126			163			9			172
Total benefits and other deductions	2,581			71			2,652			2,599			(97		)	2,502
Income (loss) from operations, before income taxes	(572		)	295			(277		)	2,478			(1,030		)	1,448
Income tax (expense) benefit	260			(103		)	157			(742		)	361			(381		)
Net income (loss)	(312		)	192			(120		)	1,736			(669		)	1,067
Net income (loss) attributable to AXA Equitable	$	(430	)	$	192		$	(238	)	$	1,619		$	(669	)	$	950
Statements of Comprehensive Income (Loss):
Net income (loss)	$	(312	)	$	192		$	(120	)	$	1,736		$	(669	)	$	1,067
Change in unrealized gains (losses), net of reclassification adjustment	144			(36		)	108			786			(69		)	717
Other comprehensive income	179			(36		)	143			795			(69		)	726
Comprehensive income (loss)	(133		)	156			23			2,531			(738		)	1,793
Comprehensive income (loss) attributable to AXA Equitable	$	(258	)	$	156		$	(102	)	$	2,411		$	(738	)	$	1,673

	Three Months Ended March 31,
	As Previously Reported and Adjusted Herein					Impact of Accounting Change						As Revised
	2017			2016		2017			2016			2017			2016
	(in millions)
Statements of Equity:
Retained earnings, beginning of year	$	7,777		$	8,896	$	(1,839	)	$	(1,933	)	$	5,938		$	6,963
Net income (loss)	(430		)	1,619		192			(669		)	(238		)	950
Retained earnings, end of period	7,347			10,515		(1,647		)	(2,602		)	5,700			7,913
Accumulated other comprehensive income, beginning of year earnings, beginning of year	7			208		(6		)	(23		)	1			185
Other comprehensive income (loss)	172			792		(36		)	(69		)	136			723
Accumulated other comprehensive income, end of period	179			1,000		(42		)	(92		)	137			908
Total AXA Equitable’s equity, end of period	12,870			16,834		(1,689		)	(2,694		)	11,181			14,140
Total Equity, End of Period	$	15,916		$	19,876	$	(1,689	)	$	(2,694	)	$	14,227		$	17,182

	Three Months Ended March 31,
	As Previously Reported and Adjusted Herein						Impact of Accounting Change						As Revised
	2017			2016			2017			2016			2017			2016
	(in millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	(312	)	$	1,736		$	192		$	(669	)	$	(120	)	$	1,067
Policy charges and fee income	(925		)	(860		)	67			65			(858		)	(795		)
Net derivative (gains) loss	733			(2,386		)	(433		)	1,062			300			(1,324		)
Changes in:
Future policy benefits	205			621			69			(106		)	274			515
Deferred Policy Acquisition costs	125			22			2			9			127			31
Current and deferred income taxes	(327		)	741			103			(361		)	(224		)	380
Net cash provided by (used in) operating activities	$	18		$	190		$	—		$	—		$	18		$	190

	Six Months Ended June 30,
	As Previously Reported and Adjusted Herein				Impact of Accounting Change						As Revised
	2017		2016		2017			2016			2017		2016
	(in millions)
Statements of Equity:
Retained earnings, beginning of year	$	7,897	$	8,896	$	(1,839	)	$	(1,933	)	$	6,058	$	6,963
Net income (loss)	906		2,568		456			(1,134		)	1,362		1,434
Retained earnings, end of period	8,684		10,964		(1,383		)	(3,067		)	7,301		7,897
Accumulated other comprehensive income, beginning of year earnings, beginning of year	7		208		(6		)	(23		)	1		185
Other comprehensive income (loss)	486		1,400		(35		)	(69		)	451		1,331
Accumulated other comprehensive income, end of period	493		1,608		(41		)	(92		)	452		1,516
Total AXA Equitable’s equity, end of period	14,540		17,892		(1,424		)	(3,159		)	13,116		14,733
Total Equity, End of Period	$	17,533	$	20,903	$	(1,424	)	$	(3,159	)	$	16,109	$	17,744

	Six Months Ended June 30,
	As Previously Reported and Adjusted Herein						Impact of Accounting Change						As Revised
	2017			2016			2017			2016			2017			2016
	(in millions)
Statements of Cash flows:
Cash flow from operating activities:
Net income (loss)	$	1,137		$	2,776		$	456		$	(1,134	)	$	1,593		$	1,642
Policy charges and fee income	(1,847		)	(1,746		)	135			132			(1,712		)	(1,614		)
Net derivative (gains) loss	(939		)	(3,926		)	(775		)	1,859			(1,714		)	(2,067		)
Changes in:
Future policy benefits	1,391			1,340			(65		)	(265		)	1,326			1,075
Deferred Policy Acquisition costs	46			(9		)	4			18			50			9
Current and deferred income taxes	(21		)	986			245			(610		)	224			376
Net cash provided by (used in) operating activities	$	(75	)	$	(385	)	$	—		$	—		$	(75	)	$	(385	)

The following table presents the effects of the accounting change to the Company's previously reported consolidated balance sheets as of June 30, 2017 and 2016:

	As Previously Reported and Adjusted Herein				Impact of Accounting Change						As Revised
	June 30,				June 30,						June 30,
	2017		2016		2017			2016			2017		2016
	(in millions)
Assets:
DAC	4,006		4,370		510			482			4,516		4,852
Total Assets	$	214,848	$	206,978	$	510		$	482		$	215,358	$	207,460
Liabilities:
Future policyholders' benefits and other policyholders' liabilities	26,855		26,291		2,701			5,341			29,556		31,632
Current and deferred taxes	3,950		6,415		(767		)	(1,700		)	3,183		4,715
Total Liabilities	196,963		185,846		1,934			3,641			198,897		189,487
Equity:
Retained Earnings	8,684		10,964		(1,383		)	(3,067		)	7,301		7,897
Accumulated other comprehensive income (loss)	493		1,608		(41		)	(92		)	452		1,516
AXA Equitable Equity	14,540		17,892		(1,424		)	(3,159		)	13,116		14,733
Equity	12,524		20,903		(1,424		)	(3,159		)	11,100		17,744
Total Liabilities and Equity	$	214,848	$	206,978	$	510		$	482		$	215,358	$	207,460

XML

INVESTMENTS (Tables)

9 Months Ended

Sep. 30, 2017

Investments, Debt and Equity Securities [Abstract]

Available-for-sale Securities by Classification

The following table provides information relating to fixed maturities and equity securities classified as AFS:

Available-for-Sale Securities by Classification

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		OTTI in AOCI (3)
	(in millions)
September 30, 2017:
Fixed Maturity Securities:
Public corporate	$	12,429	$	748	$	39	$	13,138	$	—
Private corporate	7,069		256		34		7,291		—
U.S. Treasury, government and agency	10,842		473		379		10,936		—
States and political subdivisions	414		67		—		481		—
Foreign governments	369		29		5		393		—
Commercial mortgage-backed	280		8		26		262		1
Residential mortgage-backed(1)	249		16		—		265		—
Asset-backed(2)	30		1		1		30		2
Redeemable preferred stock	457		48		1		504		—
Total Fixed Maturities	32,139		1,646		485		33,300		3
Equity securities	135		—		—		135		—
Total at September 30, 2017	$	32,274	$	1,646	$	485	$	33,435	$	3
December 31, 2016:
Fixed Maturity Securities:
Public corporate	$	12,418	$	675	$	81	$	13,012	$	—
Private corporate	6,880		215		55		7,040		—
U.S. Treasury, government and agency	10,739		221		624		10,336		—
States and political subdivisions	432		63		2		493		—
Foreign governments	375		29		14		390		—
Commercial mortgage-backed	415		28		72		371		7
Residential mortgage-backed(1)	294		20		—		314		—
Asset-backed(2)	51		10		1		60		3
Redeemable preferred stock	519		45		10		554		—
Total Fixed Maturities	32,123		1,306		859		32,570		10
Equity securities	113		—		—		113		—
Total at December 31, 2016	$	32,236	$	1,306	$	859	$	32,683	$	10

(1) Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.

(2) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.

(3) Amounts represent OTTI losses in AOCI, which were not included in Net income (loss) in accordance with current accounting guidance.

Available-for-sale Securities Fixed Maturities Contractual Maturities

The contractual maturities of AFS fixed maturities at September 30, 2017 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

Available-for-Sale Fixed Maturities

Contractual Maturities at September 30, 2017

	Amortized Cost		Fair Value
	(in millions)
Due in one year or less	$	1,701	$	1,723
Due in years two through five	7,349		7,686
Due in years six through ten	9,256		9,530
Due after ten years	12,817		13,300
Subtotal	31,123		32,239
Commercial mortgage-backed securities	280		262
Residential mortgage-backed securities	249		265
Asset-backed securities	30		30
Redeemable preferred stock	457		504
Total	$	32,139	$	33,300

Proceeds from Sales, Gross Gains (Losses) and OTTI for AFS Fixed Maturities

The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during the third quarter and first nine months of 2017 and 2016:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
Proceeds from sales	$	1,287		$	1,080		$	1,822		$	2,866
Gross gains on sales	$	5		$	9		$	34		$	94
Gross losses on sales	$	(2	)	$	(1	)	$	(29	)	$	(47	)
Total OTTI	$	—		$	(10	)	$	(13	)	$	(35	)
Non-credit losses recognized in OCI	—			—			—			—
Credit losses recognized in income (loss)	$	—		$	(10	)	$	(13	)	$	(35	)

Fixed Maturities - Credit Loss Impairments

The following table sets forth the amount of credit loss impairments on fixed maturity securities held by the Company at the dates indicated.

Fixed Maturities - Credit Loss Impairments

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
Balances, beginning of period	$	(115	)	$	(166	)	$	(190	)	$	(198	)
Previously recognized impairments on securities that matured, paid, prepaid or sold	32			8			120			65
Recognized impairments on securities impaired to fair value this period(1)	—			—			—			(17		)
Impairments recognized this period on securities not previously impaired	—			(8		)	(13		)	(16		)
Additional impairments this period on securities previously impaired	—			(2		)	—			(2		)
Increases due to passage of time on previously recorded credit losses	—			—			—			—
Accretion of previously recognized impairments due to increases in expected cash flows	—			—			—			—
Balances at September 30,	$	(83	)	$	(168	)	$	(83	)	$	(168	)

(1) Represents circumstances where the Company determined in the current period that it intends to sell the security or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.

Net Unrealized Gain (Loss) on Fixed Maturities and Equity Securities Included in AOCI

Net unrealized investment gains (losses) on fixed maturities and equity securities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated:

	September 30, 2017		December 31, 2016
	(in millions)
AFS Securities:
Fixed maturities:
With OTTI loss	$	—	$	19
All other	1,161		428
Equity securities	—		—
Net Unrealized Gains (Losses)	$	1,161	$	447

Net Unrealized Gain (Losses) on Fixed Maturities with OTTI Losses

The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturity securities on which an OTTI loss has been recognized and all other amounts:

Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses

	Net Unrealized Gains (Losses) on Investments			DAC			Policyholders’ Liabilities			Deferred Income Tax Asset (Liability)			AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(in millions)
Balance, July 1, 2017	$	(6	)	$	2		$	1		$	1		$	(2	)
Net investment gains (losses) arising during the period	(5		)	—			—			—			(5		)
Reclassification adjustment:
Included in Net income (loss)	11			—			—			—			11
Excluded from Net income (loss)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			(1		)	—			—			(1		)
Deferred income taxes	—			—			—			(1		)	(1		)
Policyholders’ liabilities	—			—			(1		)	—			(1		)
Balance, September 30, 2017	$	—		$	1		$	—		$	—		$	1
Balance, July 1, 2016	$	15		$	—		$	—		$	(6	)	$	9
Net investment gains (losses) arising during the period	2			—			—			—			2
Reclassification adjustment:
Included in Net income (loss)	1			—			—			—			1
Excluded from Net income (loss)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			—			—			—			—
Deferred income taxes	—			—			—			(1		)	(1		)
Policyholders’ liabilities	—			—			—			—			—
Balance, September 30, 2016	$	18		$	—		$	—		$	(7	)	$	11

	Net Unrealized Gains (Losses) on Investments			DAC			Policyholders’ Liabilities			Deferred Income Tax Asset (Liability)			AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(in millions)
Balance, January 1, 2017	$	19		$	(1	)	$	(10	)	$	(3	)	$	5
Net investment gains (losses) arising during the period	—			—			—			—			—
Reclassification adjustment for OTTI losses:
Included in Net income (loss)	(19		)	—			—			—			(19		)
Excluded from Net income (loss)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			2			—			—			2
Deferred income taxes	—			—			—			3			3
Policyholders’ liabilities	—			—			10			—			10
Balance, September 30, 2017	$	—		$	1		$	—		$	—		$	1
Balance, January 1, 2016	$	16		$	—		$	(4	)	$	(5	)	$	7
Net investment gains (losses) arising during the period	(5		)	—			—			—			(5		)
Reclassification adjustment for OTTI losses:
Included in Net income (loss)	7			—			—			—			7
Excluded from Net income (loss)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			—			—			—			—
Deferred income taxes	—			—			—			(2		)	(2		)
Policyholders’ liabilities	—			—			4			—			4
Balance, September 30, 2016	$	18		$	—		$	—		$	(7	)	$	11

All Other Net Unrealized Investment Gains (Losses) in AOCI

All Other Net Unrealized Investment Gains (Losses) in AOCI

	Net Unrealized Gains (Losses) on Investments			DAC			Policyholders’ Liabilities			Deferred Income Tax Asset (Liability)			AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(In Millions)
Balance, July 1, 2017	$	1,145		$	(172	)	$	(208	)	$	(267	)	$	498
Net investment gains (losses) arising during the period	18			—			—			—			18
Reclassification adjustment:
Included in Net income (loss)	(2		)	—			—			—			(2		)
Excluded from Net income (loss)(1)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			6			—			(11		)	(5		)
Deferred income taxes	—			—			—			22			22
Policyholders’ liabilities	—			—			(24		)	(11		)	(35		)
Balance, September 30, 2017	$	1,161		$	(166	)	$	(232	)	$	(267	)	$	496
Balance, July 1, 2016	$	3,079		$	(266	)	$	(471	)	$	(821	)	$	1,521
Net investment gains (losses) arising during the period	(17		)	—			—			—			(17		)
Reclassification adjustment:
Included in Net income (loss)	—			—			—			—			—
Excluded from Net income (loss)(1)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			79			—			—			79
Deferred income taxes	—			—			—			(21		)	(21		)
Policyholders’ liabilities	—			—			5			(1		)	4
Balance, September 30, 2016	$	3,062		$	(187	)	$	(466	)	$	(843	)	$	1,566

	Net Unrealized Gains (Losses) on Investments			DAC			Policyholders’ Liabilities			Deferred Income Tax Asset (Liability)			AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
	(in millions)
Balance, January 1, 2017	$	428		$	(87	)	$	(189	)	$	(53	)	$	99
Net investment gains (losses) arising during the period	705			—			—			—			705
Reclassification adjustment for OTTI losses:
Included in Net income (loss)	28			—			—			—			28
Excluded from Net income (loss)(1)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			(79		)	—			—			(79		)
Deferred income taxes	—			—			—			(214		)	(214		)
Policyholders’ liabilities	—			—			(43		)	—			(43		)
Balance, September 30, 2017	$	1,161		$	(166	)	$	(232	)	$	(267	)	$	496
Balance, January 1, 2016	$	674		$	(131	)	$	(230	)	$	(110	)	$	203
Net investment gains (losses) arising during the period	2,417			—			—			—			2,417
Reclassification adjustment for OTTI losses:
Included in Net income (loss)	(29		)	—			—			—			(29		)
Excluded from Net income (loss)(1)	—			—			—			—			—
Impact of net unrealized investment gains (losses) on:
DAC	—			(56		)	—			8			(48		)
Deferred income taxes	—			—			—			(755		)	(755		)
Policyholders’ liabilities	—			—			(236		)	14			(222		)
Balance, September 30, 2016	$	3,062		$	(187	)	$	(466	)	$	(843	)	$	1,566

(1) Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in income (loss) for securities with no prior OTTI loss.

Schedule of Gross Unrealized Loss on Investments

The following tables disclose the fair values and gross unrealized losses of the 577 issues at September 30, 2017 and the 794 issues at December 31, 2016 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:

	Less Than 12 Months				12 Months or Longer				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
	(in millions)
September 30, 2017:
Fixed Maturity Securities:
Public corporate	$	1,207	$	15	$	752	$	24	$	1,959	$	39
Private corporate	739		11		467		23		1,206		34
U.S. Treasury, government and agency	1,354		53		3,048		326		4,402		379
States and political subdivisions	—		—		—		—		—		—
Foreign governments	13		—		59		5		72		5
Commercial mortgage-backed	49		4		137		22		186		26
Residential mortgage-backed	7		—		13		—		20		—
Asset-backed	1		—		9		1		10		1
Redeemable preferred stock	50		—		12		1		62		1
Total	$	3,420	$	83	$	4,497	$	402	$	7,917	$	485
December 31, 2016:
Fixed Maturity Securities:
Public corporate	$	2,455	$	75	$	113	$	6	$	2,568	$	81
Private corporate	1,483		38		277		17		1,760		55
U.S. Treasury, government and agency	5,356		624		—		—		5,356		624
States and political subdivisions	—		—		18		2		18		2
Foreign governments	73		3		49		11		122		14
Commercial mortgage-backed	66		5		171		67		237		72
Residential mortgage-backed	47		—		4		—		51		—
Asset-backed	4		—		8		1		12		1
Redeemable preferred stock	218		9		12		1		230		10
Total	$	9,702	$	754	$	652	$	105	$	10,354	$	859

Net Investment Income (Loss) from Trading Securities

The table below shows a breakdown of Net investment income from trading account securities during the third quarter and first nine months of 2017 and 2016:

Net Investment Income (Loss) from Trading Securities

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
	(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period	$	45	$	7	$	153	$	126
Net investment gains (losses) recognized on securities sold during the period	10		1		35		(9		)
Unrealized and realized gains (losses) on trading securities arising during the period	55		8		188		117
Interest and dividend income from trading securities	54		34		143		82
Net investment income (loss) from trading securities	$	109	$	42	$	331	$	199

Troubled Debt Restructurings - Modifications

Valuation Allowance for Mortgage Loans

Allowance for credit losses for commercial mortgage loans for the first nine months of 2017 and 2016 was as follows:

	2017		2016
Allowance for credit losses:	(in millions)
Beginning balance, January 1,	$	8	$	6
Charge-offs	—		—
Recoveries	—		(2		)
Provision	—		4
Ending balance, September 30,	$	8	$	8
September 30, Individually Evaluated for Impairment	$	8	$	8

Mortgage Loans by Loan-To-Value and Debt Service Coverage Ratios

The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at September 30, 2017 and December 31, 2016, before adjustments for valuation allowance. The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value.

Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios

September 30, 2017

	Debt Service Coverage Ratio
Loan-to-Value Ratio:(2)	Greater than 2.0x		1.8x to 2.0x		1.5x to 1.8x		1.2x to 1.5x		1.0x to 1.2x		Less than 1.0x		Total Mortgage Loans
	(in millions)
Commercial Mortgage Loans(1)
0% - 50%	$	741	$	—	$	313	$	74	$	—	$	—	$	1,128
50% - 70%	4,094		555		1,048		416		146		—		6,259
70% - 90%	170		—		196		254		50		—		670
90% plus	—		—		27		—		—		—		27
Total Commercial Mortgage Loans	$	5,005	$	555	$	1,584	$	744	$	196	$	—	$	8,084
Agricultural Mortgage Loans(1)
0% - 50%	$	270	$	141	$	297	$	504	$	300	$	33	$	1,545
50% - 70%	118		56		213		334		210		49		980
70% - 90%	—		—		—		4		—		—		4
90% plus	—		—		—		—		—		—		—
Total Agricultural Mortgage Loans	$	388	$	197	$	510	$	842	$	510	$	82	$	2,529
Total Mortgage Loans(1)
0% - 50%	$	1,011	$	141	$	610	$	578	$	300	$	33	$	2,673
50% - 70%	4,212		611		1,261		750		356		49		7,239
70% - 90%	170		—		196		258		50		—		674
90% plus	—		—		27		—		—		—		27
Total Mortgage Loans	$	5,393	$	752	$	2,094	$	1,586	$	706	$	82	$	10,613

(1) The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.

(2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.

Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios

December 31, 2016

	Debt Service Coverage Ratio
Loan-to-Value Ratio:(2)	Greater than 2.0x		1.8x to 2.0x		1.5x to 1.8x		1.2x to1.5x		1.0x to 1.2x		Less than 1.0x		Total Mortgage Loans
	(in millions)
Commercial Mortgage Loans(1)
0% - 50%	$	738	$	95	$	59	$	56	$	—	$	—	$	948
50% - 70%	3,217		430		673		1,100		76		—		5,496
70% - 90%	282		65		229		127		28		46		777
90% plus	—		—		28		15		—		—		43
Total Commercial Mortgage Loans	$	4,237	$	590	$	989	$	1,298	$	104	$	46	$	7,264
Agricultural Mortgage Loans(1)
0% - 50%	$	254	$	138	$	296	$	468	$	286	$	49	$	1,491
50% - 70%	141		57		209		333		219		45		1,004
70% - 90%	—		—		2		4		—		—		6
90% plus	—		—		—		—		—		—		—
Total Agricultural Mortgage Loans	$	395	$	195	$	507	$	805	$	505	$	94	$	2,501
Total Mortgage Loans(1)
0% - 50%	$	992	$	233	$	355	$	524	$	286	$	49	$	2,439
50% - 70%	3,358		487		882		1,433		295		45		6,500
70% - 90%	282		65		231		131		28		46		783
90% plus	—		—		28		15		—		—		43
Total Mortgage Loans	$	4,632	$	785	$	1,496	$	2,103	$	609	$	140	$	9,765

(1) The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.

(2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.

Age Analysis of Past Due Mortgage Loans

The following table provides information relating to the aging analysis of past due mortgage loans at September 30, 2017 and December 31, 2016, respectively, before adjustments for valuation allowance.

Age Analysis of Past Due Mortgage Loans

	30-59     Days		60-89     Days		90     Days     or >		Total		Current		Total Financing Receivables		Recorded Investment 90 Days or > and Accruing
							(in millions)
September 30, 2017
Commercial	$	—	$	—	$	—	$	—	$	8,084	$	8,084	$	—
Agricultural	3		15		27		45		2,484		2,529		27
Total Mortgage Loans	$	3	$	15	$	27	$	45	$	10,568	$	10,613	$	27
December 31, 2016
Commercial	$	—	$	—	$	—	$	—	$	7,264	$	7,264	$	—
Agricultural	9		2		6		17		2,484		2,501		6
Total Mortgage Loans	$	9	$	2	$	6	$	17	$	9,748	$	9,765	$	6

Impaired Mortgage Loans

The following table provides information regarding impaired mortgage loans at September 30, 2017 and December 31, 2016, respectively.

Impaired Mortgage Loans

	Recorded Investment		Unpaid Principal Balance		Related Allowance			Average Recorded Investment(1)		Interest Income Recognized
	(in millions)
September 30, 2017:
With no related allowance recorded:
Commercial mortgage loans - other	$	—	$	—	$	—		$	—	$	—
Agricultural mortgage loans	—		—		—			—		—
Total	$	—	$	—	$	—		$	—	$	—
With related allowance recorded:
Commercial mortgage loans - other	$	27	$	27	$	(8	)	$	27	$	1
Agricultural mortgage loans	—		—		—			—		—
Total	$	27	$	27	$	(8	)	$	27	$	1
December 31, 2016:
With no related allowance recorded:
Commercial mortgage loans - other	$	15	$	15	$	—		$	22	$	—
Agricultural mortgage loans	—		—		—			—		—
Total	$	15	$	15	$	—		$	22	$	—
With related allowance recorded:
Commercial mortgage loans - other	$	27	$	27	$	(8	)	$	48	$	2
Agricultural mortgage loans	—		—		—			—		—
Total	$	27	$	27	$	(8	)	$	48	$	2

(1) Represents a four-quarter average of recorded amortized cost.

Derivative Instruments by Category

The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments.

Derivative Instruments by Category

	At September 30, 2017						Gains (Losses) Reported In Net Income (Loss) Nine Months Ended September 30, 2017
			Fair Value
	Notional Amount		Asset Derivatives		Liability Derivatives
	(in millions)
Freestanding derivatives:
Equity contracts:(1)
Futures	$	3,858	$	1	$	1	$	(512	)
Swaps	4,289		—		162		(596		)
Options	16,294		2,760		1,243		831
Interest rate contracts:(1)
Floors	—		—		—		—
Swaps	19,889		272		243		523
Futures	9,133		—		—		28
Credit contracts:(1)
Credit default swaps	3,156		35		5		16
Other freestanding contracts:(1)
Foreign currency contracts	1,262		17		9		(40		)
Margin	—		46		—		—
Collateral	—		16		1,442		—
Embedded derivatives:
GMIB reinsurance contracts(4)	—		10,933		—		537
GMxB derivative features liability(2,4)	—		—		4,375		1,151
SCS, SIO, MSO and IUL indexed features(3,4)	—		—		1,437		(562		)
Total	$	57,881	$	14,080	$	8,917	$	1,376

(1) Reported in Other invested assets in the consolidated balance sheets.

(2) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.

(3) SCS and SIO indexed features are reported in Policyholders’ account balances; MSO and IUL indexed features are reported in the Future policyholders’ benefits and other policyholders’ liabilities in the consolidated balance sheets.

(4)

Offsetting Financial Assets and Liabilities and Derivative Instruments

accrual of $7 million in securities sold under agreement to repurchase.

The following table presents information about the Insurance segment’s offsetting financial assets and liabilities and derivative instruments at December 31, 2016.

Offsetting of Financial Assets and Liabilities and Derivative Instruments

At December 31, 2016

	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheets		Net Amounts Presented in the Balance Sheets
	(in millions)
ASSETS(1)
Description
Derivatives:
Equity contracts	$	2,129	$	1,220	$	909
Interest rate contracts	253		1,163		(910		)
Credit contracts	20		15		5
Currency	52		6		46
Margin	113		6		107
Collateral	713		748		(35		)
Total Derivatives, subject to an ISDA Master Agreement	3,280		3,158		122
Total Derivatives, not subject to an ISDA Master Agreement	4		—		4
Total Derivatives	3,284		3,158		126
Other financial instruments	2,100		—		2,100
Other invested assets	$	5,384	$	3,158	$	2,226
Securities purchased under agreement to resell	$	—	$	—	$	—
LIABILITIES(2)
Description
Derivatives:
Equity contracts	$	1,220	$	1,220	$	—
Interest rate contracts	1,163		1,163		—
Credit contracts	15		15		—
Currency	6		6		—
Margin	6		6		—
Collateral	748		748		—
Total Derivatives, subject to an ISDA Master Agreement	3,158		3,158		—
Total Derivatives, not subject to an ISDA Master Agreement	—		—		—
Total Derivatives	3,158		3,158		—
Other financial liabilities	2,108		—		2,108
Other liabilities	$	5,266	$	3,158	$	2,108
Securities sold under agreement to repurchase(3)	$	1,992	$	—	$	1,992

(1) Excludes $1.8 million of derivative assets of consolidated VIEs and VOEs in the Investment Management segment.

(2) Excludes $2.1 million of derivative liabilities of consolidated VIEs and VOEs in the Investment Management segment.

(3) Excludes expense of $4 million in securities sold under agreement to repurchase.

The following table presents information about the Insurance Segment’s offsetting of financial assets and liabilities and derivative instruments at September 30, 2017.

Offsetting of Financial Assets and Liabilities and Derivative Instruments

At September 30, 2017

	Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheets		Net Amounts Presented in the Balance Sheets
	(in millions)
ASSETS(1)
Description
Derivatives:
Equity contracts	$	2,761	$	1,406	$	1,355
Interest rate contracts	272		243		29
Credit contracts	35		5		30
Currency	17		9		8
Margin	46		—		46
Collateral	16		1,442		(1,426		)
Total Derivatives, subject to an ISDA Master Agreement	3,147		3,105		42
Total Derivatives, not subject to an ISDA Master Agreement	—		—		—
Total Derivatives	3,147		3,105		42
Other financial instruments	2,473		—		2,473
Other invested assets	$	5,620	$	3,105	$	2,515
Securities purchased under agreement to resell	$	—	$	—	$	—
LIABILITIES(2)
Description
Derivatives:
Equity contracts	$	1,406	$	1,406	$	—
Interest rate contracts	243		243		—
Credit contracts	5		5		—
Currency	9		9		—
Margin	—		—		—
Collateral	1,442		1,442		—
Total Derivatives, subject to an ISDA Master Agreement	3,105		3,105		—
Total Derivatives, not subject to an ISDA Master Agreement	—		—		—
Total Derivatives	3,105		3,105		—
Other financial liabilities	2,869		—		2,869
Other liabilities	$	5,974	$	3,105	$	2,869
Securities sold under agreement to repurchase(3)	$	1,830	$	—	$	1,830

(1) Excludes $1.8 million of derivative assets of consolidated VIEs and VOEs in the Investment Management segment.

(2) Excludes $2.8 million of derivative liabilities of consolidated VIEs and VOEs in the Investment Management segment.

(3) Excludes expense of $7 million in securities sold under agreement to repurchase.

Gross Collateral Amounts Not Offset in Consolidated Balance Sheets

The following table presents information about the Insurance segment’s gross collateral amounts that are not offset in the consolidated balance sheets at September 30, 2017.

Collateral Amounts Offset in the Consolidated Balance Sheets

At September 30, 2017

	Fair Value of Assets		Collateral (Received)/Held
			Financial Instruments			Cash			Net Amounts
	(in millions)
ASSETS:(1)
Total derivatives	$	1,423	$	—		$	(1,381	)	$	42
Other financial instruments	2,473		—			—			2,473
Other invested assets	$	3,896	$	—		$	(1,381	)	$	2,515
Securities purchased under agreement to resell	$	—	$	—		$	—		$	—
LIABILITIES:(2)
Securities sold under agreement to repurchase(3)	$	1,830	$	(1,894	)	$	—		$	(64	)

(1) Excludes Investment Management segment’s derivative assets of consolidated VIEs.

(2) Excludes Investment Management segment’s derivative liabilities of consolidated VIEs.

(3) Excludes expense of $7 million in securities sold under agreement to repurchase.

The following table presents information about the Insurance segment’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2016.

Collateral Amounts Offset in the Consolidated Balance Sheets

At December 31, 2016

	Net Amounts Presented in the Balance Sheets		Collateral (Received)/Held
			Financial Instruments			Cash			Net Amounts
	(in millions)
ASSETS:(1)
Total Derivatives	$	54	$	—		$	71		$	125
Other financial instruments	2,067		—			—			2,067
Other invested assets	$	2,121	$	—		$	71		$	2,192
Securities purchased under agreement to resell	$	—	$	—		$	—		$	—
LIABILITIES(2)
Securities sold under agreement to repurchase(3)	$	1,992	$	(1,986	)	$	(2	)	$	4

(1) Excludes Investment Management segment’s derivative assets of consolidated VIEs.

(2) Excludes Investment Management segment’s derivative liabilities of consolidated VIEs.

(3) Excludes expense of $4 million in securities sold under agreement to repurchase.

Repurchase Agreements Accounted for as Secured Borrowings

The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2016.

Repurchase Agreement Accounted for as Secured Borrowings

	At December 31, 2016
	Remaining Contractual Maturity of the Agreements
	Overnight and Continuous		Up to 30 days		30–90 days		Greater  Than 90 days		Total
	(in millions)
Securities sold under agreement to repurchase(1)
U.S. Treasury and agency securities	$	—	$	1,992	$	—	$	—	$	1,992
Total	$	—	$	1,992	$	—	$	—	$	1,992

(1) Excludes expense of $4 million in securities sold under agreement to repurchase

The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at September 30, 2017.

Repurchase Agreement Accounted for as Secured Borrowings

	At September 30, 2017
	Remaining Contractual Maturity of the Agreements
	Overnight and Continuous		Up to 30 days		30–90 days		Greater Than 90 days		Total
	(in millions)
Securities sold under agreement to repurchase(1)
U.S. Treasury and agency securities	$	—	$	1,830	$	—	$	—	$	1,830
Total	$	—	$	1,830	$	—	$	—	$	1,830
Securities purchased under agreement to resell
Corporate securities	$	—	$	—	$	—	$	—	$	—
Total	$	—	$	—	$	—	$	—	$	—

(1) Excludes expense accrual of $7 million in securities sold under agreement to repurchase.

XML

CLOSED BLOCK (Tables)

9 Months Ended

Sep. 30, 2017

Closed Block Disclosure [Abstract]

Summarized Financial Information for Closed Blocks

Summarized financial information for the Closed Block follows:

	September 30, 2017		December 31, 2016
	(in millions)
CLOSED BLOCK LIABILITIES:
Future policy benefits, policyholders’ account balances and other	$	7,016	$	7,179
Policyholder dividend obligation	43		52
Other liabilities	301		43
Total Closed Block liabilities	7,360		7,274
ASSETS DESIGNATED TO THE CLOSED BLOCK:
Fixed maturities, available for sale, at fair value (amortized cost of $3,951 and $3,884)	4,126		4,025
Mortgage loans on real estate	1,804		1,623
Policy loans	795		839
Cash and other invested assets	316		444
Other assets	173		181
Total assets designated to the Closed Block	7,214		7,112
Excess of Closed Block liabilities over assets designated to the Closed Block	146		162
Amounts included in accumulated other comprehensive income (loss):
Net unrealized investment gains (losses), net of policyholder dividend obligation of $(43) and $(52)	142		100
Maximum Future Earnings To Be Recognized From Closed Block Assets and Liabilities	$	288	$	262

Closed Block Revenues and Expenses

Closed Block revenues and expenses were as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
REVENUES:
Premiums and other income	$	52		$	55		$	167		$	177
Net investment income (loss)	82			96			244			270
Net investment gains (losses)	(2		)	—			(18		)	1
Total revenues	132			151			393			448
BENEFITS AND OTHER DEDUCTIONS:
Policyholders’ benefits and dividends	132			131			416			404
Other operating costs and expenses	1			1			2			3
Total benefits and other deductions	133			132			418			407
Net revenues (loss) before income taxes	(1		)	19			(25		)	41
Income tax (expense) benefit	1			(7		)	9			(15		)
Net Revenues (Losses)	$	—		$	12		$	(16	)	$	26

Reconciliation of Policy Holder Dividend Obligation

Reconciliation of the policyholder dividend obligation follows:

	Nine Months Ended September 30,
	2017			2016
	(in millions)
Balances, beginning of year	$	52		$	81
Unrealized investment gains (losses), net of DAC	(9		)	135
Balances, End of Period	$	43		$	216

XML

INSURANCE LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2017

Variable Annuity Contracts-GMDB GMIB And GWBL [Abstract]

GMDB and GMIB Liabilities and Other Policyholder's Liabilities

The following table summarizes the GMDB and GMIB liabilities without NLG, before reinsurance ceded, reflected in the Consolidated Balance Sheet in Future policy benefits and other policyholders’ liabilities:

	GMDB			GMIB			Total
	(in millions)
Balance at January 1, 2017	$	3,165		$	3,872		$	7,037
Paid guarantee benefits	(272		)	(102		)	(374		)
Other changes in reserve	1,083			847			1,930
Balance at September 30, 2017	$	3,976		$	4,617		$	8,593
Balance at January 1, 2016	$	2,991		$	3,889		$	6,880
Paid guarantee benefits	(280		)	(249		)	(529		)
Other changes in reserve	478			903			1,381
Balance at September 30, 2016	$	3,189		$	4,543		$	7,732

GMDB Reinsurance Ceded

The following table summarizes the ceded GMDB liabilities, reflected in the Consolidated Balance Sheet in amounts due to reinsurers:

	Nine Months Ended September 30,
	2017			2016
	(in millions)
Balance, beginning of year	$	1,558		$	1,430
Paid guarantee benefits	(132		)	(137		)
Other changes in reserve	555			253
Balance, End of Period	$	1,981		$	1,546

Variable Annuity Contracts with GMDB and GMIB Features

The September 30, 2017 values for variable annuity contracts in-force on such date with GMDB and GMIB features are presented in the following table. For contracts with the GMDB feature, the net amount at risk in the event of death is the amount by which the GMDB benefits exceed related account values. For contracts with the GMIB feature, the net amount at risk in the event of annuitization is the amount by which the present value of the GMIB benefits exceeds related account values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB guarantees may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive:

	Return of Premium			Ratchet			Roll-Up			Combo			Total
	(Dollars in millions)
GMDB:
Account values invested in:
General Account	$	13,860		$	112		$	67		$	207		$	14,246
Separate Accounts	$	44,277		$	9,375		$	3,479		$	35,272		$	92,403
Net amount at risk, gross	$	180		$	64		$	2,059		$	15,775		$	18,078
Net amount at risk, net of amounts reinsured	$	180		$	44		$	1,403		$	6,556		$	8,183
Average attained age of contractholders	51.4			66.2			72.8			68.1			55.3
Percentage of contractholders over age 70	9.6		%	39.4		%	62.4		%	45.6		%	18.0		%
Range of contractually specified interest rates	N/A			N/A			3%-6%			3%-6.5%			3%-6.5%
GMIB:
Account values invested in:
General Account	N/A			N/A			$	24		$	303		$	327
Separate Accounts	N/A			N/A			$	20,382		$	40,687		$	61,069
Net amount at risk, gross	N/A			N/A			$	982		$	6,655		$	7,637
Net amount at risk, net of amounts reinsured	N/A			N/A			$	297		$	1,649		$	1,946
Weighted average years remaining until annuitization	N/A			N/A			1.7			0.9			1.0
Range of contractually specified interest rates	N/A			N/A			3%-6%			3%-6.5%			3%-6.5%

Investment in Variable Insurance Trust Mutual Funds

The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB benefits and guarantees. The investment performance of the assets impacts the related account values and, consequently, the net amount of risk associated with the GMDB and GMIB benefits and guarantees. Since variable annuity contracts with GMDB benefits and guarantees may also offer GMIB benefits and guarantees in each contract, the GMDB and GMIB amounts listed are not mutually exclusive:

Investment in Variable Insurance Trust Mutual Funds

	September 30, 2017		December 31, 2016
	(in millions)
GMDB:
Equity	$	75,751	$	69,625
Fixed income	2,288		2,483
Balanced	14,056		14,434
Other	308		348
Total	$	92,403	$	86,890
GMIB:
Equity	$	49,177	$	45,931
Fixed income	1,602		1,671
Balanced	10,148		10,097
Other	142		149
Total	$	61,069	$	57,848

Summary of no-Lapse Guarantee Liabilities and Other Policyholder's Liabilities

The following table summarizes the no lapse guarantee liabilities reflected in the General Account in Future policy benefits and other policyholders’ liabilities, the related reinsurance reserve ceded, reflected in Amounts due from reinsurers and deferred cost of reinsurance, reflected in Other assets in the Consolidated balance sheets.

	Direct Liability			Reinsurance Ceded			Net
	(in millions)
Balance at January 1, 2017	$	1,208		$	(619	)	$	589
Paid Guaranteed Benefits	—			—			—
Other changes in reserves	216			(70		)	146
Balance at September 30, 2017	$	1,424		$	(689	)	$	735
Balance at January 1, 2016	$	1,155		$	(519	)	$	636
Other changes in reserves	(29		)	(82		)	(111		)
Balance at September 30, 2016	$	1,126		$	(601	)	$	525

XML

FAIR VALUE DISCLOSURES (Tables)

9 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

Fair Value Measurements at September 30, 2017

	Level 1		Level 2			Level 3		Total
	(in millions)
Assets:
Investments:
Fixed maturities, available-for-sale:
Public Corporate	$	—	$	13,052		$	87	$	13,139
Private Corporate	—		6,231			1,059		7,290
U.S. Treasury, government and agency	—		10,936			—		10,936
States and political subdivisions	—		440			41		481
Foreign governments	—		393			—		393
Commercial mortgage-backed	—		14			248		262
Residential mortgage-backed(1)	—		265			—		265
Asset-backed(2)	—		22			8		30
Redeemable preferred stock	180		323			1		504
Subtotal	180		31,676			1,444		33,300
Other equity investments	4		—			1		5
Trading securities	481		11,572			—		12,053
Other invested assets:
Short-term investments	—		770			—		770
Assets of consolidated VIEs/VOEs	670		130			2		802
Swaps	—		(125		)	—		(125		)
Credit Default Swaps	—		30			—		30
Options	—		1,517			—		1,517
Subtotal	670		2,322			2		2,994
Cash equivalents	3,271		—			—		3,271
Segregated securities	—		789			—		789
GMIB reinsurance contract asset	—		—			10,933		10,933
Separate Accounts’ assets	115,810		2,918			337		119,065
Total Assets	$	120,416	$	49,277		$	12,717	$	182,410
Liabilities
GMxB derivative features’ liability	$	—	$	—		$	4,375	$	4,375
SCS, SIO, MSO and IUL indexed features’ liability	—		1,437			—		1,437
Liabilities of consolidated VIEs/VOEs	584		3			—		587
Contingent payment arrangements	—		—			12		12
Total Liabilities	$	584	$	1,440		$	4,387	$	6,411

(1) Includes publicly-traded agency pass-through securities and collateralized obligations.

(2) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.

Fair Value Measurements at December 31, 2016

	Level 1		Level 2			Level 3		Total
	(in millions)
Assets:
Investments:
Fixed maturities, available-for-sale:
Public Corporate	$	—	$	12,984		$	28	$	13,012
Private Corporate	—		6,223			817		7,040
U.S. Treasury, government and agency	—		10,336			—		10,336
States and political subdivisions	—		451			42		493
Foreign governments	—		390			—		390
Commercial mortgage-backed	—		22			349		371
Residential mortgage-backed(1)	—		314			—		314
Asset-backed(2)	—		36			24		60
Redeemable preferred stock	218		335			1		554
Subtotal	218		31,091			1,261		32,570
Other equity investments	3		—			5		8
Trading securities	478		8,656			—		9,134
Other invested assets:
Short-term investments	—		574			—		574
Assets of consolidated VIEs	342		205			6		553
Swaps	—		(925		)	—		(925		)
Credit Default Swaps	—		5			—		5
Options	—		960			—		960
Floors	—		11			—		11
Subtotal	342		830			6		1,178
Cash equivalents	1,529		—			—		1,529
Segregated securities	—		946			—		946
GMIB reinsurance contract asset	—		—			10,309		10,309
Separate Accounts’ assets	108,085		2,818			313		111,216
Total Assets	$	110,655	$	44,341		$	11,894	$	166,890
Liabilities:
GMxB derivative features’ liability	$	—	$	—		$	5,289	$	5,289
SCS, SIO, MSO and IUL indexed features’ liability	—		875			—		875
Liabilities of consolidated VIEs/VOEs	248		2			—		250
Foreign currency contracts	—		—			—		—
Contingent payment arrangements	—		—			18		18
Total Liabilities	$	248	$	877		$	5,307	$	6,432

(1) Includes publicly-traded agency pass-through securities and collateralized obligations.

(2) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

The table below presents a reconciliation for all Level 3 assets and liabilities for the third quarter and first nine months of 2017 and 2016:

Level 3 Instruments

Fair Value Measurements

	Corporate			State and Political Sub- divisions			Foreign Govts		Commercial Mortgage- backed			Asset- backed
	(in millions)
Balance, July 1, 2017	$	1,068		$	42		$	—	$	290		$	12
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	2			—			—		—			—
Investment gains (losses), net	—			—			—		(9		)	—
Subtotal	2			—			—		(9		)	—
Other comprehensive income (loss)	6			—			—		8			(3		)
Purchases	196			—			—		—			—
Sales	(119		)	(1		)	—		(40		)	(1		)
Settlements	—			—			—		—			—
Transfers into Level 3(1)	—			—			—		—			—
Transfers out of Level 3(1)	(7		)	—			—		(1		)	—
Balance, September 30, 2017	$	1,146		$	41		$	—	$	248		$	8
Balance, July 1, 2016	$	495		$	45		$	—	$	402		$	26
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—			—			—		1			—
Investment gains (losses), net	1			—			—		(12		)	—
Subtotal	1			—			—		(11		)	—
Other comprehensive income (loss)	(2		)	—			—		10			(1		)
Purchases	256			—			—		—			—
Sales	(21		)	(1		)	—		(21		)	—
Transfers into Level 3(1)	11			—			—		—			—
Transfers out of Level 3(1)	(1		)	—			—		(6		)	—
Balance, September 30, 2016	$	739		$	44		$	—	$	374		$	25

	Corporate			State and Political Sub- divisions			Foreign Govts			Commercial Mortgage- backed			Asset- backed
	(in millions)
Balance, January 1, 2017	$	845		$	42		$	—		$	349		$	24
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	6			—			—			1			—
Investment gains (losses), net	—			—			—			(29		)	15
Subtotal	6			—			—			(28		)	15
Other comprehensive income (loss)	—			—			—			27			(10		)
Purchases	518			—			—			—			—
Sales	(224		)	(1		)	—			(99		)	(20		)
Settlements	—			—			—			—			—
Transfers into Level 3(1)	6			—			—			—			—
Transfers out of Level 3(1)	(5		)	—			—			(1		)	(1		)
Balance, September 30, 2017	$	1,146		$	41		$	—		$	248		$	8
Balance, January 1, 2016	$	420		$	45		$	1		$	503		$	40
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	(1		)	—			—			1			—
Investment gains (losses), net	1			—			—			(36		)	—
Subtotal	—			—			—			(35		)	—
Other comprehensive income (loss)	8			—			—			(1		)	1
Purchases	399			—			—			—			—
Sales	(89		)	(1		)	—			(81		)	(7		)
Transfers into Level 3(1)	29			—			—			—			—
Transfers out of Level 3(1)	(28		)	—			(1		)	(12		)	(9		)
Balance, September 30, 2016	$	739		$	44		$	—		$	374		$	25

	Redeemable Preferred Stock		Other Equity Investments(2)			GMIB Reinsurance Asset			Separate Accounts Assets			GMxB derivative features liability			Contingent Payment Arrangement
	(in millions)
Balance, July 1, 2017	$	1	$	8		$	11,290		$	333		$	(4,606	)	$	17
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—		—			—			—			—			—
Investment gains (losses), net	—		(4		)	—			4			—			—
Net derivative gains (losses)	—		—			(368		)	—			208			—
Subtotal	—		(4		)	(368		)	4			208			—
Other comprehensive income (loss)	—		—			—			—			—			—
Purchases(3)	—		—			55			1			23			—
Sales(4)	—		(1		)	(44		)	—			—			—
Settlements(5)	—		—			—			(1		)	—			(5		)
Activity related to consolidated VIEs	—		—			—			—			—			—
Transfers into Level 3(1)	—		—			—			—			—			—
Transfers out of Level 3(1)	—		—			—			—			—			—
Balance, September 30, 2017	$	1	$	3		$	10,933		$	337		$	(4,375	)	$	12
Balance, July 1, 2016	$	—	$	18		$	13,311		$	307		$	(7,286	)	$	31
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—		—			—			—			—			—
Investment gains (losses), net	—		—			—			7			—			—
Net derivative gains (losses)	—		—			(79		)	—			187			—
Subtotal	—		—			(79		)	7			187			—
Other comprehensive income (loss)	—		—			—			—			—			—
Purchases(3)	—		—			57			3			1			11
Sales(4)	—		—			(176		)	—			—			—
Settlements(5)	—		—			—			(1		)	—			(24		)
Activity related to consolidated VIEs	—		15			—			—			—			—
Transfers into Level 3(1)	—		—			—			—			—			—
Transfers out of Level 3(1)	—		(24		)	—			(1		)	—			—
Balance, September 30, 2016	$	—	$	9		$	13,113		$	315		$	(7,098	)	$	18

	Redeemable Preferred Stock		Other Equity Investments(2)			GMIB Reinsurance Asset			Separate Accounts Assets			GMxB derivative features liability			Contingent Payment Arrangement
	(in millions)
Balance, January 1, 2017	$	1	$	11		$	10,309		$	313		$	(5,289	)	$	18
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—		—			—			—			—			—
Investment gains (losses), net	—		(4		)	—			22			—			—
Net derivative gains (losses)	—		—			537			—			1,151			—
Subtotal	—		(4		)	537			22			1,151			—
Other comprehensive income (loss)	—		—			—			—			—			—
Purchases(3)	—		5			166			7			(237		)	—
Sales(4)	—		(3		)	(79		)	(2		)	—			—
Settlements(5)	—		—			—			(4		)	—			(6		)
Activity related to consolidated VIEs	—		(7		)	—			—			—			—
Transfers into Level 3(1)	—		1			—			1			—			—
Transfers out of Level 3(1)	—		—			—			—			—			—
Balance, September 30, 2017	$	1	$	3		$	10,933		$	337		$	(4,375	)	$	12
Balance, January 1, 2016	$	—	$	17		$	10,578		$	313		$	(5,150	)	$	31
Total gains (losses), realized and unrealized, included in:
Income (loss) as:
Net investment income (loss)	—		—			—			—			—			—
Investment gains (losses), net	—		(1		)	—			19			—			—
Net derivative gains (losses)	—		—			2,576			—			(1,712		)	—
Subtotal	—		(1		)	2,576			19			(1,712		)	—
Other comprehensive income (loss)	—		—			—			—			—			—
Purchases(3)	—		—			166			12			(236		)	11
Sales(4)	—		—			(207		)	—			—			—
Settlements(5)	—		—			—			(6		)	—			(24		)
Activity related to consolidated VIEs	—		17			—			—			—			—
Transfers into Level 3(1)	—		—			—			1			—			—
Transfers out of Level 3(1)	—		(24		)	—			(24		)	—			—
Balance, September 30, 2016	$	—	$	9		$	13,113		$	315		$	(7,098	)	$	18

(1) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values.

(2) Includes Level 3 amounts for Trading securities and consolidated VIE investments.

(3) For the GMIB reinsurance contract asset and GWBL and other features reserves, represents premiums.

(4) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GWBL and other features reserves represents benefits paid.

(5) For contingent payment arrangements, it represents change in estimates.

Fair Value Assets Unrealized Gains Losses By Category For Level 3 Assets And Liabilities Still Held

The table below details changes in unrealized gains (losses) for the third quarter and first nine months of 2017 and 2016 by category for Level 3 assets and liabilities still held at September 30, 2017 and 2016, respectively:

	Income (Loss)
	Investment Gains (Losses), Net		Net Derivative Gains (losses)			OCI
	(in millions)
Level 3 Instruments
Third Quarter 2017
Held at September 30, 2017:
Change in unrealized gains (losses):
Fixed maturities, available-for-sale:
Corporate	$	—	$	—		$	4
Commercial mortgage-backed	—		—			9
Asset-backed	—		—			(2		)
Subtotal	$	—	$	—		$	11
GMIB reinsurance contracts	—		(368		)	—
Separate Accounts’ assets(1)	4		—			—
GMxB derivative features' liability	—		208			—
Total	$	4	$	(160	)	$	11
Level 3 Instruments
Third Quarter 2016
Held at September 30, 2016:
Change in unrealized gains (losses):
Fixed maturities, available-for-sale:
Commercial mortgage-backed	—		—			10
Asset-backed	—		—			(1		)
Subtotal	$	—	$	—		$	9
GMIB reinsurance contracts	—		(79		)	—
Separate Accounts’ assets(1)	6		—			—
GMxB derivative features' liability	—		187			—
Total	$	6	$	108		$	9

	Income (Loss)
	Net Investment Income (Loss)		Investment Gains (Losses), Net			OCI
Level 3 Instruments
First Nine Months of 2017
Held at September 30, 2017:
Change in unrealized gains (losses):
Fixed maturities, available-for-sale:
Commercial mortgage-backed	—		—			26
Asset-backed	—		—			(9		)
Subtotal	$	—	$	—		$	17
GMIB reinsurance contracts	—		537			—
Separate Accounts’ assets(1)	22		—			—
GMxB derivative features' liability	—		1,151			—
Total	$	22	$	1,688		$	17
Level 3 Instruments
First Nine Months of 2016
Held at September 30, 2016:
Change in unrealized gains (losses):
Fixed maturities, available-for-sale:
Corporate	$	—	$	—		$	9
State and political subdivisions	—		—			1
Commercial mortgage-backed	—		—			(6		)
Asset-backed	—		—			1
Subtotal	$	—	$	—		$	5
GMIB reinsurance contracts	—		2,576			—
Separate Accounts’ assets(1)	19		—			—
GMxB derivative features' liability	—		(1,712		)	—
Total	$	19	$	864		$	5

(1) There is an investment expense that offsets this investment gain (loss).

Fair Value Inputs Quantitative Information

The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities as of September 30, 2017 and December 31, 2016, respectively.

Quantitative Information about Level 3 Fair Value Measurements

September 30, 2017

	Fair Value			Valuation Technique	Significant Unobservable Input	Range	Weighted Average
	(in millions)
Assets:
Investments:
Fixed maturities, available-for-sale:
Corporate	$	41		Matrix pricing model	Spread over the industry-specific benchmark yield curve	100 bps - 565 bps	173 bps
	779			Market comparable  companies	EBITDA multiples Discount rate Cash flow multiples	5.1x- 27.3x 7.2%-17.0% 9.0x- 17.7x	12.2x 11.2% 13.1x
Separate Accounts’ assets	318			Third party appraisal	Capitalization rate	4.6%
					Exit capitalization rate	5.7%
					Discount rate	6.6%
	1			Discounted cash flow	Spread over U.S. Treasury curve	243 bps
					Discount factor	4.0%
GMIB reinsurance contract asset	10,933			Discounted cash flow	Lapse Rates	1.0%- 6.3%
					Withdrawal Rates	0.0% - 8.0%
					GMIB Utilization Rates	0.0% - 16.0%
					Non-performance risk	5 bps - 10 bps
					Volatility rates - Equity	10.0% - 30.0%
Liabilities:
GMIBNLG	4,289			Discounted cash flow	Non-performance risk Lapse Rates Withdrawal Rates Annuitization NLG Forfeiture Rates Long-term equity Volatility	1.0% 0.8% - 26.2% 0.0% - 12.4% 0.0% - 16.0% 0.55% - 2.1% 20.0%
GWBL/GMWB	85			Discounted cash flow	Lapse Rates Withdrawal Rates Utilization Rates Volatility rates - Equity	0.9% - 5.7% 0.0% - 7.0% 100% after delay 10.0% - 30.0%
GIB	(6		)	Discounted cash flow	Lapse Rates Withdrawal Rates Utilization Rates Volatility rates - Equity	0.9% - 5.7% 0.0% - 8.0% 0.0% - 16.0% 10.0% - 30.0%
GMAB	8			Discounted cash flow	Lapse Rates Volatility rates - Equity	0.5% - 11.0% 10.0% - 30.0%

Quantitative Information about Level 3 Fair Value Measurements

December 31, 2016

	Fair Value		Valuation Technique	Significant Unobservable Input	Range	Weighted Average
	(in millions)
Assets:
Investments:
Fixed maturities, available-for-sale:
Corporate	$	55	Matrix pricing model	Spread over the industry-specific benchmark yield curve	0 bps - 565 bps	143 bps
	636		Market comparable companies	EBITDA multiples Discount Rate Cash flow Multiples	4.3x-25.6x 7.0% - 17.8% 14.0x - 16.5x	11.7x 11.4% 15.6x
Asset-backed	2		Matrix pricing model	Spread over U.S. Treasury curve	25 bps - 687 bps
Separate Accounts’ assets	295		Third party appraisal	Capitalization rate	4.8%
				Exit capitalization rate	5.7%
				Discount rate	6.6%
	3		Discounted cash flow	Spread over U.S. Treasury curve	273 bps - 512 bps	283 bps
				Discount factor	1.1% - 7.0%	4.3%
GMIB reinsurance contract asset	10,309		Discounted Cash flow	Lapse Rates	1.5% - 5.7%
				Withdrawal Rates	0.0% - 8.0%
				GMIB Utilization Rates	0.0% - 16.0%
				Non-performance risk	5 bps - 17 bps
				Volatility rates - Equity	11.0%- 38.0%
Liabilities:
GMIBNLG	5,125		Discounted cash flow	Non-performance risk Lapse Rates Withdrawal Rates Annuitization NLG Forfeiture Rates Long-term equity Volatility	1.1% 1.2% - 26.2% 0.0% - 8.0% 0.0% - 16.0% 0.55% - 2.1% 20.0%
GWBL/GMWB	114		Discounted cash flow	Lapse Rates Withdrawal Rates Utilization Rates Volatility rates - Equity	1.0% - 5.7% 0.0% - 7.0% 100% after delay 9.0% - 35.0%
GIB	30		Discounted cash flow	Lapse Rates Withdrawal Rates Utilization Rates Volatility rates - Equity	1.0% - 5.7% 0.0% - 8.0% 100% after delay 9.0% - 35.0%
GMAB	20		Discounted cash flow	Lapse Rates Volatility rates - Equity	1.0% - 11.0% 9.0% - 35.0%

Fair Value Disclosure Financial Instruments Not Carried At Fair Value

The carrying values and fair values at September 30, 2017 and December 31, 2016 for financial instruments not otherwise disclosed in Note 3 are presented in the table below. Certain financial instruments are exempt from the requirements for fair value disclosure, such as insurance liabilities other than financial guarantees and investment contracts, limited partnerships accounted for under the equity method and pension and other postretirement obligations.

	Carrying Value		Fair Value
			Level 1		Level 2		Level 3		Total
	(in millions)
September 30, 2017:
Mortgage loans on real estate	$	10,605	$	—	$	—	$	10,686	$	10,686
Loans to affiliates	703		—		772		—		772
Policyholders’ liabilities: Investment contracts	2,122		—		—		2,236		2,236
Funding Agreements	2,715		—		2,727		—		2,727
Policy loans	3,322		—		—		4,220		4,220
Short-term debt	500		—		500		—		500
Separate Account Liabilities	7,083		—		—		7,083		7,083
December 31, 2016:
Mortgage loans on real estate	$	9,757	$	—	$	—	$	9,608	$	9,608
Loans to affiliates	703		—		775		—		775
Policyholders’ liabilities: Investment contracts	2,226		—		—		2,337		2,337
Funding Agreements	2,255		—		2,202		—		2,202
Policy loans	3,361		—		—		4,257		4,257
Short-term debt	513		—		513		—		513
Separate Account Liabilities	6,194		—		—		6,194		6,194

XML

SHARE-BASED COMPENSATION PROGRAMS (Tables)

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Compensation Costs

Compensation costs for the third quarter and first nine months of 2017 and 2016 for share-based payment arrangements as further described herein are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
	(in thousands)
Performance Shares	$	2,630	$	2,953	$	15,588	$	14,774
Stock Options	350		110		1,088		825
AB Stock Options	—		200		—		200
AB Restricted Units	5,600		1,200		26,900		6,400
Other compensation plans(1)	1,518		154		1,546		(759		)
Total Compensation Expenses	$	10,098	$	4,617	$	45,122	$	21,440

(1) Other compensation plans include Restricted Stock, Stock Appreciation Rights and AXA Miles.

XML

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)

9 Months Ended

Sep. 30, 2017

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

AOCI represents cumulative gains (losses) on items that are not reflected in income (loss). The balances as of September 30, 2017 and 2016 follow:

	September 30,
	2017			2016
	(in millions)
Unrealized gains (losses) on investments	$	400		$	1,560
Foreign currency translation adjustments	(57		)	(56		)
Defined benefit pension plans	(48		)	(43		)
Total accumulated other comprehensive income (loss)	295			1,461
Less: Accumulated other comprehensive (income) loss attributable to noncontrolling interest	67			68
Accumulated other comprehensive income (loss) attributable to AXA Equitable	$	362		$	1,529

Components of Accumulated Other Comprehensive Income (Loss), Net of Taxes

The components of OCI, net-of-taxes for the third quarter and first nine months of 2017 and 2016 follow:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
Foreign currency translation adjustments:
Foreign currency translation gains (losses) arising during the period	$	6		$	(1	)	$	20		$	3
(Gains) losses reclassified into net income (loss) during the period	—			—			—			—
Foreign currency translation adjustment	6			(1		)	20			3
Net unrealized gains (losses) on investments:
Net unrealized gains (losses) arising during the period	6			(10		)	458			1,568
(Gains) losses reclassified into net income (loss) during the period(1)	8			1			6			(14		)
Net unrealized gains (losses) on investments	14			(9		)	464			1,554
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other	(69		)	25			(102		)	(212		)
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(2), $7, $234, and $20	(55		)	16			362			1,342
Change in defined benefit plans:
Less: reclassification adjustments to net income (loss) for:
Net gain (loss) arising during the period	(3		)	—			(2		)	—
Change in defined benefit plans (net of deferred income tax expense (benefit) of $0, $0, $1 and $0.	(3		)	—			(2		)	—
Total other comprehensive income (loss), net of income taxes	(52		)	15			380			1,345
Less: Other comprehensive (income) loss attributable to noncontrolling interest	(32		)	(1		)	(19		)	(1		)
Other comprehensive income (loss) attributable to AXA Equitable	$	(84	)	$	14		$	361		$	1,344

(1) See “Reclassification adjustments” in Note 3. Reclassification amounts presented net of income tax expense (benefit) of $4 million, $3 million, $1 million and $(8) million, for the third quarter and first nine months of 2017 and 2016, respectively.

XML

COMMITMENT AND CONTINGENT LIABILITIES Federal Home Loan Bank, Advances (Tables)

9 Months Ended

Sep. 30, 2017

Federal Home Loan Banks, advances [Abstract]

Federal Home Loan Bank, Advances [Table Text Block]

	Outstanding balance at end of period		Maturity of Outstanding balance	Issued during the period		Repaid during the period
September 30, 2017:	(in millions)
Short-term FHLBNY funding agreements	$	500	less than one month	$	4,500	$	4,500
Long-term FHLBNY funding agreements	548		less than 4 years	174		—
	923		Less than 5 years	303		—
	744		greater than five years	—		—
Total long-term funding agreements	2,215			477		—
Total FHLBNY funding agreements at September 30, 2017	$	2,715		$	4,977	$	4,500
December 31, 2016:
Short-term FHLBNY funding agreements	$	500	less than one month	$	6,000	$	6,000
Long-term FHLBNY funding agreements	58		less than 4 years	58		—
	862		Less than 5 years	862		—
	818		greater than five years	818		—
Total long-term funding agreements	1,738			1,738		—
Total FHLBNY funding agreements at December 31, 2016	$	2,238		$	7,738	$	6,000

XML

SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated

The following tables reconcile segment revenues and income (loss) from continuing operations before income taxes to total revenues and income (loss) as reported on the consolidated statements of income (loss) and segment assets to total assets on the consolidated balance sheets.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
	(in millions)
Segment revenues:
Insurance(1)	$	1,713		$	1,434		$	7,309		$	7,227
Investment Management(2)	814			750			2,383			2,243
Consolidation/elimination	(7		)	(7		)	(19		)	(19		)
Total Revenues	$	2,520		$	2,177		$	9,673		$	9,451

(1) Includes investment expenses charged by AB of approximately $18 million, $42 million, $14 million and $39 million for the third quarter and first nine months of 2017 and 2016, respectively, for services provided to the Insurance segment.

(2) Intersegment investment advisory and other fees of approximately $29 million, $65 million, $21 million and $58 million for the third quarter and first nine months of 2017 and 2016, respectively, are included in total revenues of the Investment Management segment.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017		2016
	(in millions)
Segment income (loss) from continuing operations, before income taxes:
Insurance	$	(229	)	$	(99	)	$	1,385	$	1,875
Investment Management	168			183			488		490
Consolidation/elimination	—			(1		)	—		—
Total Income (Loss) from Continuing Operations, before income taxes	$	(61	)	$	83		$	1,873	$	2,365

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017		2016
	(in millions)
Segment income (loss) from continuing operations, before income taxes:
Insurance	$	(229	)	$	(99	)	$	1,385	$	1,875
Investment Management	168			183			488		490
Consolidation/elimination	—			(1		)	—		—
Total Income (Loss) from Continuing Operations, before income taxes	$	(61	)	$	83		$	1,873	$	2,365

Reconciliation of Assets from Segment to Consolidated

	September 30, 2017		December 31, 2016
	(in millions)
Segment assets:
Insurance	$	205,176	$	191,033
Investment Management(1)	13,893		13,139
Consolidation/elimination	—		(3		)
Total Assets	$	219,069	$	204,169

(1) In accordance with SEC regulations, the assets of the Investment Management segment include securities with a fair value of $723 million and $893 million which have been segregated in a special reserve bank custody account at September 30, 2017 and December 31, 2016, respectively, for the exclusive benefit of securities broker-dealer or brokerage customers under the Exchange Act. They also include cash held in several special bank accounts for the exclusive benefit of customers. As of September 30, 2017 and December 31, 2016, $62 million and $53 million, respectively, of cash were segregated in these bank accounts.

XML

ORGANIZATION AND BASIS OF PRESENTATION (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
AXA Equitable
Economic interest in subsidiary (as a percent)	29.30%	29.00%
Parent Company
Economic interest in subsidiary (as a percent)	64.90%	63.70%

XML

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended	12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Variable Interest Entity [Line Items]
Net Income (Loss) Attributable to Parent	$ (56)	$ 1,601	$ (238)	$ 11	$ 485	$ 950	$ 1,362	$ 1,434	$ 1,445	$ 28	$ 667	$ 2,713
Other equity investments	1,337									1,323
Total Assets	219,069	215,358	209,551	209,432	207,460	200,475	215,358	207,460	209,432	204,169	195,220
Total liabilities	202,669	198,897	194,907	191,520	189,487	183,074	198,897	189,487	191,520	189,387	179,677
Redeemable noncontrolling interest	441									403
Total AXA Equitable’s equity	12,990	13,116	11,181	14,754	14,733	14,141	13,116	14,733	14,754	11,283	12,471
Noncontrolling interest	2,969									3,096
Retained Earnings (Accumulated Deficit)	(7,265)	(7,301)	(5,700)	(7,910)	(7,897)	(7,914)	(7,301)	(7,897)	(7,910)	(5,941)	(6,963)
Insurance
Variable Interest Entity [Line Items]
Total Assets	205,176									191,033
Investment Management
Variable Interest Entity [Line Items]
Total Assets	13,893									13,139
Variable Interest Entity, Not Primary Beneficiary | Investment Management
Variable Interest Entity [Line Items]
Variable Interest Entity, nonconsolidated net assets	52,100
Variable Interest Entity, maximum loss exposure	7
Variable Interest Entity, Not Primary Beneficiary | Adjustments for New Accounting Pronouncement
Variable Interest Entity [Line Items]
Variable Interest Entity, unfunded commitments	719
Variable Interest Entity, Not Primary Beneficiary | Adjustments for New Accounting Pronouncement | Other Equity Investments
Variable Interest Entity [Line Items]
Variable Interest Entity, nonconsolidated net assets	168,625
Variable Interest Entity, maximum loss exposure	1,169
Variable Interest Entity, Not Primary Beneficiary | Adjustments for New Accounting Pronouncement | Insurance
Variable Interest Entity [Line Items]
Other equity investments	1,169
Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure
Variable Interest Entity [Line Items]
Total Assets	1,252									956
Total liabilities	594									293
Redeemable noncontrolling interest	416									384
Total AXA Equitable’s equity	71									71
Noncontrolling interest	$ 1									35
Impact of Revision
Variable Interest Entity [Line Items]
Net Income (Loss) Attributable to Parent		(9)	1	(17)	(20)	16	(9)	(4)	(21)	(141)	11	$ (139)
Other equity investments		(21)	(23)	(93)	(100)	(120)	(21)	(100)	(93)	(29)	(81)
Total Assets		(93)	(58)	(85)	(64)	2	(93)	(64)	(85)	(135)	31
Total liabilities		(9)	(5)	(13)	46	88	(9)	46	(13)	57	140
Total AXA Equitable’s equity		(95)	(64)	(83)	(95)	(59)	(95)	(95)	(83)	(203)	(82)
Noncontrolling interest		11	11	11	(15)	(27)	11	(15)	11	11	(27)
Retained Earnings (Accumulated Deficit)		$ 95	$ 64	83	$ 66	$ 45	$ 95	$ 66	83	$ 203	62
Voluntary Change To Fair Value Accounting For Variable Annuity Products [Member] | Impact of Revision
Variable Interest Entity [Line Items]
Net Income (Loss) Attributable to Parent				$ 104					$ (1,030)
Retained Earnings (Accumulated Deficit)											$ 1,933

XML

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restatements made to the Consolidated Statement of Earnings (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Policy charges and fee income	$ 914	$ 856	$ 858	$ 854	$ 819	$ 795	$ 1,712	$ 1,614	$ 2,626	$ 2,468	$ 3,342	$ 3,284	$ 3,156
Premiums	204			226					645	638
Net derivative gains (losses)	(318)	1,997	(300)	(446)	743	1,324	1,714	2,067	1,376	1,621	(1,120)	(1,072)	3,418
Revenues	2,520	4,783	2,375	2,177	3,464	3,950	7,173	7,274	9,673	9,451	9,201	9,019	13,503
Policyholders' benefits	995	1,348	981	616	1,087	1,087	2,345	2,174	3,308	2,790	2,746	2,455	3,707
Interest credited to policyholders' account balances	350			303					1,008	779
Amortization of deferred policy acquisition cost, net	(33)	(76)	126	55	(22)	172	50	9	15	64	368	(257)	(345)
Other operating costs and expenses	449			319					992	1,070
Total benefits and other deductions	2,581	2,593	2,652	2,094	2,490	2,502	5,262	4,992	7,800	7,086	8,860	7,979	9,419
Income (loss) from operations, before income taxes	(61)	2,190	(277)	83	834	1,448	1,911	2,282	1,873	2,365	341	1,040	4,084
Income tax (expense) benefit	127	(476)	157	54	(258)	(381)	(318)	(640)	(196)	(586)	183	30	(984)
Net income (loss)	66	1,714	(120)	137	576	1,067	1,593	1,642	1,677	1,779	524	1,070	3,100
Less: net (income) loss attributable to the noncontrolling interest	(122)			(126)					(353)	(334)
Net Income (Loss) Attributable to Parent	(56)	1,601	(238)	11	485	950	1,362	1,434		1,445	28	667	2,713
Change in unrealized gains (losses), net of reclassification adjustment	(55)	315	108	16	610	717	423	1,327	362	1,342	(180)	(831)	891
Other comprehensive income (loss)	(52)	295	143	15	605	726	438	1,331	380	1,345	(201)	(860)	847
Comprehensive income (loss)	14	2,009	23	152	1,181	1,793	2,031	2,973	2,057	3,124	323	210	3,947
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	(154)			(127)					(372)	(335)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ (140)	1,916	(102)	25	1,093	1,673	2,031	2,765	$ 1,685	2,789	(156)	(178)	3,589
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Policy charges and fee income		865	896	978	915	901	1,761	1,816		2,794	3,423	3,208	3,115
Premiums			0	141	121	126		247		388	880	854	874
Net derivative gains (losses)		1,693	(724)	(656)	1,562	2,278	969	3,840		3,184	(1,277)	(208)	5,409
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Revenues		4,488	1,989	2,006	4,297	4,927	6,477	9,084		11,090	9,151	9,833	15,480
Policyholders' benefits		1,452	891	640	1,211	1,069	2,343	2,280		2,920	2,913	2,743	3,579
Interest credited to policyholders' account balances			337	272	274	251	658	525		797	981	1,048	1,155
Amortization of deferred policy acquisition cost, net		(82)	125	4	(74)	131	43	(84)		(80)	162	(331)	(413)
Other operating costs and expenses											1,458	1,415	1,692
Total benefits and other deductions		2,691	2,562	2,036	2,581	2,473	5,253	5,054		7,090	8,720	8,183	9,365
Income (loss) from operations, before income taxes		1,797	(573)	(30)	1,576	2,454	1,224	4,030		4,000	431	1,650	6,115
Income tax (expense) benefit		(338)	260	52	(515)	(734)	(78)	(1,249)		(1,197)	113	(186)	(1,695)
Net income (loss)		1,459	(313)	22	1,061	1,720	1,146	2,781		2,803	544	1,464	4,420
Less: net (income) loss attributable to the noncontrolling interest		(113)	(118)	(98)	(92)	(117)	(231)	(209)		(307)	(469)	(403)	(387)
Net Income (Loss) Attributable to Parent		1,346	(431)	(76)	969	1,603	915	2,572		2,496	75	1,061	4,033
Change in unrealized gains (losses), net of reclassification adjustment			144	(22)	625	780		1,405		1,383	(217)	(881)	969
Other comprehensive income (loss)			179	(23)	620	789		1,409		1,386	(238)	(910)	925
Comprehensive income (loss)		1,753	(134)	(1)	1,681	2,509	1,619	4,190		4,189	306	554	5,345
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest			(125)	(99)	(89)	(120)		(209)		(308)	(452)	(388)	(358)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		1,660	(259)	(100)	1,592	2,389	1,619	3,981		3,881	(146)	166	4,987
Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Policy charges and fee income		59	29	(53)	(29)	(41)	86	(70)		(123)	192	316	248
Premiums			0	85	82	83		165		250	(26)	(26)	(27)
Net derivative gains (losses)		(38)	(9)	(21)	(22)	108	(30)	86		65	43	(131)	(168)
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Revenues		21	20	11	31	150	56	181		192	209	159	53
Policyholders' benefits		30	21	(16)	35	124	67	159		143	172	123	375
Interest credited to policyholders' account balances			(1)	31	(19)	(30)	0	(49)		(18)	101	(72)	(118)
Amortization of deferred policy acquisition cost, net		4	(1)	43	43	32	3	75		118	171	13	34
Other operating costs and expenses											0	82	(24)
Total benefits and other deductions		34	19	58	59	126	70	185		243	444	146	267
Income (loss) from operations, before income taxes		(13)	1	(47)	(28)	24	(14)	(4)		(51)	(235)	13	(214)
Income tax (expense) benefit		4	0	58	7	(8)	5	(1)		57	121	(2)	75
Net income (loss)		(9)	1	11	(21)	16	(9)	(5)		6	(114)	11	(139)
Less: net (income) loss attributable to the noncontrolling interest		0	0	(28)	1	0	0	1		(27)	(27)	0	0
Net Income (Loss) Attributable to Parent		(9)	1	(17)	(20)	16	(9)	(4)		(21)	(141)	11	(139)
Change in unrealized gains (losses), net of reclassification adjustment			0	30	(15)	6		(9)		20	20	(20)	0
Other comprehensive income (loss)			0	30	(15)	6		(9)		20	20	(20)	0
Comprehensive income (loss)		(9)	1	41	(36)	22	(9)	(14)		26	(94)	(9)	(139)
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest			0	(28)	1	0		1		(27)	(27)	0	0
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		(9)	1	13	(35)	22	(9)	(13)		(1)	(121)	(9)	(139)
As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Policy charges and fee income		924	925	925	886	860	1,847	1,746		2,671	3,615	3,524	3,363
Premiums			0	226	203	209		412		638	854	828	847
Net derivative gains (losses)		1,655	(733)	(677)	1,540	2,386	939	3,926		3,249	(1,234)	(339)	5,241
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Revenues		4,509	2,009	2,017	4,328	5,077	6,533	9,265		11,282	9,360	9,992	15,533
Policyholders' benefits		1,482	912	624	1,246	1,193	2,410	2,439		3,063	3,085	2,866	3,954
Interest credited to policyholders' account balances			336	303	255	221	658	476		779	1,082	976	1,037
Amortization of deferred policy acquisition cost, net		(78)	124	47	(31)	163	46	(9)		38	333	(318)	(379)
Other operating costs and expenses											1,458	1,497	1,668
Total benefits and other deductions		2,725	2,581	2,094	2,640	2,599	5,323	5,239		7,333	9,164	8,329	9,632
Income (loss) from operations, before income taxes		1,784	(572)	(77)	1,548	2,478	1,210	4,026		3,949	196	1,663	5,901
Income tax (expense) benefit		(334)	260	110	(508)	(742)	(73)	(1,250)		(1,140)	234	(188)	(1,620)
Net income (loss)		1,450	(312)	33	1,040	1,736	1,137	2,776		2,809	430	1,475	4,281
Less: net (income) loss attributable to the noncontrolling interest		(113)	(118)	(126)	(91)	(117)	(231)	(208)		(334)	(496)	(403)	(387)
Net Income (Loss) Attributable to Parent		1,337	(430)	(93)	949	1,619	906	2,568		2,475	(66)	1,072	3,894
Change in unrealized gains (losses), net of reclassification adjustment		314	144	8	610	786	458	1,396		1,403	(197)	(901)	969
Other comprehensive income (loss)		294	179	7	605	795	473	1,400		1,406	(218)	(930)	925
Comprehensive income (loss)		1,744	(133)	40	1,645	2,531	1,610	4,176		4,215	212	545	5,206
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest			(125)	(127)	(88)	(120)		(208)		(335)	(479)	(388)	(358)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		$ 1,651	$ (258)	$ (87)	$ 1,557	$ 2,411	$ 1,610	$ 3,968		$ 3,880	$ (267)	$ 157	$ 4,848

XML

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restatements made to the Consolidated Statements of Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net derivative gains (losses)	$ (318)	$ 1,997	$ (300)	$ (446)	$ 743	$ 1,324	$ 1,714	$ 2,067	$ 1,376	$ 1,621	$ (1,120)	$ (1,072)	$ 3,418
Net income (loss)	66	1,714	(120)	137	576	1,067	1,593	1,642	1,677	1,779	524	1,070	3,100
Comprehensive income (loss)	14	2,009	23	152	1,181	1,793	2,031	2,973	2,057	3,124	323	210	3,947
Less: Comprehensive (income) loss attributable to noncontrolling interest	(154)			(127)					(372)	(335)
Comprehensive Income (Loss) Attributable to AXA Equitable	(140)	1,916	(102)	25	1,093	1,673	2,031	2,765	1,685	2,789	(156)	(178)	3,589
Change in unrealized gains (losses), net of reclassification adjustment	(55)	315	108	16	610	717	423	1,327	362	1,342	(180)	(831)	891
Other comprehensive income (loss)	$ (52)	295	143	15	605	726	438	1,331	$ 380	1,345	(201)	(860)	847
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net derivative gains (losses)		1,693	(724)	(656)	1,562	2,278	969	3,840		3,184	(1,277)	(208)	5,409
Net income (loss)		1,459	(313)	22	1,061	1,720	1,146	2,781		2,803	544	1,464	4,420
Comprehensive income (loss)		1,753	(134)	(1)	1,681	2,509	1,619	4,190		4,189	306	554	5,345
Less: Comprehensive (income) loss attributable to noncontrolling interest			(125)	(99)	(89)	(120)		(209)		(308)	(452)	(388)	(358)
Comprehensive Income (Loss) Attributable to AXA Equitable		1,660	(259)	(100)	1,592	2,389	1,619	3,981		3,881	(146)	166	4,987
Change in unrealized gains (losses), net of reclassification adjustment			144	(22)	625	780		1,405		1,383	(217)	(881)	969
Other comprehensive income (loss)			179	(23)	620	789		1,409		1,386	(238)	(910)	925
Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net derivative gains (losses)		(38)	(9)	(21)	(22)	108	(30)	86		65	43	(131)	(168)
Net income (loss)		(9)	1	11	(21)	16	(9)	(5)		6	(114)	11	(139)
Comprehensive income (loss)		(9)	1	41	(36)	22	(9)	(14)		26	(94)	(9)	(139)
Less: Comprehensive (income) loss attributable to noncontrolling interest			0	(28)	1	0		1		(27)	(27)	0	0
Comprehensive Income (Loss) Attributable to AXA Equitable		(9)	1	13	(35)	22	(9)	(13)		(1)	(121)	(9)	(139)
Change in unrealized gains (losses), net of reclassification adjustment			0	30	(15)	6		(9)		20	20	(20)	0
Other comprehensive income (loss)			0	30	(15)	6		(9)		20	20	(20)	0
As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net derivative gains (losses)		1,655	(733)	(677)	1,540	2,386	939	3,926		3,249	(1,234)	(339)	5,241
Net income (loss)		1,450	(312)	33	1,040	1,736	1,137	2,776		2,809	430	1,475	4,281
Comprehensive income (loss)		1,744	(133)	40	1,645	2,531	1,610	4,176		4,215	212	545	5,206
Less: Comprehensive (income) loss attributable to noncontrolling interest			(125)	(127)	(88)	(120)		(208)		(335)	(479)	(388)	(358)
Comprehensive Income (Loss) Attributable to AXA Equitable		1,651	(258)	(87)	1,557	2,411	1,610	3,968		3,880	(267)	157	4,848
Change in unrealized gains (losses), net of reclassification adjustment		314	144	8	610	786	458	1,396		1,403	(197)	(901)	969
Other comprehensive income (loss)		$ 294	$ 179	$ 7	$ 605	$ 795	$ 473	$ 1,400		$ 1,406	$ (218)	$ (930)	$ 925

XML

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restatements made to the Consolidated Statements of Equity (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Derivative, Non-cash Gain (Loss) on Derivative, Net										$ 1,621	$ (305)	$ (1,072)	$ 3,418
Increase (Decrease) in Deferred Policy Acquisition Costs			$ (127)			$ (31)	$ (50)	$ (9)	$ (15)	(64)	(368)	257	345
Other operating costs and expenses	$ 449			$ 319					992	1,070
Change in unrealized gains (losses), net of reclassification adjustment	(55)	$ 315	108	16	$ 610	717	423	1,327	362	1,342	(180)	(831)	891
Beginning of year	11,100	14,227	14,379	17,744	17,183	15,530	14,379	15,530	14,379	15,530	15,530	16,387
Other comprehensive income (loss)	(52)	295	143	15	605	726	438	1,331	380	1,345	(201)	(860)	847
Net income (loss)	66	1,714	(120)	137	576	1,067	1,593	1,642	1,677	1,779	524	1,070	3,100
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	(140)	1,916	(102)	25	1,093	1,673	2,031	2,765	1,685	2,789	(156)	(178)	3,589
End of year	15,959	11,100	14,227	17,764	17,744	17,183	11,100	17,744	15,959	17,764	14,379	15,530	16,387
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		16,109		17,766	17,744	17,182	16,109	17,744		17,766
Additional Paid-in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year			5,339			5,321	5,339	5,321	5,339	5,321	5,321
Deferred tax on dividend of AB Units									0
End of year	5,361			5,313					5,361	5,313	5,339	5,321
Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Revised and Adjusted											5,938	6,963
Beginning of year	7,301	5,700	5,941	7,897	7,913	8,896	5,941	8,896	5,941	8,896	8,896
Dividends									0	500	(1,050)	(912)	(381)
Net income (loss)			(238)			950	1,362	1,434		1,445	28	667	2,713
End of year	7,265	7,301	5,700	7,908	7,897	7,913	7,301	7,897	7,265	7,908	5,941	8,896
AOCI Attributable to Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	452	137	1	1,516	908	208	1	208	1	208	208
Other comprehensive income (loss)			136			723	451	1,331	361	1,344	(184)	(845)	876
End of year	362	452	137	1,529	1,516	908	452	1,516	362	1,529	1	208
Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	13,116	11,181	11,283	14,733	14,140	12,471	11,283	12,471	11,283	12,471	12,471	13,425
End of year	12,990	13,116	11,181	14,752	14,733	14,140	13,116	14,733	12,990	14,752	11,283	12,471	13,425
Noncontrolling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year			(3,096)			(3,059)	(3,096)	(3,059)	(3,096)	(3,059)	(3,059)
Other comprehensive income (loss)									19	1
Dividends									347	287
Net income (loss) attributable to noncontrolling interest									311	326
End of year	2,969			3,012					2,969	3,012	(3,096)	(3,059)
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised, Adjusted			15,969			19,963
Derivative, Non-cash Gain (Loss) on Derivative, Net											(462)	(208)	5,409
Increase (Decrease) in Deferred Policy Acquisition Costs			(125)			10	(43)	84		80	(162)	331	413
Other operating costs and expenses											1,458	1,415	1,692
Change in unrealized gains (losses), net of reclassification adjustment			144	(22)	625	780		1,405		1,383	(217)	(881)	969
Beginning of year	12,608	15,969	16,416	21,013	19,963	17,595	16,416	17,595	16,416	17,595	17,595	18,108
Other comprehensive income (loss)			179	(23)	620	789		1,409		1,386	(238)	(910)	925
Net income (loss)		1,459	(313)	22	1,061	1,720	1,146	2,781		2,803	544	1,464	4,420
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		1,660	(259)	(100)	1,592	2,389	1,619	3,981		3,881	(146)	166	4,987
End of year		12,608	15,969	20,883	21,013	19,963	12,608	21,013		20,883	16,416	17,595	18,108
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		17,617			21,013		17,617	21,013
As previously reported | Additional Paid-in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year			5,339			5,321	5,339	5,321	5,339	5,321	5,321	5,957	5,934
Deferred tax on dividend of AB Units											0	(35)	(26)
End of year											5,339	5,321	5,957
As previously reported | Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Revised and Adjusted											7,842	8,958
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised, Adjusted											7,983
Beginning of year	8,779	7,411		11,030	10,561	8,958		8,958		8,958	8,958	8,809	5,205
Dividends											(1,050)	(912)	(429)
Net income (loss)			(431)			1,603	915	2,572		2,496	75	1,061	4,033
End of year		8,779	7,411	10,954	11,030	10,561	8,779	11,030		10,954		8,958	8,809
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised											7,983	8,958	8,809
As previously reported | AOCI Attributable to Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	493		7	1,637		228	7	228	7	228	228	351	(603)
Other comprehensive income (loss)			172			786	486	1,409		1,385	(221)	(895)	954
End of year		493			1,637		493	1,637			7	228	351
As previously reported | Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	14,635	12,934	13,331	17,987	16,894	14,509	13,331	14,509	13,331	14,509	14,509	15,119
End of year		14,635	12,934	17,882	17,987	16,894	14,635	17,987		17,882	13,331	14,509	15,119
As previously reported | Noncontrolling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	0	3,035	3,085	3,026	3,069	3,086	3,085	3,086	3,085	3,086	3,086	2,989	2,903
Net income (loss) attributable to noncontrolling interest			118			117	118	203		299	464	403	387
Dividend of AB Units by AXA Equitable to AXA Financial											0	145	48
End of year		0	3,035	3,001	3,026	3,069	0	3,026		3,001	3,085	3,086	2,989
Other Changes In Noncontrolling Interest											104	132	143
Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised, Adjusted			(53)			(87)
Derivative, Non-cash Gain (Loss) on Derivative, Net											43	(131)	(168)
Increase (Decrease) in Deferred Policy Acquisition Costs			0			(32)	(3)	(75)		(118)	(171)	(13)	(34)
Other operating costs and expenses											0	82	(24)
Change in unrealized gains (losses), net of reclassification adjustment			0	30	(15)	6		(9)		20	20	(20)	0
Beginning of year	(84)	(53)	(192)	(110)		(109)	(192)	(109)	(192)	(109)	(109)	(100)
Other comprehensive income (loss)			0	30	(15)	6		(9)		20	20	(20)	0
Net income (loss)		(9)	1	11	(21)	16	(9)	(5)		6	(114)	11	(139)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		(9)	1	13	(35)	22	(9)	(13)		(1)	(121)	(9)	(139)
End of year		(84)	(53)	(72)	(110)		(84)	(110)		(72)	(192)	(109)	(100)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		(84)			(110)	(86)	(84)	(110)
Impact of Revision | Additional Paid-in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year			0			0	0	0	0	0	0	0	(26)
Deferred tax on dividend of AB Units											0	0	26
End of year											0	0	0
Impact of Revision | Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Revised and Adjusted			(65)									(62)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised, Adjusted											(86)
Beginning of year	(95)	(64)	(203)	(66)	(46)	(62)	(203)	(62)	(203)	(62)	(62)	(73)	18
Other comprehensive income (loss)													0
Dividends											0	0	48
Net income (loss)			1			16	(9)	(4)		(21)	(141)	11
End of year		(95)	(64)	(83)	(66)	(46)	(95)	(66)		(83)	(203)	(62)	(73)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised												(62)	(73)
Impact of Revision | AOCI Attributable to Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	0	0	0	(29)		(20)	0	(20)	0	(20)	(20)	0	0
Other comprehensive income (loss)			0			6	0	(9)		20	20	(20)
End of year		0	0		(29)		0	(29)			0	(20)	0
Impact of Revision | Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	(95)	(64)	(203)	(95)	(60)	(82)	(203)	(82)	(203)	(82)	(82)	(73)
End of year		(95)	(64)	(83)	(95)	(60)	(95)	(95)		(83)	(203)	(82)	(73)
Impact of Revision | Noncontrolling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	11	11	11	(15)	(27)	(27)	11	(27)	11	(27)	(27)	(27)	21
Net income (loss) attributable to noncontrolling interest			0			0	0	1		27	27	0	0
Dividend of AB Units by AXA Equitable to AXA Financial											0	0	(48)
End of year		11	11	11	(15)	(27)	11	(15)		11	11	(27)	(27)
Other Changes In Noncontrolling Interest											11	0	0
As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised, Adjusted			15,916			19,876
Derivative, Non-cash Gain (Loss) on Derivative, Net										3,249	(419)	(339)	5,241
Increase (Decrease) in Deferred Policy Acquisition Costs			(125)			(22)	(46)	9		(38)	(333)	318	379
Other operating costs and expenses											1,458	1,497	1,668
Change in unrealized gains (losses), net of reclassification adjustment		314	144	8	610	786	458	1,396		1,403	(197)	(901)	969
Beginning of year	12,524	15,916	16,224	20,903	19,877	17,486	16,224	17,486	16,224	17,486	17,486	18,008
Other comprehensive income (loss)		294	179	7	605	795	473	1,400		1,406	(218)	(930)	925
Net income (loss)		1,450	(312)	33	1,040	1,736	1,137	2,776		2,809	430	1,475	4,281
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		1,651	(258)	(87)	1,557	2,411	1,610	3,968		3,880	(267)	157	4,848
End of year		12,524	15,916	20,811	20,903	19,877	12,524	20,903		20,811	16,224	17,486	18,008
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		17,533		20,811	20,903	19,876	17,533	20,903		20,811
As Revised | Additional Paid-in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year			5,339			5,321	5,339	5,321	5,339	5,321	5,321	5,957	5,908
Deferred tax on dividend of AB Units											0	(35)	0
End of year											5,339	5,321	5,957
As Revised | Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Revised and Adjusted											7,777	8,896
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised, Adjusted											7,897
Beginning of year	8,684	7,347	7,780	10,964	10,515	8,896	7,780	8,896	7,780	8,896	8,896	8,736	5,223
Dividends											(1,050)	(912)	(381)
Net income (loss)			(430)			1,619	906	2,568		2,475	(66)	1,072	3,894
End of year		8,684	7,347	10,871	10,964	10,515	8,684	10,964		10,871	7,780	8,896	8,736
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised												8,896	8,736
As Revised | AOCI Attributable to Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	493	179	7	1,608	1,000	208	7	208	7	208	208	351	(603)
Other comprehensive income (loss)			172			792	486	1,400		1,405	(201)	(915)	954
End of year		493	179	1,613	1,608	1,000	493	1,608		1,613	7	208	351
As Revised | Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	14,540	12,870	13,128	17,892	16,834	14,427	13,128	14,427	13,128	14,427	14,427	15,046
End of year		14,540	12,870	17,799	17,892	16,834	14,540	17,892		17,799	13,128	14,427	15,046
As Revised | Noncontrolling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning of year	$ 11	3,046	3,096	3,011	3,042	3,059	3,096	3,059	$ 3,096	3,059	3,059	2,962	2,924
Net income (loss) attributable to noncontrolling interest			118			117	118	204		326	491	403	387
Dividend of AB Units by AXA Equitable to AXA Financial											0	145	0
End of year		$ 11	$ 3,046	$ 3,012	$ 3,011	$ 3,042	$ 11	$ 3,011		$ 3,012	3,096	3,059	2,962
Other Changes In Noncontrolling Interest											$ 115	$ 132	$ 143

XML

SIGNIFICANT ACCOUNTING POLICIES - Schedule of Restatements made to the Consolidated Statement of Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Change in unrealized gains (losses), net of reclassification adjustment	$ (55)	$ 315	$ 108	$ 16	$ 610	$ 717	$ 423	$ 1,327	$ 362	$ 1,342	$ (180)	$ (831)	$ 891
Net income (loss)	66	1,714	(120)	137	576	1,067	1,593	1,642	1,677	1,779	524	1,070	3,100
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	15,959	11,100	14,227	17,764	17,744	17,183	11,100	17,744	15,959	17,764	14,379	15,530	16,387
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		16,109		17,766	17,744	17,182	16,109	17,744		17,766
Policy charges and fee income	(914)	(856)	(858)	(854)	(819)	(795)	(1,712)	(1,614)	(2,626)	(2,468)	(3,342)	(3,284)	(3,156)
Interest credited to policyholders’ account balances	(350)			(303)					(1,008)	(779)
Net derivative (gains) losses	318	(1,997)	300	446	(743)	(1,324)	(1,714)	(2,067)	(1,376)	(1,621)	1,120	1,072	(3,418)
Amortization of deferred cost of reinsurance asset									111	115
Future policy benefits			(274)			(515)	(1,326)	(1,075)	(1,289)	(935)	(432)	(629)	(1,485)
Increase Decrease In Reinsurance Recoverable With Affiliate									(361)	(182)
Deferred policy acquisition costs			127			31	50	9	15	64	368	(257)	(345)
Amortization of deferred policy acquisition cost, net	33	76	(126)	(55)	22	(172)	(50)	(9)	(15)	(64)	(368)	257	345
Current and deferred income taxes			(224)			380	224	376	639	93	(841)	42	737
Other, net									711	341
Net cash provided by (used in) operating activities			18			190	(75)	(385)	994	(165)	(461)	(324)	(600)
Deposits									5,871	6,032
Policyholders' accounts balance transfer (to) from Separate Accounts									1,617	1,618
(Decrease) increase in overdrafts payable									66	(75)
Net cash provided by (used in) financing activities									5,460	4,929
Other comprehensive income (loss)	(52)	295	143	15	605	726	438	1,331	380	1,345	(201)	(860)	847
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Change in unrealized gains (losses), net of reclassification adjustment			144	(22)	625	780		1,405		1,383	(217)	(881)	969
Net income (loss)		1,459	(313)	22	1,061	1,720	1,146	2,781		2,803	544	1,464	4,420
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		12,608	15,969	20,883	21,013	19,963	12,608	21,013		20,883	16,416	17,595	18,108
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		17,617			21,013		17,617	21,013
Policy charges and fee income		(865)	(896)	(978)	(915)	(901)	(1,761)	(1,816)		(2,794)	(3,423)	(3,208)	(3,115)
Interest credited to policyholders’ account balances			(337)	(272)	(274)	(251)	(658)	(525)		(797)	(981)	(1,048)	(1,155)
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Net derivative (gains) losses		(1,693)	724	656	(1,562)	(2,278)	(969)	(3,840)		(3,184)	1,277	208	(5,409)
Amortization of deferred cost of reinsurance asset											159	39	302
Future policy benefits			(185)			(491)	(1,381)	(1,168)		(1,253)	(803)	(878)	(1,518)
Increase Decrease In Reinsurance Recoverable With Affiliate			(44)			(145)	(251)	(92)		(120)	(534)	(916)	(488)
Deferred policy acquisition costs			125			(10)	43	(84)		(80)	162	(331)	(413)
Amortization of deferred policy acquisition cost, net		82	(125)	(4)	74	(131)	(43)	84		80	(162)	331	413
Current and deferred income taxes			(327)			733	(16)	985		704	(771)	258	1,448
Other, net			0			50	0	119			31	111	(98)
Net cash provided by (used in) operating activities			18			99	(75)	(337)		(165)	(461)	(244)	(639)
Deposits											9,342	5,757	6,011
Policyholders' accounts balance transfer (to) from Separate Accounts											1,606	1,045	815
(Decrease) increase in overdrafts payable			50			0	0	0			(85)	0	0
Net cash provided by (used in) financing activities			2,306			1,468	0	4,016			5,751	3,034	3,843
Other comprehensive income (loss)			179	(23)	620	789		1,409		1,386	(238)	(910)	925
Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Change in unrealized gains (losses), net of reclassification adjustment			0	30	(15)	6		(9)		20	20	(20)	0
Net income (loss)		(9)	1	11	(21)	16	(9)	(5)		6	(114)	11	(139)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(84)	(53)	(72)	(110)		(84)	(110)		(72)	(192)	(109)	(100)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		(84)			(110)	(86)	(84)	(110)
Policy charges and fee income		(59)	(29)	53	29	41	(86)	70		123	(192)	(316)	(248)
Interest credited to policyholders’ account balances			1	(31)	19	30	0	49		18	(101)	72	118
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Net derivative (gains) losses		38	9	21	22	(108)	30	(86)		(65)	(43)	131	168
Amortization of deferred cost of reinsurance asset													(10)
Future policy benefits			(20)			(130)	(10)	(172)		45	32	(162)	(214)
Increase Decrease In Reinsurance Recoverable With Affiliate			0			(89)	57	(178)		(62)	230	(13)	174
Deferred policy acquisition costs			0			32	3	75		118	171	13	34
Amortization of deferred policy acquisition cost, net		(4)	1	(43)	(43)	(32)	(3)	(75)		(118)	(171)	(13)	(34)
Current and deferred income taxes			0			8	(5)	1		(57)	(121)	2	(75)
Other, net			0			91	0	(48)			0	(80)	39
Net cash provided by (used in) operating activities			0			91	0	(48)		0	0	(80)	39
Deposits											404	0	0
Policyholders' accounts balance transfer (to) from Separate Accounts											(404)	0	0
(Decrease) increase in overdrafts payable			0			(91)	0	48			0	80	(39)
Net cash provided by (used in) financing activities			0			(91)	0	48			0	80	(39)
Other comprehensive income (loss)			0	30	(15)	6		(9)		20	20	(20)	0
As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Change in unrealized gains (losses), net of reclassification adjustment		314	144	8	610	786	458	1,396		1,403	(197)	(901)	969
Net income (loss)		1,450	(312)	33	1,040	1,736	1,137	2,776		2,809	430	1,475	4,281
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		12,524	15,916	20,811	20,903	19,877	12,524	20,903		20,811	16,224	17,486	18,008
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		17,533		20,811	20,903	19,876	17,533	20,903		20,811
Policy charges and fee income		(924)	(925)	(925)	(886)	(860)	(1,847)	(1,746)		(2,671)	(3,615)	(3,524)	(3,363)
Interest credited to policyholders’ account balances			(336)	(303)	(255)	(221)	(658)	(476)		(779)	(1,082)	(976)	(1,037)
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Net derivative (gains) losses		(1,655)	733	677	(1,540)	(2,386)	(939)	(3,926)		(3,249)	1,234	339	(5,241)
Amortization of deferred cost of reinsurance asset											159	121	292
Future policy benefits			(205)			(621)	(1,391)	(1,340)		(1,208)	(771)	(1,040)	(1,732)
Increase Decrease In Reinsurance Recoverable With Affiliate			(44)			(234)	(194)	(270)		(182)	(304)	(929)	(314)
Deferred policy acquisition costs			125			22	46	(9)		38	333	(318)	(379)
Amortization of deferred policy acquisition cost, net		78	(124)	(47)	31	(163)	(46)	9		(38)	(333)	318	379
Current and deferred income taxes			(327)			741	(21)	986		647	(892)	260	1,373
Other, net							0	71			31	31	(59)
Net cash provided by (used in) operating activities			18			190	(75)	(385)		(165)	(461)	(324)	(600)
Deposits											9,746	5,757	6,011
Policyholders' accounts balance transfer (to) from Separate Accounts											1,202	1,045	815
(Decrease) increase in overdrafts payable			50			(91)	0	48			(85)	80	(39)
Net cash provided by (used in) financing activities			2,306			1,377	0	4,064			5,751	3,114	3,804
Other comprehensive income (loss)		294	179	7	605	795	473	1,400		1,406	(218)	(930)	925
AOCI Attributable to Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	362	452	137	1,529	1,516	908	452	1,516	362	1,529	1	208
Other comprehensive income (loss)			136			723	451	1,331	361	1,344	(184)	(845)	876
AOCI Attributable to Parent | As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		493			1,637		493	1,637			7	228	351	$ (603)
Other comprehensive income (loss)			172			786	486	1,409		1,385	(221)	(895)	954
AOCI Attributable to Parent | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		0	0		(29)		0	(29)			0	(20)	0	0
Other comprehensive income (loss)			0			6	0	(9)		20	20	(20)
AOCI Attributable to Parent | As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		493	179	1,613	1,608	1,000	493	1,608		1,613	7	208	351	(603)
Other comprehensive income (loss)			172			792	486	1,400		1,405	(201)	(915)	954
Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	12,990	13,116	11,181	14,752	14,733	14,140	13,116	14,733	12,990	14,752	11,283	12,471	13,425
Parent | As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		14,635	12,934	17,882	17,987	16,894	14,635	17,987		17,882	13,331	14,509	15,119
Parent | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(95)	(64)	(83)	(95)	(60)	(95)	(95)		(83)	(203)	(82)	(73)
Parent | As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		14,540	12,870	17,799	17,892	16,834	14,540	17,892		17,799	13,128	14,427	15,046
Additional Paid-in Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	5,361			5,313					5,361	5,313	5,339	5,321
Additional Paid-in Capital | As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest											5,339	5,321	5,957	5,934
Additional Paid-in Capital | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest											0	0	0	(26)
Additional Paid-in Capital | As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest											5,339	5,321	5,957	5,908
Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(238)			950	1,362	1,434		1,445	28	667	2,713
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	7,265	7,301	5,700	7,908	7,897	7,913	7,301	7,897	7,265	7,908	5,941	8,896
Dividends									0	500	(1,050)	(912)	(381)
Retained Earnings | As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(431)			1,603	915	2,572		2,496	75	1,061	4,033
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		8,779	7,411	10,954	11,030	10,561	8,779	11,030		10,954		8,958	8,809	5,205
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised											7,983	8,958	8,809
Dividends											(1,050)	(912)	(429)
Retained Earnings | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			1			16	(9)	(4)		(21)	(141)	11
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(95)	(64)	(83)	(66)	(46)	(95)	(66)		(83)	(203)	(62)	(73)	18
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised												(62)	(73)
Dividends											0	0	48
Other comprehensive income (loss)													0
Retained Earnings | As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(430)			1,619	906	2,568		2,475	(66)	1,072	3,894
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		8,684	7,347	10,871	10,964	10,515	8,684	10,964		10,871	7,780	8,896	8,736	5,223
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised												8,896	8,736
Dividends											(1,050)	(912)	(381)
Noncontrolling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss) attributable to noncontrolling interest									311	326
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders									(96)	(92)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 2,969			3,012					2,969	3,012	(3,096)	(3,059)
Dividends									347	287
Other comprehensive income (loss)									$ 19	1
Noncontrolling Interest | As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss) attributable to noncontrolling interest			118			117	118	203		299	464	403	387
Dividend of AB Units by AXA Equitable to AXA Financial											0	145	48
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		0	3,035	3,001	3,026	3,069	0	3,026		3,001	3,085	3,086	2,989	2,903
Noncontrolling Interest | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss) attributable to noncontrolling interest			0			0	0	1		27	27	0	0
Dividend of AB Units by AXA Equitable to AXA Financial											0	0	(48)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		11	11	11	(15)	(27)	11	(15)		11	11	(27)	(27)	21
Noncontrolling Interest | As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss) attributable to noncontrolling interest			118			117	118	204		326	491	403	387
Dividend of AB Units by AXA Equitable to AXA Financial											0	145	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		$ 11	$ 3,046	$ 3,012	$ 3,011	$ 3,042	$ 11	$ 3,011		$ 3,012	$ 3,096	$ 3,059	$ 2,962	$ 2,924

XML

SIGNIFICANT ACCOUTNING POLICIES - Schedule of Restatements made to the Consolidated Statements of Balance Sheet (Details) - USD ($) $ in Millions	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other equity investments	$ 1,337			$ 1,323
Trading securities, at fair value	12,053			9,134
Other invested assets	2,515			2,226
Investments	63,523			58,427
Deferred policy acquisition costs	4,550	$ 4,516	$ 4,491	4,666	$ 4,876	$ 4,852	$ 4,936	$ 4,996
Amounts due from reinsurers	5,016			4,664
Guaranteed minimum income benefit reinsurance contract asset, at fair value	10,933			10,309
Other assets	4,258			4,260
Total Assets	219,069	215,358	209,551	204,169	209,432	207,460	200,475	195,220
Policyholders’ account balances	42,679			38,825
Future policy benefits and other policyholders’ liabilities	29,423	29,556	28,649	28,859	31,469	31,632	30,120	28,435
Current and deferred income taxes	3,148	3,183	2,581	2,714	4,473	4,715	4,396	3,592
Other liabilities	2,869			2,108
Total liabilities	202,669	198,897	194,907	189,387	191,520	189,487	183,074	179,677
Redeemable noncontrolling interest	441			403
Retained earnings	7,265	7,301	5,700	5,941	7,910	7,897	7,914	6,963
Accumulated other comprehensive income (loss)	362	452	137	1	1,529	1,516	908	185
Total AXA Equitable’s equity	12,990	13,116	11,181	11,283	14,754	14,733	14,141	12,471
Noncontrolling interest	2,969			3,096
Equity	15,959	11,100	14,227	14,379	17,764	17,744	17,183	15,530	$ 16,387
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		16,109			17,766	17,744	17,182
Total Liabilities and Equity	$ 219,069	215,358	209,551	204,169	209,432	207,460	200,475	195,220
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other equity investments		1,477	1,463	1,408	1,454	1,447	1,398	1,477
Trading securities, at fair value		0	0	9,134	8,702	7,843	7,124	6,805
Other invested assets		2,622	2,050	2,186	2,192	2,811	2,462	1,788
Investments		62,111	60,406	58,416	60,968	60,979	56,581	52,527
Deferred policy acquisition costs		4,141	4,068	4,301	4,516	4,496	4,505	4,469
Amounts due from reinsurers		4,870	4,639	4,635	4,550	4,523	4,605	4,466
Guaranteed minimum income benefit reinsurance contract asset, at fair value				10,309				10,570
Other assets		0	0	4,260		4,501	4,516	4,634
Total Assets		214,941	209,098	203,764	209,034	207,042	199,983	194,626
Policyholders’ account balances		41,531	40,308	38,782	36,920	35,661	33,710	33,033
Future policy benefits and other policyholders’ liabilities		26,799	25,496	25,358	26,191	26,131	25,272	24,531
Current and deferred income taxes		4,000	3,523	3,816	6,160	6,421	5,833	4,647
Other liabilities			0	2,108			2,841	2,586
Total liabilities		196,972	192,712	186,945	188,005	185,800	179,802	177,018
Retained earnings		8,779	7,411	7,983	10,954	11,030	10,561	8,958
Accumulated other comprehensive income (loss)		493	179	7		1,637	1,014	228
Total AXA Equitable’s equity		14,635	12,934	13,331	17,882	17,987	16,894	14,509
Noncontrolling interest		2,973	3,035	3,085	3,001	3,026	69	3,086
Equity		12,608	15,969	16,416	20,883	21,013	19,963	17,595	18,108
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		17,617				21,013
Total Liabilities and Equity		214,941	209,098	203,764	209,034	207,042	199,983	194,626
Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other equity investments		(21)	(23)	(29)	(93)	(100)	(120)	(81)
Trading securities, at fair value		0	0	0	65	73	81	81
Other invested assets		32	34	40	39	38	39	0
Investments		11	11	11	11	11	0	0
Deferred policy acquisition costs		(135)	(88)	(175)	(123)	(126)	(59)	(36)
Amounts due from reinsurers		31	19	29	27	49	48	46
Guaranteed minimum income benefit reinsurance contract asset, at fair value				0				8
Other assets		0	0	0		2	13	13
Total Assets		(93)	(58)	(135)	(85)	(64)	2	31
Policyholders’ account balances		(15)	(16)	43	(76)	(108)	(89)	(138)
Future policy benefits and other policyholders’ liabilities		56	45	123	109	160	213	332
Current and deferred income taxes		(50)	(34)	(109)	(46)	(6)	14	(2)
Other liabilities			0	0			(50)	(52)
Total liabilities		(9)	(5)	57	(13)	46	88	140
Retained earnings		(95)	(64)	(203)	(83)	(66)	(45)	(62)
Accumulated other comprehensive income (loss)		0	0	0		(29)	(14)	(20)
Total AXA Equitable’s equity		(95)	(64)	(203)	(83)	(95)	(59)	(82)
Noncontrolling interest		11	11	11	11	(15)	(27)	(27)
Equity		(84)	(53)	(192)	(72)	(110)		(109)	(100)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		(84)				(110)	(86)
Total Liabilities and Equity		(93)	(58)	(135)	(85)	(64)	2	31
As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other equity investments		1,456	1,440	1,379	1,361	1,347	1,278	1,396
Trading securities, at fair value		0	0	9,134	8,767	7,916	7,205	6,886
Other invested assets		2,654	2,084	2,226	2,231	2,849	2,501	1,788
Investments		62,122	60,417	58,427	60,979	60,990	56,581	52,527
Deferred policy acquisition costs		4,006	3,980	4,126	4,393	4,370	4,446	4,433
Amounts due from reinsurers		4,901	4,658	4,664	4,577	4,572	4,653	4,512
Guaranteed minimum income benefit reinsurance contract asset, at fair value				10,309				10,578
Other assets		0	0	4,260		4,503	4,529	4,647
Total Assets		214,848	209,040	203,629	208,949	206,978	199,985	194,657
Policyholders’ account balances		41,516	40,292	38,825	36,844	35,553	33,621	32,895
Future policy benefits and other policyholders’ liabilities		26,855	25,541	25,481	26,300	26,291	25,485	24,863
Current and deferred income taxes		3,950	3,489	3,707	6,114	6,415	5,847	4,645
Other liabilities			0	2,108			2,791	2,534
Total liabilities		196,963	192,707	187,002	187,992	185,846	179,890	177,158
Retained earnings		8,684	7,347	7,780	10,871	10,964	10,516	8,896
Accumulated other comprehensive income (loss)		493	179	7	1,613	1,608	1,000	208
Total AXA Equitable’s equity		14,540	12,870	13,128	17,799	17,892	16,835	14,427
Noncontrolling interest		2,984	3,046	3,096	3,012	3,011	42	3,059
Equity		12,524	15,916	16,224	20,811	20,903	19,877	17,486	18,008
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		17,533			20,811	20,903	19,876
Total Liabilities and Equity		214,848	209,040	203,629	208,949	206,978	199,985	194,657
Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Deferred policy acquisition costs		510	511	540	483	482	490	563
Total Assets		510	511	540	483	482	490	563
Future policy benefits and other policyholders’ liabilities		2,701	3,108	3,378	5,169	5,341	4,635	3,572
Current and deferred income taxes		(767)	(908)	(993)	(1,641)	(1,700)	(1,451)	(1,053)
Total liabilities		1,934	2,200	2,385	3,528	3,641	3,184	2,519
Retained earnings		(1,383)	(1,647)	(1,845)	(2,961)	(3,067)	(2,602)	(1,933)
Accumulated other comprehensive income (loss)		(41)	(42)	(6)	(84)	(92)	(92)	(23)
Total AXA Equitable’s equity		(1,424)	(1,689)	(1,845)	(3,045)	(3,159)	(2,694)	(1,956)
Equity		(1,424)	(1,689)	(1,845)		(3,159)	(2,694)	(1,956)	$ (1,621)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		(1,424)			(3,045)	(3,159)
Total Liabilities and Equity		$ 510	$ 511	$ (3,150)	$ 483	$ 482	$ 490	$ 563

XML

SIGNIFICANT ACCOUNTING POLICIES - ASSUMPTION UPDATES (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Change in Accounting Estimate [Line Items]
Amortization of deferred policy acquisition cost, net	$ 33	$ 76	$ (126)	$ (55)	$ 22	$ (172)	$ (50)	$ (9)	$ (15)	$ (64)	$ (368)	$ 257	$ 345
Policy charges and fee income	914	856	858	854	819	795	1,712	1,614	2,626	2,468	3,342	3,284	3,156
Policyholders’ benefits	995	1,348	981	616	1,087	1,087	2,345	2,174	3,308	2,790	2,746	2,455	3,707
Amortization of deferred cost of reinsurance assets									(111)	(115)
Net income (loss)	$ 66	$ 1,714	$ (120)	$ 137	$ 576	$ 1,067	$ 1,593	$ 1,642	1,677	1,779	$ 524	$ 1,070	$ 3,100
Variable and Interest Sensitive Life
Change in Accounting Estimate [Line Items]
Net income (loss)										(14)
Long-term lapse and partial withdrawal behavior
Change in Accounting Estimate [Line Items]
Amortization of deferred policy acquisition cost, net									32
Policyholders’ benefits									602
Increase (decrease) in the fair value of the reinsurance contract asset									1,532
Amortization of deferred cost of reinsurance assets									226
Net income (loss)									$ 772
Mortality Assumption | Variable and Interest Sensitive Life
Change in Accounting Estimate [Line Items]
Amortization of deferred policy acquisition cost, net										70
Policy charges and fee income										(16)
General Account Spread Assumption | Variable and Interest Sensitive Life
Change in Accounting Estimate [Line Items]
Amortization of deferred policy acquisition cost, net										(79)
Policy charges and fee income										$ 4

XML

SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUTNING POLICIES - Schedule of Accounting Change Adjustments made to the Consolidated Statements Income (loss) (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ 66	$ 1,714	$ (120)	$ 137	$ 576	$ 1,067	$ 1,593	$ 1,642	$ 1,677	$ 1,779	$ 524	$ 1,070	$ 3,100
Change in unrealized gains (losses), net of reclassification adjustment	(55)	315	108	16	610	717	423	1,327	362	1,342	(180)	(831)	891
Other comprehensive income (loss)	(52)	295	143	15	605	726	438	1,331	380	1,345	(201)	(860)	847
Income Tax Expense (Benefit)	127	(476)	157	54	(258)	(381)	(318)	(640)	(196)	(586)	183	30	(984)
Income (loss) from operations, before income taxes	(61)	2,190	(277)	83	834	1,448	1,911	2,282	1,873	2,365	341	1,040	4,084
Total benefits and other deductions	2,581	2,593	2,652	2,094	2,490	2,502	5,262	4,992	7,800	7,086	8,860	7,979	9,419
Amortization of deferred policy acquisition cost, net	(33)	(76)	126	55	(22)	172	50	9	15	64	368	(257)	(345)
Interest credited to policyholders’ account balances	350			303					1,008	779
Policyholders' benefits	995	1,348	981	616	1,087	1,087	2,345	2,174	3,308	2,790	2,746	2,455	3,707
Future policy benefits			274			515	1,326	1,075	1,289	935	432	629	1,485
Revenues	2,520	4,783	2,375	2,177	3,464	3,950	7,173	7,274	9,673	9,451	9,201	9,019	13,503
Net derivative gains (losses)	(318)	1,997	(300)	(446)	743	1,324	1,714	2,067	1,376	1,621	(1,120)	(1,072)	3,418
Premiums	204			226					645	638
Insurance Commissions and Fees	914	856	858	854	819	795	1,712	1,614	2,626	2,468	3,342	3,284	3,156
Other operating costs and expenses	449			319					992	1,070
Amortization of deferred cost of reinsurance asset									111	115
Less: net (income) loss attributable to the noncontrolling interest	122			126					353	334
Net Income (Loss) Attributable to Parent	(56)	1,601	(238)	11	485	950	1,362	1,434		1,445	28	667	2,713
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	14	2,009	23	152	1,181	1,793	2,031	2,973	2,057	3,124	323	210	3,947
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	154			127					372	335
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ (140)	1,916	(102)	25	1,093	1,673	2,031	2,765	1,685	2,789	(156)	(178)	3,589
As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)		1,450	(312)	33	1,040	1,736	1,137	2,776		2,809	430	1,475	4,281
Change in unrealized gains (losses), net of reclassification adjustment		314	144	8	610	786	458	1,396		1,403	(197)	(901)	969
Other comprehensive income (loss)		294	179	7	605	795	473	1,400		1,406	(218)	(930)	925
Income Tax Expense (Benefit)		(334)	260	110	(508)	(742)	(73)	(1,250)		(1,140)	234	(188)	(1,620)
Income (loss) from operations, before income taxes		1,784	(572)	(77)	1,548	2,478	1,210	4,026		3,949	196	1,663	5,901
Total benefits and other deductions		2,725	2,581	2,094	2,640	2,599	5,323	5,239		7,333	9,164	8,329	9,632
Amortization of deferred policy acquisition cost, net		(78)	124	47	(31)	163	46	(9)		38	333	(318)	(379)
Interest credited to policyholders’ account balances			336	303	255	221	658	476		779	1,082	976	1,037
Policyholders' benefits		1,482	912	624	1,246	1,193	2,410	2,439		3,063	3,085	2,866	3,954
Future policy benefits			205			621	1,391	1,340		1,208	771	1,040	1,732
Revenues		4,509	2,009	2,017	4,328	5,077	6,533	9,265		11,282	9,360	9,992	15,533
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Net derivative gains (losses)		1,655	(733)	(677)	1,540	2,386	939	3,926		3,249	(1,234)	(339)	5,241
Premiums			0	226	203	209		412		638	854	828	847
Insurance Commissions and Fees		924	925	925	886	860	1,847	1,746		2,671	3,615	3,524	3,363
Other operating costs and expenses											1,458	1,497	1,668
Amortization of deferred cost of reinsurance asset											159	121	292
Less: net (income) loss attributable to the noncontrolling interest		113	118	126	91	117	231	208		334	496	403	387
Net Income (Loss) Attributable to Parent		1,337	(430)	(93)	949	1,619	906	2,568		2,475	(66)	1,072	3,894
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		1,744	(133)	40	1,645	2,531	1,610	4,176		4,215	212	545	5,206
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest			125	127	88	120		208		335	479	388	358
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		1,651	(258)	(87)	1,557	2,411	1,610	3,968		3,880	(267)	157	4,848
Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)		264	192	104	(464)	(669)	456	(1,134)		(1,030)	94	(405)	(1,181)
Change in unrealized gains (losses), net of reclassification adjustment		1	(36)	8	0	(69)	(35)	(69)		(61)	17	70	(78)
Other comprehensive income (loss)		1	(36)	8	0	(69)	(35)	(69)		(61)	17	70	(78)
Income Tax Expense (Benefit)		(142)	(103)	(56)	250	361	(245)	610		554	(51)	218	636
Income (loss) from operations, before income taxes		406	295	160	(714)	(1,030)	701	(1,744)		(1,584)	145	(623)	(1,817)
Total benefits and other deductions		(132)	71	0	(150)	(97)	(61)	(247)		(247)	(304)	(350)	(213)
Amortization of deferred policy acquisition cost, net		2	2	8	9	9	4	18		26	35	61	34
Policyholders' benefits		(134)	69	(8)	(159)	(106)	(65)	(265)		(390)
Future policy benefits			69			(106)	(65)	(265)		(273)	(339)	(411)	(247)
Revenues		274	366	160	(864)	(1,127)	640	(1,991)		(1,831)	(159)	(973)	(2,030)
Net derivative gains (losses)		342	433	231	(797)	(1,062)	775	(1,859)		454	114	(733)	(1,823)
Insurance Commissions and Fees		(68)	(67)	(71)	(67)	(65)	(135)	(132)		(203)	(273)	(240)	(207)
Net Income (Loss) Attributable to Parent		264	192	104	(464)	(669)	456	(1,134)		(1,030)	94	(405)	(1,181)
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		265	156	112	(464)	(738)	421	(1,203)		(1,091)	111	(335)	(1,259)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		265	156	0	(464)	(738)	421	(1,203)		0	111	(335)	(1,259)
As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)		1,459	(313)	22	1,061	1,720	1,146	2,781		2,803	544	1,464	4,420
Change in unrealized gains (losses), net of reclassification adjustment			144	(22)	625	780		1,405		1,383	(217)	(881)	969
Other comprehensive income (loss)			179	(23)	620	789		1,409		1,386	(238)	(910)	925
Income Tax Expense (Benefit)		(338)	260	52	(515)	(734)	(78)	(1,249)		(1,197)	113	(186)	(1,695)
Income (loss) from operations, before income taxes		1,797	(573)	(30)	1,576	2,454	1,224	4,030		4,000	431	1,650	6,115
Total benefits and other deductions		2,691	2,562	2,036	2,581	2,473	5,253	5,054		7,090	8,720	8,183	9,365
Amortization of deferred policy acquisition cost, net		(82)	125	4	(74)	131	43	(84)		(80)	162	(331)	(413)
Interest credited to policyholders’ account balances			337	272	274	251	658	525		797	981	1,048	1,155
Policyholders' benefits		1,452	891	640	1,211	1,069	2,343	2,280		2,920	2,913	2,743	3,579
Future policy benefits			185			491	1,381	1,168		1,253	803	878	1,518
Revenues		4,488	1,989	2,006	4,297	4,927	6,477	9,084		11,090	9,151	9,833	15,480
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Net derivative gains (losses)		1,693	(724)	(656)	1,562	2,278	969	3,840		3,184	(1,277)	(208)	5,409
Premiums			0	141	121	126		247		388	880	854	874
Insurance Commissions and Fees		865	896	978	915	901	1,761	1,816		2,794	3,423	3,208	3,115
Other operating costs and expenses											1,458	1,415	1,692
Amortization of deferred cost of reinsurance asset											159	39	302
Less: net (income) loss attributable to the noncontrolling interest		113	118	98	92	117	231	209		307	469	403	387
Net Income (Loss) Attributable to Parent		1,346	(431)	(76)	969	1,603	915	2,572		2,496	75	1,061	4,033
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		1,753	(134)	(1)	1,681	2,509	1,619	4,190		4,189	306	554	5,345
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest			125	99	89	120		209		308	452	388	358
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		1,660	(259)	(100)	1,592	2,389	1,619	3,981		3,881	(146)	166	4,987
Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)		(9)	1	11	(21)	16	(9)	(5)		6	(114)	11	(139)
Change in unrealized gains (losses), net of reclassification adjustment			0	30	(15)	6		(9)		20	20	(20)	0
Other comprehensive income (loss)			0	30	(15)	6		(9)		20	20	(20)	0
Income Tax Expense (Benefit)		4	0	58	7	(8)	5	(1)		57	121	(2)	75
Income (loss) from operations, before income taxes		(13)	1	(47)	(28)	24	(14)	(4)		(51)	(235)	13	(214)
Total benefits and other deductions		34	19	58	59	126	70	185		243	444	146	267
Amortization of deferred policy acquisition cost, net		4	(1)	43	43	32	3	75		118	171	13	34
Interest credited to policyholders’ account balances			(1)	31	(19)	(30)	0	(49)		(18)	101	(72)	(118)
Policyholders' benefits		30	21	(16)	35	124	67	159		143	172	123	375
Future policy benefits			20			130	10	172		(45)	(32)	162	214
Revenues		21	20	11	31	150	56	181		192	209	159	53
Increase (decrease) in the fair value of the reinsurance contract asset			0			0
Net derivative gains (losses)		(38)	(9)	(21)	(22)	108	(30)	86		65	43	(131)	(168)
Premiums			0	85	82	83		165		250	(26)	(26)	(27)
Insurance Commissions and Fees		59	29	(53)	(29)	(41)	86	(70)		(123)	192	316	248
Other operating costs and expenses											0	82	(24)
Amortization of deferred cost of reinsurance asset													(10)
Less: net (income) loss attributable to the noncontrolling interest		0	0	28	(1)	0	0	(1)		27	27	0	0
Net Income (Loss) Attributable to Parent		(9)	1	(17)	(20)	16	(9)	(4)		(21)	(141)	11	(139)
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		(9)	1	41	(36)	22	(9)	(14)		26	(94)	(9)	(139)
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest			0	28	(1)	0		(1)		27	27	0	0
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		$ (9)	1	$ 13	$ (35)	22	(9)	(13)		(1)	(121)	(9)	(139)
AOCI Attributable to Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive income (loss)			136			723	451	1,331	361	1,344	(184)	(845)	876
AOCI Attributable to Parent | As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive income (loss)			172			792	486	1,400		1,405	(201)	(915)	954
AOCI Attributable to Parent | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive income (loss)			(36)			(69)	(35)	(69)		(61)	17	70	(78)
AOCI Attributable to Parent | As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive income (loss)			172			786	486	1,409		1,385	(221)	(895)	954
AOCI Attributable to Parent | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Other comprehensive income (loss)			0			6	0	(9)		20	20	(20)
Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(238)			950	1,362	1,434		1,445	28	667	2,713
Net Income (Loss) Attributable to Parent									$ 1,324	1,445
Retained Earnings | As Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(430)			1,619	906	2,568		2,475	(66)	1,072	3,894
Retained Earnings | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			192			(669)	456	(1,134)		(1,030)	94	(405)	(1,181)
Retained Earnings | As previously reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(431)			1,603	915	2,572		2,496	75	1,061	4,033
Retained Earnings | Impact of Revision
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			$ 1			$ 16	$ (9)	$ (4)		$ (21)	$ (141)	$ 11
Other comprehensive income (loss)													$ 0

XML

SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUTNING POLICIES - Schedule of Accounting Change Adjustments made to the Consolidated Statements of Equity (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	$ 15,959	$ 11,100	$ 14,227	$ 17,764	$ 17,744	$ 17,183	$ 11,100	$ 17,744	$ 15,959	$ 17,764	$ 14,379	$ 15,530	$ 16,387
Net income (loss)	66	1,714	(120)	137	576	1,067	1,593	1,642	1,677	1,779	524	1,070	3,100
Other comprehensive income (loss)	(52)	295	143	15	605	726	438	1,331	380	1,345	(201)	(860)	847
Current and deferred income taxes			(224)			380	224	376	639	93	(841)	42	737
Other Noncash Income (Expense)									(711)	(341)
(Decrease) increase in overdrafts payable									66	(75)
Net cash provided by (used in) financing activities									5,460	4,929
Amortization of deferred cost of reinsurance asset									111	115
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		16,109		17,766	17,744	17,182	16,109	17,744		17,766
Noncontrolling Interest
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	2,969			3,012					2,969	3,012	(3,096)	(3,059)
Other comprehensive income (loss)									19	1
Dividends									347	287
Net income (loss) attributable to noncontrolling interest									311	326
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders									(96)	(92)
Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	12,990	13,116	11,181	14,752	14,733	14,140	13,116	14,733	12,990	14,752	11,283	12,471	13,425
AOCI Attributable to Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											1	185	258	$ (618)
Equity	362	452	137	1,529	1,516	908	452	1,516	362	1,529	1	208
Other comprehensive income (loss)			136			723	451	1,331	361	1,344	(184)	(845)	876
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance, Revised											6,058	6,963
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance, Revised											5,938	6,963
Accumulated other comprehensive income, beginning of year after accounting change											5,941	6,963	7,208	4,876
Equity	7,265	7,301	5,700	7,908	7,897	7,913	7,301	7,897	7,265	7,908	5,941	8,896
Net income (loss)			(238)			950	1,362	1,434		1,445	28	667	2,713
Dividends									0	500	(1,050)	(912)	(381)
Additional Paid-in Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	$ 5,361			5,313					5,361	5,313	5,339	5,321
Deferred tax on dividend of AB Units									$ 0
As previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		12,608	15,969	20,883	21,013	19,963	12,608	21,013		20,883	16,416	17,595	18,108
Net income (loss)		1,459	(313)	22	1,061	1,720	1,146	2,781		2,803	544	1,464	4,420
Other comprehensive income (loss)			179	(23)	620	789		1,409		1,386	(238)	(910)	925
Current and deferred income taxes			(327)			733	(16)	985		704	(771)	258	1,448
Other Noncash Income (Expense)			0			(50)	0	(119)			(31)	(111)	98
(Decrease) increase in overdrafts payable			50			0	0	0			(85)	0	0
Net cash provided by (used in) financing activities			2,306			1,468	0	4,016			5,751	3,034	3,843
Amortization of deferred cost of reinsurance asset											159	39	302
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		17,617			21,013		17,617	21,013
As previously reported | Noncontrolling Interest
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		0	3,035	3,001	3,026	3,069	0	3,026		3,001	3,085	3,086	2,989	2,903
Net income (loss) attributable to noncontrolling interest			118			117	118	203		299	464	403	387
As previously reported | Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		14,635	12,934	17,882	17,987	16,894	14,635	17,987		17,882	13,331	14,509	15,119
As previously reported | AOCI Attributable to Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		493			1,637		493	1,637			7	228	351	(603)
Other comprehensive income (loss)			172			786	486	1,409		1,385	(221)	(895)	954
As previously reported | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance, Revised											7,842	8,958
Equity		8,779	7,411	10,954	11,030	10,561	8,779	11,030		10,954		8,958	8,809	5,205
Net income (loss)			(431)			1,603	915	2,572		2,496	75	1,061	4,033
Dividends											(1,050)	(912)	(429)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised											7,983	8,958	8,809
As previously reported | Additional Paid-in Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity											5,339	5,321	5,957	5,934
Deferred tax on dividend of AB Units											0	(35)	(26)
Impact of Revision
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		(84)	(53)	(72)	(110)		(84)	(110)		(72)	(192)	(109)	(100)
Net income (loss)		(9)	1	11	(21)	16	(9)	(5)		6	(114)	11	(139)
Other comprehensive income (loss)			0	30	(15)	6		(9)		20	20	(20)	0
Current and deferred income taxes			0			8	(5)	1		(57)	(121)	2	(75)
Other Noncash Income (Expense)			0			(91)	0	48			0	80	(39)
(Decrease) increase in overdrafts payable			0			(91)	0	48			0	80	(39)
Net cash provided by (used in) financing activities			0			(91)	0	48			0	80	(39)
Amortization of deferred cost of reinsurance asset													(10)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		(84)			(110)	(86)	(84)	(110)
Impact of Revision | Noncontrolling Interest
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		11	11	11	(15)	(27)	11	(15)		11	11	(27)	(27)	21
Net income (loss) attributable to noncontrolling interest			0			0	0	1		27	27	0	0
Impact of Revision | Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		(95)	(64)	(83)	(95)	(60)	(95)	(95)		(83)	(203)	(82)	(73)
Impact of Revision | AOCI Attributable to Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		0	0		(29)		0	(29)			0	(20)	0	0
Other comprehensive income (loss)			0			6	0	(9)		20	20	(20)
Impact of Revision | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance, Revised			(65)									(62)
Equity		(95)	(64)	(83)	(66)	(46)	(95)	(66)		(83)	(203)	(62)	(73)	18
Net income (loss)			1			16	(9)	(4)		(21)	(141)	11
Other comprehensive income (loss)													0
Dividends											0	0	48
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised												(62)	(73)
Impact of Revision | Additional Paid-in Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity											0	0	0	(26)
Deferred tax on dividend of AB Units											0	0	26
As Revised
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		12,524	15,916	20,811	20,903	19,877	12,524	20,903		20,811	16,224	17,486	18,008
Net income (loss)		1,450	(312)	33	1,040	1,736	1,137	2,776		2,809	430	1,475	4,281
Other comprehensive income (loss)		294	179	7	605	795	473	1,400		1,406	(218)	(930)	925
Current and deferred income taxes			(327)			741	(21)	986		647	(892)	260	1,373
Other Noncash Income (Expense)							0	(71)			(31)	(31)	59
(Decrease) increase in overdrafts payable			50			(91)	0	48			(85)	80	(39)
Net cash provided by (used in) financing activities			2,306			1,377	0	4,064			5,751	3,114	3,804
Amortization of deferred cost of reinsurance asset											159	121	292
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		17,533		20,811	20,903	19,876	17,533	20,903		20,811
As Revised | Noncontrolling Interest
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		11	3,046	3,012	3,011	3,042	11	3,011		3,012	3,096	3,059	2,962	2,924
Net income (loss) attributable to noncontrolling interest			118			117	118	204		326	491	403	387
As Revised | Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		14,540	12,870	17,799	17,892	16,834	14,540	17,892		17,799	13,128	14,427	15,046
As Revised | AOCI Attributable to Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											7	208	351	(603)
Equity		493	179	1,613	1,608	1,000	493	1,608		1,613	7	208	351	(603)
Other comprehensive income (loss)			172			792	486	1,400		1,405	(201)	(915)	954
As Revised | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance, Revised											7,897	8,896
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance, Revised											7,777	8,896
Accumulated other comprehensive income, beginning of year after accounting change											7,780	8,896	8,736	5,223
Equity		8,684	7,347	10,871	10,964	10,515	8,684	10,964		10,871	7,780	8,896	8,736	5,223
Net income (loss)			(430)			1,619	906	2,568		2,475	(66)	1,072	3,894
Dividends											(1,050)	(912)	(381)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised												8,896	8,736
As Revised | Additional Paid-in Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity											5,339	5,321	5,957	5,908
Deferred tax on dividend of AB Units											0	(35)	0
Impact of Revision
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		(1,424)	(1,689)		(3,159)	(2,694)	(1,424)	(3,159)			(1,845)	(1,956)	(1,621)
Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Adjustment				0						0
Net income (loss)		264	192	104	(464)	(669)	456	(1,134)		(1,030)	94	(405)	(1,181)
Other comprehensive income (loss)		1	(36)	8	0	(69)	(35)	(69)		(61)	17	70	(78)
Current and deferred income taxes			103			(361)	245	(610)		(554)	51	(218)	(636)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, As Revised		(1,424)		(3,045)	(3,159)		(1,424)	(3,159)		(3,045)
Impact of Revision | Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		(1,424)	(1,689)	(5,926)	(3,159)	(2,694)	(1,424)	(3,159)		(5,926)	(1,845)	(1,956)	(1,621)
Impact of Revision | AOCI Attributable to Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											(6)	(23)	(93)	(15)
Equity		(41)	(42)	(84)	(92)	(92)	(41)	(92)		(84)
Other comprehensive income (loss)			(36)			(69)	(35)	(69)		(61)	17	70	(78)
Impact of Revision | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance, Revised											(1,839)	(1,933)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance, Revised											(1,839)	(1,933)
Accumulated other comprehensive income, beginning of year after accounting change											(1,839)	(1,933)	(1,528)	$ (347)
Equity		$ (1,383)	(1,647)	$ (2,963)	$ (3,067)	(2,602)	(1,383)	(3,067)		(2,963)
Net income (loss)			$ 192			$ (669)	$ 456	$ (1,134)		$ (1,030)	94	(405)	(1,181)
Dividends											$ 0	$ 0	$ 0

XML

SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUTNING POLICIES – Schedule of Accounting Change Adjustments made to the Consolidated Statements of Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Item Effected [Line Items]
Derivative, Non-cash Gain (Loss) on Derivative, Net										$ 1,621	$ (305)	$ (1,072)	$ 3,418
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 15,959	$ 11,100	$ 14,227	$ 17,764	$ 17,744	$ 17,183	$ 11,100	$ 17,744	$ 15,959	17,764	14,379	15,530	16,387
Net income (loss)	66	1,714	(120)	137	576	1,067	1,593	1,642	1,677	1,779	524	1,070	3,100
Insurance Commissions and Fees	(914)	(856)	(858)	(854)	(819)	(795)	(1,712)	(1,614)	(2,626)	(2,468)	(3,342)	(3,284)	(3,156)
Future policy benefits			274			515	1,326	1,075	1,289	935	432	629	1,485
Increase (Decrease) in Deferred Policy Acquisition Costs			127			31	50	9	15	64	368	(257)	(345)
Current and deferred income taxes			(224)			380	224	376	639	93	(841)	42	737
Net Cash Provided by (Used in) Operating Activities			18			190	(75)	(385)	994	(165)	(461)	(324)	(600)
As Revised
Item Effected [Line Items]
Derivative, Non-cash Gain (Loss) on Derivative, Net										3,249	(419)	(339)	5,241
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		12,524	15,916	20,811	20,903	19,877	12,524	20,903		20,811	16,224	17,486	18,008
Net income (loss)		1,450	(312)	33	1,040	1,736	1,137	2,776		2,809	430	1,475	4,281
Insurance Commissions and Fees		(924)	(925)	(925)	(886)	(860)	(1,847)	(1,746)		(2,671)	(3,615)	(3,524)	(3,363)
Future policy benefits			205			621	1,391	1,340		1,208	771	1,040	1,732
Increase (Decrease) in Deferred Policy Acquisition Costs			125			22	46	(9)		38	333	(318)	(379)
Current and deferred income taxes			(327)			741	(21)	986		647	(892)	260	1,373
Net Cash Provided by (Used in) Operating Activities			18			190	(75)	(385)		(165)	(461)	(324)	(600)
Impact of Revision
Item Effected [Line Items]
Derivative, Non-cash Gain (Loss) on Derivative, Net										(1,628)	114	(733)	(1,823)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(1,424)	(1,689)		(3,159)	(2,694)	(1,424)	(3,159)			(1,845)	(1,956)	(1,621)
Net income (loss)		264	192	104	(464)	(669)	456	(1,134)		(1,030)	94	(405)	(1,181)
Insurance Commissions and Fees		68	67	71	67	65	135	132		203	273	240	207
Future policy benefits			69			(106)	(65)	(265)		(273)	(339)	(411)	(247)
Increase (Decrease) in Deferred Policy Acquisition Costs			2			9	4	18		26	35	61	34
Current and deferred income taxes			103			(361)	245	(610)		(554)	51	(218)	(636)
Net Cash Provided by (Used in) Operating Activities			0			0	0	0		0	0	0	0
As previously reported
Item Effected [Line Items]
Derivative, Non-cash Gain (Loss) on Derivative, Net											(462)	(208)	5,409
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		12,608	15,969	20,883	21,013	19,963	12,608	21,013		20,883	16,416	17,595	18,108
Net income (loss)		1,459	(313)	22	1,061	1,720	1,146	2,781		2,803	544	1,464	4,420
Insurance Commissions and Fees		(865)	(896)	(978)	(915)	(901)	(1,761)	(1,816)		(2,794)	(3,423)	(3,208)	(3,115)
Future policy benefits			185			491	1,381	1,168		1,253	803	878	1,518
Increase (Decrease) in Deferred Policy Acquisition Costs			125			(10)	43	(84)		(80)	162	(331)	(413)
Current and deferred income taxes			(327)			733	(16)	985		704	(771)	258	1,448
Net Cash Provided by (Used in) Operating Activities			18			99	(75)	(337)		(165)	(461)	(244)	(639)
Impact of Revision
Item Effected [Line Items]
Derivative, Non-cash Gain (Loss) on Derivative, Net											43	(131)	(168)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(84)	(53)	(72)	(110)		(84)	(110)		(72)	(192)	(109)	(100)
Net income (loss)		(9)	1	11	(21)	16	(9)	(5)		6	(114)	11	(139)
Insurance Commissions and Fees		(59)	(29)	53	29	41	(86)	70		123	(192)	(316)	(248)
Future policy benefits			20			130	10	172		(45)	(32)	162	214
Increase (Decrease) in Deferred Policy Acquisition Costs			0			32	3	75		118	171	13	34
Current and deferred income taxes			0			8	(5)	1		(57)	(121)	2	(75)
Net Cash Provided by (Used in) Operating Activities			0			91	0	(48)		0	0	(80)	39
Retained Earnings
Item Effected [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											5,941	6,963	7,208	$ 4,876
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	7,265	7,301	5,700	7,908	7,897	7,913	7,301	7,897	7,265	7,908	5,941	8,896
Net income (loss)			(238)			950	1,362	1,434		1,445	28	667	2,713
Retained Earnings | As Revised
Item Effected [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											7,780	8,896	8,736	5,223
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		8,684	7,347	10,871	10,964	10,515	8,684	10,964		10,871	7,780	8,896	8,736	5,223
Net income (loss)			(430)			1,619	906	2,568		2,475	(66)	1,072	3,894
Retained Earnings | Impact of Revision
Item Effected [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											(1,839)	(1,933)	(1,528)	(347)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(1,383)	(1,647)	(2,963)	(3,067)	(2,602)	(1,383)	(3,067)		(2,963)
Net income (loss)			192			(669)	456	(1,134)		(1,030)	94	(405)	(1,181)
Retained Earnings | As previously reported
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		8,779	7,411	10,954	11,030	10,561	8,779	11,030		10,954		8,958	8,809	5,205
Net income (loss)			(431)			1,603	915	2,572		2,496	75	1,061	4,033
Retained Earnings | Impact of Revision
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(95)	(64)	(83)	(66)	(46)	(95)	(66)		(83)	(203)	(62)	(73)	18
Net income (loss)			1			16	(9)	(4)		(21)	(141)	11
AOCI Attributable to Parent
Item Effected [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											1	185	258	(618)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	362	452	137	1,529	1,516	908	452	1,516	362	1,529	1	208
AOCI Attributable to Parent | As Revised
Item Effected [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											7	208	351	(603)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		493	179	1,613	1,608	1,000	493	1,608		1,613	7	208	351	(603)
AOCI Attributable to Parent | Impact of Revision
Item Effected [Line Items]
Accumulated other comprehensive income, beginning of year after accounting change											(6)	(23)	(93)	(15)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(41)	(42)	(84)	(92)	(92)	(41)	(92)		(84)
AOCI Attributable to Parent | As previously reported
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		493			1,637		493	1,637			7	228	351	(603)
AOCI Attributable to Parent | Impact of Revision
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		0	0		(29)		0	(29)			0	(20)	0	$ 0
Parent
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 12,990	13,116	11,181	14,752	14,733	14,140	13,116	14,733	$ 12,990	14,752	11,283	12,471	13,425
Parent | As Revised
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		14,540	12,870	17,799	17,892	16,834	14,540	17,892		17,799	13,128	14,427	15,046
Parent | Impact of Revision
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(1,424)	(1,689)	(5,926)	(3,159)	(2,694)	(1,424)	(3,159)		(5,926)	(1,845)	(1,956)	(1,621)
Parent | As previously reported
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		14,635	12,934	17,882	17,987	16,894	14,635	17,987		17,882	13,331	14,509	15,119
Parent | Impact of Revision
Item Effected [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		$ (95)	$ (64)	$ (83)	$ (95)	$ (60)	$ (95)	$ (95)		$ (83)	$ (203)	$ (82)	$ (73)

XML

SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUTNING POLICIES – Schedule Accounting Change Adjustments made to the Consolidated Statements of Balance Sheet (Details) - USD ($) $ in Millions	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other equity investments	$ 1,337			$ 1,323
Amounts due from reinsurers	5,016			4,664
Trading securities, at fair value	12,053			9,134
Guaranteed minimum income benefit reinsurance contract asset, at fair value	10,933			10,309
Broker-dealer related payables	529			484
Broker-dealer related receivables	2,206			2,100
Other invested assets	2,515			2,226
Other assets	4,258			4,260
Investments	63,523			58,427
Deferred policy acquisition costs	4,550	$ 4,516	$ 4,491	4,666	$ 4,876	$ 4,852	$ 4,936	$ 4,996
Assets	219,069	215,358	209,551	204,169	209,432	207,460	200,475	195,220
Policyholders’ account balances	42,679			38,825
Redeemable noncontrolling interest	441			403
Future policy benefits and other policyholders’ liabilities	29,423	29,556	28,649	28,859	31,469	31,632	30,120	28,435
Retained earnings	7,265	7,301	5,700	5,941	7,910	7,897	7,914	6,963
Accumulated other comprehensive income (loss)	362	452	137	1	1,529	1,516	908	185
Current and deferred income taxes	3,148	3,183	2,581	2,714	4,473	4,715	4,396	3,592
Other liabilities	2,869			2,108
Liabilities	202,669	198,897	194,907	189,387	191,520	189,487	183,074	179,677
Equity	15,959	11,100	14,227	14,379	17,764	17,744	17,183	15,530	$ 16,387
Total Liabilities and Equity	219,069	215,358	209,551	204,169	209,432	207,460	200,475	195,220
Total AXA Equitable’s equity	12,990	13,116	11,181	11,283	14,754	14,733	14,141	12,471
Noncontrolling interest	2,969			3,096
As previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other equity investments		1,477	1,463	1,408	1,454	1,447	1,398	1,477
Amounts due from reinsurers		4,870	4,639	4,635	4,550	4,523	4,605	4,466
Trading securities, at fair value		0	0	9,134	8,702	7,843	7,124	6,805
Guaranteed minimum income benefit reinsurance contract asset, at fair value				10,309				10,570
Other invested assets		2,622	2,050	2,186	2,192	2,811	2,462	1,788
Other assets		0	0	4,260		4,501	4,516	4,634
Investments		62,111	60,406	58,416	60,968	60,979	56,581	52,527
Deferred policy acquisition costs		4,141	4,068	4,301	4,516	4,496	4,505	4,469
Assets		214,941	209,098	203,764	209,034	207,042	199,983	194,626
Policyholders’ account balances		41,531	40,308	38,782	36,920	35,661	33,710	33,033
Future policy benefits and other policyholders’ liabilities		26,799	25,496	25,358	26,191	26,131	25,272	24,531
Retained earnings		8,779	7,411	7,983	10,954	11,030	10,561	8,958
Accumulated other comprehensive income (loss)		493	179	7		1,637	1,014	228
Current and deferred income taxes		4,000	3,523	3,816	6,160	6,421	5,833	4,647
Other liabilities			0	2,108			2,841	2,586
Liabilities		196,972	192,712	186,945	188,005	185,800	179,802	177,018
Equity		12,608	15,969	16,416	20,883	21,013	19,963	17,595	18,108
Total Liabilities and Equity		214,941	209,098	203,764	209,034	207,042	199,983	194,626
Total AXA Equitable’s equity		14,635	12,934	13,331	17,882	17,987	16,894	14,509
Noncontrolling interest		2,973	3,035	3,085	3,001	3,026	69	3,086
Impact of Revision
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other equity investments		(21)	(23)	(29)	(93)	(100)	(120)	(81)
Amounts due from reinsurers		31	19	29	27	49	48	46
Trading securities, at fair value		0	0	0	65	73	81	81
Guaranteed minimum income benefit reinsurance contract asset, at fair value				0				8
Other invested assets		32	34	40	39	38	39	0
Other assets		0	0	0		2	13	13
Investments		11	11	11	11	11	0	0
Deferred policy acquisition costs		(135)	(88)	(175)	(123)	(126)	(59)	(36)
Assets		(93)	(58)	(135)	(85)	(64)	2	31
Policyholders’ account balances		(15)	(16)	43	(76)	(108)	(89)	(138)
Future policy benefits and other policyholders’ liabilities		56	45	123	109	160	213	332
Retained earnings		(95)	(64)	(203)	(83)	(66)	(45)	(62)
Accumulated other comprehensive income (loss)		0	0	0		(29)	(14)	(20)
Current and deferred income taxes		(50)	(34)	(109)	(46)	(6)	14	(2)
Other liabilities			0	0			(50)	(52)
Liabilities		(9)	(5)	57	(13)	46	88	140
Equity		(84)	(53)	(192)	(72)	(110)		(109)	(100)
Total Liabilities and Equity		(93)	(58)	(135)	(85)	(64)	2	31
Total AXA Equitable’s equity		(95)	(64)	(203)	(83)	(95)	(59)	(82)
Noncontrolling interest		11	11	11	11	(15)	(27)	(27)
As Revised
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other equity investments		1,456	1,440	1,379	1,361	1,347	1,278	1,396
Amounts due from reinsurers		4,901	4,658	4,664	4,577	4,572	4,653	4,512
Trading securities, at fair value		0	0	9,134	8,767	7,916	7,205	6,886
Guaranteed minimum income benefit reinsurance contract asset, at fair value				10,309				10,578
Other invested assets		2,654	2,084	2,226	2,231	2,849	2,501	1,788
Other assets		0	0	4,260		4,503	4,529	4,647
Investments		62,122	60,417	58,427	60,979	60,990	56,581	52,527
Deferred policy acquisition costs		4,006	3,980	4,126	4,393	4,370	4,446	4,433
Assets		214,848	209,040	203,629	208,949	206,978	199,985	194,657
Policyholders’ account balances		41,516	40,292	38,825	36,844	35,553	33,621	32,895
Future policy benefits and other policyholders’ liabilities		26,855	25,541	25,481	26,300	26,291	25,485	24,863
Retained earnings		8,684	7,347	7,780	10,871	10,964	10,516	8,896
Accumulated other comprehensive income (loss)		493	179	7	1,613	1,608	1,000	208
Current and deferred income taxes		3,950	3,489	3,707	6,114	6,415	5,847	4,645
Other liabilities			0	2,108			2,791	2,534
Liabilities		196,963	192,707	187,002	187,992	185,846	179,890	177,158
Equity		12,524	15,916	16,224	20,811	20,903	19,877	17,486	18,008
Total Liabilities and Equity		214,848	209,040	203,629	208,949	206,978	199,985	194,657
Total AXA Equitable’s equity		14,540	12,870	13,128	17,799	17,892	16,835	14,427
Noncontrolling interest		2,984	3,046	3,096	3,012	3,011	42	3,059
Impact of Revision
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred policy acquisition costs		510	511	540	483	482	490	563
Assets		510	511	540	483	482	490	563
Future policy benefits and other policyholders’ liabilities		2,701	3,108	3,378	5,169	5,341	4,635	3,572
Retained earnings		(1,383)	(1,647)	(1,845)	(2,961)	(3,067)	(2,602)	(1,933)
Accumulated other comprehensive income (loss)		(41)	(42)	(6)	(84)	(92)	(92)	(23)
Current and deferred income taxes		(767)	(908)	(993)	(1,641)	(1,700)	(1,451)	(1,053)
Liabilities		1,934	2,200	2,385	3,528	3,641	3,184	2,519
Equity		(1,424)	(1,689)	(1,845)		(3,159)	(2,694)	(1,956)	(1,621)
Total Liabilities and Equity		510	511	(3,150)	483	482	490	563
Total AXA Equitable’s equity		(1,424)	(1,689)	(1,845)	(3,045)	(3,159)	(2,694)	(1,956)
AOCI Attributable to Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	$ 362	452	137	1	1,529	1,516	908	208
AOCI Attributable to Parent | As previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		493		7		1,637		228	351	$ (603)
AOCI Attributable to Parent | Impact of Revision
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		0	0	0		(29)		(20)	0	0
AOCI Attributable to Parent | As Revised
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		493	179	$ 7	1,613	1,608	1,000	$ 208	$ 351	$ (603)
AOCI Attributable to Parent | Impact of Revision
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity		$ (41)	$ (42)		$ (84)	$ (92)	$ (92)

XML

SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUTNING POLICIES – Schedule of Accounting Change Adjustments made to the Consolidated Statements of Comprehensive income (loss) (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other operating costs and expenses	$ 449			$ 319					$ 992	$ 1,070
Interest credited to policyholders’ account balances	350			303					1,008	779
Net income (loss)	66	$ 1,714	$ (120)	137	$ 576	$ 1,067	$ 1,593	$ 1,642	1,677	1,779	$ 524	$ 1,070	$ 3,100
Change in unrealized gains (losses), net of reclassification adjustment	(55)	315	108	16	610	717	423	1,327	362	1,342	(180)	(831)	891
Other comprehensive income (loss)	(52)	295	143	15	605	726	438	1,331	380	1,345	(201)	(860)	847
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	14	2,009	23	152	1,181	1,793	2,031	2,973	2,057	3,124	323	210	3,947
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	154			127					372	335
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ (140)	1,916	(102)	25	1,093	1,673	2,031	2,765	1,685	2,789	(156)	(178)	3,589
As Revised
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other operating costs and expenses											1,458	1,497	1,668
Interest credited to policyholders’ account balances			336	303	255	221	658	476		779	1,082	976	1,037
Increase Decrease In Fair Value Of Reinsurance Contracts			0			0
Net income (loss)		1,450	(312)	33	1,040	1,736	1,137	2,776		2,809	430	1,475	4,281
Change in unrealized gains (losses), net of reclassification adjustment		314	144	8	610	786	458	1,396		1,403	(197)	(901)	969
Other comprehensive income (loss)		294	179	7	605	795	473	1,400		1,406	(218)	(930)	925
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		1,744	(133)	40	1,645	2,531	1,610	4,176		4,215	212	545	5,206
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest			125	127	88	120		208		335	479	388	358
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		1,651	(258)	(87)	1,557	2,411	1,610	3,968		3,880	(267)	157	4,848
Impact of Revision
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net income (loss)		264	192	104	(464)	(669)	456	(1,134)		(1,030)	94	(405)	(1,181)
Change in unrealized gains (losses), net of reclassification adjustment		1	(36)	8	0	(69)	(35)	(69)		(61)	17	70	(78)
Other comprehensive income (loss)		1	(36)	8	0	(69)	(35)	(69)		(61)	17	70	(78)
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		265	156	112	(464)	(738)	421	(1,203)		(1,091)	111	(335)	(1,259)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		265	156	0	(464)	(738)	421	(1,203)		0	111	(335)	(1,259)
As previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other operating costs and expenses											1,458	1,415	1,692
Interest credited to policyholders’ account balances			337	272	274	251	658	525		797	981	1,048	1,155
Increase Decrease In Fair Value Of Reinsurance Contracts			0			0
Net income (loss)		1,459	(313)	22	1,061	1,720	1,146	2,781		2,803	544	1,464	4,420
Change in unrealized gains (losses), net of reclassification adjustment			144	(22)	625	780		1,405		1,383	(217)	(881)	969
Other comprehensive income (loss)			179	(23)	620	789		1,409		1,386	(238)	(910)	925
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest		1,753	(134)	(1)	1,681	2,509	1,619	4,190		4,189	306	554	5,345
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest			125	99	89	120		209		308	452	388	358
Comprehensive Income (Loss), Net of Tax, Attributable to Parent		$ 1,660	(259)	$ (100)	$ 1,592	2,389	1,619	3,981		3,881	(146)	166	4,987
AOCI Attributable to Parent
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other comprehensive income (loss)			136			723	451	1,331	$ 361	1,344	(184)	(845)	876
AOCI Attributable to Parent | As Revised
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other comprehensive income (loss)			172			792	486	1,400		1,405	(201)	(915)	954
AOCI Attributable to Parent | Impact of Revision
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other comprehensive income (loss)			(36)			(69)	(35)	(69)		(61)	17	70	(78)
AOCI Attributable to Parent | As previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Other comprehensive income (loss)			$ 172			$ 786	$ 486	$ 1,409		$ 1,385	$ (221)	$ (895)	$ 954

XML

INVESTMENTS (AVAILABLE FOR SALE SECURITIES) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 32,274	$ 32,236
Gross Unrealized Gains	1,646	1,306
Gross Unrealized Losses	485	859
Fair Value	33,435	32,683
OTTI in AOCI	3	10
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]
Due in one year or less, Amortized Cost	1,701
Due in years two through five, Amortized Cost	7,349
Due in years six through ten, Amortized Cost	9,256
Due after ten years, Amortized Cost	12,817
Available for sale securities debt maturities single maturity date, Amortized Cost, Subtotal	31,123
Fixed maturities available for sale, amortized cost	32,139
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Due in one year or less, Fair Value	1,723
Due in years two through five, Fair Value	7,686
Due in years six through ten, Fair Value	9,530
Due after ten years, Fair Value	13,300
Available for sale securities debt maturities single maturity date, Fair Value, Subtotal	32,239
Available-for-sale securities, debt maturities, Fair Value, Total	33,300
Public corporate
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	12,429	12,418
Gross Unrealized Gains	748	675
Gross Unrealized Losses	39	81
Fair Value	13,138	13,012
OTTI in AOCI	0	0
Private corporate
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	7,069	6,880
Gross Unrealized Gains	256	215
Gross Unrealized Losses	34	55
Fair Value	7,291	7,040
OTTI in AOCI	0	0
U.S. Treasury, government and agency
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	10,842	10,739
Gross Unrealized Gains	473	221
Gross Unrealized Losses	379	624
Fair Value	10,936	10,336
OTTI in AOCI	0	0
State and Political Sub- divisions
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	414	432
Gross Unrealized Gains	67	63
Gross Unrealized Losses	0	2
Fair Value	481	493
OTTI in AOCI	0	0
Foreign Govts
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	369	375
Gross Unrealized Gains	29	29
Gross Unrealized Losses	5	14
Fair Value	393	390
OTTI in AOCI	0	0
Commercial Mortgage- backed
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	280	415
Gross Unrealized Gains	8	28
Gross Unrealized Losses	26	72
Fair Value	262	371
OTTI in AOCI	1	7
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]
Available-for-sale securities, debt maturities, without single maturity date, Amortized Cost	280
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Available-for-sale securities, debt maturities, without single maturity date, Fair Value	262
Residential Mortgage- backed
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	249	294
Gross Unrealized Gains	16	20
Gross Unrealized Losses	0	0
Fair Value	265	314
OTTI in AOCI	0	0
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]
Available-for-sale securities, debt maturities, without single maturity date, Amortized Cost	249
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Available-for-sale securities, debt maturities, without single maturity date, Fair Value	265
Asset- backed
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	30	51
Gross Unrealized Gains	1	10
Gross Unrealized Losses	1	1
Fair Value	30	60
OTTI in AOCI	2	3
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]
Available-for-sale securities, debt maturities, without single maturity date, Amortized Cost	30
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Available-for-sale securities, debt maturities, without single maturity date, Fair Value	30
Redeemable Preferred Stock
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	457	519
Gross Unrealized Gains	48	45
Gross Unrealized Losses	1	10
Fair Value	504	554
OTTI in AOCI	0	0
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]
Available-for-sale securities, debt maturities, without single maturity date, Amortized Cost	457
Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]
Available-for-sale securities, debt maturities, without single maturity date, Fair Value	504
Fixed Maturities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	32,139	32,123
Gross Unrealized Gains	1,646	1,306
Gross Unrealized Losses	485	859
Fair Value	33,300	32,570
OTTI in AOCI	3	10
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]
Fixed maturities available for sale, amortized cost	32,139	32,123
Equity securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	135	113
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	135	113
OTTI in AOCI	$ 0	$ 0

XML

INVESTMENTS (CREDIT LOSS IMPAIRMENTS) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities
Fixed maturities, available for sale	$ 1,287	$ 1,080	$ 1,822	$ 2,866
Gross gains on sales	5	9	34	94
Gross losses on sales	(2)	(1)	(29)	(47)
Total other-than-temporary impairment losses	0	(10)	(13)	(35)
Portion of loss recognized in other comprehensive income (loss)	0	0	0	0
Net impairment losses recognized	0	(10)	(13)	(35)
Fixed Maturities - Credit Loss Impairments
Balances at beginning of period	(115)	(166)	(190)	(198)
Previously recognized impairments on securities that matured, paid, prepaid or sold	32	8	(120)	(65)
Recognized impairments on securities impaired to fair value this period	0	0	0	(17)
Impairments recognized this period on securities not previously impaired	0	(8)	(13)	(16)
Additional impairments this period on securities previously impaired	0	(2)	0	(2)
Increases due to passage of time on previously recorded credit losses	0	0	0	0
Accretion of previously recognized impairments due to increases in expected cash flows	0	0	0	0
Balances at end of period	$ (83)	$ (168)	$ (83)	$ (168)

XML

INVESTMENTS (NET UNREALIZED INVESTMENTS) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, End of Period	$ 400	$ 1,560	$ 400	$ 1,560
Net Unrealized Gains (Losses) On Investments
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year			447
Balance, End of Period	1,161		1,161
Net Unrealized Gains (Losses) On Investments | Unrealized Investment Gains Losses With OTTI Losses
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	(6)	15	19	16
Net investment gains (losses) arising during the period	(5)	2	0	(5)
Reclassification adjustment for OTTI losses excluded from Net earnings (loss)	0	0	0	0
Balance, End of Period	0	18	0	18
Net Unrealized Gains (Losses) On Investments | Unrealized Investment Gains Losses All Other
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	1,145	3,079	428	674
Net investment gains (losses) arising during the period	18	(17)	705	2,417
Included in Net income (loss)	(2)	0	28	(29)
Reclassification adjustment for OTTI losses excluded from Net earnings (loss)	0	0	0	0
Balance, End of Period	1,161	3,062	1,161	3,062
DAC | Unrealized Investment Gains Losses With OTTI Losses
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	2	0	(1)	0
Impact of net unrealized investment gains (losses) on DAC	1	0	2	0
Balance, End of Period	1	0	1	0
DAC | Unrealized Investment Gains Losses All Other
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	(172)	(266)	(87)	(131)
Impact of net unrealized investment gains (losses) on DAC	6	79	(79)	(56)
Balance, End of Period	(166)	(187)	(166)	(187)
Policyholders Liabilities | Unrealized Investment Gains Losses With OTTI Losses
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	1	0	(10)	(4)
Impact of net unrealized investment gains (losses) on policyholders liabilities	1	0	10	4
Balance, End of Period	0	0	0	0
Policyholders Liabilities | Unrealized Investment Gains Losses All Other
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	(208)	(471)	(189)	(230)
Impact of net unrealized investment gains (losses) on policyholders liabilities	(24)	5	(43)	(236)
Balance, End of Period	(232)	(466)	(232)	(466)
Deferred Income Tax Asset Liability | Unrealized Investment Gains Losses With OTTI Losses
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	1	(6)	(3)	(5)
Impact of net unrealized investment gains (losses) on Deferred income taxes	1	1	3	(2)
Balance, End of Period	0	(7)	0	(7)
Deferred Income Tax Asset Liability | Unrealized Investment Gains Losses All Other
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	(267)	(821)	(53)	(110)
Impact of net unrealized investment gains (losses) on Deferred income taxes	22	(21)	(214)	(755)
Balance, End of Period	(267)	(843)	(267)	(843)
AOCI Gain Losses Related to Net Unrealized Investment Gains Losses | Unrealized Investment Gains Losses With OTTI Losses
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	(2)	9	5	7
Net investment gains (losses) arising during the period	(5)	2	0	(5)
Reclassification adjustment for OTTI losses excluded from Net earnings (loss)	0	0	0	0
Impact of net unrealized investment gains (losses) on DAC	1	0	(2)	0
Impact of net unrealized investment gains (losses) on Deferred income taxes	1	1	(3)	2
Impact of net unrealized investment gains (losses) on policyholders liabilities	1	0	(10)	(4)
Balance, End of Period	1	11	1	11
AOCI Gain Losses Related to Net Unrealized Investment Gains Losses | Unrealized Investment Gains Losses All Other
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year	498	1,521	99	203
Net investment gains (losses) arising during the period	18	(17)	705	2,417
Included in Net income (loss)	(2)	0	28	(29)
Reclassification adjustment for OTTI losses excluded from Net earnings (loss)	0	0	0	0
Impact of net unrealized investment gains (losses) on DAC	(5)	79	79	48
Impact of net unrealized investment gains (losses) on Deferred income taxes	22	(21)	214	755
Impact of net unrealized investment gains (losses) on policyholders liabilities	(35)	4	43	222
Balance, End of Period	496	1,566	496	1,566
Fixed Maturities | Net Unrealized Gains (Losses) On Investments | Unrealized Investment Gains Losses With OTTI Losses
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year			19
Balance, End of Period	0		0
Fixed Maturities | Net Unrealized Gains (Losses) On Investments | Unrealized Investment Gains Losses All Other
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year			428
Balance, End of Period	1,161		1,161
Fixed Maturities | AOCI Gain Losses Related to Net Unrealized Investment Gains Losses | Unrealized Investment Gains Losses With OTTI Losses
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Included in Net income (loss)	11	1	(19)	7
Fixed Maturities | Net Unrealized Gains (Losses) On Investmetns | Unrealized Investment Gains Losses With OTTI Losses
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Included in Net income (loss)	11	$ 1	(19)	$ 7
Equity securities | Net Unrealized Gains (Losses) On Investments | Unrealized Investment Gains Losses All Other
Net Unrealized Investment Gains Losses Recognized In Aoci Roll Forward [Abstract]
Balance, beginning of year			0
Balance, End of Period	$ 0		$ 0

XML

INVESTMENTS (GROSS UNREALIZED LOSSES) (Details) $ in Millions	Sep. 30, 2017 USD ($) securities	Dec. 31, 2016 USD ($) securities
Investments, Debt and Equity Securities [Abstract]
Number of fixed maturities in an unrealized loss position greater than 12 months | securities	577	794
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	$ 3,420	$ 9,702
Less Than 12 Months, Gross Unrealized Losses	(83)	(754)
Greater than 12 Months, Fair Value	4,497	652
Greater Than 12 Months, Gross Unrealized Losses	(402)	(105)
Total, Fair Value	7,917	10,354
Total, Gross Unrealized Losses	(485)	(859)
Public corporate
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	1,207	2,455
Less Than 12 Months, Gross Unrealized Losses	(15)	(75)
Greater than 12 Months, Fair Value	752	113
Greater Than 12 Months, Gross Unrealized Losses	(24)	(6)
Total, Fair Value	1,959	2,568
Total, Gross Unrealized Losses	(39)	(81)
Private corporate
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	739	1,483
Less Than 12 Months, Gross Unrealized Losses	(11)	(38)
Greater than 12 Months, Fair Value	467	277
Greater Than 12 Months, Gross Unrealized Losses	(23)	(17)
Total, Fair Value	1,206	1,760
Total, Gross Unrealized Losses	(34)	(55)
U.S. Treasury, government and agency
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	1,354	5,356
Less Than 12 Months, Gross Unrealized Losses	(53)	(624)
Greater than 12 Months, Fair Value	3,048	0
Greater Than 12 Months, Gross Unrealized Losses	(326)	0
Total, Fair Value	4,402	5,356
Total, Gross Unrealized Losses	(379)	(624)
State and Political Sub- divisions
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	0	0
Less Than 12 Months, Gross Unrealized Losses	0	0
Greater than 12 Months, Fair Value	0	18
Greater Than 12 Months, Gross Unrealized Losses	0	(2)
Total, Fair Value	0	18
Total, Gross Unrealized Losses	0	(2)
Foreign Govts
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	13	73
Less Than 12 Months, Gross Unrealized Losses	0	(3)
Greater than 12 Months, Fair Value	59	49
Greater Than 12 Months, Gross Unrealized Losses	(5)	(11)
Total, Fair Value	72	122
Total, Gross Unrealized Losses	(5)	(14)
Commercial Mortgage- backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	49	66
Less Than 12 Months, Gross Unrealized Losses	(4)	(5)
Greater than 12 Months, Fair Value	137	171
Greater Than 12 Months, Gross Unrealized Losses	(22)	(67)
Total, Fair Value	186	237
Total, Gross Unrealized Losses	(26)	(72)
Residential Mortgage- backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	7	47
Less Than 12 Months, Gross Unrealized Losses	0	0
Greater than 12 Months, Fair Value	13	4
Greater Than 12 Months, Gross Unrealized Losses	0	0
Total, Fair Value	20	51
Total, Gross Unrealized Losses	0	0
Asset- backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	1	4
Less Than 12 Months, Gross Unrealized Losses	0	0
Greater than 12 Months, Fair Value	9	8
Greater Than 12 Months, Gross Unrealized Losses	(1)	(1)
Total, Fair Value	10	12
Total, Gross Unrealized Losses	(1)	(1)
Redeemable Preferred Stock
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less Than 12 Months, Fair Value	50	218
Less Than 12 Months, Gross Unrealized Losses	0	(9)
Greater than 12 Months, Fair Value	12	12
Greater Than 12 Months, Gross Unrealized Losses	(1)	(1)
Total, Fair Value	62	230
Total, Gross Unrealized Losses	$ (1)	$ (10)

XML

INVESTMENTS (TEXTUAL) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Debt securities exposure in single issuer greater than stated percentage of total investments	0.30%		0.30%
Available-for-sale securities, amortized cost basis	$ 32,274		$ 32,274		$ 32,236
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	402		402		105
Carrying value of fixed maturities non-income producing	1		1
Investment expenses	31	$ 16	40	$ 47
Trading securities, at fair value	12,053		12,053		9,134
Separate account equity investment carrying value	49		49		63
Separate account equity investment cost	31		31		46
Derecognized US Treasury securities	2,090		2,090		2,220
Proceeds from return swap contract					2,126
Fair value of return swap contracts	(8)		(8)
Other Than Investment Grade
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Available-for-sale securities, amortized cost	$ 1,523		$ 1,523		$ 1,574
Percentage of available for sale securities	4.70%		4.70%		4.90%
Public corporate
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Debt securities exposure in single issuer of total investments	$ 178		$ 178		$ 169
Available-for-sale securities, amortized cost basis	12,429		12,429		12,418
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	24		24		6
Fixed Maturities
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Available-for-sale securities, amortized cost basis	$ 32,139		32,139		32,123
Fixed Maturities | Other Than Investment Grade
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Gross Unrealized Losses			10		28
Treasury Lock
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Unrealized gain (loss) TIPS			$ 97		$ 97

XML

INVESTMENTS (TRADING SECURITIES) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net Realized and Unrealized Gain (Loss) on Trading Securities [Abstract]
Net investment gains (losses) recognized during the period on securities held at the end of the period	$ 45	$ 7	$ 153	$ 126
Net investment gains (losses) recognized on securities sold during the period	10	1	35	(9)
Unrealized and realized gains (losses) on trading securities arising during the period	55	8	188	117
Interest and dividend income from trading securities	54	34	143	82
Net investment income (loss) from trading securities	$ 109	$ 42	$ 331	$ 199

XML

INVESTMENTS (TROUBLED DEBT RESTRUCTURING) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Commercial Mortgage Loans
Financing Receivable, Modifications [Line Items]
Mortgage loans classified as nonaccrual	$ 19	$ 34

XML

INVESTMENTS (VALUATION ALLOWANCE FOR MORTGAGE LOANS) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Mortgage loans on real estate, valuation allowances	$ 8		$ 8
Commercial Mortgage Loans
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Beginning balance, January 1,	8	$ 6
Charge-offs	0	0
Recoveries	0	(2)
Provision	0	4
Ending balance, September 30,	8	8
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Mortgage loans on real estate, valuation allowances	8	$ 8
Agricultural Mortgage Loans
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Beginning balance, January 1,	0
Ending balance, September 30,	$ 0

XML

INVESTMENTS (MORTGAGE LOANS) (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Commercial Mortgage Loans
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	$ 8,084	$ 7,264
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	0	0
Financing receivables, recorded investment, current	8,084	7,264
Total financing receivables	8,084	7,264
Financing receivable, recorded investment, 90 days or more past due and accruing	0	0
Commercial Mortgage Loans | With No Related Allowance Recorded
Impaired Mortgage Loans [Abstract]
Impaired financing receivable, recorded investment	0	15
Impaired financing receivable, unpaid principal balance	0	15
Related allowance	0	0
Impaired financing receivable, average recorded investment	0	22
Impaired financing receivable, interest income recognized	0	0
Commercial Mortgage Loans | With Related Allowance Recorded
Impaired Mortgage Loans [Abstract]
Impaired financing receivable, recorded investment	27	27
Impaired financing receivable, unpaid principal balance	27	27
Related allowance	(8)	(8)
Impaired financing receivable, average recorded investment	27	48
Impaired financing receivable, interest income recognized	1	2
Commercial Mortgage Loans | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	5,005	4,237
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	5,005	4,237
Commercial Mortgage Loans | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	555	590
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	555	590
Commercial Mortgage Loans | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	1,584	989
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,584	989
Commercial Mortgage Loans | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	744	1,298
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	744	1,298
Commercial Mortgage Loans | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	196	104
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	196	104
Commercial Mortgage Loans | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	46
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	46
Commercial Mortgage Loans | 0% - 50%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	1,128	948
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,128	948
Commercial Mortgage Loans | 0% - 50% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	741	738
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	741	738
Commercial Mortgage Loans | 0% - 50% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	95
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	95
Commercial Mortgage Loans | 0% - 50% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	313	59
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	313	59
Commercial Mortgage Loans | 0% - 50% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	74	56
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	74	56
Commercial Mortgage Loans | 0% - 50% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Mortgage Loans | 0% - 50% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Mortgage Loans | 50% - 70%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	6,259	5,496
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	6,259	5,496
Commercial Mortgage Loans | 50% - 70% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	4,094	3,217
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	4,094	3,217
Commercial Mortgage Loans | 50% - 70% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	555	430
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	555	430
Commercial Mortgage Loans | 50% - 70% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	1,048	673
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,048	673
Commercial Mortgage Loans | 50% - 70% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	416	1,100
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	416	1,100
Commercial Mortgage Loans | 50% - 70% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	146	76
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	146	76
Commercial Mortgage Loans | 50% - 70% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Mortgage Loans | 70% - 90%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	670	777
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	670	777
Commercial Mortgage Loans | 70% - 90% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	170	282
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	170	282
Commercial Mortgage Loans | 70% - 90% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	65
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	65
Commercial Mortgage Loans | 70% - 90% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	196	229
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	196	229
Commercial Mortgage Loans | 70% - 90% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	254	127
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	254	127
Commercial Mortgage Loans | 70% - 90% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	50	28
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	50	28
Commercial Mortgage Loans | 70% - 90% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	46
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	46
Commercial Mortgage Loans | 90% plus
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	27	43
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	43
Commercial Mortgage Loans | 90% plus | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Mortgage Loans | 90% plus | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Mortgage Loans | 90% plus | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	27	28
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	28
Commercial Mortgage Loans | 90% plus | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	15
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	15
Commercial Mortgage Loans | 90% plus | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Mortgage Loans | 90% plus | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Commercial Mortgage Loans | 30 to 59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	0	0
Commercial Mortgage Loans | 60 to 89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	0	0
Commercial Mortgage Loans | 90 Days or More
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	0	0
Agricultural Mortgages [Member] | With No Related Allowance Recorded
Impaired Mortgage Loans [Abstract]
Impaired financing receivable, recorded investment	0	0
Impaired financing receivable, unpaid principal balance	0	0
Related allowance	0	0
Impaired financing receivable, average recorded investment	0	0
Impaired financing receivable, interest income recognized	0	0
Agricultural Mortgages [Member] | With Related Allowance Recorded
Impaired Mortgage Loans [Abstract]
Impaired financing receivable, recorded investment	0	0
Impaired financing receivable, unpaid principal balance	0	0
Related allowance	0	0
Impaired financing receivable, average recorded investment	0	0
Impaired financing receivable, interest income recognized	0	0
Agricultural Mortgage Loans
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	2,529	2,501
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	45	17
Financing receivables, recorded investment, current	2,484	2,484
Total financing receivables	2,529	2,501
Financing receivable, recorded investment, 90 days or more past due and accruing	27	6
Agricultural Mortgage Loans | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	388	395
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	388	395
Agricultural Mortgage Loans | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	197	195
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	197	195
Agricultural Mortgage Loans | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	510	507
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	510	507
Agricultural Mortgage Loans | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	842	805
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	842	805
Agricultural Mortgage Loans | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	510	505
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	510	505
Agricultural Mortgage Loans | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	82	94
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	82	94
Agricultural Mortgage Loans | 0% - 50%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	1,545	1,491
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,545	1,491
Agricultural Mortgage Loans | 0% - 50% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	270	254
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	270	254
Agricultural Mortgage Loans | 0% - 50% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	141	138
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	141	138
Agricultural Mortgage Loans | 0% - 50% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	297	296
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	297	296
Agricultural Mortgage Loans | 0% - 50% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	504	468
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	504	468
Agricultural Mortgage Loans | 0% - 50% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	300	286
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	300	286
Agricultural Mortgage Loans | 0% - 50% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	33	49
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	33	49
Agricultural Mortgage Loans | 50% - 70%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	980	1,004
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	980	1,004
Agricultural Mortgage Loans | 50% - 70% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	118	141
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	118	141
Agricultural Mortgage Loans | 50% - 70% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	56	57
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	56	57
Agricultural Mortgage Loans | 50% - 70% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	213	209
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	213	209
Agricultural Mortgage Loans | 50% - 70% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	334	333
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	334	333
Agricultural Mortgage Loans | 50% - 70% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	210	219
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	210	219
Agricultural Mortgage Loans | 50% - 70% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	49	45
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	49	45
Agricultural Mortgage Loans | 70% - 90%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	4	6
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	4	6
Agricultural Mortgage Loans | 70% - 90% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 70% - 90% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 70% - 90% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	2
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	2
Agricultural Mortgage Loans | 70% - 90% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	4	4
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	4	4
Agricultural Mortgage Loans | 70% - 90% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 70% - 90% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 90% plus
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 90% plus | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 90% plus | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 90% plus | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 90% plus | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 90% plus | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 90% plus | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Agricultural Mortgage Loans | 30 to 59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	3	9
Agricultural Mortgage Loans | 60 to 89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	15	2
Agricultural Mortgage Loans | 90 Days or More
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	27	6
Total Mortgages Loan
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	10,613	9,765
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	45	17
Financing receivables, recorded investment, current	10,568	9,748
Total financing receivables	10,613	9,765
Financing receivable, recorded investment, 90 days or more past due and accruing	27	6
Total Mortgages Loan | With No Related Allowance Recorded
Impaired Mortgage Loans [Abstract]
Impaired financing receivable, recorded investment	0	15
Impaired financing receivable, unpaid principal balance	0	15
Related allowance	0	0
Impaired financing receivable, average recorded investment	0	22
Impaired financing receivable, interest income recognized	0	0
Total Mortgages Loan | With Related Allowance Recorded
Impaired Mortgage Loans [Abstract]
Impaired financing receivable, recorded investment	27	27
Impaired financing receivable, unpaid principal balance	27	27
Related allowance	(8)	(8)
Impaired financing receivable, average recorded investment	27	48
Impaired financing receivable, interest income recognized	1	2
Total Mortgages Loan | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	5,393	4,632
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	5,393	4,632
Total Mortgages Loan | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	752	785
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	752	785
Total Mortgages Loan | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	2,094	1,496
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	2,094	1,496
Total Mortgages Loan | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	1,586	2,103
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,586	2,103
Total Mortgages Loan | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	706	609
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	706	609
Total Mortgages Loan | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	82	140
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	82	140
Total Mortgages Loan | 0% - 50%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	2,673	2,439
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	2,673	2,439
Total Mortgages Loan | 0% - 50% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	1,011	992
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,011	992
Total Mortgages Loan | 0% - 50% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	141	233
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	141	233
Total Mortgages Loan | 0% - 50% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	610	355
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	610	355
Total Mortgages Loan | 0% - 50% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	578	524
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	578	524
Total Mortgages Loan | 0% - 50% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	300	286
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	300	286
Total Mortgages Loan | 0% - 50% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	33	49
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	33	49
Total Mortgages Loan | 50% - 70%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	7,239	6,500
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	7,239	6,500
Total Mortgages Loan | 50% - 70% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	4,212	3,358
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	4,212	3,358
Total Mortgages Loan | 50% - 70% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	611	487
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	611	487
Total Mortgages Loan | 50% - 70% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	1,261	882
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	1,261	882
Total Mortgages Loan | 50% - 70% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	750	1,433
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	750	1,433
Total Mortgages Loan | 50% - 70% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	356	295
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	356	295
Total Mortgages Loan | 50% - 70% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	49	45
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	49	45
Total Mortgages Loan | 70% - 90%
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	674	783
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	674	783
Total Mortgages Loan | 70% - 90% | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	170	282
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	170	282
Total Mortgages Loan | 70% - 90% | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	65
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	65
Total Mortgages Loan | 70% - 90% | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	196	231
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	196	231
Total Mortgages Loan | 70% - 90% | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	258	131
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	258	131
Total Mortgages Loan | 70% - 90% | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	50	28
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	50	28
Total Mortgages Loan | 70% - 90% | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	46
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	46
Total Mortgages Loan | 90% plus
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	27	43
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	43
Total Mortgages Loan | 90% plus | Greater than 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan | 90% plus | 1.8x to 2.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan | 90% plus | 1.5x to 1.8x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	27	28
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	27	28
Total Mortgages Loan | 90% plus | 1.2x to 1.5x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	15
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	15
Total Mortgages Loan | 90% plus | 1.0x to 1.2x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan | 90% plus | Less than 1.0x
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total financing receivables	0	0
Total Mortgages Loan | 30 to 59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	3	9
Total Mortgages Loan | 60 to 89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	15	2
Total Mortgages Loan | 90 Days or More
Financing Receivable, Recorded Investment, Aging [Abstract]
Financing receivables, recorded investment, past due	$ 27	$ 6

XML

INVESTMENTS (DERIVATIVES BY CATEGORY) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	$ 57,881
Fair Value Assets Derivatives	14,080
Fair Value Liabilities Derivatives	8,917
Gains (losses) included in net earnings (loss)	1,376
Other Accrued Liabilities, Current	7
Equity Futures
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	3,858		$ 5,086
Fair Value Assets Derivatives	1		1
Fair Value Liabilities Derivatives	1		1
Gains (losses) included in net earnings (loss)	(512)	$ (581)
Equity Swaps
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	4,289		3,529
Fair Value Assets Derivatives	0		13
Fair Value Liabilities Derivatives	162		67
Gains (losses) included in net earnings (loss)	(596)	(193)
Equity Option
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	16,294		11,465
Fair Value Assets Derivatives	2,760		2,114
Fair Value Liabilities Derivatives	1,243		1,154
Gains (losses) included in net earnings (loss)	831	435
Floors
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	0		1,500
Fair Value Assets Derivatives	0		11
Fair Value Liabilities Derivatives	0		0
Gains (losses) included in net earnings (loss)	0	4
Interest Rate Swap
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	19,889		18,933
Fair Value Assets Derivatives	272		246
Fair Value Liabilities Derivatives	243		1,163
Gains (losses) included in net earnings (loss)	523	1,460
Interest rate contracts Futures
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	9,133		6,926
Fair Value Assets Derivatives	0		0
Fair Value Liabilities Derivatives	0		0
Gains (losses) included in net earnings (loss)	28	(23)
Interest Rate Swaption
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount			0
Fair Value Assets Derivatives			0
Fair Value Liabilities Derivatives			0
Gains (losses) included in net earnings (loss)		0
Credit Default Swaps
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	3,156		2,757
Fair Value Assets Derivatives	35		20
Fair Value Liabilities Derivatives	5		15
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0
Gains (losses) included in net earnings (loss)	16	9
Cross currency swaps
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	1,262
Fair Value Assets Derivatives	17
Fair Value Liabilities Derivatives	9
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0
Gains (losses) included in net earnings (loss)	(40)
Margin
Derivatives, Fair Value [Line Items]
Fair Value Assets Derivatives	46		113
Fair Value Liabilities Derivatives	0		6
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0		0
Collateralized Securities
Derivatives, Fair Value [Line Items]
Fair Value Assets Derivatives	16		713
Fair Value Liabilities Derivatives	1,442		748
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0
Currency Contracts
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount			730
Fair Value Assets Derivatives			52
Fair Value Liabilities Derivatives			6
Net Amounts Of Liabilities Presented In Statement Of Financial Position			0
Gains (losses) included in net earnings (loss)		(13)
GMIB Reinsurance
Derivatives, Fair Value [Line Items]
Fair Value Assets Derivatives	10,933		10,309
Gains (losses) included in net earnings (loss)	537	2,576
GMxB derivative features’ liability
Derivatives, Fair Value [Line Items]
Fair Value Liabilities Derivatives	4,375		5,289
Gains (losses) included in net earnings (loss)	1,151	(1,712)
SCS, SIO, MSO and IUL indexed features’ liability
Derivatives, Fair Value [Line Items]
Fair Value Liabilities Derivatives	1,437		$ 875
Gains (losses) included in net earnings (loss)	$ (562)	$ (341)

XML

INVESTMENTS (EQUITY-BASED AND TREASURY FUTURE CONTRACTS) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Investments, Debt and Equity Securities [Abstract]
Cash and securities collateral for derivative contract	$ 1,429	$ 35
Collateralized derivative transactions	14	128
Cash and securities collateral	14	131
Exchange Traded Future Contract [Line Items]
Net amounts presented in the balance sheets		(35)
Securities sold under agreements to repurchase	1,837	1,996
Securities sold under agreement to repurchase
Exchange Traded Future Contract [Line Items]
Securities sold under agreements to repurchase	1,830	$ 1,992
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices
Exchange Traded Future Contract [Line Items]
Exchange-Traded Future Contract, Initial Margin Requirement	124
Us Treasury Notes And Euro Dollar
Exchange Traded Future Contract [Line Items]
Exchange-Traded Future Contract, Initial Margin Requirement	16
Euro Stoxx, FTSE100, EAFE And Topix Indices
Exchange Traded Future Contract [Line Items]
Exchange-Traded Future Contract, Initial Margin Requirement	$ 14

XML

INVESTMENTS (DERIVATIVES OFFSETING FINANCIAL ASSETS) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Offsetting Assets [Line Items]
Net amounts presented in the balance sheets		$ (35)
Fair Value Assets Derivatives	$ 14,080
Equity Contract
Offsetting Assets [Line Items]
Gross amounts recognized	2,761	2,129
Gross amounts offset in the balance sheets	1,406	1,220
Net amounts presented in the balance sheets	1,355	909
Reverse Repurchase agreements [Abstract]
Gross amount recognized	1,406	1,220
Gross amounts offset in the balance sheets	1,406	1,220
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0	0
Interest Rate Contract
Offsetting Assets [Line Items]
Gross amounts recognized	272	253
Gross amounts offset in the balance sheets	243	1,163
Net amounts presented in the balance sheets	29	(910)
Reverse Repurchase agreements [Abstract]
Gross amount recognized	243	1,163
Gross amounts offset in the balance sheets	243	1,163
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0	0
Credit Risk Contract
Reverse Repurchase agreements [Abstract]
Gross amount recognized		15
Gross amounts offset in the balance sheets		15
Net Amounts Of Liabilities Presented In Statement Of Financial Position		0
Credit Default Swaps
Offsetting Assets [Line Items]
Gross amounts recognized	35	20
Gross amounts offset in the balance sheets	5	15
Net amounts presented in the balance sheets	30	5
Fair Value Assets Derivatives	35	20
Reverse Repurchase agreements [Abstract]
Gross amount recognized	5
Gross amounts offset in the balance sheets	5
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0
Currency Swap
Offsetting Assets [Line Items]
Gross amounts recognized	17
Gross amounts offset in the balance sheets	9
Net amounts presented in the balance sheets	8
Fair Value Assets Derivatives	17
Reverse Repurchase agreements [Abstract]
Gross amount recognized	9
Gross amounts offset in the balance sheets	9
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0
Derivatives Subject to an ISDA Master Agreements
Offsetting Assets [Line Items]
Gross amounts recognized	3,147	3,280
Gross amounts offset in the balance sheets	3,105	3,158
Net amounts presented in the balance sheets	42	122
Reverse Repurchase agreements [Abstract]
Gross amount recognized	3,105	3,158
Gross amounts offset in the balance sheets	3,105	3,158
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0	0
Derivatives not subject to an ISDA Master Agreements
Offsetting Assets [Line Items]
Gross amounts recognized	0	4
Gross amounts offset in the balance sheets	0	0
Net amounts presented in the balance sheets	0	4
Reverse Repurchase agreements [Abstract]
Gross amount recognized	0	0
Gross amounts offset in the balance sheets	0	0
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0	0
Total Derivatives
Offsetting Assets [Line Items]
Gross amounts recognized	3,147	3,284
Gross amounts offset in the balance sheets	3,105	3,158
Net amounts presented in the balance sheets	42	126
Reverse Repurchase agreements [Abstract]
Gross amount recognized	3,105	3,158
Gross amounts offset in the balance sheets	3,105	3,158
Net Amounts Of Liabilities Presented In Statement Of Financial Position	0	0
Other Financial Instruments
Offsetting Assets [Line Items]
Gross amounts recognized	2,473	2,100
Gross amounts offset in the balance sheets	0	0
Net amounts presented in the balance sheets	2,473	2,100
Other Invested Assets
Offsetting Assets [Line Items]
Gross amounts recognized	5,620	5,384
Gross amounts offset in the balance sheets	3,105	3,158
Net amounts presented in the balance sheets	2,515	2,226
Securities purchased under agreement to resell
Reverse Repurchase agreements [Abstract]
Securities purchased under agreement to resell, gross amount recognized	0	0
Securities purchased under agreement to resell, gross amount offset in the Balance Sheets	0	0
Securities purchased under agreements to resell, net amount presented in the Balance Sheet,	0	0
Other Financial Liabilities
Reverse Repurchase agreements [Abstract]
Gross amount recognized	2,869	2,108
Gross amounts offset in the balance sheets	0	0
Net Amounts Of Liabilities Presented In Statement Of Financial Position	2,869	2,108
Initial Margin
Offsetting Assets [Line Items]
Fair Value Assets Derivatives		4
Margin
Offsetting Assets [Line Items]
Gross amounts recognized	46	113
Gross amounts offset in the balance sheets	0	6
Net amounts presented in the balance sheets	46	107
Fair Value Assets Derivatives	46	113
Reverse Repurchase agreements [Abstract]
Gross amount recognized	0	6
Gross amounts offset in the balance sheets	0	6
Net Amounts Of Liabilities Presented In Statement Of Financial Position	$ 0	0
Collateral Contracts
Offsetting Assets [Line Items]
Gross amounts recognized		713
Gross amounts offset in the balance sheets		748
Reverse Repurchase agreements [Abstract]
Gross amount recognized		748
Gross amounts offset in the balance sheets		748
Net Amounts Of Liabilities Presented In Statement Of Financial Position		$ 0

XML

INVESTMENTS (DERIVATIVES OFFSETING FINANCIAL LIABILITES ) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Offsetting Liabilities [Line Items]
Net amounts presented in the balance sheets		$ (35)
Fair Value Liabilities Derivatives	$ 8,917
Expense accrual	7
Repurchase agreements [Abstract]
Repurchase agreements, net amount presented on the Balance Sheet	1,837	1,996
Equity Contract
Offsetting Liabilities [Line Items]
Gross amounts recognized	2,761	2,129
Gross amounts offset in the balance sheets	1,406	1,220
Net amounts presented in the balance sheets	1,355	909
Gross amount recognized	1,406	1,220
Gross amounts offset in the balance sheets	1,406	1,220
Net amounts presented in the balance sheets	0	0
Interest Rate Contract
Offsetting Liabilities [Line Items]
Gross amounts recognized	272	253
Gross amounts offset in the balance sheets	243	1,163
Net amounts presented in the balance sheets	29	(910)
Gross amount recognized	243	1,163
Gross amounts offset in the balance sheets	243	1,163
Net amounts presented in the balance sheets	0	0
Credit Risk Contract
Offsetting Liabilities [Line Items]
Gross amount recognized		15
Gross amounts offset in the balance sheets		15
Net amounts presented in the balance sheets		0
Credit Default Swaps
Offsetting Liabilities [Line Items]
Gross amounts recognized	35	20
Gross amounts offset in the balance sheets	5	15
Net amounts presented in the balance sheets	30	5
Gross amount recognized	5
Gross amounts offset in the balance sheets	5
Net amounts presented in the balance sheets	0
Fair Value Liabilities Derivatives	5	15
Currency Contracts
Offsetting Liabilities [Line Items]
Gross amounts recognized		52
Gross amounts offset in the balance sheets		6
Net amounts presented in the balance sheets		46
Gross amount recognized		6
Gross amounts offset in the balance sheets		6
Net amounts presented in the balance sheets		0
Fair Value Liabilities Derivatives		6
Margin
Offsetting Liabilities [Line Items]
Gross amounts recognized	46	113
Gross amounts offset in the balance sheets	0	6
Net amounts presented in the balance sheets	46	107
Gross amount recognized	0	6
Gross amounts offset in the balance sheets	0	6
Net amounts presented in the balance sheets	0	0
Fair Value Liabilities Derivatives	0	6
Collateral Contracts
Offsetting Liabilities [Line Items]
Gross amounts recognized		713
Gross amounts offset in the balance sheets		748
Gross amount recognized		748
Gross amounts offset in the balance sheets		748
Net amounts presented in the balance sheets		0
Currency Swap
Offsetting Liabilities [Line Items]
Gross amounts recognized	17
Gross amounts offset in the balance sheets	9
Net amounts presented in the balance sheets	8
Gross amount recognized	9
Gross amounts offset in the balance sheets	9
Net amounts presented in the balance sheets	0
Fair Value Liabilities Derivatives	9
Collateralized Securities
Offsetting Liabilities [Line Items]
Gross amounts recognized	16
Gross amounts offset in the balance sheets	1,442
Net amounts presented in the balance sheets	(1,426)
Gross amount recognized	1,442
Gross amounts offset in the balance sheets	1,442
Net amounts presented in the balance sheets	0
Fair Value Liabilities Derivatives	1,442	748
Derivatives Subject to an ISDA Master Agreements
Offsetting Liabilities [Line Items]
Gross amounts recognized	3,147	3,280
Gross amounts offset in the balance sheets	3,105	3,158
Net amounts presented in the balance sheets	42	122
Gross amount recognized	3,105	3,158
Gross amounts offset in the balance sheets	3,105	3,158
Net amounts presented in the balance sheets	0	0
Derivatives not subject to an ISDA Master Agreements
Offsetting Liabilities [Line Items]
Gross amounts recognized	0	4
Gross amounts offset in the balance sheets	0	0
Net amounts presented in the balance sheets	0	4
Gross amount recognized	0	0
Gross amounts offset in the balance sheets	0	0
Net amounts presented in the balance sheets	0	0
Total Derivatives
Offsetting Liabilities [Line Items]
Gross amounts recognized	3,147	3,284
Gross amounts offset in the balance sheets	3,105	3,158
Net amounts presented in the balance sheets	42	126
Gross amount recognized	3,105	3,158
Gross amounts offset in the balance sheets	3,105	3,158
Net amounts presented in the balance sheets	0	0
Other Financial Liabilities
Offsetting Liabilities [Line Items]
Gross amount recognized	2,869	2,108
Gross amounts offset in the balance sheets	0	0
Net amounts presented in the balance sheets	2,869	2,108
Other Liabilities
Offsetting Liabilities [Line Items]
Gross amount recognized	5,974	5,266
Gross amounts offset in the balance sheets	3,105	3,158
Net amounts presented in the balance sheets	2,869	2,108
Securities sold under agreement to repurchase
Repurchase agreements [Abstract]
Securities sold under agreements to repurchase, gross amount recognized	1,830	1,992
Securities sold under agreement to repurchase, gross amount offset in the Balance Sheets	0	0
Repurchase agreements, net amount presented on the Balance Sheet	1,830	1,992
Securities sold under agreement to repurchase
Repurchase agreements [Abstract]
Repurchase agreements, net amount presented on the Balance Sheet		1,992
Other Financial Instruments
Offsetting Liabilities [Line Items]
Net amounts presented in the balance sheets	2,473	2,067
Derivative, Collateral, Obligation to Return Cash	0	0
Other
Offsetting Liabilities [Line Items]
Net amounts presented in the balance sheets	3,896	2,121
Derivative, Collateral, Obligation to Return Cash	$ (1,381)	$ 71

XML

INVESTMENTS (DERIVATIVES GROSS COLLATERAL AMOUNTS ASSETS) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Offsetting Assets [Line Items]
Repurchase agreements, net amount presented on the Balance Sheet	$ 1,837	$ 1,996
Net amounts presented in the balance sheets		(35)
Derivative Asset, Fair Value, Amount Not Offset Against Collateral	14,080
Securities sold under agreement to repurchase
Offsetting Assets [Line Items]
Repurchase agreements, net amount presented on the Balance Sheet		1,992
Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Securities		(1,986)
Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Cash		(2)
Securities Sold under Agreements to Repurchase, Amount Offset Against Collateral	(64)	4
Reverse repurchase agreements [Abstract]
Securities purchased under agreements to resell, net amount presented in the Balance Sheet,		0
Reverse repurchase agreements, collateral securities received		0
Reverse repurchase agreements, collateral cash received		0
Reverse repurchase agreements, net amounts		0
Other
Offsetting Assets [Line Items]
Net amounts presented in the balance sheets	3,896	2,121
Calleteral Securities (Received)	0	0
Callateral Cash (Received)	(1,381)	71
Derivative Asset, Fair Value, Amount Offset Against Collateral	2,515	2,192
Derivative
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Amount Offset Against Collateral	42	125
Other Financial Instruments
Offsetting Assets [Line Items]
Net amounts presented in the balance sheets	2,473	2,067
Calleteral Securities (Received)	0	0
Callateral Cash (Received)	0	0
Derivative Asset, Fair Value, Amount Offset Against Collateral	2,473	$ 2,067
Securities purchased under agreement to resell
Reverse repurchase agreements [Abstract]
Securities purchased under agreements to resell, net amount presented in the Balance Sheet,	0
Reverse repurchase agreements, collateral securities received	0
Reverse repurchase agreements, collateral cash received	0
Reverse repurchase agreements, net amounts	$ 0

XML

INVESTMENTS (DERIVATIVES GROSS COLLATERAL AMOUNTS LIABILITES) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Offsetting Liabilities [Line Items]
Repurchase agreements, net amount presented on the balance sheet	$ 1,837	$ 1,996
Securities sold under agreement to repurchase
Offsetting Liabilities [Line Items]
Repurchase agreements, net amount presented on the balance sheet		1,992
Repurchase agreements, collateral securities held		(1,986)
Repurchase agreements, collateral cash held		(2)
Securities Sold under Agreements to Repurchase, Amount Offset Against Collateral	$ (64)	$ 4

XML

INVESTMENTS (REPURCHASE AGREEMENTS ACCCOUNTED FOR AS BORROWINGS) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	$ 1,830	$ 1,992
Reverse repurchase agreements	0
Net amounts presented in the balance sheets		(35)
Maturity Overnight
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	0	0
Reverse repurchase agreements	0
Maturity up to 30 days
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	1,830	1,992
Reverse repurchase agreements	0
Maturity 30 to 90 Days
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	0	0
Reverse repurchase agreements	0
Maturity over 90 days
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	0	0
Reverse repurchase agreements	0
U.S. Treasury, government and agency
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	1,830	1,992
U.S. Treasury, government and agency | Maturity Overnight
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	0	0
U.S. Treasury, government and agency | Maturity up to 30 days
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	1,830	1,992
U.S. Treasury, government and agency | Maturity 30 to 90 Days
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	0	0
U.S. Treasury, government and agency | Maturity over 90 days
Repurchase agreements accounted for as secured borrowings [Line Items]
Repurchase agreements	0	0
Public corporate
Repurchase agreements accounted for as secured borrowings [Line Items]
Reverse repurchase agreements	0
Public corporate | Maturity Overnight
Repurchase agreements accounted for as secured borrowings [Line Items]
Reverse repurchase agreements	0
Public corporate | Maturity up to 30 days
Repurchase agreements accounted for as secured borrowings [Line Items]
Reverse repurchase agreements	0
Public corporate | Maturity 30 to 90 Days
Repurchase agreements accounted for as secured borrowings [Line Items]
Reverse repurchase agreements	0
Public corporate | Maturity over 90 days
Repurchase agreements accounted for as secured borrowings [Line Items]
Reverse repurchase agreements	$ 0
Investment Management
Repurchase agreements accounted for as secured borrowings [Line Items]
Securities Loaned		$ 0

XML

CLOSED BLOCK (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015
CLOSED BLOCK LIABILITIES:
Future policy benefits, policyholders’ account balances and other	$ 7,016	$ 7,179
Policyholder dividend obligation	43	52	$ 216	$ 81
Other liabilities	301	43
Total Closed Block liabilities	7,360	7,274
ASSETS DESIGNATED TO THE CLOSED BLOCK:
Fixed maturities, available for sale, at fair value (amortized cost of $3,951 and $3,884)	4,126	4,025
Mortgage loans on real estate	1,804	1,623
Policy loans	795	839
Cash and other invested assets	316	444
Other assets	173	181
Total assets designated to the Closed Block	7,214	7,112
Excess of Closed Block liabilities over assets designated to the Closed Block	146	162
Closed Block Assets and Liabilities, Effect on Other Comprehensive Income (Loss) [Abstract]
Net unrealized investment gains (losses), net of policyholder dividend obligation of $(43) and $(52)	142	100
Maximum Future Earnings To Be Recognized From Closed Block Assets and Liabilities	$ 288	$ 262

XML

CLOSED BLOCK (REVENUES AND EXPENSES) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015
REVENUES:
Premiums and other income	$ 52	$ 55	$ 167	$ 177
Net investment income (loss)	82	96	244	270
Net investment gains (losses)	(2)	0	(18)	1
Total revenues	132	151	393	448
BENEFITS AND OTHER DEDUCTIONS:
Policyholders’ benefits and dividends	132	131	416	404
Other operating costs and expenses	1	1	2	3
Total benefits and other deductions	133	132	418	407
Net revenues (loss) before income taxes	(1)	19	(25)	41
Income tax (expense) benefit	1	(7)	9	(15)
Net Revenues (Losses)	0	12	(16)	26
Closed Block Investments, Fixed Maturity, Available-for-sale, Amortized Cost	3,951		3,951		$ 3,884
Closed Block Liabilities Policyholder Dividend Obligation	$ (43)	$ (216)	$ (43)	$ (216)	$ (52)	$ (81)

XML

CLOSED BLOCK (RECONCILIATION OF POLICYHOLDER DIVIDEND OBLIGATION) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Movement in Closed Block Dividend Obligation [Roll Forward]
Balances, beginning of year	$ 52	$ 81
Unrealized investment gains (losses), net of DAC	(9)	135
Balances, end of year	$ 43	$ 216

XML

INSURANCE LIABILITIES (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Movement In Guaranteed Benefit Liability Gross [Line Items]
Balance, beginning of period	$ 7,037	$ 6,880
Paid guarantee benefits	(374)	(529)
Other changes in reserve	1,930	1,381
Balance, end of period	8,593	7,732
Guaranteed Minimum Death Benefit
Movement In Guaranteed Benefit Liability Gross [Line Items]
Balance, beginning of period	3,165	2,991
Paid guarantee benefits	(272)	(280)
Other changes in reserve	1,083	478
Balance, end of period	3,976	3,189
Guaranteed Minimum Income Benefit
Movement In Guaranteed Benefit Liability Gross [Line Items]
Balance, beginning of period	3,872	3,889
Paid guarantee benefits	(102)	(249)
Other changes in reserve	847	903
Balance, end of period	$ 4,617	$ 4,543

XML

INSURANCE LIABILITIES 1 (Details) - Guaranteed Minimum Death Benefit - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Guaranteed Minimum Death Benefit Reinsurance Ceded [Abstract]
Balance, beginning of year	$ 1,558	$ 1,430
Paid guarantee benefits	(132)	(137)
Other changes in reserve	555	253
Balance, End of Period	$ 1,981	$ 1,546

XML

INSURANCE LIABILITIES 2 (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2017	Dec. 31, 2016
Guaranteed Minimum Death Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 14,246	$ 14,246
Account Value Invested In Separate Accounts	92,403	92,403	$ 86,890
Net amount at risk, gross	18,078	18,078
Net amount at risk, net of amounts reinsured	$ 8,183	$ 8,183
Average attained age of contractholders (in years)	55 years 3 months 18 days
Percentage of contractholders over age 70		18.00%
Guaranteed Minimum Death Benefit | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		3.00%
Guaranteed Minimum Death Benefit | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		6.50%
Guaranteed Minimum Death Benefit | Return of Premium
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 13,860	$ 13,860
Account Value Invested In Separate Accounts	44,277	44,277
Net amount at risk, gross	180	180
Net amount at risk, net of amounts reinsured	$ 180	$ 180
Average attained age of contractholders (in years)	51 years 4 months 24 days
Percentage of contractholders over age 70		9.60%
Guaranteed Minimum Death Benefit | Ratchet
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 112	$ 112
Account Value Invested In Separate Accounts	9,375	9,375
Net amount at risk, gross	64	64
Net amount at risk, net of amounts reinsured	$ 44	$ 44
Average attained age of contractholders (in years)	66 years 2 months 12 days
Percentage of contractholders over age 70		39.40%
Guaranteed Minimum Death Benefit | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 67	$ 67
Account Value Invested In Separate Accounts	3,479	3,479
Net amount at risk, gross	2,059	2,059
Net amount at risk, net of amounts reinsured	$ 1,403	$ 1,403
Average attained age of contractholders (in years)	72 years 9 months 18 days
Percentage of contractholders over age 70		62.40%
Guaranteed Minimum Death Benefit | Roll-Up | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		3.00%
Guaranteed Minimum Death Benefit | Roll-Up | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		6.00%
Guaranteed Minimum Death Benefit | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 207	$ 207
Account Value Invested In Separate Accounts	35,272	35,272
Net amount at risk, gross	15,775	15,775
Net amount at risk, net of amounts reinsured	$ 6,556	$ 6,556
Average attained age of contractholders (in years)	68 years 1 month 6 days
Percentage of contractholders over age 70		45.60%
Guaranteed Minimum Death Benefit | Roll-Up | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		3.00%
Guaranteed Minimum Death Benefit | Roll-Up | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		6.50%
Guaranteed Minimum Income Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 327	$ 327
Account Value Invested In Separate Accounts	61,069	61,069	$ 57,848
Net amount at risk, gross	7,637	7,637
Net amount at risk, net of amounts reinsured	$ 1,946	$ 1,946
Weighted average years remaining until annuitization	1 year
Guaranteed Minimum Income Benefit | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		3.00%
Guaranteed Minimum Income Benefit | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		6.50%
Guaranteed Minimum Income Benefit | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 24	$ 24
Account Value Invested In Separate Accounts	20,382	20,382
Net amount at risk, gross	982	982
Net amount at risk, net of amounts reinsured	$ 297	$ 297
Weighted average years remaining until annuitization	1 year 8 months 12 days
Guaranteed Minimum Income Benefit | Roll-Up | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		3.00%
Guaranteed Minimum Income Benefit | Roll-Up | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		6.00%
Guaranteed Minimum Income Benefit | Roll-Up
Net Amount at Risk by Product and Guarantee [Line Items]
Account Value Invested In General Account	$ 303	$ 303
Account Value Invested In Separate Accounts	40,687	40,687
Net amount at risk, gross	6,655	6,655
Net amount at risk, net of amounts reinsured	$ 1,649	$ 1,649
Weighted average years remaining until annuitization	10 months 24 days
Guaranteed Minimum Income Benefit | Roll-Up | Minimum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		3.00%
Guaranteed Minimum Income Benefit | Roll-Up | Maximum
Net Amount at Risk by Product and Guarantee [Line Items]
Range of contractually specified interest rates (as a percent)		6.50%
Non Affiliated Entity [Member] | Guaranteed Minimum Death Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Exposure Reinsured Percentage, Quota Share of Liabilities for Variable Annuities	3.70%	3.70%
Non Affiliated Entity [Member] | Guaranteed Minimum Income Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Exposure Reinsured Percentage, Quota Share of Liabilities for Variable Annuities	17.20%	17.20%
Affiliates | Guaranteed Minimum Death Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Exposure Reinsured Percentage, Quota Share of Liabilities for Variable Annuities	51.10%	51.10%
Affiliates | Guaranteed Minimum Income Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Exposure Reinsured Percentage, Quota Share of Liabilities for Variable Annuities	57.30%	57.30%

XML

INSURANCE LIABILITIES 3 (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Guaranteed Minimum Death Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	$ 92,403	$ 86,890
Price Risk Fair Value Hedge Derivative On Balance Sheet [Abstract]
Account value hedged of variable annuity contracts	54,712
Net amount at risk hedged of variable annuity contracts	7,195
Guaranteed Minimum Income Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	61,069	57,848
Price Risk Fair Value Hedge Derivative On Balance Sheet [Abstract]
Account value hedged of variable annuity contracts	41,146
Net amount at risk hedged of variable annuity contracts	2,866
Equity | Guaranteed Minimum Death Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	75,751	69,625
Equity | Guaranteed Minimum Income Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	49,177	45,931
Fixed income | Guaranteed Minimum Death Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	2,288	2,483
Fixed income | Guaranteed Minimum Income Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	1,602	1,671
Balanced | Guaranteed Minimum Death Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	14,056	14,434
Balanced | Guaranteed Minimum Income Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	10,148	10,097
Other | Guaranteed Minimum Death Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	308	348
Other | Guaranteed Minimum Income Benefit
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate Account Investments by Investment Category	$ 142	$ 149

XML

INSURANCE LIABILITIES 4 (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Direct Liability, Gross [Roll Forward]
Balance, beginning of period	$ 7,037	$ 6,880
Balance, end of period	8,593	7,732
Direct Liability
Direct Liability, Gross [Roll Forward]
Balance, beginning of period	1,208	1,155
Other changes in reserves	216	(29)
Balance, end of period	1,424	1,126
Reinsurance Ceded
Reinsurance Ceded [Roll Forward]
Balance, beginning of period	(619)	(519)
Other changes in reserves	(70)	(82)
Balance, end of period	(689)	(601)
Net
Direct Liability, Net [Roll Forward]
Balance, beginning of period	589	636
Other changes in reserves	146	(111)
Balance, end of period	$ 735	$ 525

XML

INSURANCE LIABILITIES INSURANCE LIABILITIES 5 (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Guaranteed minimum income benefit reinsurance contract asset, at fair value	$ 10,933	$ 10,309
Derivative Instruments in Hedges, Liabilities, at Fair Value	5,813	6,164
GMIBNLG
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Derivative Instruments in Hedges, Liabilities, at Fair Value	4,289	5,125
GMAB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Derivative Instruments in Hedges, Liabilities, at Fair Value	8	20
GWBL/GMWB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Derivative Instruments in Hedges, Liabilities, at Fair Value	85	114
SCS,MSO, IUL features
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Derivative Instruments in Hedges, Liabilities, at Fair Value	1,437	875
GIB
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Derivative Instruments in Hedges, Liabilities, at Fair Value	$ (6)	$ 30

XML

FAIR VALUE DISCLOSURES (FAIR VALUE MEASUREMENTS) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	$ 33,435	$ 32,683
Trading securities	12,053	9,134
Fair Value, Measurements, Recurring
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	33,300	32,570
Other equity investments	5	8
Trading securities	12,053	9,134
Other invested assets	2,994	1,178
Cash equivalents	3,271	1,529
Segregated securities	789	946
GMIB reinsurance contract asset	10,933	10,309
Separate Accounts’ assets	119,065	111,216
Total Assets	182,410	166,890
Liabilities, Fair Value Disclosure [Abstract]
Contingent payment arrangements	12	18
Total Liabilities	6,411	6,432
Fair Value, Measurements, Recurring | Corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	13,139	13,012
Fair Value, Measurements, Recurring | Private corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	7,290	7,040
Fair Value, Measurements, Recurring | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	10,936	10,336
Fair Value, Measurements, Recurring | State and Political Sub- divisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	481	493
Fair Value, Measurements, Recurring | Foreign Govts
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	393	390
Fair Value, Measurements, Recurring | Commercial Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	262	371
Fair Value, Measurements, Recurring | Residential Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	265	314
Fair Value, Measurements, Recurring | Asset- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	30	60
Fair Value, Measurements, Recurring | Redeemable Preferred Stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	504	554
Fair Value, Measurements, Recurring | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	770	574
Fair Value, Measurements, Recurring | Assets of Consolidated VIEs/VOEs [Member]
Investment Fair Value Disclosure [Abstract]
Other invested assets	802	553
Fair Value, Measurements, Recurring | Swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	(125)	(925)
Fair Value, Measurements, Recurring | Credit Default Swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	30	5
Fair Value, Measurements, Recurring | Options
Investment Fair Value Disclosure [Abstract]
Other invested assets	1,517	960
Fair Value, Measurements, Recurring | Floors
Investment Fair Value Disclosure [Abstract]
Other invested assets		11
Fair Value, Measurements, Recurring | GMxB derivative features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees, Fair Value Disclosure	4,375	5,289
Fair Value, Measurements, Recurring | SCS, SIO, MSO and IUL indexed features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees, Fair Value Disclosure	1,437	875
Fair Value, Measurements, Recurring | Level 1
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	180	218
Other equity investments	4	3
Trading securities	481	478
Other invested assets	670	342
Cash equivalents	3,271	1,529
Segregated securities	0
Separate Accounts’ assets	115,810	108,085
Total Assets	120,416	110,655
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	584	248
Fair Value, Measurements, Recurring | Level 1 | Corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0
Fair Value, Measurements, Recurring | Level 1 | Redeemable Preferred Stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	180	218
Fair Value, Measurements, Recurring | Level 1 | Assets of Consolidated VIEs/VOEs [Member]
Investment Fair Value Disclosure [Abstract]
Other invested assets	670	342
Fair Value, Measurements, Recurring | Level 2
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	31,676	31,091
Other equity investments	0	0
Trading securities	11,572	8,656
Other invested assets	2,322	830
Cash equivalents	0
Segregated securities	789	946
Separate Accounts’ assets	2,918	2,818
Total Assets	49,277	44,341
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	1,440	877
Fair Value, Measurements, Recurring | Level 2 | Corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	13,052	12,984
Fair Value, Measurements, Recurring | Level 2 | Private corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	6,231	6,223
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	10,936	10,336
Fair Value, Measurements, Recurring | Level 2 | State and Political Sub- divisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	440	451
Fair Value, Measurements, Recurring | Level 2 | Foreign Govts
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	393	390
Fair Value, Measurements, Recurring | Level 2 | Commercial Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	14	22
Fair Value, Measurements, Recurring | Level 2 | Residential Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	265	314
Fair Value, Measurements, Recurring | Level 2 | Asset- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	22	36
Fair Value, Measurements, Recurring | Level 2 | Redeemable Preferred Stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	323	335
Fair Value, Measurements, Recurring | Level 2 | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	770	574
Fair Value, Measurements, Recurring | Level 2 | Assets of Consolidated VIEs/VOEs [Member]
Investment Fair Value Disclosure [Abstract]
Other invested assets	130	205
Fair Value, Measurements, Recurring | Level 2 | Swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	(125)	(925)
Fair Value, Measurements, Recurring | Level 2 | Credit Default Swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	30	5
Fair Value, Measurements, Recurring | Level 2 | Options
Investment Fair Value Disclosure [Abstract]
Other invested assets	1,517	960
Fair Value, Measurements, Recurring | Level 2 | Floors
Investment Fair Value Disclosure [Abstract]
Other invested assets		11
Fair Value, Measurements, Recurring | Level 2 | GMxB derivative features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees, Fair Value Disclosure	0
Fair Value, Measurements, Recurring | Level 2 | SCS, SIO, MSO and IUL indexed features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees, Fair Value Disclosure	1,437	875
Fair Value, Measurements, Recurring | Level 3
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	1,444	1,261
Other equity investments	1	5
Trading securities	0
Other invested assets	2	6
GMIB reinsurance contract asset	10,933	10,309
Separate Accounts’ assets	337	313
Total Assets	12,717	11,894
Liabilities, Fair Value Disclosure [Abstract]
Contingent payment arrangements	12	18
Total Liabilities	4,387	5,307
Fair Value, Measurements, Recurring | Level 3 | Corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	87	28
Fair Value, Measurements, Recurring | Level 3 | Private corporate
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	1,059	817
Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0
Fair Value, Measurements, Recurring | Level 3 | State and Political Sub- divisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	41	42
Fair Value, Measurements, Recurring | Level 3 | Foreign Govts
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 3 | Commercial Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	248	349
Fair Value, Measurements, Recurring | Level 3 | Residential Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 3 | Asset- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	8	24
Fair Value, Measurements, Recurring | Level 3 | Redeemable Preferred Stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	1	1
Fair Value, Measurements, Recurring | Level 3 | Assets of Consolidated VIEs/VOEs [Member]
Investment Fair Value Disclosure [Abstract]
Other invested assets	2	6
Fair Value, Measurements, Recurring | Level 3 | GMxB derivative features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Guarantees, Fair Value Disclosure	4,375	5,289
Variable Interest Entity, Primary Beneficiary | Fair Value, Measurements, Recurring
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability	587	250
Variable Interest Entity, Primary Beneficiary | Fair Value, Measurements, Recurring | Level 1
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability	584	248
Variable Interest Entity, Primary Beneficiary | Fair Value, Measurements, Recurring | Level 2
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability	$ 3	$ 2

XML

FAIR VALUE DISCLOSURES (TEXTUAL) (Details) - USD ($) $ in Millions	9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fixed maturities, available-for-sale	$ 33,435		$ 32,683
Fair value freestanding contract	$ 1,422		$ 51
Freestanding contract invested assets (as a percent)	47.50%		8.20%
Fair value adjustments on GMIB asset	$ 97		$ 139
Transfers out of Level 3	(7)	$ (50)
Transfers into level 3	$ 6	$ 29
Transfers out of Levels 2 and 3 to Total Equity (as a percent)	0.10%	0.50%
Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Assets measured at fair value on recurring basis (as a percent)	70.50%		71.10%
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Assets measured at fair value on recurring basis (as a percent)	28.40%		27.90%
Mortgages and asset-backed securities owned	$ 282		$ 340
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Assets measured at fair value on recurring basis (as a percent)	1.10%		1.00%
Mortgages and asset-backed securities owned	$ 256		$ 373
Fair value disclosures broker priced	100		111
Public Fixed Maturities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fixed maturities, available-for-sale	$ 25,492		$ 24,918
Available-for-sale fixed maturity assets measured at fair value on recurring basis (as a percent)	14.90%		16.00%
Private Fixed Maturities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fixed maturities, available-for-sale	$ 7,808		$ 7,652
Available-for-sale fixed maturity assets measured at fair value on recurring basis (as a percent)	4.60%		4.90%

XML

FAIR VALUE DISCLOSURES (LEVEL 3 UNOBSERVABLE INPUT RECONCILIATION) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Total Gains Losses Realized Unrealized Included In [Abstract]
Transfers into level 3			$ 6	$ 29
Transfers out of Level 3			(7)	(50)
Corporate | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	$ 1,068	$ 495	845	420
Total Gains Losses Realized Unrealized Included In [Abstract]
Net investment income (loss)	2	0	6	(1)
Investment Gains (Losses), Net	0	1	0	1
Subtotal	2	1	6	0
Other comprehensive income (loss)	6	(2)	0	8
Purchases	196	256	518	399
Sales	(119)	(21)	(224)	(89)
Transfers into level 3	0	11	6	29
Transfers out of Level 3	(7)	(1)	(5)	(28)
Closing Balance	1,146	739	1,146	739
State and Political Sub- divisions | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	42	45	42	45
Total Gains Losses Realized Unrealized Included In [Abstract]
Subtotal	0	0
Other comprehensive income (loss)	0	0	0	0
Sales	(1)	(1)	(1)	(1)
Closing Balance	41	44	41	44
Foreign Govts | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	0	0	0	1
Total Gains Losses Realized Unrealized Included In [Abstract]
Subtotal	0	0
Other comprehensive income (loss)			0	0
Transfers into level 3		0
Transfers out of Level 3	0	0	0	1
Closing Balance	0	0	0	0
Commercial Mortgage- backed | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	290	402	349	503
Total Gains Losses Realized Unrealized Included In [Abstract]
Net investment income (loss)	0	1	1	1
Investment Gains (Losses), Net	(9)	(12)	(29)	(36)
Subtotal	(9)	(11)	(28)	(35)
Other comprehensive income (loss)	8	10	27	(1)
Purchases	0	0	0
Sales	(40)	(21)	(99)	(81)
Transfers out of Level 3	(1)	(6)	(1)	(12)
Closing Balance	248	374	248	374
Asset- backed | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	12	26	24	40
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment Gains (Losses), Net	0		15
Subtotal	0	0	15
Other comprehensive income (loss)	(3)	(1)	(10)	1
Sales	(1)	0	(20)	(7)
Transfers into level 3			0
Transfers out of Level 3	0	0	(1)	9
Closing Balance	8	25	8	25
Redeemable Preferred Stock | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	1	0	1	0
Total Gains Losses Realized Unrealized Included In [Abstract]
Subtotal	0	0
Other comprehensive income (loss)				0
Purchases			0	0
Closing Balance	1	0	1	0
Other Equity Investments | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	8	18	11	17
Total Gains Losses Realized Unrealized Included In [Abstract]
Net investment income (loss)			0	0
Investment Gains (Losses), Net	(4)	0	(4)	(1)
Subtotal	(4)	0	(4)	(1)
Other comprehensive income (loss)		0	0	0
Purchases	0		5	0
Sales			(3)	0
Activity related to consolidated VIEs	0	15	(7)	17
Transfers into level 3	0		1	0
Transfers out of Level 3	0	(24)	0	(24)
Closing Balance	3	9	3	9
GMIB Reinsurance Asset | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	11,290	13,311	10,309	10,578
Total Gains Losses Realized Unrealized Included In [Abstract]
Increase (Decrease) in the Fair Value of the Reinsurance Contract Asset		(79)	537	2,576
Subtotal	(368)	(79)	537	2,576
Purchases	55	57	166	166
Sales	(44)	(176)	(79)	(207)
Closing Balance	10,933	13,113	10,933	13,113
Separate Accounts Assets | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	333	307	313	313
Total Gains Losses Realized Unrealized Included In [Abstract]
Net investment income (loss)		0	0	0
Investment Gains (Losses), Net	4	7	22	19
Subtotal	4	7	22	19
Other comprehensive income (loss)			0	0
Purchases	1	3	7	12
Sales	0	0	(2)	0
Settlements	(1)	(1)	(4)	(6)
Transfers into level 3	0	0	1	1
Transfers out of Level 3	0	(1)	0	(24)
Closing Balance	337	315	337	315
GMxB derivative features liability | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	(4,606)	(7,286)	(5,289)	(5,150)
Total Gains Losses Realized Unrealized Included In [Abstract]
Subtotal	208	187	1,151	(1,712)
Purchases	23	1	(237)	(236)
Closing Balance	(4,375)	(7,098)	(4,375)	(7,098)
Contingent Payment Arrangement | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening Balance	17	31	18	31
Total Gains Losses Realized Unrealized Included In [Abstract]
Net investment income (loss)	0	0	0	0
Subtotal	0	0	0	0
Purchases		11	0	11
Settlements	(5)	(24)	(6)	(24)
Closing Balance	12	18	12	18
Assets and Liabilities Still Held | Corporate | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Other comprehensive income (loss)	4			9
Assets and Liabilities Still Held | State and Political Sub- divisions | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Other comprehensive income (loss)				1
Assets and Liabilities Still Held | Commercial Mortgage- backed | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Other comprehensive income (loss)	9	10	26	(6)
Assets and Liabilities Still Held | Asset- backed | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Other comprehensive income (loss)	(2)	(1)	(9)	1
Assets and Liabilities Still Held | Fixed Maturities, Available-for-Sale [Member] | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Other comprehensive income (loss)	11	9	17	5
Assets and Liabilities Still Held | Total Debt Maturities Available For Sale | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Other comprehensive income (loss)	11	9	17	5
Assets and Liabilities Still Held | GMIB Reinsurance Asset | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment Gains (Losses), Net	(368)
Assets and Liabilities Still Held | Separate Accounts Assets | Level 3
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment Gains (Losses), Net	$ 0	$ 0	$ 0	$ 0

XML

FAIR VALUE DISCLOSURES (UNREALIZED GAINS (LOSSES) FOR LEVEL 3 STILL HELD) (Details) - Level 3 - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Corporate
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	$ 0	$ 1	$ 0	$ 1
Other comprehensive income (loss)	6	(2)	0	8
State and Political Sub- divisions
Change in Accounting Estimate [Line Items]
Other comprehensive income (loss)	0	0	0	0
Commercial Mortgage- backed
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	(9)	(12)	(29)	(36)
Other comprehensive income (loss)	8	10	27	(1)
Asset-backed Securities
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	0		15
Other comprehensive income (loss)	(3)	(1)	(10)	1
GMIB Reinsurance
Change in Accounting Estimate [Line Items]
Increase (Decrease) in the Fair Value of the Reinsurance Contract Asset		(79)	537	2,576
Equity Method Investments
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	(4)	0	(4)	(1)
Other comprehensive income (loss)		0	0	0
Separate Accounts Assets
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	4	7	22	19
Other comprehensive income (loss)			0	0
Assets and Liabilities Still Held | Corporate
Change in Accounting Estimate [Line Items]
Other comprehensive income (loss)	4			9
Assets and Liabilities Still Held | State and Political Sub- divisions
Change in Accounting Estimate [Line Items]
Other comprehensive income (loss)				1
Assets and Liabilities Still Held | Commercial Mortgage- backed
Change in Accounting Estimate [Line Items]
Other comprehensive income (loss)	9	10	26	(6)
Assets and Liabilities Still Held | Asset-backed Securities
Change in Accounting Estimate [Line Items]
Other comprehensive income (loss)	(2)	(1)	(9)	1
Assets and Liabilities Still Held | Fixed Maturities, Available-for-Sale [Member]
Change in Accounting Estimate [Line Items]
Other comprehensive income (loss)	11	9	17	5
Assets and Liabilities Still Held | Total Debt Maturities Available For Sale
Change in Accounting Estimate [Line Items]
Other comprehensive income (loss)	11	9	17	5
Assets and Liabilities Still Held | GMIB Reinsurance
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	(368)
Assets and Liabilities Still Held | Separate Accounts Assets
Change in Accounting Estimate [Line Items]
Investment Gains (Losses), Net	$ 0	$ 0	$ 0	$ 0

XML

FAIR VALUE DISCLOSURES (QUANTITATIVE INFORMATION ABOUT LEVEL 3) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2015
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value measurements not included In quantitative information about level 3	$ 645		$ 645		$ 594
Level 3 fair value measurements not included in quantitative information classified as level 3 (as a percent)	36.20%		36.20%		37.50%
Level 3 fair value measurements not included in quantitative information as a percentage of total assets measured at fair value on a recurring basis (as a percent)	0.40%		0.40%		0.40%
Other Invested Assets | Market Comparable Companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, discount rate (as a percent)			0.00%		0.00%
Corporate | Matrix Pricing Model | Private Available For Sale Corporate Securities
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	$ 820		$ 820		$ 691
Percentage of level 3 asset fair value (as a percent)			71.60%		81.80%
Asset-backed Securities | Matrix Pricing Model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Percentage of level 3 asset fair value (as a percent)			0.00%		8.30%
Separate Accounts | Mortgage Backed Securities
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	12		$ 12		$ 12
Separate Accounts | Asset-backed Securities
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	6		$ 6		$ 3
Separate Accounts | Third Party Appraisal
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, discount rate (as a percent)			6.60%		6.60%
Fair value inputs, capitalization rate (as a percent)			4.60%		4.80%
Fair value inputs, exit capitalization rate (as a percent)			5.70%		5.70%
Separate Accounts | Third Party Appraisal | Mortgage Loans on Real Estate
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	1		$ 1		$ 2
Separate Accounts | Third Party Appraisal | Private Real Estate Fund
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	318		318		295
Separate Accounts | Third Party Appraisal | Private Equity Funds
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	0		$ 0		1
Separate Accounts | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, spread over industry yield curve (bps)			243
Fair value inputs, discount rate (as a percent)			4.00%
Contingent Payment Arrangement
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	12		$ 12		$ 18
Fair value inputs, assets under management growth rate (as a percent)					18.00%
Minimum | Other Invested Assets | Market Comparable Companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, revenue multiple			0		0
Minimum | GMIB Reinsurance | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, lapse rates (as a percent)			1.00%		1.50%
Fair value inputs, withdrawal rates (as a percent)			0.00%		0.00%
Fair value inputs, GIMB utilization rates (as a percent)			0.00%		0.00%
Fair value inputs, non-performance risk (bps)			5		5
Fair value input, expected volatility rate (as a percent)			10.00%		11.00%
Minimum | Corporate | Matrix Pricing Model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, spread over industry yield curve (bps)			100		0
Minimum | Corporate | Market Comparable Companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, earnings before interest, taxes, depreciation and amortization multiple			5.1		4.3
Fair value inputs, discount rate (as a percent)			7.20%		7.00%
Fair value inputs, cash flow multiple			9.0		14.0
Minimum | Asset-backed Securities | Matrix Pricing Model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, spread over industry yield curve (bps)			0		25
Minimum | Separate Accounts | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, spread over industry yield curve (bps)					273
Fair value inputs, discount rate (as a percent)					1.10%
Fair value inputs, inflation rate (as a percent)			0.00%		0.00%
Minimum | GMWB and GWBL | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, lapse rates (as a percent)			0.50%		1.00%
Fair value inputs, withdrawal rates (as a percent)			0.00%		0.00%
Fair value input, expected volatility rate (as a percent)			10.00%		11.00%
Minimum | Contingent Payment Arrangement
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, discount rate (as a percent)			1.40%
Fair value inputs, long-term revenue growth rate (as a percent)			4.00%
Maximum | Other Invested Assets | Market Comparable Companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, revenue multiple			0		0
Maximum | GMIB Reinsurance | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, lapse rates (as a percent)			6.30%		5.70%
Fair value inputs, withdrawal rates (as a percent)			8.00%		8.00%
Fair value inputs, GIMB utilization rates (as a percent)			16.00%		16.00%
Fair value inputs, non-performance risk (bps)			10		17
Fair value input, expected volatility rate (as a percent)			30.00%		38.00%
Maximum | Corporate | Matrix Pricing Model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, spread over industry yield curve (bps)			565		565
Maximum | Corporate | Market Comparable Companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, earnings before interest, taxes, depreciation and amortization multiple			27.3		25.6
Fair value inputs, discount rate (as a percent)			17.00%		17.80%
Fair value inputs, cash flow multiple			17.7		16.5
Maximum | Asset-backed Securities | Matrix Pricing Model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, spread over industry yield curve (bps)			0		687
Maximum | Separate Accounts | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, spread over industry yield curve (bps)					512
Fair value inputs, discount rate (as a percent)					7.00%
Maximum | GMWB and GWBL | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, lapse rates (as a percent)			11.00%		11.00%
Fair value inputs, withdrawal rates (as a percent)			8.00%		8.00%
Fair value input, expected volatility rate (as a percent)			30.00%		38.00%
Maximum | Contingent Payment Arrangement
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value inputs, discount rate (as a percent)			6.40%
Fair value inputs, long-term revenue growth rate (as a percent)			31.00%
Level 3 | GMIB Reinsurance | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	10,933		$ 10,933		$ 10,309
Level 3 | Corporate | Matrix Pricing Model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	41		41		55
Level 3 | Corporate | Market Comparable Companies
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	779		779		636
Level 3 | Asset-backed Securities | Matrix Pricing Model
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets					2
Level 3 | Separate Accounts | Third Party Appraisal
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	318		318		295
Level 3 | Separate Accounts | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	1		1		3
Level 3 | GMIBNLG | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liabilities	4,289		4,289		5,125
Level 3 | GMWB and GWBL | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liabilities	85		85		114
Level 3 | GIB | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liabilities	(6)		(6)		30
Level 3 | GMAB | Discounted Cash Flow
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liabilities	8		8		20
GMxB derivative features liability | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	(4,375)	$ (7,098)	(4,375)	$ (7,098)	(5,289)	$ (4,606)	$ (7,286)	$ (5,150)
US States and Political Subdivisions Debt Securities [Member] | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	0	0	0	0
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	41	44	41	44	42	42	45	45
GMIB Reinsurance | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	10,933	13,113	10,933	13,113	10,309	11,290	13,311	10,578
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Reinsurance Contracts		(79)	537	2,576
Separate Accounts | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)			0	0
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	337	315	337	315	313	333	307	313
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	4	7	22	19
Asset-backed Securities | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	(3)	(1)	(10)	1
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	8	25	8	25	24	12	26	40
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	0		15
Corporate | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	6	(2)	0	8
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	1,146	739	1,146	739	845	1,068	495	420
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	0	1	0	1
Commercial Mortgage- backed | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	8	10	27	(1)
Fair value, measurement with unobservable inputs reconciliation, recurring basis, assets	248	374	248	374	$ 349	$ 290	$ 402	$ 503
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	(9)	(12)	(29)	(36)
Continuing Operations [Member] | GMxB derivative features' liability [Member] | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	208
Continuing Operations [Member] | Fixed Maturities, Available-for-Sale [Member] | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	11	9	17	5
Continuing Operations [Member] | US States and Political Subdivisions Debt Securities [Member] | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)				1
Continuing Operations [Member] | GMIB Reinsurance | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	(368)
Continuing Operations [Member] | Separate Accounts | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value Assets Measured On Recurring Basis Gain Loss Included In Net Investment Gains Losses	0	0	0	0
Continuing Operations [Member] | Asset-backed Securities | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	(2)	(1)	(9)	1
Continuing Operations [Member] | Corporate | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	4			9
Continuing Operations [Member] | Commercial Mortgage- backed | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	9	10	26	(6)
Continuing Operations [Member] | Total Debt Maturities Available For Sale | Level 3
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	$ 11	$ 9	$ 17	$ 5

XML

FAIR VALUE DISCLOSURES (CARRYING VALUES AND FAIR VALUES OF FINANCIAL INSTRUMENTS) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Consolidated Amounts [Abstract]
Mortgage loans on real estate	$ 10,605	$ 9,757
Loans to affiliates	703	703
Policyholders' account balances, Investment contracts	42,679	38,825
Policy loans	3,322	3,361
Separate Accounts’ liabilities	119,184	111,403
Estimate of Fair Value
Consolidated Amounts [Abstract]
Mortgage loans on real estate	10,686	9,608
Loans to affiliates	772	775
Policyholders' account balances, Investment contracts	2,236	2,337
Funding Agreements	2,727	2,202
Policy loans	4,220	4,257
Short-term and Long-term debt	500	513
Separate Accounts’ liabilities	7,083	6,194
Estimate of Fair Value | Level 2
Consolidated Amounts [Abstract]
Loans to affiliates	772	775
Funding Agreements	2,727	2,202
Short-term and Long-term debt	500	513
Estimate of Fair Value | Level 3
Consolidated Amounts [Abstract]
Mortgage loans on real estate	10,686	9,608
Loans to affiliates	0	0
Policyholders' account balances, Investment contracts	2,236	2,337
Policy loans	4,220	4,257
Short-term and Long-term debt	0	0
Separate Accounts’ liabilities	7,083	6,194
Carrying Value
Consolidated Amounts [Abstract]
Mortgage loans on real estate	10,605	9,757
Loans to affiliates	703	703
Policyholders' account balances, Investment contracts	2,122	2,226
Funding Agreements	2,715	2,255
Policy loans	3,322	3,361
Short-term and Long-term debt	500	513
Separate Accounts’ liabilities	$ 7,083	$ 6,194

XML

SHARE-BASED COMPENSATION PROGRAMS (Details) $ in Thousands					3 Months Ended		9 Months Ended
	Oct. 11, 2017 € / shares Rate	Jun. 21, 2017 USD ($) Rate shares	Jun. 21, 2017 € / shares	Mar. 24, 2017 USD ($) shares	Sep. 30, 2017 USD ($) shares	Sep. 30, 2016 USD ($) shares	Sep. 30, 2017 USD ($) shares	Sep. 30, 2016 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense					$ 10,098	$ 4,617	$ 45,122	$ 21,440
Purchased Holding Units to help fund anticipated obligations under its incentive compensation award program Value							$ 134,000	$ 129,000
Alliance Bernstein
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchased Holding Units to help fund anticipated obligations under its incentive compensation award program shares (in shares) | shares					300,000	0	5,900,000	0
Open market purchase (in shares) | shares					300,000	0	5,200,000	5,700,000
Open market purchase value					$ 7,000	$ 45,000	$ 117,000	$ 127,000
Restricted holding unit awards granted to employees (in shares) | shares							1,000,000	100,000
Purchased Holding Units to help fund anticipated obligations under its incentive compensation award program Value					7,000	45,000	$ 135,000	$ 129,000
Proceeds from Stock Options Exercised							18,000	2,400
Performance Unit Plan Current Year [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares		1,690,000
Share based compensation expense		$ 8,000
Performance Units/Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense					2,630	2,953	15,588	14,774
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense					350	110	1,088	825
Employee Stock Option | Alliance Bernstein
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense					0	200	0	200
Restricted Stock | Alliance Bernstein
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense					5,600	1,200	26,900	6,400
Other compensation plan | Parent Company
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense					$ 1,518	$ 154	$ 1,546	$ (759)
Performance Unit Plan Year 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation arrangement by share based payment award equity instruments other than options equity settlement of vested units with ordinary shares value				$ 21,000
Performance shares earned (in shares) | shares				1,000,000
Stock Option Plan Current Year [Member] | Parent Company
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures		$ 1,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | Rate		6.53%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | Rate		0.59%
Share based compensation expense		$ 400
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares		487,840
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | € / shares			€ 23.92
Weighted average grant date fair value (in dollars and euros per share) | € / shares			€ 1.78
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		5 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term		10 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | Rate		25.05%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term		8 years 9 months 18 days
Employees and eligible Directors [Member] | Alliance Bernstein
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted holding unit awards granted to employees (in shares) | shares							2,200,000	700,000
Minimum | Performance Unit Plan Current Year [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		0.00%
Maximum | Performance Unit Plan Current Year [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		130.00%
Conditional Vesting Term [Member] | Stock Option Plan Current Year [Member] | Parent Company
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conditional Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period | shares		275,942
Option B [Member] | 2017 AXA Shareplan [Member] | Parent Company
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date | Rate	8.98%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value | € / shares	€ 22.96
Option A [Member] | 2017 AXA Shareplan [Member] | Parent Company
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date | Rate	20.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value | € / shares	€ 20.19

XML

INCOME TAXES INCOME TAXES (Details)	9 Months Ended
	Sep. 30, 2017 USD ($)
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Tax Settlement, Amount	$ 221

XML

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Millions	1 Months Ended			3 Months Ended		9 Months Ended
	Jan. 31, 2016	Nov. 30, 2014	Jun. 30, 2009	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Guaranteed minimum income benefit reinsurance contract asset, at fair value				$ 10,933		$ 10,933		$ 10,309
Due from affiliates				703		703		$ 703
AXA Financial
Gain on sale of assets							$ 20
AXA Financial | Mortgage Note 2009
Mortgage loans on real estate, carrying amount of mortgages			$ 1,100
AXA Financial | Mortgage Note 2014
Due from affiliates		$ 382
Related party transaction mortgage note payable, interest rate (as a percent)		4.00%
Debt instrument, term (in years)		7 years
Repayment of loans from affiliates	$ 382
Repayments of related party debt, prepayment penalty	$ 65
AXA Equitable
Equity method investment, ownership percentage								70.00%
Investment in affiliate								$ 25
AXA Equitable | Mortgage Note 2009
Due from affiliates			400
Proceeds from sale of real estate held-for-investment			$ 700
Related party transaction mortgage note payable, interest rate (as a percent)			8.00%
Debt instrument, term (in years)			10 years
AXA Arizona
Guaranteed minimum income benefit reinsurance contract asset, at fair value				8,720		8,720		$ 8,574
Ceded premiums earned affiliated				44	$ 113	268	329
Reinsurance effect on claims and benefits incurred amount ceded to affiliates				$ 59	$ 62	$ 194	336
AXA Foundation
Donations to affiliates							$ 21
Saum Sing
Equity method investment, ownership percentage								30.00%

XML

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (CUMMULATIVE GAINS (LOSSES)) (Details) - USD ($) $ in Millions	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Unrealized gains (losses) on investments	$ 400				$ 1,560
Foreign currency translation adjustments	(57)				(56)
Defined benefit pension plans	(48)				(43)
Total accumulated other comprehensive income (loss)	295				1,461
Less: Accumulated other comprehensive (income) loss attributable to noncontrolling interest	67				68
Accumulated other comprehensive income (loss) attributable to AXA Equitable	$ 362	$ 452	$ 137	$ 1	$ 1,529	$ 1,516	$ 908	$ 185

XML

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (COMPONENTS OF OCI, NET OF TAXES) (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Foreign currency translation adjustments:
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	$ 6			$ (1)					$ 20	$ 3
(Gains) losses reclassified into net income (loss) during the period	0			0					0	0
Foreign currency translation adjustment	6			(1)					20	3
Net unrealized gains (losses) arising during the period
Net unrealized gains (losses) arising during the period	6			(10)					458	1,568
(Gains) losses reclassified into net income (loss) during the period(1)	8			1					6	(14)
Net unrealized gains (losses) on investments	14			(9)					464	1,554
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other	(69)			25					(102)	(212)
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(2), $7, $234, and $20	(55)	$ 315	$ 108	16	$ 610	$ 717	$ 423	$ 1,327	362	1,342	$ (180)	$ (831)	$ 891
Less: reclassification adjustments to net income (loss) for:
Net gain (loss) arising during the period	(3)			0					(2)	0
Change in defined benefit plans (net of deferred income tax expense (benefit) of $0, $0, $1 and $0.	(3)			0					(2)	0
Total other comprehensive income (loss), net of income taxes	(52)	$ 295	$ 143	15	$ 605	$ 726	$ 438	$ 1,331	380	1,345	$ (201)	$ (860)	$ 847
Less: Other comprehensive (income) loss attributable to noncontrolling interest	(32)			(1)					(19)	(1)
Other comprehensive income (loss) attributable to AXA Equitable	(84)			14					361	1,344
Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]
Other Comprehensive Income (Loss), Available-for-sale Securities, Tax	(2)			7					234	20
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Available for sale securities, Tax	4			1					3	(8)
Other Comprehensive (Income) Loss, Benefit Plans, Tax	$ 0			$ 0					$ 1	$ 0

XML

COMMITMENT AND CONTINGENT LIABILITIES (Details) - USD ($) $ in Millions	9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Restructuring and Related Cost [Abstract]
Advances from Federal Home Loan Banks	$ 2,715		$ 2,238
Proceeds from Federal Home Loan Bank Borrowings	4,977		7,738
Repayments of Federal Home Loan Bank Borrowings	4,500		6,000
Unaccrued amounts of reasonably possible range of losses	9
AXA Equitable
Restructuring and Related Cost [Abstract]
Letters of credit outstanding	18
Equity financing arrangements with Limited Partnerships	719
Equity financing arrangements with affiliates	213
Mortgage loans on real estate	709
Facility Closing | Other Operating Costs and Expenses | Alliance Bernstein | AB Consolidation Plan
Restructuring and Related Cost [Abstract]
Restructuring Charges	39	$ 25
Federal Home Loan Bank of New York Short-Term Funding Agreements Maturing in Less than One Month [Member]
Restructuring and Related Cost [Abstract]
Advances from Federal Home Loan Banks	500		500
Proceeds from Federal Home Loan Bank Borrowings	4,500		6,000
Repayments of Federal Home Loan Bank Borrowings	4,500		6,000
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Less than Four Years [Member]
Restructuring and Related Cost [Abstract]
Advances from Federal Home Loan Banks	548		58
Proceeds from Federal Home Loan Bank Borrowings	174		58
Repayments of Federal Home Loan Bank Borrowings	0		0
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Less than Five Years [Member]
Restructuring and Related Cost [Abstract]
Advances from Federal Home Loan Banks	923		862
Proceeds from Federal Home Loan Bank Borrowings	303		862
Repayments of Federal Home Loan Bank Borrowings	0		0
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Greater than Five Years [Member]
Restructuring and Related Cost [Abstract]
Advances from Federal Home Loan Banks	744		818
Proceeds from Federal Home Loan Bank Borrowings	0		818
Repayments of Federal Home Loan Bank Borrowings	0		0
Federal Home Loan Bank of New York Long-Term Funding Agreements [Member]
Restructuring and Related Cost [Abstract]
Advances from Federal Home Loan Banks	2,215		1,738
Proceeds from Federal Home Loan Bank Borrowings	477		1,738
Repayments of Federal Home Loan Bank Borrowings	$ 0		$ 0

XML

SEGMENT INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information [Line Items]
Segment revenues	$ 2,520	$ 4,783	$ 2,375	$ 2,177	$ 3,464	$ 3,950	$ 7,173	$ 7,274	$ 9,673	$ 9,451	$ 9,201	$ 9,019	$ 13,503
Segment interest expense, debt				14
Segment investment advisory fees				(21)
Segment earnings (loss) from continuing operations, before income taxes	(61)			83					1,873	2,365
Segment assets	219,069	$ 215,358	$ 209,551	209,432	$ 207,460	$ 200,475	$ 215,358	$ 207,460	219,069	209,432	204,169	$ 195,220
Consolidation/Elimination
Segment Reporting Information [Line Items]
Segment revenues	(7)			(7)					(19)	(19)
Segment earnings (loss) from continuing operations, before income taxes	0			(1)					0	0
Segment assets	0								0		(3)
Insurance
Segment Reporting Information [Line Items]
Segment revenues	1,713								7,309	7,227
Segment earnings (loss) from continuing operations, before income taxes	(229)			(99)					1,385	1,875
Segment assets	205,176								205,176		191,033
Insurance | Intersegment Eliminations
Segment Reporting Information [Line Items]
Segment interest expense, debt	18								42	39
Investment Management
Segment Reporting Information [Line Items]
Segment revenues	814								2,383	2,243
Segment earnings (loss) from continuing operations, before income taxes	168			$ 183					488	490
Segment assets	13,893								13,893		13,139
Fair value of marketable securities	723								723		893
Cash segregated in special bank accounts	62								62		$ 53
Investment Management | Intersegment Eliminations
Segment Reporting Information [Line Items]
Segment investment advisory fees	$ 29								$ 65	$ 58